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The addition of allylmetals to aldehydes, particularly in an asymmetric fashion, is of prime 
importance in the synthetic chemist’s arsenal of C–C bond-forming methodologies, as the 
secondary homoallylic alcohol products are primed for further transformations. So far, 
reagent-controlled approaches with chiral metal-based Lewis acids have been the most 
effective means for controlling the enantioselectivity of this reaction. However, this approach 
cannot be used when acetals are employed as the latent electrophiles. Since Brønsted acids 
also mediate the Hosomi-Sakurai reaction of acetals, we hypothesised that a chiral Brønsted 
acid HY* has the potential to introduce stereoselectivity into this bond-forming process via 
the formation of a chiral contact ion pair in which the chiral conjugate base controls the 
nucleophilic addition to the achiral oxacarbenium ion with which it will be associated. For the 
investigation, three types of Brønsted acids with different acidity, all based on a binaphthyl 
core, have been synthesised. 3,3’-Substituted phosphoric acids and phosphoramides were 
employed in a brief study of the reaction of acyclic dialkyl acetals with allyltrimethylsilane. 
However, since the rate of reaction was very slow, we turned our attention to more reactive 
acetal substrates. A more detailed study was carried out with racemic cyclic acetals: 1-
alkoxyisochromans were reacted with allyltrimethylsilane in the presence of different 
phosphoramide catalysts. Non-polar solvents gave the best e.r. values. The optimisation 
procedure also revealed the new 10-Br-9-anthracenyl phosphoramide (R)-45g as the catalyst 
of choice for this particular acetal substrate. An interesting leaving group effect on the 
 ii
enantioselectivity of the 1-allylisochroman product was also observed. A range of 1-
ethoxyisochromans were synthesised to probe the scope and the limitations of the method. 
The products were obtained in moderate to good yields and moderate to very good 
enantioselectivities. The synthetic utility of the developed method was also demonstrated by 
two applications, one of these being a drug synthesis. To shed light on the origins of the 
enantioselectivity, several experiments were carried out. These confirmed that the process is a 
dynamic kinetic resolution. Finally, all results and observations were used to formulate a 
transition state which rationalises the observed stereochemical outcome. In summary, the first 
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1.1 The Hosomi-Sakurai reaction – an important allylation process 
 
The Hosomi-Sakurai reaction of a carbon electrophile (such as aldehydes, ketones, Michael 
acceptors, imines, acetals, epoxides and acid chlorides) with an allylsilane is a particularly 
widely used method for forming C–C bonds.[1-3] Allylsilanes are very popular reagents 
because they are thermally stable and relatively inert to water and oxygen. In contrast to other 
allylating reagents, they are therefore isolable and storable without having to take special 
precautions. Allyl metals have been classified by Denmark[4] into three types according to the 
way in which they react with aldehydes. Allyltrialkylsilanes are so-called Type II allylating 
agents. This type of allyl nucleophile reacts with aldehydes through an open acyclic transition 
state in which there is no interaction between the silicon group in the nucleophile and the 






















Scheme 1. Mechanism of the allylation of aldehydes by a Type II allylating agent. 
 2 
Allylsilanes are not particularly nucleophilic so an external activ tor (e.g. Lewis acid) is 
generally required to effect reaction. The allylation reaction is a stepwise process, and 
proceeds via a cationic intermediate 1 in which the positive charge is stabilised by the β-effect 
of silicon. In this stabilising interaction, the unfilled pAO on the carbocationic carbon is in 
hyperconjugation with the filled σ(C–Si) bond. Maximum hyperconjugation, and therefore 
stabilisation, is obtained when the σ(C–Si) bond is aligned parallel to the adjacent p orbital 
(Figure 1).[5] In the second step, cleavage of the silyl group then provides the homoallylic 
alcohol product 2. This type of allylation reaction is not a stereospecific process, however, it 






Figure 1. Stabilisation of a positive charge by the β- ffect of silicon. 
 
 
1.2 Asymmetric allylation  
 
1.2.1 Stereoselective synthesis 
 
Controlling the stereochemical outcome of a reaction is one of the most challenging aspects of 
synthetic organic chemistry. Traditionally, substrate-controlled approaches have been 
employed, and indeed, are still widely used, particularly in the synthesis of complex 
molecular architectures.[as an example: 6] When chiral information is not present in the substrate, 
however, it needs to be introduced. Modifying the substrate through covalent attachment of a 
chiral auxiliary has proven to be an immensely useful strategy; however in recent decades, 
 3 
attention has increasingly focused on developing reagent-controlled processes, which offer a 
more general and atom-economical approach to asymmetric synthesis. 
 
 
1.2.2 Asymmetric allylation of aldehydes 
 
The reaction of allylsilanes with aldehydes is of prime importance in the synthetic chemist’s 
arsenal of C–C bond-forming methodologies, as the secondary homoallylic alcohol product is 
particularly suitable for further transformations. Controlling the stereochemical outcome of 
this type of allylation reaction, in both an absolute (enantioselectivity) and relative 
(diastereoselectivity) sense, is integral for maximising its synthetic utility.  
 
An example of a substrate-controlled allylation is that used by Trost et al. in the total 
syntheses of furaquinocin A and B (Scheme 2).[6] The side-chain core was introduced by 
reaction of allyltrimethylsilane with aldehyde 3 mediated by TiCl4 and proceeded with high 
diastereoselectivity (d.r. 9:1). The desired homoallylic alcohol 4 could be obtained in pure 

































furaquinocin       R1           R2
         A               CH3     CH2OH




Scheme 2. Substrate-controlled allylation in the total syntheses of furaquinocin A and B. 
 
 
The observed diastereoselectivity can be explained by the polar model proposed by Evans 
(Figure 2).[7,8] The Newman projection depicts the conformation that minimises the dipole 
moment in the molecule. The bottom face of the aldehyde is blocked toward the attack of the 











Figure 2. Evans’ polar model explains the observed diastereoselectivity. 
 
 
Williams used a chelation-controlled allylation in the synthesis of one of the building blocks 6 
required for the total synthesis of (+)-4,5-deoxyneodolabelline (Scheme 3).[9] Aldehyde 7 was 
 5 
reacted with allyltrimethylsilane in the presence of SnCl4 to afford a single diastereoisomer 8 
















40% yield  
 
Scheme 3. Chelation-controlled allylation in the total synthesis of (+)-4,5-deoxyneodolabelline. 
 
 
The chelation model explains the observed diastereoselectivity in this reaction (Figure 3). In 
the favoured conformation, chelation to tin holds the oxygen from the carbonyl group and the 











Figure 3. The chelation model explains the observed diastereoselectivity. 
 
 
Another substrate-controlled allylation was utilised in the same publication when coupling the 
two building blocks 6 and 9 (Scheme 4). The reaction, activated this time by BF3·OEt2, 






























Scheme 4. Substrate-controlled allylation in the total synthesis of (+)-4,5-deoxyneodolabelline. 
 
 
An intensive study revealed that both anomers of the starting acetal were equally reaction-
competent via a common oxacarbenium ion or rapid acetal isomerisation. Two conformers of 
the oxacarbenium intermediate were recognised and distinguished by the pseudoequatorial 
substituent in 10 and the pseudoaxial substituent in 11 (Figure 4). The stereoelectronically 
controlled axial attack of the allylsilane 9 on the more stable conformer 10 dominates the 





















Figure 4. The two conformers of the oxacarbenium intermediate  
in coupling the two building blocks 6 and 9. 
 
 
Another way of controlling the stereochemistry of an allylation using allyltrialkylsilanes is to 
use a chiral auxiliary. Indeed this strategy was exploited in Rychnovsky’s approach to the 
asymmetric allylation of aldehydes.[10,11] The group investigated the diastereoselective 
 7 
addition of allyltrimethylsilane to oxacarbenium ion 14 which was generated in situ from a 
variety of aldehydes 15 and TMS-protected phenylsilylcarbinol 16 using Markó’s protocol 















15 16 14 up to d.r. 97:3  
 
Scheme 5. Asymmetric allylation of aldehydes using chiral auxiliary 16.
 
 
The excellent diastereoselectivities observed in these reactions could be rationalised by 
Linderman’s model,[13-16] which predicts (E)-oxacarbenium ion (E)-14 as an intermediate in a 
well-defined conformation as the result of a stereoelectronic preference analogous to the β-
silyl effect (Figure 5). This preferred conformation provides maximum overlap of the σ(C–Si) 
and π*(C=O) orbitals of the oxacarbenium ion. The nucleophile then adds to the face opposite 









Figure 5. Linderman’s model of (E)-oxacarbenium ion (E)-14 adopting a well-defined  
conformation rationalises the observed diastereoselectivities.  
 
 
Reagent-controlled approaches provide the most powerful means for controlling the 
stereochemical outcome of a reaction. Since allylation reactions with allyltrimethylsilane 
 8 
generally require an external source of activation, chiral metal-based Lewis acids have been 
the most effective way for controlling the enantioselectivity of this transformation. The metal-
BINOL Lewis acids developed by Keck and Carreira provide important examples in this area. 
Keck developed the allylation of aldehydes 17 with allyltributylstannane using a (R)-
BINOL/Ti(Oi-Pr)4 complex as the catalyst (Scheme 7).
[17,18] The products 18 were obtained in 















up to 98% yield
up to e.r. 98:2  
 
Scheme 7. Reagent-controlled asymmetric allylation of aldehydes by Keck. 
 
 
Since the BINOL/Ti(IV) catalysts are relatively weak Lewis acids, they found little use for 
promoting reactions with the less nucleophilic (and less toxic) allylsilanes. An elegant 
solution to this problem was developed by Carreira, who found that enhanced reactivity could 
be secured by using TiF4 instead of Ti(O
iPr)4 (Scheme 8).
[19,20] The allylation of aldehydes 19 
with allyltrimethylsilane employing (S)-BINOL/TiF4 complex as the catalyst now led to 
















2)      Bu4NF/THF, 23 °C
 
 
Scheme 8. Reagent-controlled asymmetric allylation of aldehydes by Carreira. 
 9 
Carreira attributed the high reactivity of the catalyst to twimportant factors: i) the strong 
Lewis acidity of TiF4-derived complexes and ii) the greater strength of the Ti–F bond 
compared to the Si–F bond which assists in catalyst turnover. In addition, Duthaler proposed a 
ternary transition structure in which the electrophilic titanium centre activates the aldehyde 
and a nucleophilic fluoride bridge to silicon increases the reactivity of the allylsilane (Scheme 
9).[21] A reaction that proceeds through this transition structure could give the silylated adduct 































Scheme 9. Duthaler’s proposal of a ternary transition structure. 
 
 
Carreira’s method has found application in the total synthesis of the anti-Helicobacter pylori 
agent (+)-spirolaxine methyl ether 21 (Scheme 10).[22] The (3R)-stereochemistry in phthalide-
aldehyde 22 was set up via asymmetric allylation of 3,5-dimethoxybenzaldehyde 23, 







TiF4 (10 mol%)    
CH2Cl2/MeCN, −20 °C
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Scheme 10. Reagent-controlled asymmetric allylation in the total synthesis of the  
anti-Helicobacter pylori agent (+)-spirolaxine methyl ether 21. 
 
This short overview gave examples for substrate-controlled allylations, which find particular 
application in the synthesis of complex molecules, as well as an example of a chiral auxiliary 
approach. The most common, and indeed most desirable, way for achieving an asymmetric 
allylation is to exploit reagent-control with chiral metal-based Lewis acids. Among the 
methods developed for simple allylation with Type II reagents, the addition of 
allyltributylstannane catalysed by the BINOL/Ti(IV) complexes has the broadest substrate 
scope and is therefore particularly useful in target-oriented synthesis.[23] The use of 
 11 




1.3 Allylation of acetals 
 
1.3.1 Racemic allylation of acetals 
  
Acetals are useful intermediates in organic synthesis and undergo coupling reactions with 
different nucleophiles via C–C bond formation.[24] Successfully used nucleophiles include 
silyl enol ethers,[25-31] allyl transfer reagents,[32] vinyl ethers,[33] as well as simple olefins[34-36] 
and cyanide sources.[37-44] A particularly valuable transformation is the already mentioned 
Hosomi–Sakurai reaction of acetals with allyltrimethylsilane,[45,46] which furnishes 
homoallylic ethers. Such protected homoallylic alcohols can simplify the synthetic planning 
in target-oriented synthesis. Catalysts, which have been employed for the racemic version of 













montmorillonite,[60] trityl perchlorate,[61] diphenylboryl triflate,[61] and TMSI.[62] 





[67] and CuBr/microwave, have also been used.[68] Several of these methods suffer from 
drawbacks such as the involvement of compounds that are corrosive, difficult to handle, 
expensive, or toxic. Others require strictly anhydrous conditions or less practical reaction 
temperatures. Brønsted acids offer a useful alternative to these metal-based activators, and 
have great potential as easily tunable, economic, and environmentally acceptable catalysts. 
Surprisingly, the use of Brønsted acids in this important allylation has only been reported in a 
few recent publications.[69-71]  
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1.3.2 Hypothesis for an asymmetric allylation of acetals 
 
Chiral metal-based Lewis acids have to-date been the most effective means for controlling the 
enantioselectivity of the asymmetric allylation of carbonyl compounds. However, my 
supervisor and me hypothesised that they are not applicable to the asymmetric allylation of 
acetals, since the activator is not a component of the oxacarbenium ion, which is the active 
electrophile in this important variant of the allylation reaction (Scheme 11). Since Brønsted 
acids also mediate this type of allylation reaction, I hypothesised that a chiral Brønsted acid 
HY* has the potential to impart stereoselectivity on this bond-forming process (Scheme 11). 
So far, no examples exist of chiral Brønsted acids catalysing the intermolecular allylation of 
acetals. Analogously to Lewis acid activation, protonation of the acetal 25 nd displacement 
of R1OH through anchimeric assistance from the adjacent alkoxy group provides the active 
oxacarbenium ion electrophile 26.[72-74] In the case of Lewis acid activation, the chiral 
information is carried away in the alkoxy leaving group; however, this is not necessarily the 
case when a chiral Brønsted acid is employed since the chirality is now embedded in the 














chiral Lewis acid LA*:





























Scheme 11. Whilst chiral Lewis acids do not effect the asymmetric allylation of acetals,  
a chiral Brønsted acid potentially can. 
 
Of course, the nature of this ion pair 26 will depend critically on the reaction environment. 
There are three different types of ion pairs.[75,76] In a contact ion pair (or tight ion pair) the two 
ions of opposite charge are in contact, with no solvent molecules between them. In a solvent-
separated ion pair (or loose ion pair) the two ions are more separated from each other, with a 
small number of solvent molecules between them; however they are still held together by 
coulombic attraction. The ions are considered to be completely dissociated if the solvent 
radius is large enough so as not to allow any coulombic attraction between the two ions. A 
contact ion pair will maximise the opportunity for the chirality embedded in the associated 
anion to differentiate the enantiotopic faces of the oxacarbenium ion; non-coordinating 
solvents of low dielectric constant, such as CH2 l2 and even better, cyclohexane and toluene, 
which have been used for allylation reactions, should encourage this. Indeed this has been 
exploited in Rychnovsky’s chiral auxiliary approach to asymmetric allylation of acetals, 
where the highest selectivities were observed under conditions that produce tight ion 
pairs.[10,11]  
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Another point which needs to be considered is catalyst turnover. My supervisor and me 
hypothesised that the alcohol leaving group will allow catalyst turnover and permit the use of 
sub-stoichiometric quantities of the catalyst (Scheme 12). Acetal 25 is protonated by the 
chiral Brønsted acid HY* and forms an intermediate chiral ion pair 26, involving the 
oxacarbenium ion and the conjugate base, after displacement of alcohol R1OH. 
Allyltrimethylsilane attacks the electrophile in the chiral environment to release the 
enantioenriched homoallylic ether 27. The silylated conjugate base reacts with alcohol R1OH 
to give silylether Me3SiOR
1 and the regenerated chiral Brønsted acid HY*. A strong driving 
force of this reaction is the thermodynamic strength of a Si–O bond because on pKa grounds 
the equilibrium lies on the side of R1OH and Y*– instead of R1O– and HY*. Indeed, this 


















Scheme 12. Catalytic cycle for employing a chiral Brønsted acid 
 in sub-stoichiometric quantities. 
 
To the best of my knowledge there is no literature example of chiral Brønsted acids catalysing 
the enantioselective intermolecular allylation of acetals and only one example where a chiral 
Lewis acid catalyst has successfully controlled the enantioselectivity of an allylation with 
 15 
allyltrimethylsilane involving a planar, achiral carbenium ion.[77] Braun discovered the 
asymmetric allylation of silyl ether ac-28 catalysed by the chiral titanium complex 29
(Scheme 13). The product (S)-30 was obtained in 96% yield with 99.45:0.55 





CH2Cl2, −78 to 0 °C
1)















Scheme 13. The only example where a chiral Lewis acid controls  
the intermolecular allylation involving an achiral intermediate. 
 
The essentially complete conversion of the racemic substrate rac-28 into the allylation 
product (S)-30 was rationalised as a dynamic kinetic asymmetric transformation (Scheme 14): 
First, it is assumed that the chiral Lewis acid 29 and both enantiomers of the silyl ether 28 
form two diastereomeric contact ion pairs, (R)-28·29 and (S)-28·29. They rapidly equilibrate 
via the planar, achiral carbenium ion 31. In the subsequent reaction with allyltrimethylsilane, 
one of the ion pairs, (S)-28·29, is postulated to react faster than its diastereomer (R)-28·29. 
Presumably, the allyl residue attacks the indanyl cation from the face that is not occupied by 






































1.4.1 Chiral BINOL-based Brønsted acids 
 
The area of chiral Brønsted acids has grown strongly within organocatalysis and is now able 
to deliver extremely active catalysts.[78-84] Chiral Brønsted acids can be classified into three 
categories (Figure 6): 
i) neutral Brønsted acids, such as thiourea (pKa ~ 21)
[82] and TADDOL (pKa ~ 20)
[85] 
derivatives. The characteristic mode of activation of this class of acid involves a single or 
double hydrogen bond (H-bond) to the substrate; in these cases, the proton is still bound to the 
catalyst. 
 17 
ii) stronger Brønsted acids, which include phosphoric acids (pKa ~ 1.4)
[86] and 
phosphoramides (pKa < 1.4)
[87,88] derived from BINOL. The characteristic mode of activation 
for this class of acid likely involves a more complete transfer of a proton to the substrate 
potentially leading to an ion pair in the case of the more acidic phosphoramides. Depending 
on the reaction, phosphoric acids are able to transfer their proton completely or still form a 
weak O---H bond. 
iii) neutral Brønsted acids, such as BINOL derivatives (pKa ~ 10).
1 Since these acids are 
weakly acidic, they can be classified somewhere between H-bond catalysis and stronger 























hydrogen-bonding catalysts stronger Brønsted acid catalysts  
 









                                                
1 derived from pKa(phenol)~10 
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In early 2004, Akiyama[89] and Terada[90] independently introduced the chiral phosphoric 









32a: Ar = 4-NO2C6H4
32b: Ar = 4-β-naphthyl-C6H4
32c: Ar = 2,4,6-(i-Pr)3C6H2
32d: Ar = 1-naphthyl
32e: Ar = t-BuC6H4




Figure 7. Chiral phosphoric acids 32. 
 
Only the enantiomerically pure 3,3’-unsubstituted compound 33 was known at that time. 
Apart from employing 33 as a chiral resolving agent,[91] Inanaga et al. had used its lanthanide 
salt as a catalyst for hetero Diels-Alder reactions.[92] Phosphoric acids 32 attracted the 
attention of synthetic organic chemists for several reasons (Figure 8): 
i) they are bifunctional catalysts bearing both a Brønsted-acidic site (O–H) and a Lewis-basic 
site (P=O). 
ii) the 3,3’-substituents can play a crucial role in realising high enantioselectivity and can be 


















Figure 8. Functional chiral phosphoric acids. 
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Akiyama and co-workers presented the Mannich-Type reaction of ketene silyl acetals 34 with 
aldimines 35 in the presence of various chiral phosphoric acids 32 (Scheme 15).[89] While 
3,3’-unsubstituted 33 gave a racemic mixture, 32a bearing 4-nitrophenyl groups at the 3,3’-






















Scheme 15. Akiyama’s asymmetric Mannich-Type reaction 
 of silyl ketene acetals 34 with aldimines 35 catalysed by chiral 32a. 
 
On the basis of experimental results (the o-hydroxy group in the aldimines is essential to 
realise excellent enantioselectivity) and DFT calculations, the reactions proceeds via the nine-
membered zwitterionic cyclic transition-state 36 (Figure 9).[93] There is a dicoordination 
between the aldimine and the phosphoric acid due to the bifunctionality of the catalyst. The 
nine-membered cyclic structure and the aromatic π-stacking interaction between the 4-
nitrophenyl group and the N-aryl group fix the geometry of the aldimine in the transition state. 
The 3,3’-aryl substituents lead to a sterically hindered si-face ensuring nucleophilic attack 

















Figure 9. Proposed nine-membered zwitterionic cyclic transition-state 36  
between phosphoric acid and aldimine substrate. 
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Terada and Uraguchi also reported a Mannich-type reaction.[90] Aldimines 37 react with 2,4-
pentandione 38 in the presence of chiral catalyst 32b providing β-aminoketones 39 in 











up to 96% yield









Scheme 16. Terada’s asymmetric Mannich-Type reaction of  
2,4-pentandione 38 with aldimines 37 catalysed by chiral 32b. 
 
They used computational and NMR analyses to rationalise the observed 
enantioselectivities.[94] Preliminary computational results show that the exothermic formation 
of associates between the chiral phosphoric acid and the imine substrate is sterically 
controlled by the bulky substituents of the catalyst. The activation of the substrate happens via 
a H-bond between the N-atom of the imine and the acidic H-atom of the catalyst which allows 
the substrate to accommodate itself in only two different ways using either of the two 
























Figure 10. The H-bond between the imine and the catalyst allows two lowest conformations. 
 
Furthermore, the isomerisation of the more stable E-aldimine into its Z-isomer (which could 
be the one reacting faster in the transition state as shown by Jacobsen)[95] n eds to be 
considered. A detailed analysis of the four different conformations of the H-bond associates 
 21 
revealed that only the one presented in Figure 11 makes the imine susc ptible to the 









Figure 11. Conformation which makes the imine susceptible  
to the enantioselective nucleophilic attack. 
 
The sterically bulky t-Bu group in the imine acts like an anchor preventing the free rotation 
around the H-bond, thus ensuring the high order of the enantioselection as shown by the drop 
of e.r. with smaller protecting groups. 
 
In a very recent set of publication, Goodman has developed a model, based on DFT 
calculations, which predicts the correct enantioselectivity of imine reactions catalysed by 
BINOL-based phosphoric acids.[96] He rationalised the different factors on which the 
enantioselectivity depends, focusing on the E- or Z-preference of the transition structures and 
the orientation of the catalyst with respect to the electrophile (Type I and Type II reaction). 
Application of the model to the above reaction would predict a (Type I, E)-transition state 












Figure 12. Goodman’s model predicts the correct enantioselectivity. 
 
 
A great number of publications employing various chiral phosphoric acids 32 has followed 
these pioneering studies.[82,97-99] In the beginning, a common feature of the reactions catalysed 
by these catalysts has been an imine as the substrate. More recently, synthetic organic 
chemists have started to investigate the activation of carbonyl compounds which will be 
described in the next Chapter.  
 
 
1.4.2 Organocatalytic activation of carbonyl compounds 
 
Carbonyl compounds play a central role in a diverse array of organic reactions. In particular, 
the activation of aldehydes for further reaction represents one of the most important strategies 
for employing this functional group in synthesis, and in particular enantioselective 
synthesis.[100] The following summary mainly contains carbonyl compounds as electrophiles 
which are activated by either ester- or trifluoromethyl substituents. A phosphoric acid as 
catalyst is acidic enough to induce reaction with these more reactive electrophiles. For non-
activated carbonyl compounds more acidic Brønsted acids like phosphoramides or 
thiophosphoramides are usually necessary. 
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The activation of carbonyl compounds by using a chiral Brønsted acid was first reported by 
Rawal and co-workers, who performed a hetero Diels-Alder reaction in the presence of a sub-
stoichiometric amount of (R,R)-1-naphthyl TADDOL (R,R)-40 (Scheme 17).[101] 1-Amino-3-
siloxy diene 41 was reacted with a range of aldehydes 42 and the resulting cycloadducts 43































Scheme 17. Rawal’s hetero Diels-Alder reaction catalysed by TADDOL (R,R)-40. 
 
 
BINOL-derived phosphoric acids and phosphoramides have been scarcely explored in the 
activation of carbonyl compounds. In 2006, Yamamoto introduced the highly reactive and 











45a: Ar = 2,4,6-(i-Pr)3C6H2
45b: Ar = 9-phenanthryl





Figure 13. Chiral N-triflyl phosphoramides 45. 
 
 
He employed the 2,4,6-triisopropylbenzene-substituted derivative (S)-45a in an asymmetric 
Diels-Alder reaction of α,β-unsaturated ethyl vinyl ketone 46 with silyloxydienes 47 (Scheme 
18).[87] In most cases, the endo Diels-Alder adducts 48 were obtained quantitatively with high 












up to >99% yield
up to 96:4 e.r.  
 
Scheme 18. Yamamoto’s Diels-Alder reaction of α,β-unsaturated ethyl vinyl ketone 46  
with silyloxydienes 47 catalysed by (S)-45a. 
 
 
The activation of carbonyl compounds was subsequently expanded by Rueping et al. who 
reported the asymmetric Nazarov cyclisation of dienones 49 catalysed by N-triflyl 
phosphoramide (R)-45b (Scheme 19).[102] This method provides the corresponding 
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cyclopentenones 50 in good yields and with excellent enantioselectivities for the cis as well as 
















up to 92% yield
up to 9.3:1 cis:trans
up to 96:4 e.r.(cis)




Scheme 19. Rueping’s Nazarov cyclisation of dienones 49 catalysed by (R)-45b. 
 
 
One year later, the same group published an asymmetric Friedel-Crafts alkylation of indoles, 
also catalysed by N-triflyl phosphoramide (R)-45b.[103] In the reaction of N-methylindole 51 
with α-keto ester 52, a variety of N-triflyl phosphoramides gave mainly bisindole 53 with the 
highest atropisomeric ratio being 81:19 (Scheme 20). Two molecules of indole added to the α-
keto group, the first in a 1,2-addition to the enone contained in α-keto ester 52, and the second 


















Scheme 20. A variety of N-triflyl phosphoramides (R)-45b gave bisindole 53   
in the Friedel-Crafts alkylation of N-methylindole 51. 
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Interestingly, employing catalyst (R)-54 led to the predominant formation of the 3-substituted 
indole product 55 resulting from a highly enantioselective 1,4-addition to 56 (Scheme 21). 
The authors reasoned this may be attributed to the steric properties of the catalyst. The 3,3’-
C–Si bond is longer than the corresponding C–C bond in catalysts (R)-45, and the spherically 
arranged phenyl groups on the silicon atoms increase the steric demand at the catalytically 
active centre, resulting in better shielding of the carbonyl groups in the activation process, 






























Scheme 21. (R)-54 led to the 3-substituted indole product 55 resulting from a 1,4-addition to 56. 
 
 
This publication was followed by three other examples on the Friedel-Crafts reaction of 
indoles. Activation of carbonyl compounds by chiral Brønsted acids afforded a range of 2- 
and 3-substituted indoles. 
 
The work of You and co-workers opened the door to enantiopure 2-substituted indole 
derivatives, which hitherto had been difficult to access by catalytic asymmetric synthesis.[104] 
They developed the Friedel-Crafts alkylation of 4,7-dihydroindole 57 with β,γ-unsaturated α-
keto esters 58. The reaction was catalysed by N-triflyl phosphoramide (S)-45a and proceeded 
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in a highly enantioselective manner (up to 99:1 e.r.) (Scheme 22). Subsequent oxidation of the 
products with p-benzoquinone led to 2-alkylated indole derivatives 59 with perfect retention 


















up to 96% yield












Scheme 22. You’s route to enantiopure 2-substituted indole derivatives 59. 
 
 
Ma et al. reported the asymmetric synthesis of trifluoromethyl-substituted tertiary alcohols 60 
by the reaction of indole derivatives 61 with aryl trifluoromethyl ketones 62 (Scheme 23).[105] 
The CF3 group, with its electron-withdrawing ability, improved the reactivity of substrates 














up to 99% yield




Scheme 23. Ma’s synthesis of trifluoromethyl-substituted tertiary alcohols 60. 
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In contrast to Rueping’s publication[103] (see above), the reaction stops at the tertiary alcohol. 
A plausible explanation for this is given by DFT calculations showing that Brønsted acid-
catalysed OH activation would be difficult due to an apparent shortening of the C–O bond in 
comparison to its non-fluorinated analogue (CF3 = CH3). The consequence is a suppression of 
further arylation of the alcohol products by another indole molecule. 
 
In another publication from You et al., the chiral phosphoric acid (S)-32d catalysed the 
tandem double Friedel-Crafts reaction of indoles 63 with 2-formylbiphenyl compounds 64, 

























up to 96% yield
up to 98:2 e.r.  
 
Scheme 24. You published the tandem double Friedel-Crafts reaction of indoles 63  
with 2-formylbiphenyl compounds 64 catalysed by (S)-32d. 
 
 
The use of more reactive aldehydes allows the less acidic phosphoric acid (S)-32 to promote 
the first Friedel-Crafts reaction (Scheme 25). The secondary alcohol 66 is unstable under the 
reaction conditions and undergoes loss of H2O to form a contact ion pair 67, in which the 
chiral phosphate counteranion creates a chiral environment to differentiate the enantiotopic 
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faces of the 3-benzylidene-3H-indolium cation in the second Friedel-Crafts reaction. 































Scheme 25. The reaction proceeds via contact ion pair 67. 
 
 
Only a few months after their work on 3-substituted indoles, Rueping et al. published a highly 
enantioselective organocatalytic carbonyl-ene reaction (Scheme 26).[107] Similar to the 
allylation of aldehydes, this reaction is an important C–C bond-forming process for the 
preparation of synthetically valuable homoallylic alcohols. A broad range of styrene 
derivatives 68 were reacted with trifluoropyruvate 69 to afford α-hydroxyesters 70 in good 
yields (55-96%) and with excellent enantioselectivities (up to 98.5:1.5 e.r.). Only 1 mol% of 
phosphoramide (R)-H8-45c was necessary to mediate the reaction of the highly reactive 
carbonyl starting material 69. The structure of the chiral Brønsted acids was also described for 
the first time in this publication and demonstrated that the catalyst which was put into the 
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reaction is the protonated N-triflyl phosphoramide and not the corresponding salt (a detailed 
discussion of the nature of the catalyst is described in Chapter 3.1). 
 
Ar F3C CO2Et







up to 98.5:1.5 e.r.  
 
Scheme 26. Rueping’s enantioselective carbonyl-ene reaction. 
 
 
The first example of the activation of carbonyl compounds by chiral phosphoric acids was 
described by Terada et al. in early 2008.[108] They reported the activation of glyoxylate 71 for 
an aza-ene-type reaction with ene-carbamates 72 which proceeded in a highly enantio- and 



















up to 89% yield
anti:syn >99:1 
e.r. >99.5:0.5  
 
Scheme 27. Terada’s aza-ene-type reaction of glyoxylate 71 with  
enecarbamates 72 catalysed by (R)-32e. 
 
 
DFT computational analysis of the complexation modes demonstrated that a double hydrogen 
bonding interaction between the phosphoric acid and the glyoxylate is crucial in providing the 
high enantioselectivity (Figure 14). The hydrogen bond between the formyl hydrogen atom 
and the phosphoryl oxygen atom forces a coplanar orientation of the formyl group and the 
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phosphoric acid sub-unit, which results in one enantiotopic face of the aldehyde being 
effectively shielded by one of the phenyl groups. In contrast, the other face is fully accessible 











Figure 14. DFT computational analysis demonstrates the importance of  
double hydrogen bonding interaction between the phosphoric acid and the glyoxylate. 
 
 
One year later, the same group published the highly enantio- and anti-selective hetero Diels-
Alder reaction between glyoxylate 71 and siloxy- or methoxydienes 73 catalysed by chiral 
phosphoric acid (R)-32f (Scheme 28).[109] The anti-dihydropyran products 74 (d.r. >99:1) 
were obtained in good yields (51-95%) and with excellent enantioselectivity (all examples 
























e.r. >97.5:2.5  
 
Scheme 28. Terada’s hetero Diels-Alder reaction between glyoxylate 71 and dienes 73 catalysed by (R)-32f. 
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It is noteworthy that for this type of reaction, only chiral Lewis acids (e.g. enantiomerically 
pure BINOL complexed with Ti(Oi-Pr)4 and tridentate Schiff base ligands complexed with 
Ti(Oi-Pr)4)
[110] had been used previously to provide high levels of stereoselectivity, albeit with 
a syn relationship between the vicinal substituents of the dihydropyran. When BF3·OEt2 was 
employed in this Diels-Alder reaction, the diastereoselectivity dropped to 1:1. This result 
indicates that i) the secondary orbital interactions are weak in this hetero-Diels-Alder reaction 
and ii) the steric demand of the catalyst seems to be the dominant factor in increasing the yn 
selectivity. The last consideration was supported by the fact that incorporating bulkier groups 
than the phenyl substituent, such as 2,4,6-(i-Pr)3C6H2-substituents on the 3,3’-positions of the 
catalyst, led to a significant reduction in selectivity in favour of the syn diastereoisomer. Two 
plausible transition-state structures were reported where the ndo orientation is not favourable 


























Figure 15. In the transition state the exo orientation is favoured over the endo one. 
 
 
The following two examples describe the first aldol reactions where chiral phosphoric acids 
and N-triflyl phosphoramides are used to catalyse this powerful C–C bond-forming process. 
Blanchet and coworkers developed the direct aldol reaction between ethyl glyoxylate 71 nd 
different ketone nucleophiles 75 in the presence of the H8-BINOL-derived phosphoric acid 
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catalyst (R)-76 (Scheme 29).[111] The β-hydroxy ketone products 77 were obtained in 
moderate to excellent diastereo- and enantioselectivities (up to 95:5 d.r. and 95:5 e.r.). 
Notably, this syn-enantioselective aldol reaction is complementary to enamine (proline) 




















up to 95:5 syn:anti









Scheme 29. Blanchet’s direct aldol reaction between ethyl glyoxylate 71  
and ketones 75 catalysed by (R)-76. 
 
 
Yamamoto used the more acidic N-triflyl thiophosphoramide (S)-78 to catalyse an asymmetric 
Mukaiyama aldol reaction between various aldehydes 79 and silyl enol ethers 80 (Scheme 














up to 97% yield



















Scheme 30. Yamamoto’s Mukaiyama aldol reaction between various aldehydes 79  
and silyl enol ethers 80 catalysed by (S)-78. 
 
 
Mechanistic studies revealed that the silylated Brønsted acid may be an actual catalyst at R.T. 
(Lewis acid pathway), whereas at low temperature, the Brønsted acid itself may be the actual 
catalyst (Brønsted acid pathway). 
 
 
1.4.3 Organocatalytic activation via reactive intermediates 
 
Another challenge within the growing field of chiral Brønsted acid catalysis is the 
investigation of reactions where a positively charged reactive intermediate (carbocation, 
oxacarbenium ion) is associated with the negatively charged conjugate base in a contact ion 
pair. The intermediate might be stabilised through intermolecular π-π stacking interactions as 
well as electrostatic interactions and hydrogen bonding. These interactions determine the 
relative orientation of the cationic intermediate in the chiral environment created by the 
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associated anion. The underlying principle, namely Asymmetric Counteranion-Directed 
Catalysis (ACDC), was first introduced by List[113] and forms the basis for our hypothesis on 
the asymmetric allylation of acetals. So far, there have been only four examples in the 
literature where this challenge has been tackled using organocatalysts. Noteworthy is the work 
of Jacobsen and co-workers who have applied the principle of H-bond donor catalysis by 
anion binding of urea and thiourea derivatives to the enantioselective transformation of 
oxacarbenium ions[114] and carbocations.[115] The above mentioned nucleophilic additions of 
indole to carbonyl groups (Chapter 1.4.2) also follow the concept of ACDC because in each 
case a mesomeric stabilised cation is formed. 
 
Yamamoto again employed the more acidic N-triflyl thiophosphoramide (S)-82 as a catalyst 
for the enantioselective protonation of prochiral enol derivatives to prepare enantiomerically 
enriched α-substituted carbonyl compounds.[116] This work provides the first metal-free 
Brønsted acid-catalysed asymmetric protonation of silyl enol ethers 83 using a chiral Brønsted 
acid catalyst in the presence of achiral Brønsted acid media (Scheme 31). The ketone products 

































Scheme 31. Yamamoto published the enantioselective protonation of prochiral enol derivatives. 
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Scheme 32 outlines the proposed mechanism of this interesting reaction: Initially, the 
protonation of silyl enol ether 83 takes place enantioselectively from the chiral Brønsted acid 
HY* (S)-82 or achiral oxonium ion pair [PhOH2]
+·[Y*] – 85, generated by rapid proton 
transfer between (S)-82 and the achiral proton source PhOH. An intermediate chiral ion pair 
[83H]+·[Y*] – 86 of the oxacarbenium ion and the conjugate base is formed. This is followed 
by desilylation with PhOH to form the corresponding ketone 84, the silylated achiral proton 






















Scheme 32. Proposed mechanism for the enantioselective protonation reaction. 
 
 
Terada et al. demonstrated the direct aldol-type reaction of azlactones 87 via protonation of 
vinyl ethers 88 by chiral Brønsted acid (R)-32c (Scheme 33).[117] The β-hydroxy-α-amino acid 
products 89 possessing a quaternary stereogenic centre at the α-carbon atom were afforded in 






















up to 98:2 syn:anti 





Scheme 33. Terada’s direct aldol-type reaction of azlactones 87 via  
protonation of vinyl ethers 88 catalysed by (R)-32c. 
 
The proposed mechanism suggests proton transfer from the chiral Brønsted acid (R)-32c to 
vinyl ether 88 to generate an oxacarbenium ion, which forms an intermediate chiral ion pair 
[88H]+·[Y*] – 90 with the negatively charged conjugate base (Scheme 34). Asymmetric 
induction occurs via stereochemical communication, namely via hydrogen bonding, between 
the cationic intermediate and the chiral counteranion. This ion pair then reacts with the 
azlactone 87 via its oxazole tautomer 91 to form the corresponding product 89 and the 














































Scheme 34. The proposed mechanism suggests an oxacarbenium ion as intermediate,  
which forms a chiral ion pair 90 with the conjugate base.  
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List et al. described the highly enantioselective kinetic resolution of alcohols tethered to an 
acetal moiety via a transacetalisation reaction.[118] Both secondary and tertiary acetal 
homoaldols (γ-hydroxyacetals) rac-92 were exposed to the newly designed spirocyclic 
phosphoric acid STRIP (S)-93 [6,6’-bis(2,4,6-triisopropylphenyl)-1,1’-spirobiindan-7,7’-diyl 
hydrogen phosphate] to lead to enantioenriched (up to 99:1 e.r.) cyclic acetals 94 s cis 
diastereoisomers (up to >50:1 d.r.) and enantioenriched acetal homoaldols 95 (up to 98.5:1.5 


















up to 98.5:1.5 e.r.up to >50:1 d.r.
















Scheme 35. List’s kinetic resolution of alcohols rac-92 via a transacetalisation reaction. 
 
 
The method represents a very atom-economical kinetic resolution because it does not require 
any stoichiometric reagents and forms EtOH as the only by-product. Furthermore, the acetal 
group in cyclic acetals 94 can easily be modified, giving access to enantioenriched 
tetrahydrofurans and γ-butyrolactones. Although the authors did not comment on the actual 
mechanism, one possibility is that the reaction proceeds via contact ion pair 96 where the 
cationic oxacarbenium ion comes from the one homoaldol enantiomer that undergoes 






















Figure 16. A possible contact ion pair for the transacetalisation reaction. 
 
 
In the fourth example, Rueping and coworkers described the asymmetric intramolecular 
allylic substitution of allylic alcohols 97 to 2H-chromenes 98 (Scheme 36).[119] The reaction is 
catalysed by chiral N-triflyl phosphoramide (R)-99 and proceeds with good to excellent yields 

























Scheme 36. Rueping’s intramolecular allylic substitution of allylic alcohols 97 to  
2H-chromenes 98 catalysed by (R)-99.  
 
 
On the basis of different experiments described in the article, they propose that the Brønsted 
acid (R)-99 protonates the allylic alcohol 97. Subsequent dehydration gives a carbocation 
which is associated with the phosphoramide anion in a chiral contact ion pair 100 (Figure 17). 
Their model favours a carbocation with an ti,anti configuration, which is stabilised through 
intramolecular π-π stacking interactions as well as an intermolecular electrostatic interaction 
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with the counteranion. The two ions of the ion pair orientate in such a way that the positive 
charge of the cation is compensated by the negative charge delocalised on the OPNTf system. 
The HO phenolic group is subsequently deprotonated by the catalyst, enabling intramolecular 
attack of the oxygen nucleophile and regeneration of the effective catalyst. Cation-π 
interactions between the substrate and the catalyst are most likely responsible for the excellent 















1.4.4 Organocatalytic allylations 
 
To the best of my knowledge, no allylation reaction involving one of those reactive 
intermediates mentioned in Chapter 1.4.3 has been reported in the literature. There are only 
two examples of an allylation process mediated by chiral phosphoric acids. In 2010, Antilla 
reported the chiral phosphoric acid-catalysed allylboration of aldehydes 101 (Scheme 37).[120] 
The homoallylic alcohol products 102 were obtained in high yields (up to 99%) and with high 














up to 99% yield
up to 99.5:0.5 e.r.  
 
Scheme 37. Antilla’s allylboration of aldehydes 101 catalysed by (R)-32c. 
 
 
They propose that activation via protonation of the boronate oxygen would provide a 
reasonable explanation for the reactivity (Figure 18). Work by Hall[121,122] and Schaus[123] 
















Figure 18. Antilla proposes protonation of the boronate oxygen as activation mode. 
 
 
Very recently Terada developed the highly enantio- (up to 99:1 e.r.) and syn dia tereoselective 
(up to 93:7 d.r.) Hosomi-Sakurai reaction of imines 103 with allyl- and crotyltrimethylsilane 




























up to 94% yield
up to 99:1 e.r.
t-Bu2C6H3 t-Bu2C6H3
104a   R1 = Me, R2 = H
104b   R1 = H, R2 = Me 104a   80% yield
            93:7 syn:anti
            99:1 e.r.(syn)
104b   86% yield
            84:16 syn:anti
















Scheme 38. Terada’s Hosomi-Sakurai reaction of imines 103 catalysed by (R)-105. 
 
 
A combined Brønsted acid system employing chiral phosphoric acid (R)-105 (20 mol%) and 
achiral Brønsted acid 106 (80 mol%) allowed for an enantioselective catalytic process. In this 
system, regeneration of the chiral Brønsted acid HY* is possible by proton transfer from the 







Figure 19. A combined Brønsted acid system allows an enantioselective catalytic process. 
 43 
This section on organocatalysis has introduced into the concept of chiral Brønsted acids, in 
particular BINOL-based phosphoric acids and phosphoramides (Chapter 1.4.1). The first two 
examples of chiral phosphoric acid-mediated processes were described in 2004 and all 
involve an imine as the substrate. In the following years, the number of publications 
describing enantioselective additions to imines has increased rapidly, enabling Goodman to 
introduce his model for imine reactions catalysed by BINOL-based phosphoric acids in 2011. 
Turning the focus to the activation of carbonyl compounds (Chapter 1.4.2), the research 
community found a clear trend: Reactive carbonyl compounds (with ester- or trifluoromethyl 
substituents) can be activated by phosphoric acids whilst “normal” carbonyl groups require 
more acidic phosphoramides and thiophosphoramides. To the best of our knowledge only a 
few reactions have been described, which involve a positively charged reactive intermediate 
(carbocation, oxacarbenium ion) following the concept of ACDC (Chapter 1.4.3) and so far, 
no allylation reaction involving one of those reactive intermediates has been reported 
(Chapter 1.4.4). There are only two examples of an allylation process mediated by a chiral 
phosphoric acid. One involves the allylboration of aldehydes reported by Antilla in 2010, 
which proceeds via a six-membered transition state. In the second example, Terada achieved 
the Hosomi-Sakurai reaction using the less nucleophilic allyltrimethylsilane with imines in 
early 2011. An obvious next stage in the development of this field would be to investigate the 
Hosomi-Sakurai reaction of allyltrimethylsilane with a latent electrophile like an acetal. This 













2 Project Aims and Objectives 
 
Based on the hypothesis described in Chapter 1.3.2, our group wished to investigate the use of 
different chiral Brønsted acids derived from BINOL in an asymmetric allylation of acetals. To 
this end we have the following objectives: 
 
i) To synthesise a range of enantiomerically pure phosphoric acids based on a BINOL core, 
some of which have already been successfully employed in other Brønsted acid-mediated 










Figure 20. Chiral phosphoric acids based on a BINOL core. 
 
 
ii) To synthesise a range of enantiomerically pure phosphoramides based on a BINOL core, 
which are more acidic than the phosphoric acids and which have also already been 













Figure 21. Chiral phosphoramides based on a BINOL core. 
 
iii) To synthesise a range of enantiomerically pure sulfonic acids, which represent a new class 







Figure 22. Chiral sulfonic acids based on a binaphthyl core. 
 
iv) To investigate the use of these chiral Brønsted acids, which differ in their acidity, in a 





























3 Results and Discussion 
 
 
3.1 Synthesis of chiral BINOL-based phosphoric acids and phosphoramides 
 
As described in Chapter 1.4.1, various 3,3’-disubstituted phosphoric acids and 
phosphoramides based on a BINOL core, have already proven their worth as catalysts in a 
range of asymmetric processes.[97-99] Models which are used to rationalise the observed 
stereoselectivity in these reactions commonly refer to well-defined molecular conformations 
associated with non-covalent π-π interactions (face-face and edge-face) between the aromatic 
substrate/intermediate and the aromatic 3,3’-substituents in the accompanying BINOL 
catalyst. There is no single 3,3’-substituent which is universally successful for all 
transformations. We therefore synthesised a range of BINOL-based phosphoric acids and 
phosphoramides bearing different substituents on the 3,3’-positions (Table 1). Our synthetic 

















catalyst Ar X Y 
(S)-45d and (R)-45d p-tolyl O NHTf 
(S)-45e 3,5-(CF3)2C6H3 O NHTf 
(R)-45a 2,4,6-(i-Pr)3C6H2 O NHTf 
(R)-45f 9-anthracenyl O NHTf 
(R)-45g 10-Br-9-anthracenyl O NHTf 
(R)-45h 10-p-tolyl-9-anthracenyl O NHTf 
(R)-45i 4-Br-1-naphthyl O NHTf 
(R)-H8-45j 10-Br-9-anthracenyl O NHTf 
(R)-107 10-Br-9-anthracenyl O NHC6F5 
(R)-108 10-Br-9-anthracenyl S NHTf 
(S)-32g p-tolyl O OH 
(R)-32h 10-Br-9-anthracenyl O OH 
(R)-32i 10-F-9-anthracenyl O OH 
 
Table 1. Synthesised BINOL-based phosphoric acids and phosphoramides. 
 
 
Preparatively useful syntheses generally begin with BINOL rac-109, which was prepared 
from 2-naphthol 110 and FeCl3 in an oxidative radical coupling reaction in 77% yield.
[125,126] 
Subsequent resolution of this racemic material with N-benzylcinchonidium chloride 111 gave 
(R)-BINOL (R)-109 in 99.5:0.5 e.r., and (S)-BINOL (S)-109 in 99.55:0.45 e.r., as determined 





























Scheme 40. Synthesis of BINOL rac-109 and 
its subsequent resolution with N-benzylcinchonidium chloride 111. 
 
 
Aryl groups on the 3,3’-positions of the BINOL scaffold are usually introduced by a cross-
coupling reaction of a boronic acid with an aryl halide.[128] To obtain these precursors, the 
alcohol functionality in enantiomerically pure BINOL 109 was first protected by reaction with 
MeI in the presence of K2CO3 to afford dimethoxy-ether 112 in 97% yield (85% yield after 
recrystallisation) (Scheme 41).[128,129] In the next step, directed ortholithiation, trapping the 
resulting dilithio intermediate with B(OEt)3, and subsequent hydrolysis, provided bis-boronic 
acid 113 in 55% yield after recrystallisation.[128] Bis-iodo-ether (R)-114 was also synthesised 
by ortholithiation of (R)-112 and subsequent trapping with I2.
[130] Recrystallisation of the 
crude product afforded the enantiomerically pure product in 67% yield.  
 
Reduction of the BINOL core in (R)-109 was achieved quantitively with Adams’ catalyst 
under H2 atmosphere.
[131] Beller has developed an elegant synthetic sequence for the direct 
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Suzuki coupling of unprotected H8-BINOLs which would allow us to avoid the use of a 
protecting group.[132] Following this lead, we brominated diol (R)-H8-115 at –30 °C to obtain 
bis-bromo-diol (R)-H8-116 in 82% yield. The other precursors for the Suzuki coupling on 
route to catalyst (R)-H8-45j were obtained by protection of diol (R)-H8-115 with MeI in the 
presence of K2CO3 to afford dimethoxy-ether (R)-H8-117 in 85% yield after 
recrystallisation.[128,129] Subsequent bromination[131] or ortholithiation-iodination[133] gave bis-














































Conditions: (a) MeI, K2CO3, acetone, reflux, 97% (85% after recrystallisation). (b) (i) n-BuLi,
TMEDA, Et2O, R.T.; (ii) B(OEt)3, −78 °C to R.T.; (iii) 1 M HCl, R.T., 55%. (c) (i) n-BuLi,
TMEDA, Et2O, R.T. (ii) I2, −78 °C to R.T., 67%. (d) H 2, PtO2, AcOH, quantitative. (e) Br2,
CH2Cl2, −30 °C, 82%.(f) MeI, K 2CO3, acetone, reflux, 97% (85% after recrystallisation). (g)







Scheme 41. Synthesis of cross-coupling precursors. 
 
 
Bis-bromo-diol (R)-H8-116 and bis-bromo-ether (R)-H8-118 were employed in a Suzuki 
coupling with 10-bromoanthracene-9-boronic acid 120 following a literature procedure for 
coupling the structurally similar 9-anthracene boronic acid 121 with 3,3’-diiodo-2,2’-
dimethoxy-[1,1’]-binaphthalenyl (R)-114.[134]; however both substrates were not sufficiently 
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reactive to give the desired bis-coupled product under the coupling conditions employed. 
Although I could have investigated more reactive catalysts, I instead decided to turn to the 
more reactive bis-iodo-ether (R)-H8-119 as the aryl halide component in the Suzuki coupling. 
Now the desired bis-coupled product was formed (Scheme 42). After work-up, the crude 
product was demethylated with BBr3 and diol (R)-H8-122 was isolated in 17% yield after 
column chromatography.[128] In comparison to the high-yielding Suzuki coupling of (R)-bis-
iodo-ether (R)-114 with boronic acid 120 (vide infra), the low yield in this reaction can be 
explained by the fact that more electron-rich aryl halides are less reactive substrates in this 










1) boronic acid 120, Na2CO3, Pd(PPh3)4, 
    toluene/EtOH/H2O (2:1:1), reflux
2) work-up




Scheme 42. Suzuki coupling and demethylation to obtain diol (R)-H8-122. 
  
 
Bis-boronic acid 113 was used as a precursor en route to catalysts (S)- and (R)-45d and (S)-
45e (Scheme 43). Suzuki coupling with 4-bromotoluene provided the desired bis-coupled 
product 123 in 61% yield, together with a small amount of the mono-coupled product 124 in 
18% yield, which was readily separable from bis-tolyl 123 by flash column chromatography. 
Subsequent deprotection of bis-tolyl product 123 with BBr3 gave diol 125 in 97% yield.
[128] 
The same sequence was followed for the preparation of diol (S)-126: Suzuki coupling of bis-
boronic acid (S)-113 with 3,5-bis(trifluoromethyl)iodobenzene led to bis- and mono-coupled 
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product (S)-127 and (S)-128 in 49% and 10% yield, respectively. Demethylation of bis-ether 








































Conditions: (a) 4-bromotoluene, Ba(OH)2, Pd(PPh3)4, dioxane/H2O (3:1), reflux, bis-ether 123: 61%, 
mono-ether 124: 18%. (b) BBr3, CH2Cl2, 0 °C to R.T., 97%. (c) 3,5-bis(trifluoromethyl)iodoenzen e,
Na2CO3, Pd(PPh3)4, DME/EtOH/H2O, reflux, bis-ether (S)-127: 49%, mono-ether (S)-128: 10%. (d)
BBr3, CH2Cl2, 0 °C to R.T., 97%.
 
 
 Scheme 43. Suzuki coupling and demethylation to obtain diols (R)- and (S)-125 and (S)-126. 
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A Negishi coupling was employed in the synthesis of catalyst (R)-45a (Scheme 44). Sterically 
hindered 1-bromo-2,4,6-triisopropylbenzene was converted into the corresponding organozinc 
reagent, which was bis-coupled to bis-iodo-ether (R)-114 in the presence of 1 mol% of a 
highly reactive bis-(tri-tert-butylphosphine)palladium catalyst. After work-up, the crude 







    THF, −78 °C
2) ZnBr2 










3) BBr3, CH2Cl2, 0 °C to R.T.











Scheme 44. Negishi coupling and demethylation to obtain diol (R)-129. 
 
 
For the synthesis of the diol-precursor (R)-130, 9-anthracene boronic acid 121 was prepared 
by reaction of 9-lithioanthracene (generated by the action of n-BuLi on 9-bromoanthracene) 
with B(OMe)3 and subsequent hydrolysis (Scheme 45).
[137] The crude product was used in a 
Suzuki coupling with bis-iodo-ether (R)-114 to afford diol (R)-130 in 93% yield after 
deprotection with BBr3.
[134] The same conditions were used in the Suzuki coupling of bis-
iodo-ether (R)-114 with commercially available 10-bromoanthracene-9-boronic acid 120 to 
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provide bis-ether (R)-131 in 80% yield. This compound was exposed to another cross-
coupling[138] with 4-tolylboronic acid 132[139] which was prepared from 4-bromotoluene by 
lithiation and treatment with B(OMe)3, followed by hydrolysis to the boronic acid. After 
demethylation with BBr3, diol (R)-133 was isolated in 96% yield.
[128] When preparing diol 
(R)-134, bis-ether (R)-131 was not isolated; instead the crude product was treated with BBr3 
to provide the diol (R)-134 in 75% yield, alongside mono-bromo-diol (R)-135 in 19% 
yield.[128] The Suzuki coupling–deprotection sequence was also applied to the synthesis of 





































Conditions: (a) (i) 9-anthracene boronic acid 121, Na2CO3, Pd(PPh3)4, toluene/EtOH/H2O (2:1:1), reflux;
(ii) work-up; (iii) BBr3, CH2Cl2, 0 °C to R.T., 93%. (b) (i) 10-bromoanthracene-9-boronic ac id 120,
Na2CO3, Pd(PPh3)4, toluene/EtOH/H2O (2:1:1), reflux; (ii) work-up; (iii) BBr3, CH2Cl2, 0 °C to R.T., bis-
diol (R)-134: 75%, mono-diol (R)-135: 19%. (c) 10-bromoanthracene-9-boronic acid 120, Na2CO3,
Pd(PPh3)4, toluene/EtOH/H2O (2:1:1), reflux, 80%. (d) (i) 4-tolylboronic acid 132,  K2CO3, Pd(OAc)2, tri(3-
tolyl)-phosphine, toluene/DME/H2O (2:2:1), reflux; (ii) work-up; (iii) BBr3, CH2Cl2, 0 °C to R.T., 96%. (e)
(i) 4-bromonaphthyl-1-boronic acid, Na2CO3, Pd(PPh3)4, toluene/EtOH/H2O (2:1:1), reflux; (ii) work-up;
(iii) BBr3, CH2Cl2, 0 °C to R.T., 73%.
a
 
Scheme 45. Suzuki coupling–deprotection sequences to obtain diol precursors. 
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For the synthesis of the N-triflyl phosphoramide catalysts 45, a general procedure was 
followed which was published by Yamamoto when he first introduced this class of chiral 
Brønsted acids in 2006.[87] The diol precursors 137 were first reacted with phosphorus 
oxychloride to generate the corresponding phosphoryl chloride intermediates 138 which were 
not isolated (Table 2). Instead, the reflux temperature of the reaction mixture was increased 
by adding EtCN and then trifluoromethanesulfonamide was added to convert the phosphoryl 
chlorides into the corresponding N-triflyl phosphoramides 45. All catalysts were prepared 
uneventfully in this manner and the yields of this final step are summarised in Table 2 (entries 
1-8). The N-pentafluorophenylsulfonyl phosphoramide 107, which is a more acidic Brønsted 
acid, was synthesised by addition of pentafluorophenylsulfonamide instead of  
trifluoromethanesulfonamide (entry 9). 
 
N-Triflyl thiophosphoramide 108 represents a class of more acidic chiral Brønsted acids and 
was obtained by the use of phosphorus thiochloride in place of phosphorus oxychloride (entry 
10). Yamamoto introduced this type of catalyst in 2008.[116] In general, acidity increases on 
descending a group of the Periodic Table due to the larger atoms better stabilising the 
negatively charged conjugate base. For example, the pKa values of PhOH, PhSH, and PhSeH 
in DMSO are 18.0, 10.3, and 7.1, respectively.[140] Yamamoto showed by X-ray 
crystallography that their synthesised N-triflyl thiophosphoramide has a P=S double bond 
rather than a P=N double bond, which implies the proton is located on the nitrogen and not 
the sulfur atom..  
 
It is important to note that an acid wash with 4 M hydrochloric acid (twice) was necessary 
with all phosphoramides after purification of the crude product by column chromatography to 
convert the obtained phosphoramide salt into the acid. After removing the solvent (usually 
Et2O) in vacuo, with each product, a change in consistency and colour in comparison to the 
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salt was observed. This fits with Rueping’s observations.[141] He examined the X-ray crystal 
structure of a N-triflyl phosphoramide PA isolated after column chromatography and showed 
that this was not the free acid, but the corresponding calcium salt Ca(PA)2. Since no calcium 
ions are present during the synthesis or work-up procedures, it is likely that the PA 
sequestered calcium cations from the silica gel used for the final column chromatography.2 
After the extraction with hydrochloric acid no calcium was detected in a sample analysed by 
































entry catalyst Ar X Y yield [%] 
1 (S)-45d and (R)-45d p-tolyl O NHTf 89 
2 (S)-45e 3,5-(CF3)2C6H3 O NHTf 91 
3 (R)-45a 2,4,6-(i-Pr)3C6H2 O NHTf 83 
4 (R)-45f 9-anthracenyl O NHTf 75 
5 (R)-45g 10-Br-9-anthracenyl O NHTF 70 
6 (R)-45h 10-p-tolyl-9-anthracenyl O NHTf 63 
7 (R)-45i 4-Br-1-naphthyl O NHTf 72 
8 (R)-H8-45j 10-Br-9-anthracenyl O NHTf 70 
9 (R)-107 10-Br-9-anthracenyl O NHC6F5 78 
10 (R)-108 10-Br-9-anthracenyl S NHTf 46 
11 (S)-32g p-tolyl O OH 87 
12 (R)-32h 10-Br-9-anthracenyl O OH 93 
13 (R)-32i 10-F-9-anthracenyl O OH 91 
 
 
Table 2. Synthesised N-triflyl phosphoramide and phosphoric acid catalysts. 
                                                
2 commercially available silica gel contains traces of calcium 
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Phosphoric acids 32 were prepared following a general procedure.[90] Again, the diol 
precursors 137 were reacted with phosphorus oxychloride, this time in pyridine, to generate 
the corresponding phosphoryl chloride intermediates 138, which were not isolated (Scheme 
46), but hydrolysed directly to provide the corresponding phosphoric acids 32. Since BINOL-
derived phosphoric acids are also known to bind calcium upon purification on silica, an acid 
wash was carried out to release the cation and ensure the phosphoric acid was isolated.[142] 
Phosphoric acids 32g-32i were prepared in this manner and the yields of this final step are 





























Scheme 46. Synthesis of phosphoric acid catalysts. 
 
 
Diol precursor (R)-139 was synthesised from diol (R)-134 in three additional steps (Scheme 
47). The TMS-protection was achieved with HMDS and a sub-stoichiometric amount I2 to 
afford TMS-protected bis-bromo-diol (R)-140 in 96% yield.[143] In the next step, a metal-
halogen exchange with t-BuLi afforded the bis-lithiated species, which was quenched by the 
addition of N-fluorodibenzenesulfonimide to provide TMS-protected bis-fluoro-diol (R)-141 
in 77% yield. Three long columns with the mixed fractions were needed to fully separate 
TMS-protected bis-fluoro-diol (R)-141 from TMS-protected mono-fluoro-diol (R)-142 and 
bis-anthracenyl-diol (R)-130. TBAF was used for the deprotection to afford diol precursor 

















−78 °C, 2 h
2) N-fluorodibenzenesulfonimide
THF











Scheme 47. Synthesis of bis-fluoro-diol (R)-139. 
 
 
Originally, it was planned to convert diol (R)-139 into the corresponding N-triflyl 
phosphoramide (see Chapter 3.2.2.2). Following the general procedure,[87] th  diol was readily 
transformed into the phosphoryl chloride intermediate; however I was surprised to discover 
that the subsequent phosphoramidation step failed. I had expected the bis-fluoro-phosphoryl 
chloride intermediate to be even more reactive than the corresponding bis-bromo-phosphoryl 
chloride; however for unknown reasons the reaction failed. Therefore, we hydrolysed the 
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phosphoryl chloride to provide phosphoric acid (R)-32i in 91% yield after column 
chromatography and a final acid wash (entry 13). 
 
In summary a range of phosphoric acids and phosphoramides were synthesised and then used 
to investigate the asymmetric allylation of acetals as described in the next section. 
 
 
3.2 Investigation of the asymmetric allylation of acetals 
 
We first chose to focus on acetals derived from aryl aldehydes, since the proposed 
oxacarbenium ions, generated from these types of substrate, may form favourable non-
covalent π-π interactions with the binaphthalene scaffold and a well defined conformation in 
which the enantiotopic faces of the electrophile are differentiated. All reported e.r. values 
were measured twice by chiral HPLC which usually led to the same value or to a maximum in 
error of 1%. In the later case the reported e.r. is the higher value.    
 
 
3.2.1 Acyclic acetals derived from different benzaldehyde derivatives 
 
3.2.1.1 Investigation of phosphoric acids 
 
In order to investigate whether phosphoric acids based on a BINOL core (pKa ~ 1.4)
[86] are 
sufficiently acidic to activate acyclic acetals, we investigated the reaction between 
commercially available benzaldehyde dimethyl acetal as the latent electrophile and 
allyltrimethylsilane under different reaction conditions. Since the racemic phosphoric acid 
rac-143 is commercially available we started our study with this 3,3’-unsubstituted 
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compound. Table 3 summarises the results from these reactions and includes information on 























solvent temp [°C] solubility 
of acid 
% yielda of 
allylation 
product 























3 5 10 toluene R.T. not fully < 1 








a determined by GC 
 
Table 3. Allylation reactions carried out using phosphoric acid rac-143 as the activator. 
 
 
Carrying out the reaction with 1 equivalent of phosphoric acid rac-143 in different solvents 
(toluene, CH2Cl2, Et2O and CH3CN) failed to afford any allylation product as indicated by 
TLC (entry 1). A significant problem was the low solubility of the acid activator in all four 
solvents tested. Reducing the amount of Brønsted acid rac-143 to 10 mol% (entry 2) proved 
to be the right choice: the catalyst was now completely soluble in CH2Cl2 and CH3CN but not 
in our favoured solvent, toluene, which is an aromatic solvent with low dielectric constant. 
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The allylation product was only observed in the reaction with CH2Cl2 in < 5% yield. 
Employing 5 equivalents of allyltrimethylsilane in toluene provided only trace quantities of 
the allylation product (entry 3). Increasing the reaction temperature in toluene and CH2Cl2 
also failed to improve the yield of the desired product (entry 4). 
 
In order to overcome the solubility problems of catalyst rac-143 in toluene, we decided to 
synthesise the 3,3’-substituted phosphoric acid (S)-32g. This acid catalyst was then used in the 
allylation reaction with benzaldehyde dimethyl acetal. Table 4 summarises the results from 




















(S)-32g [mol%] solvent temp. [°C] acid 
soluble 
producta 






















a  indicated by TLC 
 
Table 4. Summary of allylation study using phosphoric acid (S)-32g. 
 
 
Gratifyingly, the Brønsted acid catalyst (S)-32g was now soluble in toluene at R.T. but still no 
allylation product was observed after 24 h as evidenced by TLC, neither in toluene nor in 
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CH2Cl2 or CHCl3 (entry 1). Increasing the reaction temperature failed to improve matters 
(entry 2). 
The conclusions which could be drawn from these experiments with catalysts rac-143 and 
(S)-32g were: 
i) These phosphoric acids are not sufficiently acidic to induce the allylation reaction of 
benzaldehyde dimethyl acetal with allyltrimethylsilane. 
ii) We would need to be aware of the potential solubility issues when moving to more acidic 
catalysts based on a BINOL core. 
 
 
3.2.1.2 Investigation of phosphoramides 
 
Since the Brønsted acidity of the employed phosphoric acids proved too low to activate the 
dimethyl acetal, we turned towards more acidic BINOL-based phosphoramides (pKa ~ –3 to –
4),[141] although in light of List’s work (Chapter 1.4.3) and our own observations with the 10-
F-9-anthracenyl phosphoric acid (R)-32i (vide infra), it may have been worthwhile 
investigating a wider range of phosphoric acids. 
All the following reactions were conducted with 10 mol% of the phosphoramide (S)-45d in 
different solvents and at ambient temperature (19 to 25 ºC), unless otherwise stated. Since we 
did not want to waste any precious material, all reactions were carried out on a very small 
scale (0.300 mmol) although this led to a few problems: 
i) Trace amounts of H2O led to competing hydrolysis of the acyclic acetals to their 
corresponding aldehydes. We planned to overcome this issue, if it were still a problem on 
scale up, by using molecular sieves or other drying agents as an additive.  
ii) Material is lost during work-up and purification by column chromatography and for this 
reason, isolated yields for these reactions are not representative of the efficiency of the 
reaction and therefore are not reported. 
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At this stage of the investigation I wanted to focus on the possible chirality transfer from the 
Brønsted acid activator, and I was therefore mainly interested in isolating sufficient pure 
material to allow determination of the enantiomeric ratio (e.r.) by HPLC. In order to be able to 
determine the e.r. of our allylation products, the retention times of both enantiomers were 
identified by first analysing racemic samples. For this purpose, all products were prepared by 
carrying out a reaction of the acyclic acetals with allyltrimethylsilane in the presence of the 
achiral acid, methanesulfonic acid.[69] The starting acyclic acetals were prepared uneventfully 
by reacting the corresponding aldehyde with trimethylorthoformate in MeOH in the presence 
of pTSA.[144] In all cases, the crude product was sufficiently pure to be used directly in the 
next allylation step. Table 5 summarises the acyclic acetals 144 and allylation products 145 











































































































a  reduced yield owing to high volatility of the product 
 
Table 5. Acyclic acetals and their corresponding racemic allylation products. 
 
 
The isolated yields of the racemic allylation products correlate with the reactivity of the 
starting acetals under Brønsted acid activation as indicated by TLC. Whilst the electron-poor 
4-nitro-acetal 148 was not very reactive (after 17 h stirring at R.T. only 25% allylation 
product was isolated) the electron-rich 4-methoxy-acetal 150 was consumed within 20 min 
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stirring at 0 °C. In this particular case, in addition to the mono-allylated product 157, the bis-





















Scheme 48. Mechanism of formation of bis-allylated product 160. 
 
 
Next, phosphoramide (S)-45d was employed in a series of asymmetric allylation reactions 
with acetals 144 under different reaction conditions as summarised in Table 6. Since we were 
unable to obtain baseline separation of the enantiomeric methyl ether products 153, 154, and 
156 we were unable to determine accurately the enantioselectivity of these reactions and in 





















entry acetal 45d  solvent conditions e.r. 




24 h, R.T. yesa 
yesa 
2 2-naphthyl-acetal 147 (S) toluene 24 h, R.T. yesa 




48 h, R.T. almost no 
product 
formed 




7 h, R.T. 
7 h, R.T. 
yesa 
yesa 




7 h, 0 °C 
–78 to –25 °C, 
then 4 h –25 °C  
54:46 
54:46 
6 4-fluoro-acetal 151 (S) toluene 24 h, R.T. 62:38 

































8 4-chloro-acetal 152 (R) toluene 24 h, R.T. 37:63 
a the chromatogram does not allow the accurate determination of e.r.
 




The reactions of acetals 146 and 147 (entries 1 and 2) supported the postulate of the catalytic 
cycle described in Chapter 1.3.2. In both reactions with CH2Cl2, the starting material was 
consumed completely as indicated by TLC, and despite the loss of material during work-up 
and column chromatography, the isolated yield of the allylation product was in both cases 
higher than 10% (this was the amount of Brønsted acid employed). In general, the reactions in 
CH2Cl2 or solvents with higher polarity showed better conversion than those carried out in 
toluene or solvents with a similarly low polarity (Table 7). This is to be expected because the 
rate-determining step in the allylation reaction of acetals (Scheme 11) is the formation of the 
oxacarbenium ion and a more polar solvent better stabilises both the charged intermediate, 
and the transition state leading up to it. 
  













Table 7. Solvents employed in the asymmetric allylation and their dielectric constant at 20 °C.[145]  
 
 
The influence of the substituents on the aromatic ring can be observed nicely by comparing 
entries 3 and 4 in Table 6. In the case of the electron-deficient 4-nitro-acetal 148, almost no 
product was formed even after 48 h. In contrast, reaction with the more electron-rich 3-
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methoxy-acetal 149 was complete within 7 h. This was also the case with the 4-methoxy-
acetal 150 even though the reactions were performed at lower temperatures (entry 5). 
Interestingly, both reactions (at 0 °C and –25 °C) gave the same e.r. Originally, I had 
postulated a slightly higher value might be observed in the reaction with 4-fluoro-acetal 151 
in comparison to 4-chloro-acetal 152 reasoning that the more electron-withdrawing fluoro-
substituent might lead to a tighter ion pair between the oxacarbenium ion and the chiral anion 
and therefore to a better differentiation of the enantiotopic faces. The reaction with 4-fluoro-
acetal 151 was performed in toluene and surprisingly, gave a slightly lower e.r. than the 
reaction with 4-chloro-acetal 152 under the same conditions (entry 6 and 7). Since the 
reaction with 4-methoxy-acetal 150 did not give a good e.r. in toluene we chose to screen 
different solvents in the reaction with the less reactive 4-chloro-acetal 152 because the 
allylation products from this substrate showed baseline separation by chiral HPLC analysis 
(entry 7). The fact that cyclohexane and p-xylene gave the best e.r. values was in line with our 
expectations; both non-polar solvents (Table 7) should maintain a contact ion pair in the 
reactive intermediate which we postulated would be critical for effective enantiocontrol. 
Unfortunately, when cyclohexane was employed as the solvent, the catalyst precipitated out 
of solution after 1.5 h; this was not a problem using p-xylene as solvent. I also synthesised the 
(R)-enantiomer of the phosphoramide (R)-45d to check that this woul provide the opposite 
enantiomer. Indeed, employing this acid in the reaction of 4-chloro-acetal 152 in toluene 
pleasingly led to the same e.r. value for the product although now favouring the opposite 
enantiomer (entry 8). 
 
In order to investigate the influence of different 3,3’-substituents on the e.r., we synthesised 
catalysts (S)-45e, (R)-45a and (R)-45g and employed these in the allylation reaction with 4-
chlorobenzaldehyde dimethyl acetal 152 in different solvents. Table 8 summarises the results 














152 159  
 
entry catalyst solvent e.r. 
1 (S)-45e toluene 41:59 
2 (S)-45e cyclohexane/toluene (2:1) 41:59 
3 (S)-45e CHCl3 48:52 
4 (R)-45a toluene 58:42 
5 (R)-45a cyclohexane 60:40 
6 (R)-45a CHCl3 50:50 
7 (R)-45g toluene 54:46 
8 (R)-45g p-xylene 57:43 
9 (R)-45g CHCl3 52:48 
 
Table 8. Catalyst and solvent study of the asymmetric allylation of 4-chloro-acetal 152.  
 
 
With each catalyst the highest selectivity was obtained again with non-polar solvents (entries 
1, 2, 5, 8) in comparison to CHCl3 (entries 3, 6, 9). Catalysts (S)-45e and (R)-45g are more 
acidic due to their electron-withdrawing groups and, as indicated by TLC, showed better 
activity than catalysts 45d and (R)-45a. Sterically demanding i-Pr-(R)-45a catalyst which has 
proved to be the catalyst of choice in many asymmetric Brønsted acid-catalysed reactions,[81] 
did not show a significantly higher selectivity in our case. Unfortunately, 10-Br-9-
anthracenyl-(R)-45g catalyst with a flat anthracene moiety, which maybe predisposed to 
forming non-covalent π-π interactions with the substrate/intermediate, gave the lowest 
selectivities. Overall, the tolyl-(S)-45d catalyst was the best match for the dimethyl acetal 
system in terms of enantioselectivity affording allylated methyl ether 159 in 67:33 e.r under 
the best conditions. 
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Finally, I looked at other dialkyl acetals and found that 4-chlorobenzaldehyde diethyl acetal 
gave poor results with the tolyl-(S)-45d catalyst in terms of conversion and enantioselectivity 
(48:52). The corresponding di-n-propyl and dibenzyl acetals were also investigated but we 
were unable to obtain baseline separation of the enantiomers to allow an accurate 
determination of the enantioselectivity with these substrates. 
 
The conclusions which can be drawn from this set of experiments with different 
phosphoramide catalysts 45 and the different starting acetals 144 were: 
i) A chiral Brønsted acid can impart enantioselectivity on the allylation of dimethyl acetals. 
ii) Reactions carried out in solvents with a low polarity like toluene, p-xylene and 
cyclohexane (note: solubility issues) were more enantioselective than those carried out in 
more polar solvents like CH3CN and CH2Cl2. This can be explained by a contact ion pair as 
an intermediate, which is better maintained in a less polar solvent. 
iii) However, whilst a non-polar solvent is necessary to obtain noticeable e.r. values, 
conversion of the starting acetal is significantly reduced by carrying out the reaction in such 
solvents. Decreasing the reaction temperature might improve the e.r. but it will also lead to a 
further reduction in the rate of the reaction. 
iv) Catalyst (S)-45d gave the highest enantioselectivities for the dimethyl acetal system. 
 
 
3.2.2 Racemic cyclic acetals derived from an isochroman framework 
 
The outline study had shown that a chiral Brønsted acid could be used to catalyse an 
enantioselective Hosomi Sakurai allylation of a simple acetal; however the very slow rate of 
reaction suggested that this was not going to be a particularly efficient process. Whilst I could 
have investigated more acidic activators (vide infra), we instead turned our primary attention 
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to a more reactive acetal substrate, namely 1-methoxyisochroman 161, which proved more 
suitable for a detailed study. Acetals contained within an isochroman framework are 
particularly attractive substrates since this structural motif is present in a number of drugs 
(medicines, agrochemicals), and drug candidates, as well as in a range of natural products.[146]  
 
1-Methoxyisochroman 161 was prepared in one step by DDQ oxidation of isochroman in the 
presence of MeOH (vide infra). A test reaction with racemic catalyst 162 revealed that this 
new class of acetal reacts more readily under N-triflyl phosphoramide catalysis than did the 
dimethyl acetals we had investigated in our outline study (Scheme 49). The 1-allylisochroman 
product 163 was isolated in 76% yield. Racemic N-triflyl phosphoramide 162 was prepared 























Scheme 49. Allylation of 1-methoxyisochroman 161 using racemic N-triflyl phosphoramide 162 as catalyst. 
 
 
3.2.2.1 Solvent screen 
 
A small solvent screen, employing tolyl-(S)-45d as the catalyst, once again highlighted the 












entry solvent e.r. 
1 CH3CN 53:47 
2 CH2Cl2 57:43 
3 toluene 60:40 
4 p-xylene 62:38 
 
Table 9. Solvent screen with 1-methoxyisochroman 161 employing tolyl-(S)-45d as catalyst. 
 
 
CH3CN and CH2Cl2 functioned as good solvents in terms of reactivity but were poor choices 
for enantioselectivity (entries 1 and 2). Using toluene as the solvent, a product e.r. of 60:40 
was obtained (entry 3); the use of p-xylene led to a further small improvement (e.r. 62:38) 
(entry 4). Thus once again, reactions carried out in non-polar solvents led to better e.r. values.  
 
 
3.2.2.2 Screening of different catalysts 
 
In order to identify the optimal catalyst for our system, a selection of chiral Brønsted acids 






























entry catalyst Ar Y solvent 
e.r. 
R = Me 
e.r. 
R = Et 
1 (S)-45d p-tolyl NHTf p-xylene 62:38  
2 (S)-45e 3,5-(CF3)2C6H3 NHTf p-xylene 50:50  
3 (R)-45a 2,4,6-(i-Pr)3C6H2 NHTf p-xylene 50:50  
















NHTf o-xylene 63:37 67:33 


















OH o-xylene  50:50 
 
Table 10. Catalyst screening of asymmetric allylation of 1-alkoxyisochromans 164 in xylenes. 
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Analogues possessing the commonly used 3,5-bis-trifluoromethylphenyl and 2,4,6-
triisopropylphenyl substituents at the 3,3’-positions of the binaphthyl scaffold, catalysed the 
reaction, but afforded racemic product (entries 2 and 3). It was only when we introduced 
anthracenyl substituents at the 3,3’-positions that we began to observe more significant levels 
of enantioselectivity (entry 4). Incorporating a bromo substituent into the 10-position of the 
anthracene unit led to a further improvement from 73:27 to 82:12 in enantiomeric ratio (entry 
5).  The 10-bromoanthracene-9-boronic acid is commercially available and therefore as 
readily accessible as its unsubstituted analogue, and from a practical viewpoint, 
phosphoramide (R)-45g is a more soluble catalyst compared with unsubstituted anthracenyl 
derivative (R)-45f. Employing p- and m-xylene as solvents with this catalyst, gave the same 
level of enantioselectivity than in o-xylene (entries 6 and 7). In a brief structure-activity study, 
the significance of the anthracenyl framework was demonstrated by the poor 
enantioselectivity observed with the 4-bromo-naphthyl derivative (R)-45i (entry 9). Partially 
reducing the binapthyl core to afford an acid with a tetrahydronaphthyl core ((R)-H8-45j) also 
failed to improve matters (entry 10). When we replaced the bromo substituent in (R)-45g with 
a larger 4-tolyl substituent ((R)-45h), this change also led to a reduction in enantioselectivity 
and also in reactivity (entry 8). Racemic product was obtained when the triflyl group in (R)-
45g was substituted for a pentafluorophenylsulfonyl group ((R)-107), which makes the 
catalyst more acidic (entry 11). In order to probe the influence of the bromo substituent on the 
10-anthracenyl position, I planned to synthesise the other 10-halo-9-anthracenyl 
phosphoramides. My first target was the 10-fluoro-9-anthracenyl phosphoramide, which 
turned out not to be accessable as described in Chapter 3.1. However, whilst we were unable 
to access the phosphoramide, we did synthesise the phosphoric acid. The fluoro substituents 
appeared to have a significant effect on the acidity of this phosphoric acid. While the 10-
bromo-9-anthracenyl phosphoric acid (R)-32h was not acidic enough to induce allylation 
(entry 12), 10-fluoro-9-anthracenyl phosphoric acid (R)-32i was now able to catalyse the 
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allylation, although with no enantioselectivity (entry 13), which might suggest a different 
reaction mechanism. With this result and the synthetic problems in mind, we decided not to 
pursue the preparation of other 10-halo-9-anthracenyl phosphoramides. 
 
In summary, catalyst (R)-45g, bearing a 10-Br-9-anthracenyl substituent on the 3,3’-positions 
of the binaphthyl scaffold provided the highest enantioselectivities. This catalyst has not been 




3.2.2.3 Further optimisation 
 
With the optimal catalyst in hand, we next investigated the effect of different catalyst loadings 
and reaction concentrations on the enantioselectivity of the product. Employing 30 mol% of 
(R)-45g increased the reaction rate, as indicated by TLC, but led to the same level of 
enantioselectivity (e.r. 80:20) than when 10 mol% catalyst was used (e.r. 82:18). Similar 
observations were made by running the reaction at 0.1 M (e.r. 76:24) and 2 M (e.r. 80:20) in 
comparison to 0.5 M (e.r. 82:18). While the more concentrated reaction gave almost the same 
e.r. and an increase of the rate, more dilute reaction concentrations exhibited a slight decrease 
in both selectivity and rate. 
 
We were pleased to find out that catalyst (R)-45g could be recovered and re-used without 
observing any decrease in enantioselectivity or activity. To achieve this, the catalyst was 
eluted from the column by increasing the polarity of the eluents after the allylated product had 
been collected. When a significant amount of the used catalyst from several reactions had 
been collected, the material was columned again with the usual eluents (see Experimental 
Section). After the HCl wash the catalyst was ready to be used again. 
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3.2.2.4 Effect of the leaving group 
 
Before moving on to investigate the scope of the reaction with various substituted isochroman 
acetals, I chose to study one last variable in the substrate, namely the nature of the alkoxy 
leaving group. Whilst the generally accepted mechanism of reaction of acetals involves an 
SN1-like process in which expulsion of the leaving group precedes nucleophilic addition, 
detailed mechanistic studies have shown that SN2-like pathways or at least ‘exploded 
transition states’ in which the leaving group is still associated with the substrate as the new 
bond is being formed, can also operate.[71,147,148] We therefore investigated the allylation of 
different 1-alkoxyisochromans 164, which were synthesised by DDQ oxidation of isochroman 
165 in the presence of the corresponding alcohol ROH.[ 114] Table 11 summarises the isolated 











R yield [%] R yield [%] 
Me 74 i-Pr 52 
Et 58 t-Bu 22 
n-Pr 49 CH2CF3 52 
 
Table 11.  Summary of yields of 1-alkoxyisochromans 164 prepared by DDQ oxidation of  
isochroman 165 in the presence of the corresponding alcohol. 
 
 
These alkyl acetals were employed in the allylation using our optimal phosphoramide catalyst 





























Table 12.  Summary of e.r. values obtained from the asymmetric allylation of  
different 1-alkoxyisochromans 164 employing (R)-45g as catalyst. 
 
 
In the allylation of ethyl acetal 166 we observed a change, and more specifically, an increase 
in enantioselectivity (e.r. 90:10) (entry 3) when the reaction was performed under otherwise 
identical reaction conditions as with methyl acetal 161. Increasing the size of the leaving 
group further, however, had a deleterious effect; thus the n-propoxy acetal 167 gave the 
allylation product in 76:24 e.r. (entry 4), and with i-propoxy acetal 168, a further reduction to 
70:30 e.r. was observed (entry 5). The t-butyl acetal 169 was not only a comparatively poor 
substrate in terms of reactivity, but also afforded essentially racemic product (entry 6). These 
results follow a trend, namely that the more sterically hindered the leaving group in the 
starting material, the lower is the e.r. of the allylated product. Only the methyl acetal 161 did 
not follow this trend, giving a lower e.r. (82:12) than might have been expected (entry 2). 
Analysis of the reaction mixture revealed this particular starting material reacted rapidly 
entry R e.r. 
1 H 59:41 
2 Me 82:18 
3 Et 90:10 
4 n-Pr 76:24 
5 i-Pr 70:30 
6 t-Bu 50:50 
7 171 59:41 
8 Ph 53:47 
9 CH2CF3 51:49 
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(within minutes) with adventitious water, to provide the lactol 170, which under the reaction 
conditions, led to the dimer 171. We prepared this bis-acetal independently by DDQ oxidation 
of isochroman 165 in the presence of H2O in 78% yield as single diastereoisomer
[149] 
(stereochemistry was not determined), and showed that not only was this a substrate for the 
reaction, but it also provided the allylation product in much lower enantioselectivity (e.r. 
























e.r. 82:18 (from 161)
e.r. 59:41 (from 171)  
 
Scheme 50. Competing allylation between 1-methoxyisochroman 161 and dimer 171. 
 
 
The same result was obtained by employing lactol 170 as the starting material (entry 1), 
which was prepared quantitatively by DIBALH-reduction of isochroman-1-one 172.[150] Since 
the methyl acetal is more susceptible to hydrolysis than ethyl acetal 166 (as indicated by 
TLC), this racemic background reaction serves to erode the enantioselectivity in the former 
reaction and goes some way to accounting for the reduced enantioselectivity observed with 
methyl acetal 161. In an effort to prevent this racemic background reaction, we added 3 Å 
molecular sieves to the reaction mixture, hoping that these would scavenge any adventitious 
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H2O from the reaction mixture. However, we now observed a significant decrease in product 
enantioselectivity when employing methyl acetal 161 (e.r. 63:37) as well as ethyl acetal 166 
(65:35) in distilled o-xylene. The drop in enantioselectivity may arise from an interaction of 
the molecular sieves with the catalyst since no reaction was observed when stirring ethyl 
acetal 166 with allyltrimethylsilane in distilled o-xylene in the presence of molecular sieves. 
In synthesising phenyl acetal 173, we hoped the flat leaving group might lead to an increase in 
enantioselectivity; however, this substrate afforded essentially racemic allylation product (e.r. 
53:47) (entry 8). A similar result was observed in the allylation of 1-(2’,2’,2’-
trifluoroethoxy)isochroman 174 (e.r. 51:49) (entry 9). This result was particularly 
disappointing considering the structural similarity to 1-ethoxyisochroman 166. 
The leaving group effect described above was also observed when ethyl acetal 166 was 
employed in the allylation with different phosphoramide catalysts (Table 10). In each case, 
the product enantioselectivity was higher than when using methyl acetal 161 as the starting 
material. Again, the 10-Br-9-anthracenyl phosphoramide (R)-45g gave the best selectivity, 
and in the case of ethyl acetal 166, a pleasing 90:10 e.r. In another attempt to improve this 
enantioselectivity we reduced the reaction temperature to 5 °C; however this had no effect on 
the enantioselectivity but, as indicated by TLC, the reaction rate was significantly lower. The 
e.r. value dropped to 81:19 when the reaction temperature was increased to 40 °C although as 
expected, the rate of the reaction was slightly higher. 
 
In summary, I have shown that the alkoxy leaving group in the starting material plays a 
significant role in the product enantiomeric ratio. Generally, the smaller the alkoxy leaving 
group, the higher is the e.r. of the product. Methyl acetal 161 is an apparent exception to this 
rule, although in this particular case, reaction of the starting acetal with adventitious water 
provides dimer 171 which reacts in an almost racemic allylation, leading to a reduced overall 
enantioselectivity. Ethyl acetal 166 together with catalyst (R)-45g gave the highest product 
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enantioselectivity (90:10) which provides the basis for the investigation of the scope and 
limitations of the developed method in Chapter 3.2.2.7. 
 
 
3.2.2.5 Employing different allylsilanes 
 
In employing different allylsilanes, we investigated a last variable in the optimisation of our 
developed process. Table 13 gives an overview of the allylsilanes which were examined in the 
reaction with different isochroman acetals 164 together with the observed e.r. values of the 














R = Me, Et, i-Pr
R1 = H, Me
 
 
entry allylsilane e.r. 
R = Me 
e.r. 
R = Et 
1 SiMe3  82:12 90:10 
2 SiEt3  67:33 75:25 








4 SiMe3  
60:40 59:41 
 
Table 13.  Summary of e.r. values obtained from the asymmetric allylation of  
1-alkoxyisochromans 164 employing different allylsilanes. 
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In comparison to allyltrimethylsilane (entry 1), the use of allyltriethylsilane (entry 2) led to a 
reduction in enantioselectivity with methyl acetal 161 (e.r. 67:33) as well as ethyl acetal 166 
(e.r. 75:25) as starting material. Again, the latter gave the higher e.r. value. 
Allyltriisopropylsilane did not provide the desired allylation product (entry 3); instead, 
compound 175 was isolated in 26% yield as a single diastereoisomer amongst a range of 
unidentified by-products. The stereochemistry in 175 was not determined. 2-
Methallyltrimethylsilane afforded the corresponding allylation product 176 with low 
enantioselectivtiy with both starting materials (e.r. 60:40 and 59:41, respectively) (entry 4). 
 
In conclusion, allyltrimethylsilane is the allylsilane of choice and was used as the nucleophile 
when investigating the scope and limitations of the reaction (Chapter 3.2.2.7). 
    
 
3.2.2.6 Determination of the absolute stereochemistry 
 
The absolute stereochemistry of 1-allylisochroman 163, which was prepared by employing 
phosphoramide 45g with (R)-configuration, was determined by comparison of the observed 
[α]D value with the literature [α]D value of enantiomerically enriched alcohol 177. 177 was 
prepared by a one-pot oxidative cleavage–reduction sequence in 77% yield (the intermediate 
aldehyde 178 was not isolated) (Scheme 51).[151] For a sample of 163 with 82:18 e.r. we 
measured an [α]D
20 = +102.2 (c 1.08, CH2Cl2) and compared it with the literature [α]D
20 = 
+43.5 (c 0.20, CH2Cl2) for a sample with 80:20 e.r.
[152] This leads to a (R)-(+)-configuration 










0 °C, 5 min
OHO
163 178 177  
 
Scheme 51. One-pot oxidative cleavage–reduction sequence of  
1-allylisochroman 163 to obtain alcohol 177. 
 
 
The absolute stereochemistry of other allylation products from different substrates was 
assigned by analogy. 
 
 
3.2.2.7 Scope and Limitations 
 
In order to probe the scope and limitations of our developed method, we next synthesised a 
range of differently substituted ethyl acetal substrates 179, which were reacted with 
allyltrimethylsilane in the presence of phosphoramide (R)-45g. Figure 23 outlines the 






















3.2.2.7.1 Synthesis of substrates 
 
The majority of substrates were prepared following the steps in the Scheme in Table 14. It 



















0 °C to R.T., overnight
alternative:
TiCl4, CH2Cl2
0 °C to R.T., overnight
KMnO4
cat. Et3BnNCl
CH2Cl2, R.T., 24 h
DIBALH
toluene
−78 °C, 2 h
Amberlite 
IR 120 beads























1 5-Me a 97 86 76 89 
2 6-Me b - 68a,b 65 83 
3 7-Me c quant. 80 - 41d 
4 8-Me d - 68a,b 28 78 
5 5-Br e 99 89 82 98 
6 5-CF3 f - 44
b 82 88 
7 7-OMe g quant. - 42b 74 
8 7-F h 99 77 75 77 
9 3,3-dimethyl i - - 38c 72 
10 4,4-cyclopropyl j 85 - 24b 84 
a 182b : 182d = 2.6 : 1.0; b over two steps;; c over three steps; 
d prepared from 182c by DDQ oxidation in the presence of EtOH 
 
Table 14. Summary of yields towards the synthesis of 1-ethoxyisochromans 179. 
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Apart from 1-phenyl-1-(hydroxymethyl)cyclopropane 180j, which was prepared 
quantitatively by reduction of 1-phenyl-1-cyclopropane-carboxylic acid,[154] all alcohols 180 
were commercially available. MOM-protection with FDMA in the presence of 5 mol% of 
Sc(Otf)3 gave MOM ethers 181 in excellent yields.
[155] These underwent a Friedel Crafts 
cyclisation induced by TiCl4,
[156] or 10 mol% of TMSOTf,[114] to afford isochromans 182 in 
moderate to good yields. MOM ether 181b/d gave a mixture of inseparable isochromans 182b 
and 182d in a 2.6 : 1.0 ratio (entries 2 and 4). The ratio reflects the steric hindrance in the 
Friedel Crafts cyclisation; thus the electrophilic substitution preferably occurs at the para 
position leading to isochroman 182b, than at the ortho position, leading to isochroman 182d. 
Oxidation to lactones 183 was achieved with KMnO4 in the presence of a phase-transfer 
catalyst TEBAC.[157] Pleasingly, isochroman-1-ones 183b and 183d were now separable by 
column chromatography (entries 2 and 4). A smooth DIBALH-reduction led to lactols 184, 
which were isolated but not characterised.[150] The crude products were instead stirred in 
EtOH with acidic Amberlite IR 120 beads to provide ethyl acetals 179 in good to excellent 
yields. Ethyl acetal 179c was prepared by DDQ oxidation of isochroman 182c in the presence 
of EtOH. In the same fashion, 1-ethoxyisobenzofuran 179k was synthesised from 











Scheme 52. DDQ oxidation of phthalan 185 to obtain 1-ethoxyisobenzofuran 179k. 
 
 
Whilst the DDQ oxidation approach to isochroman acetals 179 is potentially more efficient in 
terms of number of steps, I did not favour this route for three reasons: first, the work-up on 
larger scale was very time-consuming; second, it was difficult to remove traces of unreacted 
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isochroman from the desired 1-ethoxy product by column chromatography since both 
compounds have similar polarity; third, the reaction is not particularly high yielding with 
sterically more hindered alcohols than MeOH. Therefore, we decided to use this route only 
where necessary. 
 
We thought we might be able to employ a DDQ oxidation to prepare 1-ethoxy-3,4,5-trihydro-
2-benzoxepin 179l from benzoxepin 186 (Scheme 53). To this end, MOM ether 181l was 
prepared from commercially available alcohol 180l in 98% yield according to the general 
procedure.[155] Unfortunately, intramolecular cyclisation of MOM ether 181l with either TiCl4 
or TMSOTf failed and the product mixture contained unreacted starting material together with 















Figure 24. Formaldeyde diphenpropyl acetal 187. 
 
 
Considering an alternative route to 1-ethoxybenzoxepin 179l, we postulated that aldehyde 188 
should undergo cyclisation and acetalisation when stirring in EtOH in the presence of an acid 
catalyst. For the preparation of 188, we were able to find a literature procedure starting with 
1-tetralone 189, which underwent a reduction–dehydration sequence to provide 1,2-
dihydronaphthalene 190 in 87% overall yield (Scheme 54).[158] Ozonolysis and subsequent 
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reduction of the intermediate ozonide led to 2-(3’-hydroxypropyl)benzyl alcohol 191 in 76% 
yield.[159] Activated MnO2 (85%) chemoselectively oxidised the benzylic alcohol in 191 to 
afford 2-(3’-hydroxypropyl)benzaldeyde 188 in 86% yield.[159] Finally, hydroxyl aldehyde 
188, which exists in CDCl3 100% in the open form, was stirred in EtOH with Amberlite IR 
120 beads to provide a mixture of the desired 1-ethoxy-3,4,5-trihydro-2-benzoxepin 179l 
(56%) and 2-(3’-hydroxypropyl)benzaldehyde diethyl acetal 192 (12%) as a by-product, along 





































 Scheme 54. Synthetic route to 1-ethoxy-3,4,5-trihydro-2-benzoxepin 179l starting from 1-tetralone 189. 
 
 
To avoid a DDQ oxidation, we planned to prepare 1-ethoxy-3H-naphtho[1,8-cd]pyran 179m 
from 1H,3H-naphtho[1,8-cd]pyran-1-one 193 (Scheme 55). In a first attempt, 1,8-naphthalic 
anhydride 194 was reduced with NaBH4 and BF3·OEt2 to provide 1H,3H-naphtho[1,8-
cd]pyran 195 in 74% yield. Its partial oxidation to pyran-1-one 193 using KMnO4 in the 
presence of a phase-transfer catalyst TEBAC failed and led instead to anhydride 194. 
Fortunately, a literature procedure reported 193 as a “by-product” in the LiAlH4 reduction of 
1,8-naphthalic anhydride 194.[160] Using these conditions provided 1,8-
dihydroxymethylnaphthalene 196 in 24% and desired pyran-1-one 193 in 41% yield. 
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Subsequent DIBALH reduction and conversion of the lactol to the ethyl acetal as before 













-78 °C, 2 h
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Scheme 55. Synthetic route to 1-ethoxy-3H-naphtho[1,8-cd]pyran 179m  
starting from 1,8-naphthalic anhydride 194. 
 
 
I also wanted to synthesise 1-ethoxy-1-methylisochroman 179n by DDQ oxidation of 1-
methylisochroman 197, expecting oxidation of this electron-rich starting material would give 
the desired acetal in a good yield. A literature procedure suggested the cyclisation of 2-
phenylethyl trimethylsilyl ether 198, which was prepared by TMS protection of 2-phenylethyl 
alcohol in 98% yield, with TMSI-masked acetaldehyde would provide the isochroman 197 
(Scheme 56).[161] Unfortunately, the desired product was obtained in impure form in only 32% 
yield after difficult column chromatography because several other products with similar 














50 °C, 2 h O
198 197  
 
Scheme 56. Attempt to 1-methylisochroman 197. 
 
 
Therefore, I decided to carry out a nucleophilic addition of MeLi on to lactone 172 (Scheme 
57), which was synthesised by oxidation of isochroman with fuming nitric acid in 99% 
yield.[162] The resulting lactol 199 was isolated, but not characterised, and stirred in EtOH 
with acidic Amberlite beads to afford 1-ethoxy-1-methylisochroman 179n in 60% yield. The 
material was not stored but freshly prepared when employed for the asymmetric allylation 














EtOH, R.T., 2 h
172 199 179n  
 
Scheme 57. Preparation of 1-ethoxy-1-methylisochroman 179n. 
 
 
Finally, 1-ethoxy-1-phenylisochroman 179o was prepared in a similar fashion to its 1-methyl 
analogue, by addition of PhLi to lactone 172 (Scheme 58). Two products were obtained after 
column chromatography, namely benzophenones 200 and 201. Stirring both compounds in 
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EtOH with acidic Amberlite beads provided 1-ethoxy-1-phenylisochroman 179o (40% yield 

























Scheme 58. Preparation of 1-ethoxy-1-phenylisochroman 179o. 
 
 
3.2.2.7.2 Asymmetric allylation 
 
In order to be able to determine the e.r. of our allylation products, the retention times of both 
enantiomers were identified by first analysing racemic samples by chiral HPLC. For this 
purpose, all racemic products were prepared by carrying out a reaction of the 1-
ethoxyisochromans 179 with allyltrimethylsilane in the presence of the achiral acid, 
methanesulfonic acid. In the case of 5-ring 202k, a baseline separation of the two enantiomers 
was not possible. Therefore, an oxidative cleavage–reduction sequence according to Scheme 
51 was carried out. It was possible to separate the two enantiomers of alcohol 203 by chiral 















entry Substrate product yield [%] 
1 unsub. 166 163 94a 
2 5-Me 179a 202a 95 
3 6-Me 179b 202b 95 
4 7-Me 179c 202c 91 
5 8-Me 179d 202d 57 
6 5-Br 179e 202e 62 
7 5-CF3 179f 202f 78 
8 7-MeO 179g 202g 72 
9 7-F 179h 202h 83 





11 1-Ph 179o 202o 44 
12 5-ring 179k 202k 72a 





14 3,3-dimethyl 179i 202i 88 
15 4,4-cyclopropyl 179j 202j 94 
16 naphthopyran 179m 202m 96 
a reduced yield owing to volatility of the product 
 
Table 15. Summary of yields of racemic allylation products 202. 
 
TLC results and comparison of the isolated yields of the allylation products gave an early 
indication of the reactivity of each substrate under Brønsted acid activation. Most products 
were prepared uneventfully in good to excellent yields (entries 1-4, 7-9, 12, 14-16). 8-Me 
179d was less reactive and the corresponding product 202d was isolated in only 57% yield 
(entry 5), which is probably a consequence of the methyl group being close to the reactive 
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centre and increasing the steric hindrance for the nucleophilic attack. 5-Br 179e was also less 
reactive due to the electron-withdrawing bromo substituent, and provided the allylation 
product in only 62% (entry 6). In 1-Me 179n, the reactive centre is a quaternary carbon which 
also increases the steric hindrance and might explain the low product yield of 41% (entry 10). 
A second product 204 whose structure was not determined was also isolated in 38% as a 
mixture of diastereoisomers. 1-Ph 202o was obtained in only 44% yield probably for the same 
reason as 1-Me 202n (entry 11). Changing the six-membered ring in the isochroman system to 
a seven-membered ring had a negative influence on the reactivity of the ethyl acetal. 1-
Allylbenzoxepin 202l was isolated in only 26% together with by-product 205 in 15% yield. 




























Scheme 59. A possible mechanism for the formation of by-product 205. 
 
1-Ethoxybenzoxepin 179l gets protonated on the ring oxygen and forms cation 206. This ring 
opens through anchimeric assistance from the adjacent ethoxy group. The resulting planar 
oxacarbenium ion 207 gets attacked by allyltrimethylsilane to give the cationic intermediate 
208 in which the positive charge is stabilised by the β-effect of silicon. Cleavage of the silyl 
electrofuge then provides alcohol 209 which attacks oxacarbenium 210 to lead to by-product 
205 after deprotonation. 
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To investigate the scope and limitations of our asymmetric allylation method we reacted each 
substrate 179 with allyltrimethylsilane under the optimised reaction conditions. To ensure 
reproducibility, each reaction was repeated at least twice. Table 16 summarises the specific 
conditions regarding reaction time, concentration and catalyst loading, as well as the yields 










179 202  
 







product yield [%] e.r. 
1 unsub. 166 24 1.5 15 163 74a 90:10 
2 5-Me 179a 7 1.5 10 202a 84 92:8 
3 6-Me 179b 6 1 15 202b 79 87:13 
4 7-Me 179c 8 1.5 15 202c 71 87:13 
5 8-Me 179d 48 1.5 20 202d 52 79:21 
6 5-Br 179e 48 1.5 20 202e 45 83:17 
7 5-CF3 179f 48 1.5 20 202f 24 88:12 
8 7-MeO 179g 24 1.5 15 202g 65 79:21 
9 7-F 179h 48 1.5 15 202h 41 80:20 
10 1-Me 179n 24 1.5 15 202n 33 63:37 
11 1-Ph 179o 24 1.5 15 202o 16 51:49 
12 5-ring 179k 24 1.5 15 202k 61a 74:26 
13 7-ring 179l 48 1.5 20 202l traces n.d. 
14 3,3-dimethyl 179i 24 1.5 20 202i 67 57:43 
15 4,4-cyclopropyl 179j 8 1.5 20 202j 44 57:43 
16 naphthopyran 179m 24 1.15 15 202m 42 69:31 
a reduced yield owing to volatility of the product 
 
Table 16. Overview of the asymmetric allylation of 1-ethoxyisochromans 179.
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As already mentioned 1-ethoxyisochroman 166 led to a pleasing 90:10 enantiomeric ratio and 
the product 163 was isolated in 74% yield after 24 h. The volatility of the 1-allylisochroman 
led to a reduction in yield (entry 1). Introducing an electron-donating methyl group on to the 
aromatic ring led to an increase in the reaction rate in the case of 179a, 179b and 179c, and a 
slower rate in the case of 179d, which can be explained by the Me group increasing the steric 
hindrance close to the reacting centre (entries 2-5). A higher catalyst loading was necessary to 
achieve an acceptable yield with this substrate in a reasonable reaction time. The same 
explanation accounts for the decrease in yield going from 5-Me 202a to 8-Me 202d. The 
enantioselectivity also decreases in this order which is most likely due to the latter substrates 
not effectively fitting in the “chiral pocket” of the chiral counterion.  It is noteworthy, that the 
highest enantioselectivity (e.r. 92:8) was obtained with 5-Me 179a. 179e and 179f with an 
electron-withdrawing bromo- and trifluoromethyl group on the 5-position also led to good e.r. 
values (entries 6 and 7), which shows that substituents on the 5-position are well tolerated. 
However, in these two cases the low reactivity of both substrates warranted the use of a high 
catalyst loading and a longer reaction time for the products to be isolated in acceptable yields. 
The methoxy group on the 7-position gave 65% yield (entry 8), and the enantioselectivity (e.r. 
79:21) was comparable with that obtained with the 7-F substrate 179h (e.r. 80:20), which 
provided the product in 41% yield after 48 h (entry 9). These results suggest that sterics and 
not electronics might be key in controlling the enantioselectivity of these allylations. Having a 
quaternary carbon as the reactive centre led to a moderate enantioselectivity of 63:37 e.r. in 
the case of 1-Me 179n and to no selectivity in the case of 1-Ph 179o (entries 10 and 11). Both 
corresponding products were also isolated in low yields (33% and 16%, respectively). A 
change from the six-membered ring in the isochroman system to a five-membered ring also 
led to a significant drop in product enantioselectivity (e.r. 74:26) for 5-ring 202k (entry 12). 
The yield of 61% was reduced due to the volatility of the product and is therefore not 
representative of the efficiency of this reaction. I did not determine the e.r. of the allylation 
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product derived from 7-ring 179l because only traces of product were obtained even with a 
higher catalyst loading (entry 13). Introducing substituents on the 3- and 4-positions of the 
isochroman system was not tolerated: both substrates, 3,3-dimethyl 179i and 4,4-cyclopropyl 
179j, reacted with very low enantioselectivity of 57:43 e.r. (entries 14 and 15), and with a 
high catalyst loading, yields of 67% and 44%, respectively, were achieved. Changing the 
whole structure of the starting material from an isochroman system to naphthopyran 179m led 
to a product in moderate e.r. of 69:31 and a yield of 42% (entry 16). 
 
In summary, the majority of the 1-ethoxyisochromans 179 gave moderate to good yields of 
the allylation product. Those substrates which led to low product yields can be explained by 
electronic and steric factors. In terms of enantioselectivity, substituents on the 5-position of 
the isochroman system were well tolerated while with substituents on the 7- and 8-positions a 
slight drop in selectivity was observed. This is most likely due to the substrate not effectively 
fitting in the “chiral pocket” of the chiral counterion meaning both enantiotopic faces are 
available for reaction. Converting the reactive centre into a quaternary carbon also led to a 
significant drop in the corresponding product e.r. values. Introducing substituents on to the 3- 
and 4-positions was also not tolerated very well, whilst a change of the whole isochroman 
structure resulted in moderate enantioselectivities at best.  
   
 
3.2.2.8 Applications of the method 
 
In order to demonstrate the synthetic utility of our developed allylation method, we employed 
the procedure in two applications. First, enantiomerically enriched 1-allyl-5-
bromoisochroman 202e underwent a Suzuki coupling with 4-tolylboronic acid to provide 1-














Scheme 60. Suzuki coupling of enantiomerically enriched 1-allyl-5-bromoisochroman 202e 
to provide 1-allyl-5-tolylisochroman 211. 
 
 
The e.r. of the starting material (83:17) used in this reaction was maintained in the product as 
revealed by chiral HPLC analysis. This reaction suggests enantiomerically enriched 
halogenated 1-allylisochromans can be used in cross-coupling reactions which opens the door 
to a broad range of transformations after the asymmetric allylation step.   
In the second application, drug (R)-(+)-U-101387 212 which is used for the treatment of 
psychosis especially schizophrenia, was synthesised from enantiomerically enriched alcohol 























Scheme 61. Synthesis of drug (R)-(+)-U-101387 212. 
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177 was prepared from 1-allylisochroman 163 (e.r. 90:10) in an oxidative cleavage–reduction 
sequence as outlined in Scheme 51. The alcohol functionality in 177 was next converted into 
a good leaving group with MsCl. The resulting mesylate was not isolated but treated with 
piperazine 213 in a nucleophilic substitution. Drug 212 was isolated in 69% yield after 
column chromatography and the [α]D
21 = +41.1 (c 0.36, DMF) was a good match with the 




3.2.2.9 Understanding the origins of enantioselectivity 
 
3.2.2.9.1 Additives and catalyst preparation 
 
To shed some light on the origins of the observed enantioselectivity, a few test reactions and 
experiments were carried out. We decided to investigate the effect of different catalyst 
preparations and additives on the e.r. of the product. To do so, we reacted 1-
ethoxyisochroman 166 was reacted with allyltrimethylsilane under conditions which vary 
from the optimised ones, changing one variable at a time. Table 17 summarises the employed 
conditions together with the corresponding e.r. value of product 163. All of the reactions were 
carried out with the same batch of catalyst which gave 88:12 e.r. for the allylation product in a 


















entry Conditions e.r. of 163 
1 catalyst treated with toluene 66:34 
2 catalyst treated with MgSO4 and toluene 69:31 
3 catalyst treated with 3 Å MS and toluene 69:31 
4 catalyst HCl wash in Pr2O 81:19 
5 catalyst HCl wash in THF 84:16 
6 catalyst HCl wash in THP 83:17 
7 catalyst HCl wash in dioxane 80:20 
8 o-xylene + H2O (1 drop) 76:24 



















14 anisol (solvent) 72:28 
15 benzyl methyl ether (solvent) 66:34 
16 Et2O
a (solvent) 71:29 
17 DME (solvent) 55:45 
a light yellow precipitate observed after stirring for 1 h 
 
Table 17. Summary of the employed conditions together  
with the corresponding e.r. value of allylation product 163. 
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First, I wanted to look at the preparation of the catalyst. The usual treatment includes washing 
with hydrochoric acid after column chromatography to ensure the Ca salt is protonated and 
enters the Et2O phase. After drying the organic phase over MgSO4 and removing the solvent 
under reduced pressure, the protonated phosphoramide (R)-45g was obtained as its ether 
solvate as analysed by 1H-NMR spectroscopy and this was used in the asymmetric allylation 
reactions. Because the ether solvate was isolated, we questioned whether different methods of 
catalyst preparation might influence the enantioselectivity of the reaction. I started my 
investigation by treating a portion of the catalyst with dry toluene in order to try to remove the 
ether. To this end, the catalyst was dissolved in toluene and then the solvent was removed 
under reduced pressure. This procedure was repeated three times and after drying under 
reduced pressure, the catalyst was used in the asymmetric allylation under otherwise 
optimised conditions. 1H-NMR spectroscopy analysis proved that the Et2O solvate molecules 
had been removed. Interestingly, a significant drop in product enantioselectivity (e.r. 66:34) 
was observed (entry 1) which is not obvious why this happens. Similar results were obtained 
by adding MgSO4 or 3 Å MS to a solution of catalyst in dry toluene. After filtration, removal 
of the solvent and drying under reduced pressure, the phosphoramide was employed in the 
asymmetric allylation. In both cases, the product e.r. was 69:31 (entries 2 and 3). Clearly, the 
way in which the catalyst is isolated, plays a crucial role in determining the enantioselectivity 
of the reaction. A possible explanation is not immediately forthcoming at this stage and 
further experiments are necessary to draw conclusions from these results. Because the catalyst 
is used as its Et2O solvate, we were also interested in investigating if and how other ethers 
would influence the product e.r. Therefore, we carried out the HCl (aq) wash in different 
ethers, namely Pr2O, THF, THP and dioxane. The 
1H-NMR spectra revealed that in all four 
cases the catalyst was isolated as its corresponding ether solvate. In comparison to the 
optimised conditions using the Et2O solvate (e.r. 88:12), a slight decrease in e.r. was observed 
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when employing each ether solvate in the allylation reaction (entries 4-7), again indicating 
that the preparation of the catalyst affects the e.r. of the allylation product. 
 
I wanted to go a step further by investigating whether or not additives affected the 
enantioselectivity of the reaction. Adding one drop of H2O to the reaction mixture led to a 
drop in the product e.r. (entry 8), which can be explained by the formation of dimer 171 f om 
the starting material and additional H2O as described in Chapter 3.2.2.4. Dimer 171 itself 
reacts in an essentially non-enantioselective fashion, and accounts for the overall reduction in 
enantioselectivity (Scheme 50). Adding one drop of EtOH had little effect on the product 
enantioselectivity giving a product with 87:13 e.r. (entry 9). To investigate the influence of a 
chiral additive (if there are interactions with the chiral catalyst in a match – mismatch 
fashion), in separate reactions, I added one equivalent of (S)-1-methoxyethylbenzene 214 
(entry 10) and (R)-214 (entry 11) to the reaction mixture; however this had no effect on the 
enantioselectivity. Employing both ether enantiomers as solvents did not show any significant 
change in enantioselectivity (entries 12 and 13), showing that at least these chiral solvent 
molecules did not influence the chiral catalyst and resulting contact ion pair to any great 
extent. Because of the structural similarity to 214, I also decided to test anisol (entry 14) and 
benzyl methyl ether (entry 15) as solvents. Both led to a drop in enantioselectivity to 72:28 
and 66:34, respectively, which is probably due to the difference in polarity in comparison to 
214. Anisol and benzyl methyl ether show more of an “ether polarity” where the oxygen atom 
splits the molecule in two halves while in 214 the methoxy group behaves more like a 
substituent on the ethylbenzene core. This explanation is strengthened by the fact that 
employing Et2O and DME as solvents, both having an even higher polarity, also led to a 
decrease in product enantioselectivity (71:29 and 55:45, respectively) (entries 16 and 17). 
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This short study shows that the pre-treatment of the catalyst can have an effect on the 
enantioselectivity of the product. Different ether solvates led to slight changes in the e.r., 
whilst treatment of the catalyst with toluene and drying agents led to a larger drop in e.r. 
Chiral additives did not affect enantioselectivity, neither did their use as solvents. 
 
 
3.2.2.9.2 Thiophosphoramide (R)-108 
 
In order to probe the role of the oxygen in the P=O bond in the optimal catalyst, I synthesised 














Figure 25. Thiophosphoramide (R)-108. 
 
 
When employing (R)-108 in the asymmetric allylation of 1-ethoxyisochroman 166 I observed 
two important changes in comparison to its oxygen analogue: i) The rate of the reaction was 
significantly higher, which fits with the fact that thiophosphoramides are more acidic than 
phosphoramides;[116] ii) the 1-allylisochroman product 163 was obtained as almost a racemic 
mixture. This drop in enantioselectivity from 90:10 with the phosphoramide catalyst (R)-45g 
to 55:45 with the thiophosphoramide catalyst (R)-108 suggests that the oxygen in the P=O 
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bond plays an important role in the stereodetermining step. Most likely, a h drogen bond is 
formed between the substrate/intermediate to the oxygen of the phosphoramide catalyst in the 
transition state which will be discussed further in Chapter 3.2.2.10. A hydrogen bond to sulfur 
is much weaker than to oxygen and therefore longer which leads to a looser association of 
catalyst and substrate and concomitant reduction in enantioselectivity. 
   
 
3.2.2.9.3 Proof of a dynamic kinetic resolution 
 
In order to probe the mechanism of our Brønsted acid-catalysed asymmetric allylation, we 
separated both enantiomers of 1-ethoxyisochroman 166 by chiral semi-preparative HPLC. 
Each enantiomer was exposed to 10 mol% of phosphoramide catalyst (R)-45g in o-xylene, 
aliquots were taken and the product e.r. was analysed by chiral HPLC. Aliquots were taken 
after 30 s, 1 min, 2 min, 5 min, 10 min, 20 min, 30 min, 40 min, 1 h, 2 h, 4 h, 8 h, 24 h and 
quenched with a few drops of NEt3. A yellow precipitate was observed which most likely is 
the triethylammonium salt of the catalyst, and residual NEt3 was evaporated under reduced 
pressure (~ 10 mmHg). A few drops of hexane were added and the resulting solution, which 
contained the product, was analysed by chiral HPLC. We also quenched three aliquots with a 
mixture of hexane and aqueous NaOH solution to demonstrate that the method of reaction 
sampling was not affecting the results. Thus, these three times, two aliquots were taken at the 
same time and quenched with the different methods. In each case, the measured e.r. values 
were the same. Investigation of the first enantiomer (tR,first = 8.6 min) revealed a rapid 
epimerisation within 30 s after addition of the chiral catalyst. Interestingly, each aliquot gave 
an e.r. value around 53:47 in favour of the first enantiomer instead of a 50:50 mixture. When 
analysing the second enantiomer (tR,second = 10.5 min), again rapid epimerisation was 
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observed, this time with e.r. values around 48:52 in favour of the second enantiomer. Scheme 



















Scheme 62. A possible mechanism for the epimerisation of the starting acetal. 
 
Protonation of 166 on the ring-oxygen forms cation 215, which ring opens through 
anchimeric assistance from the adjacent ethoxy group. The resulting planar oxacarbenium ion 
216 can then be attacked by the free alcohol group from the si- or re-face. In the Scheme 
above, attack from the re-face provides cation 217, which, after deprotonation by the 
conjugate base Y–, gives enantiomer 166 with the opposite stereochemistry to the starting one. 


























Scheme 63. A second possible mechanism for the epimerisation of the starting acetal. 
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Protonation of enantiomer 166 may alternatively occur on the ethoxy oxygen to form cation 
218, which expels EtOH to leave oxacarbenium ion 219. This can be attacked by the free 
EtOH from the si- or re-face. In the Scheme, attack from the re-face provides cation 220, 
which after deprotonation by the conjugate base Y–, gives enantiomer 166 with the opposite 
stereochemistry to the starting acetal. 
 
In another experiment, the e.r. value of the product was followed throughout the reaction. 
Racemic 1-ethoxyisochroman 166 was exposed to allylsilane and 10 mol% of catalyst (R)-
45g, and aliquots were taken over 48 h and in each case the e.r. of the product was analysed 
by chiral HPLC. Aliquots were taken after the times listed in Table 18 and quenched and 
analysed as described above.  
 
time e.r. of product time e.r. of product 
1 min 88:12 2 h 89:11 
2 min 86:14 2.5 h 89:11 
5 min 89:11 3 h 89:11 
10 min 89:11 4 h 89:11 
20 min 89:11 5 h 89:11 
30 min 89:11 8 h 88:12 
40 min 90:10 24 h 89:11 
1 h 89:11 48 h 89:11 




Table 18. Following the e.r. value throughout the reaction. 
 
 
Considering, the error in the HPLC measurement is 1.5%, there is no significant change in the 
e.r. value of the product over the course of the reaction. These experiments suggest that the 














all rates >> k5 and k6
for efficient DKR k5 > k6
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Scheme 64. Dynamic kinetic resolution. 
 
 
It is therefore assumed, that the chiral Brønsted acid (R)-45g and both enantiomers of the 
ethyl acetal form two diastereomeric contact ion pairs. In the subsequent reaction with 
allyltrimethylsilane, one of the ion pairs reacts distinctly faster than its diastereomer. That is 
how complete conversion of the racemic substrate 166 into the allylation product 163 with 
high enantiomeric excess can be rationalised.  
 
 
3.2.2.10 Proposed transition state 
 
With all our results in hand, I am now able to propose a transition state for each enantiomer of 
the starting material (Figure 26) with TS A being lower in energy than TS B and accounting 


























TS A TS B  
 
Figure 26. Proposed transition states TS A and TS B. 
 
 
Brønsted acid (R)-45g protonates the alkoxy group of the acetal. Due to the observed leaving 
group effect, we reason that the alcohol leaving group is still “attached” or at least in close 
proximity to the oxacarbenium ion which is associated with the phosphoramide anion in a 
chiral contact ion pair. This is stabilised through intermolecular π-π stacking interactions as 
well as intermolecular electrostatic interactions. The two ions in the ion pair orientate in such 
a way that the positive charge of the oxacarbenium ion is compensated by the negative charge 
delocalised on the OPNTf system. I also invoke a hydrogen bond between the Lewis basic 
oxygen of the counterion and the hydrogen of the alcohol leaving group which is supported by 
the result with thiophosphoramide catalyst (R)-108. A sulfur atom forms a much weaker and 
therefore longer hydrogen bond than oxygen which results in a looser association of the 
substrate with the conjugate base. This explains the drop in enantioselectivity on exchanging 
the oxygen for a sulfur atom. Attack of allyltrimethylsilane occurs from the side opposite to 
the alcohol leaving group. Transition state TS A is favoured over TS B since the nucleophilic 
attack is sterically hindered by one of the 10-Br-anthracenyl-substituents in the latter one. 
This means the energy difference between TS A and TS B determines the enantioselectivity 




3.3 Synthesis of sulfonic acids 
 
The outline study described in Chapter 3.2.1 had shown that a chiral Brønsted acid could be 
used to catalyse an enantioselective Hosomi Sakurai allylation of a simple acetal; however the 
very slow rate of reaction suggested that this was not going to be a particularly efficient 
process. At that time I decided to turn my attention to more reactive acetal systems, namely 1-
alkoxyisochromans. After carrying out a detailed study on these substrates (Chapter 3.2.2), we 
again turned towards simple acyclic acetals and decided to investigate more acidic activators. 
Since sulfonic acids are effective activators for the allylation of acyclic acetals with 
allyltrimethylsilane,[69] we were interested in synthesising a range of enantiomerically pure 
chiral sulfonic acids. Whilst a few chiral sulfonic acids have been reported,[163,164] these 
approaches do not allow sufficient flexibility to generate the structural diversity that we 
desired, and which is invariably required for optimisation studies in asymmetric synthesis 
methodology. We therefore wanted to synthesise a new class of sulfonic acids based on the 
binaphthalene framework (Figure 27). When we started this project, sulfonic acids based on a 
binaphthalene framework were not known in the literature and we designed our own strategy 










Figure 27. A new class of sulfonic acids. 
 
 
In all cases, the sulfonic acid would be introduced at the 2-position of the binaphthalene 
framework; structural diversity would be introduced by functionalising the 2’-position. We 
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would also use the 3-position (and 3’-position for simplifying the synthesis) a  a second site 
for introducing structural diversity. The retrosynthesis of these acids is summarised in Scheme 
65: Substituents would be introduced to the 3,3’-positions by cross-coupling reactions. Then, 
the 2’-position would be derivatised. This can be achieved in a variety of ways. Simple alkyl 
ethers can be introduced by standard Williamson ether synthesis[165] or with Mitsunobu 
chemistry.[166] O-Arylation could be achieved by Ullmann[167] or Buchwald-Hartwig-type O-
arylations,[168] whilst aryl substituents can be introduced by Suzuki coupling of the 
monotriflate with different boronic acid coupling partners.[169] Finally, manipulation of the 























Scheme 65. Retrosynthesis of 3,3’-substituted chiral sulfonic acids. 
  
 
A literature search identified an excellent procedure for carrying out the final part of the 
sequence. In 1997, Woodward developed a route to a 2-thiobinaphthol[170] which we proposed 
should be easily converted into a sulfonic acid by oxidation of the thiol moiety. This 
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transformation can be achieved with a variety of oxidants,[171,172] although most commonly 
with H2O2.
[164,173,174] Since the route allows access to 5-10 g quantities of the product with 
excellent yields for all intermediates, and also delivers an enantiomerically pure end-product, 
we decided to follow this approach to our sulfonic acids.   
 
The synthesis of our first target is outlined in Scheme 66. For a first attempt we decided to 
convert the alcohol functionality at the 2’-position into a simple methoxy functionality. This 
would allow a simpler interpretation of NMR spectra since the chemical shift of a methoxy 
group is remote from the aromatic region where the signals for all the other protons and 














































 Scheme 66. Synthesis of sulfonic acid (R)-226 starting from BINOL (R)-109.  
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Beginning with enantiomerically pure BINOL (R)- or (S)-109, I introduced the methoxy 
group into the 2’-position via Mitsunobu chemistry,[166] which gave the monomethyl ether 
(R)- or (S)-221 in 83% yield. Flash column chromatography in 100% toluene allowed 
separation of the product from small amounts of bis-methyl ether and starting material. 
Reaction of the remaining hydroxyl group in (R)- or (S)-221 with N,N-dimethylcarbamoyl 
chloride provided the corresponding thiocarbamate (R)- or (S)-222 in 88% yield.[170]  
Noteworthy, N,N-dimethylcarbamoyl chloride was used as delivered by the supplier while 
Woodward recrystallised the reagent, and may explain why in our case the reaction time was 
twice as long and also required higher reaction temperature. Recrystallisation of the product 
from ethanol ensured the enantiomeric purity of (R)-222 and (S)-222. Thermolysis of (R)- or 
(S)-222 effected Newmann-Kwart rearrangement and provided carbamate (R)- or (S)-223 in 
83% yield.[166] Remarkably, despite the forcing conditions required to effect this 
transformation (250 °C, 3.5 h), the rearrangement proceeded with only slight erosion in 
enantiopurity; (R)-223 and (S)-223 were isolated in 97.5:2.5 e.r. and 98.7:1.3 e.r., 
respectively, as measured by chiral HPLC. Unfortunately, it was not possible to find suitable 
recrystallisation conditions. Since it is only my first attempt towards the sulfonic acids I 
decided not to improve the e.r. and instead choose to move on to the base-mediated hydrolysis 
of (R)-223, which provided thiol (R)-224 in 73% yield.[170] Owing to the propensity for the 
thiol to undergo air oxidation, the disulfide (R,R)-225 was also isolated in 11% yield. The last 
step in our synthesis involved the oxidation of thiol (R)-224 to the sulfonic acid (R)-226. The 
most common oxidant for effecting this conversion is H2O2 in acetic acid at high 
temperature.[164,175] Following this approach, complete conversion of starting material 
occurred within 2 h. Unfortunately, purification of the crude product turned out to be a 
problem and could not be solved before the end of the laboratory work. The following 
strategies will help to find a way of successfully introducing the SO3H moiety in my class of 
sulfonic acids.Recently, research groups have started to use 3,3’-disubstituted BINSA 227[176-
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180] and its disulfonimide derivative 228[181,182] as strong chiral Brønsted acids in asymmetric 













227 228  
 
Figure 28. 3,3’-Disubstituted BINSA 227 and its disulfonimide derivative 228. 
  
The first class was introduced independently by List and Ishihara who use different 
approaches for the introduction of the disulfonic acid motif. While List chose the direct 
oxidation of thiocarbamate 229 with performic acid to obtain BINSA 227, Ishihara converted 
thiocarbamate 230 into bis-thiol 231 before oxidation to BINSA 232 under O2 pressure in 
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4 Conclusions and Further Work 
 
 
4.1 Summary  
 
To confirm our hypothesis that a chiral Brønsted acid is able to impart stereoselectivity on the 
Hosomi-Sakurai reaction of acetals, I investigated the reaction of both acyclic dialkyl acetals 
as well as racemic cyclic acetals with allyltrimethylsilane, which was catalysed by different 
chiral Brønsted acids based on a binaphthyl core.   
 
In the first section of the Results and Discussion (Chapter 3.1), the synthesis of a range of 
phosphoric acids and phosphoramides based on a BINOL core was described. I prepared 
some catalysts which were already known in the literature but also a selection of new chiral 
Brønsted acids. In particular, the previously unreported 10-Br-9-anthracenyl phosphoramide 
(R)-45g turned out to be the catalyst of choice for our isochroman actal investigation and may 
find application in other Brønsted acid-catalysed reactions. 
 
In the second section of the Results and Discussion (Chapter 3.2), we employed our 
synthesised Brønsted acids as catalysts in the Hosomi-Sakurai reaction of acetals with 
allyltrimethylsilane. First, we started with acyclic acetals derived from benzaldehyde 
derivatives (Chapter 3.2.1). We tested 3,3’-unsubstituted racemic phosphoric acid rac-143 
and 3,3’-bis-tolyl-substituted phosphoric acid (S)-32g in the reaction of benzaldehyde 
 113 
dimethyl acetal with allyltrimethylsilane under various reaction conditions; however no 
allylation product was observed. Since the employed phosphoric acids were not sufficiently 
acidic to induce the allylation reaction, I decided to turn my attention to more acidic 
phosphoramides. By employing tolyl-(S)-45d, allylation product was now formed and more 
pleasingly, with moderate enantioselectivity as analysed by chiral HPLC. A solvent screen, 
using tolyl-(S)-45d, was carried out with 4-chloro-acetal 159 as starting material. 
Cyclohexane and p-xylene, both solvents with a relatively low polarity, gave the best e.r. 
values, while acetonitrile led to a racemic mixture. This observation fits with the proposal that 
maintaining the contact ion pair in the reactive intermediate is critical for enantioselectivity. A 
selection of different dimethyl acetals was synthesised in excellent yields and investigated in 
the asymmetric allylation. We also examined other 3,3’-substituted phosphoramides and other 
dialkyl acetals. In this study, the best e.r. values were obtained by employing the tolyl-(S)-45d 
catalyst with the dimethyl acetal system. Whilst a low-polarity solvent had proven necessary 
to obtain noticeable enantioselectivity, conversion of the starting acetal was poor in these 
solvents. Decreasing the reaction temperature might have improved the enantioselectivity but 
it would likely also have led to a further reduction in the rate of the reaction. Therefore, we 
concluded that it would be necessary to investigate a more reactive acetal system and/or more 
acidic Brønsted acids. 
 
I turned my primary attention to a more reactive acetal system, namely 1-alkoxyisochromans 
164, which proved more suitable for a detailed study of the asymmetric allylation (Chapter 
3.2.2). A solvent screen with 1-methoxyisochroman 161 as starting material and tolyl-(S)-45d 
as catalyst, once again showed the best enantioselectivity was obtained with solvents of low 
polarity (p-xylene). In order to identify the optimal catalyst for our system, a selection of 
chiral Brønsted acids was screened. I varied the 3,3’-substituents, reduced the BINOL core to 
a H8-BINOL system and replaced the NHTf group by a more acidic NHSO2C6F5 group. 
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Overall, the 10-Br-9-anthracenyl phosphoramide (R)-45g turned out to give the highest 
enantioselectivities.  
 
Further optimisation studies revealed that different catalyst loadings and reaction 
concentrations did not affect the enantioselectivity of the reaction but could be used to 
increase the reaction rate. Changing the temperature also affected the reaction rate but also the 
selectivity: increasing the temperature above R.T., a drop in enantioselectivity was observed, 
while a decrease in temperature did not lead to any improvement in selectivity and just served 
to reduce the rate. Employing other allylsilanes also failed to improve the enantioselectivity. 
Pleasingly, catalyst (R)-45g could be recovered and re-used without observing any decrease in 
enantioselectivity or activity. We also investigated the nature of the alkoxy leaving group. To 
this end, different 1-alkoxyisochromans 164 were exposed to the usual reaction conditions. To 
our surprise, the leaving group in the starting material was found to play a significant role in 
the product selectivity. Generally, the smaller the alkoxy leaving group, the higher was the e.r. 
of the product. 1-Methoxyisochroman 161 was an apparent exception to this rule; however in 
this particular case, reaction with adventitious water provides dimer 171, which also reacts in 
a poorly enantioselective allylation and goes some way to accounting for the erosion in 
enantioselectivity in this case. 1-Ethoxyisochroman 166 together with catalyst (R)-45g gave 
the highest product enantioselectivity and provided the basis for investigating the scope and 
limitations of the developed method. To this end, differently substituted ethyl acetal substrates 
179 were synthesised and reacted with allyltrimethylsilane in the presence of phosphoramide 
(R)-45g. The majority of these substrates gave moderate to good product yields. In terms of 
enantioselectivity, substituents on the 5-position of the isochroman system were well tolerated 
whilst with substituents at the 7- and 8-positions, a slight drop in selectivity was observed. 
This is most likely due to the substrate not effectively fitting in the “chiral pocket” of the 
chiral counterion meaning both enantiotopic faces are available for reaction. Converting the 
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reactive centre into a quaternary carbon also led to a significant drop in enantioselectivity. 
Introducing substituents into the 3- and 4-positions was not tolerated very well either, and 
changing the whole isochroman structure gave moderate enantioselectivities.  
 
The absolute stereochemistry of 1-allylisochroman 163 was determined and the other reaction 
products were assigned by analogy. In order to demonstrate the synthetic utility of our 
developed method, we employed the procedure in two applications: the Suzuki coupling of 
enantiomerically enriched 5-brominated 1-allylisochroman 202e and the synthesis of drug 
(R)-(+)-U-101387 212.  
 
To shed light on the origins of the observed enantioselectivity, we decided to carry out some 
test reactions with different additives, although unfortunately these turned out not be 
particularly helpful. We also paid special attention to the catalyst preparation, which seems to 
play a significant role in the enantioselectivity. In another experiment, we employed the sulfur 
analogue of phosphoramide (R)-45g in the allylation reaction and a big drop in the e.r. value 
was observed. Therefore, we reasoned that the oxygen in the P=O bond plays an important 
role in the stereodetermining step, most likely forming a hydrogen bond to the 
substrate/intermediate in the transition state. Our Brønsted acid-catalysed asymmetric 
allylation may be a dynamic kinetic resolution. This is suggested by the rapid racemisation of 
both single enantiomers of 1-ethoxyisochroman 166 under the optimised reaction conditions 
and by following the e.r. value during the asymmetric allylation, which remained constant 
over the course of the reaction. Finally, all results and observations were brought together to 




In the final section of the Results and Discussion (Chapter 3.3), we focused on chiral sulfonic 
acids. A possible pathway for the synthesis of two new classes of chiral sulfonic acids based 




4.2 Further Work  
 
After finishing the synthesis of the 3,3’-unsubstituted sulfonic acid (R)-226 and its 
investigation in the asymmetric allylation of dimethyl acetals, a range of 3,3’-substituted 
sulfonic acids could be prepared (based on the knowledge transfer from the 3,3’-substituted 
phosphoramides) and their enantioselective catalytic potential investigated.  
 
Other mechanistic studies of the isochroman based acetal system could be carried out: 
• a cross-over experiment to investigate the mechanism of the acetal epimerisation; 
• D-labelling on the 1-position of 1-ethoxyisochroman 166 and measurement of 
secondary KIEs to shed light on the nature of the reactive electrophile (sp3 → SN2-like 
or sp2 → oxacarbenium ion)  
 
Computational modelling of the isochroman-based acetal system with a simplified 
phosphoramide would also be interesting. 
 























Elemental analyses were recorded on a Carlo Erba EA1110 simultaneous CHNS analyser and 
performed by the University of Birmingham microanalytical services. Infra red spectra were 
recorded either neat as thin films or as a CHCl3 solution between NaCl discs, on a Perkin 
Elmer FT-IR PARAGON 1000 spectrometer. The intensity of each band is described as s 
(strong), m (medium), or w (weak) and with the prefix v (very) and suffix br (broad) where 
appropriate. 1H-NMR spectra were recorded in CDCl3 (unless stated otherwise) at ambient 
temperature on a Bruker AC-300 (300 MHz), Bruker AMX 400 (400 MHz) or Bruker DRX 
500 (500 MHz) spectrometer, and are reported as follows: chemical shift δ (ppm), (number of 
protons, multiplicity, coupling constant J (Hz), assignment). Connectivities were deduced 
from COSY90, HSQC and HMBC experiments. The term “stack” is used to describe a region 
where resonances arising from non-equivalent nuclei are coincident, or, in the case of 
mixtures of compounds (e.g. diastereoisomers), to refer to the coincidence of an unresolved 
resonance proton(s) in both diastereoisomers. “Multiplet”, m, is used to describe a region 
where resonances arising from a single nucleus (or equivalent nuclei) are coincident but 
coupling constants cannot be readily assigned. Fractional integrations are used when 
describing mixtures of diastereoisomers, when the resonance for the same proton in the two 
diastereoisomers does not coincide. Residual protic solvent CHCl3 (δH = 7.26 ppm) was used 
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as an internal reference. 13C-NMR spectra were recorded in CDCl3 (unless stated otherwise) 
at ambient temperature on a Bruker AC-300 (75 MHz), Bruker AV-300 (75 MHz), Bruker 
AMX 400 (100 MHz) or Bruker DRX 500 (125 MHz) spectrometer, and are reported as 
follows: chemical shift δ (ppm), (multiplicity, assignment). The central resonance of CDCl3 
(δC = 77.0 ppm) was used as an internal reference. 31P-NMR spectra were recorded in CDCl3 
(unless stated otherwise) at ambient temperature on a Bruker AV-300 (121 MHz) 
spectrometer, and are reported as follows: chemical shift δ (ppm), (multiplicity, assignment). 
19F-NMR spectra were recorded in CDCl3 (unless stated otherwise) at ambient temperature on 
Bruker AV-300 (282 MHz) spectrometer, and are reported as follows: chemical shift δ (ppm), 
(multiplicity, assignment). EI (electron impact) and GC-MS mass spectra were recorded on a 
VG Prospec mass spectrometer, and TOF-ES+ mass spectra were recorded on a Micromass 
LCT spectrometer, and are reported as (m/z (%)). HRMS were recorded on a Micromass LCT 
spectrometer, using a lock mass incorporated into the mobile phase. Melting points were 
determined using open capillaries on a Gallenkamp MDP350 melting point apparatus and are 
uncorrected. Optical rotations were measured in chloroform (unless stated otherwise) using an 
Optical Activity PolAAr2001 automatic polarimeter. Analytical chiral HPLC was performed 
using a Daicel Chiral Pak AD DAIC19025 250 mm x 4.6 mm chiral column with a flow rate 
of 1 mL/min. 
 
 
5.2 Chemicals and Reagents 
 
All reagents were obtained from commercial sources and used without further purification 
unless stated otherwise. THF and Et2O were freshly distilled from sodium benzophenone 
ketyl. Toluene was distilled from Na. MeOH was distilled from Mg + I2 and stored under N2 
at room temperature over activated 4 Å molecular sieves (activated by heating under a 
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vacuum for 15 min with a Bunsen flame immediately before use). NEt3 was distilled from 






All reactions were conducted in oven-dried (140 °C) or flame-dried glassware under a argon 
atmosphere, and at ambient temperature (19 to 25 °C) unless stated otherwise, with magnetic 
stirring. Volumes of 1 mL or less were measured and dispensed with Hamilton gastight 
syringes. Reactions were monitored by thin-layer chromatography (TLC) using pre-coated 
glass-backed silica-rapid plates (60A F254) and visualised by UV detection (at 254 nm) and 
with ammonium molybdate(IV)-cerium(IV) sulfate or potassium manganate(VII) staining dip. 
Column chromatography was performed on Fluka 60 (40-60 µm mesh) silica gel. Evaporation 
and concentration under reduced pressure were performed at 50-500 mbar. Residual solvent 





General procedure for the formation of dimethyl acetals derived from arylaldehydes  
 
The dimethyl acetals 147-152 were prepared following a previously reported procedure for 
the preparation of 2-naphthaldehyde dimethyl acetal 147:[144]  
Trimethylorthoformate (0.82 mL, 7.50 mmol) and pTSA (5 mg, 0.028 mmol) were added to a 
solution of the aldehyde (5.00 mmol) in dry MeOH (1.5 mL). After stirring at R. T. for the 
specified time, NaHCO3 solution (25 mL) and CH2Cl2 (25 mL) were added, and the layers 
 120 
were separated. The organic layer was washed with brine (25 mL) and dried (Na2SO4). The 
drying agent was removed by filtration and the filtrate concentrated under reduced pressure to 
provide the crude product. Unless otherwise stated, the isolated crude product was sufficiently 
pure for characterisation and further use. 
 
 
2-Naphthaldehyde dimethyl acetal 147 
 
OCH3
OCH3 Chemical Formula: C13H14O2
Exact Mass: 202.0994
Molecular Weight: 202.2491
Elemental Analysis: C, 77.20; H, 6.98; O, 15.82  
 
Acetal 147 was prepared from 2-naphthaldehyde (781 mg, 5.00 mmol), trimethylorthoformate 
(0.82 mL, 7.50 mmol) and  pTSA (5 mg, 0.028 mmol) in MeOH (1.5 mL) according to the 
general procedure. After 2 h, work-up afforded acetal 147 as a yellowish liquid (630 mg, 
97%): δH(300 MHz) 3.38 (6H, s, CH(OCH3)2), 5.57 (1H, s, CH(OCH3)2), 7.44-7.59 (3H, 
stack, ArH), 7.81-7.96 (4H, stack, ArH); δC(75 MHz, C6D6) 52.1 (CH3, OCH3), 103.0 (CH, 
CH(OCH3)2), 125.1 (CH, Ar), 126.36 (CH, Ar), 126.40 (CH, Ar), 126.7 (CH, 2 × Ar, 
resonance overlap), 128.3 (CH, Ar), 128.7 (CH, Ar), 133.7 (quat. C, ipso Ar), 134.0 (quat. C, 
ipso Ar), 136.4 (quat. C, ipso Ar); m/z (EI) 202 ([M]+, 16%), 171 (100, [M – OCH3]
+), 155 
(22), 127 (28), 75 (13).  
 









OCH3 Chemical Formula: C9H11NO4
Exact Mass: 197.0688
Molecular Weight: 197.1879
Elemental Analysis: C, 54.82; H, 5.62; N, 7.10; O, 32.46
 
 
Acetal 148 was prepared from 4-nitrobenzaldehyde (500 mg, 3.31 mmol), 
trimethylorthoformate (545 µL, 4.96 mmol) and  pTSA (3 mg, 0.019 mmol) in MeOH (1.0 
mL) according to the general procedure. After 3 h, work-up afforded acetal 148 as a yellow 
liquid (642 mg, 98%): δH(300 MHz) 3.33 (6H, s, CH(OCH3)2), 5.47 (1H, s, CH(OCH3)2), 
7.64 (2H, d, J 8.6, ArH), 8.23 (2H, d, J 8.6, ArH); δC(75 MHz) 52.6 (CH3, OCH3), 101.5 (CH, 
CH(OCH3)2), 123.3 (CH, Ar), 127.7 (CH, Ar), 145.0 (quat. C, ipso Ar), 147.9 (quat. C, ipso 
Ar); m/z (EI) 196 ([M – H]+, 13%), 166 (100, [M – OCH3]
+), 120 (27), 75 (15).  
 
Data were in agreement with those reported in the literature.[183]  
 
 








Elemental Analysis: C, 65.91; H, 7.74; O, 26.34  
 
Acetal 149 was prepared from 3-methoxybenzaldehyde (560 mg, 4.11 mmol), 
trimethylorthoformate (675 µL, 6.17 mmol) and  pTSA (4 mg, 0.023 mmol) in MeOH (1.2 
mL) according to the general procedure. After 2 h, work-up afforded acetal 149 as a pale 
orange liquid (749 mg, 100%): δH(300 MHz, C6D6) 3.14 (6H, s, CH(OCH3)2), 3.32 (3H, s, 
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ArOCH3), 5.35 (1H, s, CH(OCH3)2), 6.75-6.82 (1H, m, ArH), 7.10-7.29 (3H, stack, ArH); 
δC(75 MHz, C6D6) 52.0 (CH3, CH(OCH3)2), 54.8 (CH3, ArOCH3), 102.8 (CH, CH(OCH3)2), 
112.7 (CH, Ar), 114.5 (CH, Ar), 119.6 (CH, Ar), 129.5 (CH, Ar), 140.6 (quat. C, ipso Ar), 
160.3 (quat. C, ipso Ar); m/z (EI) 182 ([M]+, 12%), 151 (100, [M – OCH3]
+), 136 (12), 135 
(12), 108 (9), 75 (14).  
 
 




OCH3 Chemical Formula: C10H14O3
Exact Mass: 182.0943
Molecular Weight: 182.2164
Elemental Analysis: C, 65.91; H, 7.74; O, 26.34
 
 
Acetal 150 was prepared from 4-methoxybenzaldehyde (5.60 g, 41.1 mmol), 
trimethylorthoformate (6.75 mL, 61.7 mmol) and  pTSA (44 mg, 0.230 mmol) in MeOH (12 
mL) according to the general procedure. After 2 h, work-up with 2 M NaOH solution (100 
mL) [instead of NaHCO3 solution] afforded acetal 150 as a colourless liquid (7.49 g, 100%): 
δH(300 MHz, C6D6) 3.16 (6H, s, CH(OCH3)2), 3.29 (3H, s, ArOCH3), 5.37 (1H, s, 
CH(OCH3)2), 6.81 (2H, d, J 8.6, ArH), 7.50 (2H, d, J 8.6, ArH); δC(75 MHz, C6D6) 51.9 
(CH3, CH(OCH3)2), 54.8 (CH3, ArOCH3), 102.9 (CH, CH(OCH3)2), 113.8 (CH, Ar), 128.5 
(CH, Ar), 131.1 (quat. C, ipso Ar), 160.2 (quat. C, ipso Ar); m/z (EI) 182 ([M]+, 7%), 151 
(100, [M – OCH3]
+), 135 (16).  
 








OCH3 Chemical Formula: C9H11FO2
Exact Mass: 170.0743
Molecular Weight: 170.1808
Elemental Analysis: C, 63.52; H, 6.52; F, 11.16; O, 18.80
 
 
Acetal 151 was prepared from 4-fluorobenzaldehyde (588 mg, 4.74 mmol), 
trimethylorthoformate (775 µL, 7.11 mmol) and  pTSA (5 mg, 0.028 mmol) in MeOH (1.5 
mL) according to the general procedure. After 8 h, work-up afforded acetal 151 as a 
colourless liquid (734 mg, 91%): δH(300 MHz) 3.31 (6H, s, CH(OCH3)2), 5.37 (1H, s, 
CH(OCH3)2), 7.00-7.10 (2H, m, ArH), 7.39-7.46 (2H, m, ArH); δC(75 MHz) 52.0 (CH3, 
CH(OCH3)2), 101.9 (CH, CH(OCH3)2), 114.4 (CH, d, 
2JC-F 21.4, Ar), 127.8 (CH, d, 
3JC-F 8.3, 
Ar), 133.4 (quat. C, d, 4JC-F 3.1, ipso Ar), 162.1 (quat. C, d, 
1JC-F 245.0, ipso Ar); δF(282 
MHz) –114.2 (F, s, ArF); m/z (EI) 170 ([M]+, 4%), 139 (100, [M – OCH3]
+), 123 (47), 109 
(43), 95 (43), 91 (10), 75 (30).  
 
Data were in agreement with those reported in the literature.[185]  
 
 




OCH3 Chemical Formula: C9H11ClO2
Exact Mass: 186.0448
Molecular Weight: 186.6354
Elemental Analysis: C, 57.92; H, 5.94; Cl, 19.00; O, 17.15
 
 
Acetal 152 was prepared from 4-chlorobenzaldehyde (15.0 g, 107 mmol), 
trimethylorthoformate (17.5 mL, 160 mmol) and  pTSA (45 mg, 0.237 mmol) in MeOH (30 
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mL) according to the general procedure. After 8 h, work-up and purification by vacuum 
distillation (bp 90 °C/10 mmHg) afforded acetal 152 as a colourless liquid (18.2 g, 91%): 
δH(300 MHz) 3.31 (6H, s, CH(OCH3)2), 5.37 (1H, s, CH(OCH3)2), 7.31-7.42 (4H, stack, 
ArH); δC(75 MHz) 52.5 (CH3, OCH3), 102.2 (CH, CH(OCH3)2), 128.1 (CH, Ar), 128.3 (CH, 
Ar), 134.2 (quat. C, ipso Ar), 136.6 (quat. C, ipso Ar); m/z (EI) 186 ([M – H]+, 6%), 155 (100, 
[M – OCH3]
+), 139 (20), 111 (14), 91 (32), 75 (22).  
 
Data were in agreement with those reported in the literature.[184]  
 
 
General procedure for the formation of homoallylic methylethers 153-159 
 
Method A: Racemic allylation 
MeSO3H (215 µL, 3.29 mmol) was added to a solution of the dimethyl acetal (3.29 mmol) 
and allyltrimethylsilane (575 µL, 3.61 mmol) in CH2Cl2 (16 mL) at 0 °C. After stirring at R.T. 
for the specified time, NaHCO3 solution (50 mL) and CH2Cl2 (90 mL) were added, and the 
layers were separated. The aqueous phase was extracted with CH2Cl2 (15 mL) and the 
combined organic fractions were washed with brine (50 mL) and dried (Na2SO4). The drying 
agent was removed by filtration and the filtrate concentrated under reduced pressure to 
provide the crude product, which was purified by flash column chromatography. 
 
Method B: Asymmetric allylation 
Phosphoric acid (S)-32g or phosphoramide (R)- or (S)-45d, respectively (0.033 mmol) was 
added to a solution of the dimethyl acetal (0.332 mmol) and allyltrimethylsilane (65 µL, 0.399 
mmol) in a specified solvent (0.75 mL) and stirred at R.T. After the specified time, NaHCO3 
solution (10 mL) and CH2Cl2 (10 mL) were added, and the layers were separated. The 
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aqueous layer was extracted with CH2 l2 (5 mL) and the combined organic layers were 
washed with brine (10 mL) and dried (Na2SO4). The drying agent was removed by filtration 
and the filtrate concentrated under reduced pressure to provide the crude product, which was 





OCH3 Chemical Formula: C11H14O
Exact Mass: 162.1045
Molecular Weight: 162.2283
Elemental Analysis: C, 81.44; H, 8.70; O, 9.86  
 
Racemic ether 153 was prepared from benzaldehyde dimethyl acetal 146 (495 µL, 3.29 
mmol), allyltrimethylsilane (575 µL, 3.61 mmol) and MeSO3H (215 µL, 3.29 mmol) in 
CH2Cl2 (16 mL) according to Method A. After 5 h, work-up and purification by flash column 
chromatography (95% hexane, 5% Et2O) afforded methyl ether 153 as a colourless liquid 
(251 mg, 47% (reduced yield owing to volatility of the product)): Rf = 0.36 (95% hexane, 5% 
Et2O); νmax(film)/cm-1 3076s (CH=CH2), 3029m, 2980s (CH2CH=CH2), 2936s 
(CH2CH=CH2), 2854m, 2821s (OCH3), 1951w, 1876w, 1829w, 1641s, 1602m (C=C 
aromatic), 1547w, 1494s (C=C aromatic), 1454s, 1440w, 1357m, 1339w, 1307m, 1288w, 
1238m, 1198m, 1155w, 1101s, 1073w, 1042w, 1027w, 999m, 975m, 915s, 856m, 824w, 
758s, 701s, 654m, 608m; δH(300 MHz) 2.36-2.47 (1H, m, CHaHbCH=CH2), 2.52-2.64 (1H, 
m, CHaHbCH=CH2), 3.23 (3H, s, OCH3), 4.18 (1H, dd, J 7.2, 6.1, CH(OCH3)), 5.00-5.11 (2H, 
stack, CH2CH=CH2), 5.70-5.86 (1H, m, CH2CH=CH2), 7.24-7.40 (5H, stack, PhH); δC(75 
MHz) 42.5 (CH2, CH2CH=CH2), 56.6 (CH3, OCH3), 83.6 (CH, CH(OCH3)), 116.8 (CH2, 
CH2CH=CH2), 126.7 (CH, Ar), 127.5 (CH, Ar), 128.3 (CH, Ar), 134.8 (CH, CH2 =CH2), 
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141.6 (quat. C, ipso Ar); m/z (EI) 121 ([M – C3H5]
+, 100%), 91 (21), 84 (14), 77 (36), 49 (19), 
44 (54).  
 





OCH3 Chemical Formula: C15H16O
Exact Mass: 212.1201
Molecular Weight: 212.2869
Elemental Analysis: C, 84.87; H, 7.60; O, 7.54  
 
Racemic ether 154 was prepared from 2-naphthaldehyde dimethyl acetal 147 (300 mg, 1.48 
mmol), allyltrimethylsilane (260 µL, 1.63 mmol) and MeSO3H (95 µL, 1.48 mmol) in CH2Cl2 
(7 mL) according to Method A. After 15 min at 0 °C, work-up and purification by flash 
column chromatography (95% hexane, 5% Et2O) afforded methyl ether 154 as a colourless 
liquid (225 mg, 72%): Rf = 0.25 (95% hexane, 5% Et2O); νmax(film)/cm-1 3057s (CH=CH2), 
2980s (CH2CH=CH2), 2934s (CH2CH=CH2), 2903m, 2853m, 2820s (OCH3), 1922w, 1830w, 
1641m, 1602m (C=C aromatic), 1508m, 1464m, 1444m, 1371m, 1322m, 1271m, 1236w, 
1190m, 1170w, 1154w, 1098s, 1042w, 1019w, 998m, 982m, 950w, 916s, 857s, 820s, 747s, 
717w, 665m, 620w; δH(300 MHz) 2.45-2.57 (1H, m, CHaHbCH=CH2), 2.61-2.73 (1H, m, 
CHaHbCH=CH2), 3.27 (3H, s, OCH3), 4.35 (1H, app. t, J 6.8, CH(OCH3)), 5.00-5.12 (2H, 
stack, CH2CH=CH2), 5.72-5.87 (1H, m, CH2CH=CH2), 7.43-7.54 (3H, stack, ArH), 7.73 (1H, 
s, ArH), 7.80-7.89 (3H, stack, ArH); δC(75 MHz) 42.4 (CH2, CH2CH=CH2), 56.7 (CH3, 
OCH3), 83.7 (CH, CH(OCH3)), 117.0 (CH2, CH2CH=CH2), 124.4 (CH, Ar), 125.7 (CH, Ar), 
125.9 (CH, Ar), 126.0 (CH, Ar), 127.7 (CH, Ar), 127.8 (CH, Ar), 128.2 (CH, Ar), 133.07 
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(quat. C, ipso Ar), 133.14 (quat. C, ipso Ar), 134.6 (CH, CH2CH=CH2), 139.0 (quat. C, ipso 
Ar); m/z (TOF ES+) 425.1 ([M + Na]+, 100%); HRMS: C15H16ONa calcd 235.1099 ([M + 






OCH3 Chemical Formula: C11H13NO3
Exact Mass: 207.0895
Molecular Weight: 207.2258
Elemental Analysis: C, 63.76; H, 6.32; N, 6.76; O, 23.16
 
 
Racemic ether 155 was prepared from 4-nitrobenzaldehyde dimethyl acetal 148 (300 mg, 1.52 
mmol), allyltrimethylsilane (265 µL, 1.67 mmol) and MeSO3H (100 µL, 1.52 mmol) in 
CH2Cl2 (7 mL) according to Method A. After 17 h, work-up and purification by flash column 
chromatography (90% hexane, 10% Et2O) afforded methyl ether 155 as a yellow-orange oil 
(78 mg, 25%): Rf = 0.19 (90% hexane, 10% Et2O); νmax(film)/cm-1 3078m (CH=CH2), 2983m 
(CH2CH=CH2), 2934s (CH2CH=CH2), 2825m (OCH3), 2361w, 1641m, 1607s (C=C 
aromatic), 1522s (NO2), 1491w, 1443w, 1416w, 1346s (NO2), 1317w, 1290m, 1239w, 
1198m, 1156w, 1106s, 1039w, 1014m, 999w, 982w, 920s, 855s, 842w, 777w, 754m, 722w, 
701s, 666m; δH(300 MHz) 2.34-2.46 (1H, m, CHaHbCH=CH2), 2.48-2.60 (1H, m, 
CHaHbCH=CH2), 3.25 (3H, s, OCH3), 4.29 (1H, app. t, J 6.4, CH(OCH3)), 4.97-5.07 (2H, 
stack, CH2CH=CH2), 5.64-5.80 (1H, m, CH2CH=CH2), 7.45 (2H, d, J 8.6, ArH), 8.21 (2H, d, 
J 8.6, ArH); δC(75 MHz) 42.1 (CH2, CH2CH=CH2), 57.1 (CH3, OCH3), 82.7 (CH, 
CH(OCH3)), 117.8 (CH2, CH2CH=CH2), 123.6 (CH, Ar), 127.4 (CH, Ar), 133.4 (CH, 
CH2CH=CH2), 147.4 (quat. C, ipso Ar), 149.4 (quat. C, ipso Ar); m/z (EI) 166 ([M – C3H5]
+, 
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100%), 136 (10), 120 (34), 108 (16), 91 (12), 77 (11), 51 (10); HRMS: C8H8NO3 calcd 
166.0504 ([M – C3H5]










Elemental Analysis: C, 74.97; H, 8.39; O, 16.64  
 
Racemic ether 156 was prepared from 3-methoxybenzaldehyde dimethyl acetal 149 (200 mg, 
1.10 mmol), allyltrimethylsilane (190 µL, 1.21 mmol) and MeSO3H (70 µL, 1.10 mmol) in 
CH2Cl2 (5 mL) according to Method A. After 30 min stirring at 0 °C, work-up and 
purification by flash column chromatography (95% hexane, 5% Et2O) afforded methyl ether 
156 as a colourless liquid (129 mg, 61%): Rf = 0.14 (95% hexane, 5% Et2O); νmax(film)/cm-1 
3075m (CH=CH2), 2979s (CH2CH=CH2), 2937s (CH2CH=CH2), 2835s, 2822s (OCH3), 
1839w, 1641m, 1601s (C=C aromatic), 1587s, 1499s, 1455m, 1435m, 1351m, 1316m, 1286s, 
1258s, 1191m, 1155m, 1102s, 1050s, 996m, 983m, 917m, 876m, 826w, 784m, 755w, 735w, 
702s, 666m; δH(300 MHz) 2.34-2.45 (1H, m, CHaHbCH=CH2), 2.49-2.60 (1H, m, 
CHaHbCH=CH2), 3.22 (3H, s, OCH3), 3.81 (3H, s, ArOCH3), 4.14 (1H, dd, J 7.5, 5.7, 
CH(OCH3)), 4.98-5.11 (2H, stack, CH2CH=CH2), 5.69-5.84 (1H, m, CH2CH=CH2), 6.77-6.90 
(3H, stack, ArH), 7.20-7.30 (1H, m, ArH); δC(75 MHz) 42.4 (CH2, CH2CH=CH2), 55.1 (CH3, 
CH(OCH3) or ArOCH3), 56.6 (CH3, CH(OCH3) or ArOCH3),  83.5 (CH, CH(OCH3)), 111.9 
(CH, Ar), 112.9 (CH, Ar), 116.7 (CH2, CH2CH=CH2), 119.1 (CH, Ar), 129.2 (CH, Ar), 134.7 
(CH, CH2CH=CH2), 143.4 (quat. C, ipso Ar), 159.7 (quat. C, ipso Ar); m/z (EI) 151 ([M – 
C3H5]
+, 100%), 136 (9); HRMS: C9H11O2 calcd 151.0759 ([M – C3H5]
+), obsd 151.0753. 
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OCH3 Chemical Formula: C12H16O2
Exact Mass: 192.115
Molecular Weight: 192.2542
Elemental Analysis: C, 74.97; H, 8.39; O, 16.64
 






Elemental Analysis: C, 83.12; H, 8.97; O, 7.91
 
                                 160 
 
Racemic ether 157 was prepared from 4-methoxybenzaldehyde dimethyl acetal 150 (200 mg, 
1.10 mmol), allyltrimethylsilane (190 µL, 1.21 mmol) and MeSO3H (70 µL, 1.10 mmol) in 
CH2Cl2 (5 mL) according to Method A. After 17 h, work-up and purification by flash column 
chromatography (95% hexane, 5% Et2O) afforded, in order of elution, diene 160 as a 
colourless liquid (3 mg, 1%): Rf = 0.43 (95% hexane, 5% Et2O); δH(300 MHz) 2.24-2.46 (4H, 
m, CH2CH=CH2), 2.69-2.73 (1H, m, CH(CH2CH=CH2)2), 3.79 (3H, s, ArOCH3), 4.89-5.02 
(4H, m, CH2CH=CH2), 5.58-5.74 (2H, stack, CH2CH=CH2), 6.83 (2H, d, J 8.5, ArH), 7.07 
(2H, d, J 8.5, ArH); δC(75 MHz) 40.5 (CH2, CH2CH=CH2), 44.7 (CH, CH(CH2CH=CH2)2), 
55.2 (CH3, ArOCH3), 113.6 (CH, Ar), 116.0 (CH2, CH2CH=CH2), 128.6 (CH, Ar), 136.7 
(quat. C, ipso Ar), 136.9 (CH, CH2CH=CH2), 157.8 (quat. C, ipso Ar); m/z (EI) 202 ([M]
+, 
4%), 161 (100, [M – C3H5]
+), 146 (10), 91 (13); and then methyl ether 157 as a colourless 
liquid (150 mg, 71%): Rf = 0.14 (95% hexane, 5% Et2O); νmax(film)/cm-1 3075m (CH=CH2), 
2979s (CH2CH=CH2), 2935s (CH2CH=CH2), 2904s, 2836s, 2820s (OCH3), 2061w, 1885w, 
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1641m, 1612s (C=C aromatic), 1586m, 1513s (C=C aromatic), 1464m, 1442m, 1355m, 
1303s, 1248s, 1173s, 1096s, 1036s, 999m, 976m, 916s, 862m, 832s, 812m, 771m, 740w, 
632w; δH(300 MHz) 2.33-2.44 (1H, m, CHaHbCH=CH2), 2.51-2.62 (1H, m, CHaHbCH=CH2), 
3.19 (3H, s, CH(OCH3)), 3.81 (3H, s, ArOCH3), 4.12 (1H, t, J 7.7, CH(OCH3)), 4.98-5.10 
(2H, stack, CH2CH=CH2), 5.67-5.83 (1H, m, CH2CH=CH2), 6.89 (2H, d, J 8.6, ArH), 7.21 
(2H, d, J 8.6, ArH); δC(75 MHz) 42.4 (CH2, CH2CH=CH2), 55.1 (CH3, CH(OCH3) or 
ArOCH3), 56.3 (CH3, CH(OCH3) or ArOCH3),  83.1 (CH, CH(OCH3)), 113.6 (CH, Ar), 116.7 
(CH2, CH2CH=CH2), 127.8 (CH, Ar), 133.5 (quat. C, ipso Ar), 134.8 (CH, CH2CH=CH2), 
159.0 (quat. C, ipso Ar); m/z (EI) 151 ([M – C3H5]
+, 100%), 136 (9); HRMS: C9H11O2 calcd 
151.0759 ([M – C3H5]
+), obsd 151.0753. 
 






OCH3 Chemical Formula: C11H13FO
Exact Mass: 180.095
Molecular Weight: 180.2187
Elemental Analysis: C, 73.31; H, 7.27; F, 10.54; O, 8.88
 
 
Racemic ether 158 was prepared from 4-fluorobenzaldehyde dimethyl acetal 151 (200 mg, 
1.18 mmol), allyltrimethylsilane (205 µL, 1.29 mmol) and MeSO3H (75 µL, 1.18 mmol) in 
CH2Cl2 (5 mL) according to Method A. After 3 h, work-up and purification by flash column 
chromatography (95% hexane, 5% Et2O) afforded methyl ether 158 as a colourless liquid (75 
mg, 36% (reduced yield owing to volatility of the product)): Rf = 0.20 (95% hexane, 5% 
Et2O); νmax(film)/cm-1 3077m (CH=CH2), 2982s (CH2CH=CH2), 2934s (CH2CH=CH2), 
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2905s, 2854m, 2822s (OCH3), 1894w, 1642m, 1605s (C=C aromatic), 1509s (C=C aromatic), 
1466w, 1443w, 1417w, 1347m, 1296m, 1223s (ArC–F), 1156s, 1102s, 1042w, 1014m, 999m, 
978m, 918s, 864m, 836s, 783w, 740w, 722w, 649w, 631w, 568s; δH(300 MHz) 2.32-2.44 
(1H, m, CHaHbCH=CH2), 2.49-2.61 (1H, m, CHaHbCH=CH2), 3.20 (3H, s, OCH3), 4.15 (1H, 
app. t, J 6.6, CH(OCH3)), 4.99-5.09 (2H, stack, CH2CH=CH2), 5.65-5.81 (1H, m, 
CH2CH=CH2), 6.99-7.08 (2H, stack, ArH), 7.21-7.29 (2H, stack, ArH); δC(75 MHz) 42.5 
(CH2, CH2CH=CH2), 56.6 (CH3, OCH3), 82.9 (CH, CH(OCH3)), 115.2 (CH, d, 
2JC-F 21.1, 
Ar), 117.1 (CH2, CH2CH=CH2), 128.3 (CH,  d, 
3JC-F 8.3, Ar), 134.4 (CH, CH2CH=CH2), 
137.3 (quat. C, d, 4JC-F 3.1, ipso Ar), 162.2 (quat. C, d, 
1JC-F 243.9, ipso Ar); δF(282 MHz) –
115.5 (F, s, ArF); m/z (EI) 139 ([M – C3H5]
+, 100%), 109 (17); HRMS: C8H8FO calcd 
139.0559 ([M – C3H5]






OCH3 Chemical Formula: C11H13ClO
Exact Mass: 196.0655
Molecular Weight: 196.6733
Elemental Analysis: C, 67.18; H, 6.66; Cl, 18.03; O, 8.14
 
 
Racemic ether 159 was prepared from 4-chlorobenzaldehyde dimethyl acetal 152 (200 mg, 
1.07 mmol), allyltrimethylsilane (185 µL, 1.18 mmol) and MeSO3H (70 µL, 1.07 mmol) in 
CH2Cl2 (5 mL) according to Method A. After 3 h, work-up and purification by flash column 
chromatography (95% hexane, 5% Et2O) afforded methyl ether 159 as a colourless liquid 
(116 mg, 55%): Rf = 0.31 (95% hexane, 5% Et2O); (Found: C, 67.27; H, 6.73. C11H13ClO 
requires C, 67.18; H, 6.66%); νmax(film)/cm-1 3077m (CH=CH2), 2981s (CH2CH=CH2), 
2933s (CH2CH=CH2), 2904m, 2851m, 2822s (OCH3), 1906w, 1642m, 1598m (C=C 
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aromatic), 1490s (C=C aromatic), 1464w, 1442w, 1409m, 1346m, 1277w, 1236w, 1187m, 
1105s, 1090s, 1041w, 1014s, 999w, 979m, 917s, 856m, 827s (ArC–Cl), 786m, 743w, 666w; 
δH(300 MHz) 2.31-2.44 (1H, m, CHaHbCH=CH2), 2.48-2.60 (1H, m, CHaHbCH=CH2), 3.21 
(3H, s, OCH3), 4.15 (1H, app. t, J6.6, CH(OCH3)), 4.96-5.09 (2H, stack, CH2CH=CH2), 5.65-
5.82 (1H, m, CH2CH=CH2), 7.20-7.28 (2H, stack, ArH), 7.29-7.36 (2H, stack, ArH); δC(75 
MHz) 42.4 (CH2, CH2CH=CH2), 56.7 (CH3, OCH3), 82.9 (CH, CH(OCH3)), 117.2 (CH2, 
CH2CH=CH2), 128.1 (CH, Ar), 128.5 (CH, Ar), 133.2 (quat. C, ipso Ar), 134.2 (CH, 
CH2CH=CH2), 140.2 (quat. C, ipso Ar); m/z (EI) 155 ([M – C3H5]
+, 100%); HRMS: C8H8ClO 
calcd 155.0264 ([M – C3H5]
+), obsd 155.0259. 
 
Data were in agreement with those reported in the literature.[53]  
 
 







Elemental Analysis: C, 24.80; H, 3.47; Br, 55.00; Mg, 16.73  
 
A 250 mL three-neck round-bottom flask, equipped with a reflux condenser and a dropping 
funnel, was charged with Mg turnings (7.00 g, 288 mmol). Sufficient Et2O (~ 15 mL) was 
added to cover the Mg turnings under fast stirring. A few I2 crystals were added and the 
brown colour disappeared within 1 min indicating the activation of the Mg. A solution of allyl 
bromide (9.95 mL, 115 mmol) in Et2O (90 mL) was then added dropwise (1 drop every 3 
seconds) until the reaction started and then the addition rate was increased to maintain a 
gentle reflux (1-2 drops every second). After the addition was finished, the suspension was 
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stirred for an additional 30 min and then left to settle. The ethereal solution was filtered and 
transferred via cannula (fitted with an oven-dried Whatman 1 filter paper) into a flask 









Elemental Analysis: C, 69.14; H, 12.89; Si, 17.96  
 
Chlorotriethylsilane (1.54 mL, 9.20 mmol) was added dropwise over 1 min to a vigorously 
stirred solution of allylmagnesium bromide in Et2O (0.92 M, 20 mL, 18.4 mmol). After 
heating at reflux overnight, the pale yellow suspension was cooled to 0 °C and a mixture of 
aqueous NH4Cl/NH3 solution (1:1, 25 mL) was added over a period of 3 min. The layers were 
separated and the aqueous phase was extracted with Et2O (20 mL). The combined organic 
fractions were washed with brine (30 mL) and dried (MgSO4). The drying agent was removed 
by filtration and the filtrate concentrated under reduced pressure to provide the crude product. 
Purification by silica plug (100% pentane) afforded allyltriethylsilane as a colourless liquid 
(753 mg, 52%): Rf = 0.80 (100% pentane); δH(300 MHz) 0.52 (6H, q, J 7.7, Si(CH2CH3)3), 
0.93 (9H, t, J 7.7, Si(CH2CH3)3), 1.51-1.57 (2H, m, SiCH2CH=CH2), 4.76-4.89 (2H, stack, 
SiCH2CH=CH2), 5.71-5.88 (1H, m, SiCH2CH=CH2); δC(75 MHz) 3.1 (CH2, Si(CH2CH3)3), 
7.3 (CH3, Si(CH2CH3)3), 19.5 (CH2, SiCH2CH=CH2), 112.4 (CH2, SiCH2CH=CH2), 135.4 
(CH, SiCH2CH=CH2); m/z (EI) 156 (11, [M]
+), 115 (100, [M – C3H5]
+), 99 (11), 87 (50). 
 








Elemental Analysis: C, 72.64; H, 13.21; Si, 14.15  
 
Chlorotriisopropylsilane (1.00 mL, 4.67 mmol) was added dropwise over 1 min to a 
vigorously stirred solution of allylmagnesium bromide in Et2O (0.92 M, 7.60 mL, 7.01 
mmol). After heating at reflux overnight, the pale yellow suspension was cooled to 0 °C and a 
mixture of aqueous NH4Cl/NH3 solution (1:1, 10 mL) was added over a period of 3 min. The 
layers were separated and the aqueous phase was extracted with Et2O (15 mL). The combined 
organic fractions were washed with brine (20 mL) and dried (MgSO4). The drying agent was 
removed by filtration and the filtrate concentrated under reduced pressure to provide the crude 
product. Purification by silica plug (100% hexane) afforded allyltriisopropylsilane as a 
colourless liquid (390 mg, 42%): Rf = 0.85 (100% hexane); δH(300 MHz) 0.90-1.12 (21H, 
stack, Si(CH(CH3)2)3, 1.58-1.67 (2H, m, SiCH2CH=CH2), 4.75-4.95 (2H, stack, 
SiCH2CH=CH2), 5.78-5.96 (1H, m, SiCH2CH=CH2); δC(75 MHz) 11.0 (CH, Si(CH(CH3)2)3), 
17.3 (CH2, SiCH2CH=CH2), 18.7 (CH3, Si(CH(CH3)2)3), 112.8 (CH2, SiCH2CH=CH2), 136.2 
(CH, SiCH2CH=CH2); m/z (EI) 198 (3, [M]
+), 157 (100, [M – C3H5]
+), 115 (50), 99 (13), 87 
(39), 85 (43), 73 (42), 59 (77), 43 (30) . 
 














Elemental Analysis: C, 72.87; H, 10.56; O, 8.82; Si, 7.75
 
 
Racemic phosphoramide 162 (9 mg, 0.018 mmol) was added to a solution of 1-
methoxyisochroman (30 mg, 0.183 mmol) and allyltriisopropylsilane (65 µL, 0.274 mmol) in 
p-xylene (360 µL). After stirring at R.T. for 24 h, NaHCO3 solution (15 mL) and Et2O (15 
mL) were added. The two phases were separated and the aqueous phase was extracted with 
Et2O (10 mL). The combined organic fractions were washed with brine (15 mL) and then 
dried (MgSO4). The drying agent was removed by filtration and the filtrate concentrated 
under reduced pressure to provide the crude product. Purification by flash column 
chromatography afforded isochroman 175 as a colourless liquid (17 mg, 26%; single 
diastereoisomer; stereochemistry not determined) amongst a range of unidentified by-
products: Rf = 0.31 (90% hexane, 10% Et2O); νmax(film)/cm-1 2942m, 2864m, 1497w, 1455m, 
1382m, 1231w, 1104s, 1066m, 987m, 944m, 873m, 743s; δH(500 MHz) 1.03-1.12 (23H, 
stack, CH2Si(CH(CH3)2)3), 1.79 (1H, ddd, J 13.6, 9.0, 3.0, CHaHb), 2.32 (1H, ddd, J 13.6, 
10.3, 3.4, CHaHb), 2.71 (1H, app. dt, J 16.2, 3.9, CHaHbCH2O), 2.99 (1H, ddd, J 15.7, 9.4, 
5.3, CHaHbCH2O), 3.27 (3H, s, OCH3), 3.64-3.71 (1H, m, CHOCH3), 3.75 (1H, ddd, J 11.3, 
9.4, 3.9, CH2CHaHbO), 4.12 (1H, ddd, J 11.3, 5.3, 4.1, CH2CHaHbO), 4.81 (1H, app. d, J 9.0, 
CHO), 7.07-7.21 (4H, stack, ArH); δC(125 MHz) 11.5 (CH, Si(CH(CH3)2)3), 15.4 (CH2, 
SiCH2), 18.8 (CH3, Si(CH(CH3)a(CH3)b)3), 18.9 (CH3, Si(CH(CH3)a(CH3)b)3), 29.0 (CH2, 
CH2CH2O), 42.3 (CH2, CH2), 55.6 (CH3, OCH3), 63.0 (CH2, CH2O), 73.6 (CH, CHO), 75.9 
(CH, CHOCH3), 124.6 (CH, Ar), 126.1 (CH, Ar), 126.2 (CH, Ar), 128.9 (CH, Ar), 133.7 
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(quat. C, ipso Ar), 138.6 (quat. C, ipso Ar); m/z (TOF ES+) 385.3 ([M + Na]+, 100%); 
HRMS: C22H38O2SiNa calcd 385.2539 ([M + Na]













MeSO3H (50 µL, 0.74 mmol) was added to a solution of 1-ethoxyisochroman 166 (120 mg, 
0.673 mmol) and 2-methallyltrimethylsilane (177 µL, 1.01 mmol) in CH2Cl2 (1.35 mL) at 0 
°C. A colour change from colourless to orange was observed. After stirring at R.T. for 20 
min, NaHCO3 solution (15 mL) and Et2O (15 mL) were added. The two phases were 
separated and the aqueous phase was extracted with Et2O (15 mL). The combined organic 
fractions were washed with brine (15 mL) and then dried (MgSO4). The drying agent was 
removed by filtration and the filtrate concentrated under reduced pressure to provide the crude 
product. Purification by flash column chromatography (99% hexane, 1% Et2O) afforded 
racemic isochroman 176 as a colourless liquid (56 mg, 44%): Rf = 0.30 (90% hexane, 10% 
Et2O); νmax(film)/cm-1 2965m, 2922m, 1649w, 1491m, 1452m, 1374m, 1279w, 1107s, 
1067m, 1040m, 886s, 743s; δH(300 MHz) 1.85 (3H, s, C(CH3)=CH2), 2.46-2.78 (3H, stack, 
CH2C(CH3)=CH2 and CHaHbCH2O), 2.98 (1H, ddd, J 15.8, 9.3, 5.5, CHaHbCH2O), 3.78 (1H, 
ddd, J 11.4, 9.3, 4.1, CH2CHaHbO), 4.15 (1H, app. td, J 11.4, 4.4, CH2CHaHbO), 4.81-4.97 
(3H, stack, CHCH2C(CH3)=CH2), 7.06-7.20 (4H, stack, ArH); δC(100 MHz) 22.5 (CH3, CH3), 
29.0 (CH2, CH2CH2O), 44.4 (CH2, CH2C(CH3)=CH2), 62.9 (CH2, CH2CH2O), 74.1 (CH, 
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CHO), 112.8 (CH2, CH2C(CH3)=CH2), 124.9 (CH, Ar), 126.0 (CH, Ar), 126.2 (CH, Ar), 
128.9 (CH, Ar), [133.9, 138.3, 142.8 (quat. C, CH2 (CH3)=CH2) and 2 × (quat. C, ipso Ar)]; 
m/z (EI) 188 ([M]+, 4%), 170 (56), 133 (100, [M – C4H7]
+), 129 (30), 116 (20), 104 (31), 90 
(12); HRMS: C13H16O calcd 188.1201 ([M]
+), obsd 188.1203. 
 
Asymmetric allylation:  
The phosphoramide catalyst (R)-45g (18 mg, 0.018 mmol) was added to a solution of the 1-
alkoxyisochroman (0.183 mmol) and allyltrimethylsilane (50 µL, 0.27 mmol) in o-xylene 
(360 µL). After stirring for 24 h at R.T., NaHCO3 solution (15 mL) and Et2O (15 mL) were 
added. The two phases were separated and the aqueous phase was extracted with Et2O (10 
mL). The combined organic fractions were washed with brine (15 mL) and then dried 
(MgSO4). The drying agent was removed by filtration and the filtrate concentrated under 
reduced pressure to provide the crude methallylisochroman product. After purification by 
flash column chromatography the e.r. was determined by chiral HPLC: Chiralpak AD, 1.0 
mL/min, 100% hexane, λ = 210 nm, tR,minor = 9.5 min, tR,major = 12.9 min; e.r. (using 1-
methoxyisochroman as starting material) = 40:60; e.r. (using 1-ethoxyisochroman as starting 
material) = 41:59. 
 
 






Elemental Analysis: C, 78.65; H, 8.25; O, 13.10  
 
Benzyl alcohol (1.50 g, 13.9 mmol) was added to a suspension of NaH (666 mg of a 60 wt % 
suspension in mineral oil, 16.6 mmol) in DMF (50 mL) at 0 °C. The mixture was stirred for 2 
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h at R.T. and then cooled to 0 °C.  MeI (1.10 mL, 18.0 mmol) was added and the mix ure was 
warmed to R.T. overnight. NH4Cl solution (50 mL) and Et2O (50 mL) were added and the 
layers were separated. The organic phase was washed sequentially with NaHCO3 solution (30 
mL), H2O (30 mL) and brine (30 mL), and then dried (MgSO4). The drying agent was 
removed by filtration and the filtrate concentrated under reduced pressure to provide the crude 
product. Purification by flash column chromatography (gradient: 99% pentane, 1% Et2O → 
95% pentane, 5% Et2O) afforded benzyl methyl ether as a colourless liquid (1.02 g, 60%, 
reduced yield owing to product volatility): Rf = 0.34 (90% hexane, 10% Et2O); δH(300 MHz) 
3.41 (3H, s, OCH3), 4.48 (2H, s, CH2O), 7.27-7.41 (5H, stack, ArH); δC(100 MHz) 58.0 (CH3, 
OCH3), 74.7 (CH2, CH2O), 127.6 (CH, Ar), 127.7 (CH, Ar), 128.4 (CH, Ar), 138.2 (quat. C, 
ipso Ar); m/z (EI) 122 ([M]+, 75%), 121 (65, [M – H]+), 91 (100, ([M – OCH3]




Data were in agreement with those reported in the literature.[189] 
 
 
(R)- and (S)-1-Methoxyethylbenzene (R)- and (S)-214 
 
OMe OMe Chemical Formula: C9H12O
Exact Mass: 136.0888
Molecular Weight: 136.191
Elemental Analysis: C, 79.37; H, 8.88; O, 11.75  
 
(S)-2-Phenyl ethanol (1.50 g, 12.3 mmol) was added to a suspension of NaH (540 mg of a 60 
wt % suspension in mineral oil, 13.5 mmol) in DMF (50 mL) at 0 °C. The mixture was stirred 
for 2 h at R.T. and then cooled to 0 °C.  MeI (920 µL, 14.7 mmol) was added and the mixture 
was warmed to R.T. overnight. NH4Cl solution (50 mL) and Et2O (50 mL) were added and 
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the layers were separated. The organic phase was washed sequentially with NaHCO3 solution 
(30 mL), H2O (30 mL) and brine (30 mL), and then dried (MgSO4). The drying agent was 
removed by filtration and the filtrate concentrated under reduced pressure to provide the crude 
product. Purification by flash column chromatography (gradient: 99% pentane, 1% Et2O → 
95% pentane, 5% Et2O) afforded (S)-ether 214 as a colourless liquid (1.04 g, 62%, reduced 
yield owing to product volatility): Rf = 0.38 (90% pentane, 10% Et2O); [α]D
20
 = –118.3 (neat) 
(lit. [190] [α]D
26
 = –114.0 (neat); δH(300 MHz) 1.44 (3H, d, J 6.5, CH3), 3.23 (3H, s, OCH3), 
4.30 (1H, q, J 6.5, ArCHO), 7.24-7.39 (5H, stack, ArH); δC(100 MHz) 23.9 (CH3, CH3), 56.4 
(CH3, OCH3), 79.6 (CH, CHO), 126.1 (CH, Ar), 127.4 (CH, Ar), 128.4 (CH, Ar), 143.5 (quat. 
C, ipso Ar); m/z (EI) 121 ([M – CH3]
+, 100%). 
  
The same protocol was followed for the preparation of the (R)-enantiomer: [α]D
20
 = +117.6 
(neat) (lit.[191] [α]D
25
 = +120.0 (neat)). 
 
Data were in agreement with those reported in the literature.[192] 
 
 
General procedure for the MOM-protection of different phenethyl alcohols 
 
The MOM-protected phenethyl alcohols 181 were prepared following a previously reported 
procedure for the preparation of [2-(methoxymethoxy)ethyl]benzene:[155]  
Sc(OTf)3 (191 mg, 0.389 mmol) was added to a solution of the alcohol (7.78 mmol) in FDMA 
(27 mL, 389 mmol) and CHCl3 (27 mL). The resulting mixture was heated at 75 °C. After the 
specified time, deionised H2O (20 mL) was added, and the layers were separated. The 
aqueous phase was extracted with CH2 l2 (2 × 10 mL) and the combined organic fractions 
were washed with brine (30 mL) and dried (MgSO4). [Removal of the H2O from the aqueous 
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phase allows recovery of the Sc(OTf)3, which can be reused]. The drying agent was removed 
by filtration and the filtrate concentrated under reduced pressure to provide the crude product. 
Unless otherwise stated, the isolated crude product was sufficiently pure for characterisation 









Elemental Analysis: C, 73.30; H, 8.95; O, 17.75  
 
Acetal 181a was prepared from 2-methylphenethyl alcohol (1.06 g, 7.78 mmol), FDMA (27 
mL, 389 mmol) and Sc(OTf)3 (191 mg, 0.389 mmol) in CHCl3 (27 mL) according to the 
general procedure. After 24 h, work-up afforded MOM ether 181a as a colourless liquid (1.40 
g, 97%): Rf = 0.23 (90% hexane, 10% Et2O); δH(300 MHz, C6D6) 2.13 (3H, s, ArCH3), 2.79 
(2H, t, J 7.2, CH2CH2O), 3.09 (3H, s, OCH3), 3.60 (2H, t, J 7.2, CH2CH2O), 4.44 (2H, s, 
OCH2OCH3), 6.98-7.11 (4H, stack, ArH); δC(75 MHz, C6D6) 19.4 (CH3, ArCH3), 33.9 (CH2, 
CH2CH2O), 54.8 (CH3, OCH3), 67.9 (CH2, CH2CH2O), 96.5 (CH2, OCH2OCH3), 126.3 (CH, 
Ar), 126.7 (CH, Ar), 129.9 (CH, Ar), 130.4 (CH, Ar), 136.5 (quat. C, ipso Ar), 137.5 (quat. C, 
ipso Ar); m/z (EI) 148 ([M – H – OCH3]
+, 13%), 119 (43, [M – OCH2OCH3]
+), 118 (100, [M 
– H – OCH2OCH3]
+), 105 (63, [M – CH2OCH2OCH3]
+), 91 (12, [M – H – 
CH2CH2OCH2OCH3]












Elemental Analysis: C, 73.30; H, 8.95; O, 17.75  
 
Acetal 181c was prepared from 4-methylphenethyl alcohol (1.76 g, 12.9 mmol), FDMA (45 
mL, 645 mmol) and Sc(OTf)3 (317 mg, 0.645 mmol) in CHCl3 (45 mL) according to the 
general procedure. After 24 h, work-up afforded MOM ether 181c as a pale brown liquid 
(2.46 g, quant): Rf = 0.25 (90% hexane, 10% Et2O); δH(300 MHz, C6D6) 2.13 (3H, s, ArCH3), 
2.78 (2H, t, J 6.9, CH2CH2O), 3.10 (3H, s, OCH3), 3.63 (2H, t, J 6.9, CH2CH2O), 4.45 (2H, s, 
OCH2OCH3), 6.98 (2H, d, J 8.0, ArH), 7.05 (2H, d, J 8.0, ArH); δC(100 MHz, C6D6) 21.1 
(CH3, ArCH3), 36.4 (CH2, CH2CH2O), 54.9 (CH3, OCH3), 68.9 (CH2, CH2CH2O), 96.6 (CH2, 
OCH2OCH3), 129.2 (CH, Ar), 129.3 (CH, Ar), 135.6 (quat. C, ipso Ar), 136.5 (quat. C, ipso 
Ar); m/z (EI) 119 ([M – OCH2OCH3]
+, 39%), 118 (90, [M – H – OCH2OCH3]











Elemental Analysis: C, 73.30; H, 8.95; O, 17.75  
 
Acetal 181l was prepared from phenpropyl alcohol (2.00 mL, 14.8 mmol), FDMA (65 mL, 
740 mmol) and Sc(OTf)3 (364 mg, 0.740 mmol) in CHCl3 (65 mL) according to the general 
procedure. After 24 h, work-up afforded MOM ether 181l as a colourless liquid (2.62 g, 
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98%): Rf = 0.24 (90% hexane, 10% Et2O); δH(300 MHz) 1.91-2.03 (2H, m, ArCH2CH2), 2.76 
(2H, t, J 7.5, ArCH2CH2), 3.42 (3H, s, OCH3), 3.60 (2H, t, J 6.4, CH2CH2O), 4.68 (2H, s, 
OCH2OCH3), 7.19-7.38 (5H, stack, ArH); δC(100 MHz) 31.4 (CH2, ArCH2 or ArCH2CH2), 
32.4 (CH2, ArCH2 or ArCH2CH2), 55.1 (CH3, OCH3), 67.1 (CH2, CH2CH2O), 96.4 (CH2, 
OCH2OCH3), 125.8 (CH, p-Ar), 128.3 (CH, Ar), 128.4 (CH, Ar), 141.8 (quat. C, ipso Ar); 
m/z (EI) 148 ([M – H – OCH3]
+, 18%), 118 (34, [M – H – OCH2OCH3]
+), 117 (31), 105 (29, 
[M – CH2OCH2OCH3]










Elemental Analysis: C, 81.04; H, 8.16; O, 10.80  
 
NaBH4 (620 mg, 16.5 mmol) was added to a solution of 1-phenyl-1-cyclopropane-carboxylic 
acid (2.00 g, 12.3 mmol) in THF (7 mL) at 0 °C (caution: gas formation!). A solution of 
BF3·OEt2 (2.70 mL, 21.8 mmol) in THF (5 mL) was added over 3 min at 0 °C and the 
reaction mixture was stirred for 1 h at R.T. A mixture of THF/H2O (1:1, 30 mL) was then 
added carefully (caution: gas formation), followed by the addition of more H2O (20 mL). The 
two phases were separated and the aqueous phase was extracted with Et2O (3 × 20 mL). The 
combined organic fractions were washed with brine (30 mL), and then dried (MgSO4). The 
drying agent was removed by filtration and the filtrate concentrated under reduced pressure to 
provide the crude alcohol 180j as a colourless liquid (1.83 g, quantitative), which was 
sufficiently pure for characterisation and further use: Rf = 0.45 (70% hexane, 30% EtOAc); 
δH(300 MHz) 0.81-0.94 (4H, stack, CH2CH2), 1.72 (1H, br s, OH), 3.65 (2H, s, CH2OH), 
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7.19-7.41 (5H, stack, ArH); δC(100 MHz) 11.3 (CH2, cyclopropyl CH2), 28.0 (quat. C, 
cyclopropyl C), 70.6 (CH2, CH2OH), 126.5 (CH, Ar), 128.3 (CH, Ar), 128.9 (CH, Ar), 142.7 
(quat. C, ipso Ar); m/z (EI) 148 ([M]+, 40%), 133 (19), 130 (35), 117 (100, [M – CH2OH]
+), 
105 (23), 91 (92), 77 (19, [C6H5]
+), 65 (16), 51 (20). 
 









Elemental Analysis: C, 74.97; H, 8.39; O, 16.64  
 
Acetal 181j was prepared from 1-phenyl-1-(hydroxymethyl)cyclopropane 180j (2.00 mL, 
14.8 mmol), FDMA (65 mL, 740 mmol) and Sc(OTf)3 (364 mg, 0.740 mmol) in CHCl3 (65 
mL) according to the general procedure. After 24 h, work-up and purification by flash column 
chromatography (gradient: 98% hexane, 2% Et2O → 95% hexane, 5% Et2O) afforded MOM 
ether 181j as a colourless liquid (2.50 g, 85%): Rf = 0.19 (90% hexane, 10% Et2O); 
νmax(film)/cm-1 2884m, 1603w, 1497w, 1446w, 1384w, 1213w, 1149m, 1103m, 1046s, 1017s, 
974m, 917m, 857w, 758m, 697s; δH(300 MHz) 0.90-1.00 (4H, stack, cyclopropylCH2), 3.29 
(3H, s, OCH3), 3.70 (2H, s, CH2O), 4.62 (2H, s, OCH2OCH3), 7.20-7.44 (5H, stack, ArH); 
δC(75 MHz) 11.9 (CH2, cyclopropylCH2), 25.1 (quat. C, cyclopropylC), 55.0 (CH3, OCH3), 
74.9 (CH2, CH2OCH2OCH3), 96.0 (CH2, CH2OCH3), 126.1 (CH, p-Ar), 128.1 (CH, Ar), 
128.4 (CH, Ar), 143.3 (quat. C, ipso Ar); m/z (EI) 192 ([M]+, 7%), 132 (44), 131 (55, [M – 
OCH2OCH3]
+), 130 (96, [M – H – OCH2OCH3]
+), 129 (58), 117 (100), 115 (57, [M – 
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CH2OCH2OCH3]
+), 104 (33), 103 (34), 91 (50), 77 (18, [C6H5]
+), 45 (39, [CH2OCH3]
+); 
HRMS: C12H16O2 calcd 192.1150 ([M]










Elemental Analysis: C, 49.00; H, 5.35; Br, 32.60; O, 13.05  
 
Acetal 181e was prepared from 2-bromophenethyl alcohol (5.04 mL, 25.1 mmol), FDMA (88 
mL, 1.25 mol) and Sc(OTf)3 (617 mg, 1.25 mmol) in CHCl3 (88 mL) according to the general 
procedure. After 48 h, work-up afforded MOM ether 181e as a colourless liquid (6.06 g, 
99%): Rf = 0.28 (90% hexane, 10% Et2O); δH(300 MHz, C6D6) 2.95 (2H, t, J 6.9, CH2CH2O), 
3.08 (3H, s, OCH3), 3.64 (2H, t, J 6.9, CH2CH2O), 4.41 (2H, s, OCH2OCH3), 6.68 (1H, app. t, 
J 7.6, ArH), 6.89 (1H, app. t, J 7.5, ArH), 7.01 (1H, dd, J 7.6, 1.7, ArH), 7.36 (1H, dd, J 8.0, 
1.2, ArH); δC(75 MHz, C6D6) 36.5 (CH2, CH2CH2O), 54.5 (CH3, OCH3), 66.4 (CH2, 
CH2CH2O), 96.0 (CH2, OCH2OCH3), 124.7 (quat. C, ipso ArBr), 127.1 (CH, Ar), 127.8 (CH, 
Ar), 131.1 (CH, Ar), 132.6 (CH, Ar), 138.4 (quat. C, ipso Ar); m/z (EI) 246 ([M]+, 1%), 244 
([M] +, 1%), 216 (12), 214 (18), 212 (12), 186 (12), 185 (43), 184 (71), 183 (47), 182 (69), 171 
(28), 169 (29), 158 (16), 156 (16), 135 (100), 105 (22), 104 (43), 103 (37), 91 (11), 90 (16), 
89 (16), 77 (26, [C6H5]
+), 45 (58, [CH2OCH3]
+); HRMS: C10H13O2
79Br calcd 244.0099 












Elemental Analysis: C, 67.32; H, 8.22; O, 24.46  
 
Acetal 181g was prepared from 4-methoxyphenethyl alcohol (2.00 g, 13.1 mmol), FDMA (46 
mL, 657 mmol) and Sc(OTf)3 (323 mg, 0.657 mmol) in CHCl3 (46 mL) according to the 
general procedure. After 15 h, work-up afforded MOM ether 181g as a colourless oil (2.58 g, 
quant): Rf = 0.20 (90% hexane, 10% Et2O); δH(300 MHz, C6D6) 2.76 (2H, t, J 7.0, 
CH2CH2O), 3.11 (3H, s, CH2OCH3), 3.32 (3H, s, ArOCH3), 3.62 (2H, t, J 7.0, CH2CH2O), 
4.47 (2H, s, OCH2OCH3), 6.74-6.83 (2H, m, ArH), 6.99-7.07 (2H, m, ArH); δC(100 MHz, 
C6D6) 35.9 (CH2, CH2CH2O), 54.8 (CH3, CH2OCH3 or ArOCH3), 54.9 (CH3, CH2OCH3 or 
ArOCH3), 69.0 (CH2, CH2CH2O), 96.5 (CH2, OCH2OCH3), 114.1 (CH, Ar), 130.2 (CH, Ar), 
131.5 (quat. C, ipso Ar), 158.8 (quat. C, ipso ArOMe); m/z (EI) 196 ([M]+, 7%), 134 (50, [M 
– H – OCH2OCH3]
+), 121 (100, [M – CH2OCH2OCH3]











Elemental Analysis: C, 65.20; H, 7.11; F, 10.31; O, 17.37  
 
Acetal 181h was prepared from 4-fluorophenethyl alcohol (2.00 g, 14.3 mmol), FDMA (50 
mL, 714 mmol) and Sc(OTf)3 (351 mg, 0.714 mmol) in CHCl3 (50 mL) according to the 
general procedure. After 48 h, work-up afforded MOM ether 181h as a colourless liquid (2.61 
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g, 99%): Rf = 0.19 (90% hexane, 10% Et2O); δH(300 MHz, C6D6) 2.60 (2H, t, J 6.8, 
CH2CH2O), 3.06 (3H, s, OCH3), 3.49 (2H, t, J 6.8, CH2CH2O), 4.41 (2H, s, OCH2OCH3), 
6.74-6.89 (4H, stack, ArH); δC(100 MHz, C6D6) 35.8 (CH2, CH2CH2O), 54.8 (CH3, 
CH2OCH3), 68.5 (CH2, CH2CH2O), 96.5 (CH2, OCH2OCH3), 115.2 (CH, d, 
2JC-F 21.0, Ar), 
130.7 (CH, d, 3JC-F 7.6, Ar), 135.3 (quat. C, d, 
4JC-F 2.4, ipso Ar), 162.0 (quat. C, d, 
1JC-F 
241.9, ipso Ar); δF(282 MHz, C6D6) –117.3- –117.1 (m, ArF); m/z (EI) 122 (100, [M – H –  
OCH2OCH3]
+), 109 (61, [M – CH2OCH2OCH3]




General procedure for the formation of isochromans 182 via Friedel Crafts cyclisation of 
MOM-protected phenethyl alcohols 181 
 
Isochromans 182 were prepared by modification of previously reported procedures for the 




TMSOTf (0.694 or 1.39 mmol (see specific experimental details)) was added to a solution of 
MOM-protected phenethyl alcohol (6.94 mmol) in MeCN (35 mL) at 0 °C. After stirring at 
R.T. for 15 h, NaHCO3 solution (10 mL) was added and the MeCN was removed under 
reduced pressure. Et2O (20 mL) and more NaHCO3 solution (10 mL) were added to the 
residue and the layers were separated. The aqueous phase was extracted with Et2O (2 × 20 
mL) and the combined organic fractions were washed with brine (25 mL) and dried (MgSO4). 
The drying agent was removed by filtration and the filtrate concentrated under reduced 




A solution of TiCl4 in CH2Cl2 (1 M, 2.40 mL, 2.40 mmol) was added dropwise over 5 min to 
a solution of MOM-protected phenethyl alcohol (2.00 mmol) in CH2 l2 (20 mL) at 0 °C. 
After stirring at R.T. for 15 h, MeOH (1 mL) was added and the brown colouration 
disappeared. Hydrochloric acid (1 M, 25 mL) was added and the layers were separated. The 
aqueous phase was extracted with CH2 l2 (2 × 10 mL) and the combined organic fractions 
were washed with brine (25 mL) and dried (MgSO4). The drying agent was removed by 
filtration and the filtrate concentrated under reduced pressure to provide the crude product, 









Elemental Analysis: C, 81.04; H, 8.16; O, 10.80  
 
Isochroman 182a was prepared from MOM ether 181a (1.36 g, 7.55 mmol) and TMSOTf 
(273 µL, 1.51 mmol) in MeCN (35 mL) according to Method A. After 15 h, work-up and 
purification by flash column chromatography (gradient: 99% hexane, 1% Et2O → 95% 
hexane, 5% Et2O) afforded isochroman 182a as a colourless liquid (0.96 g, 86%): Rf = 0.25 
(90% hexane, 10% Et2O); δH(300 MHz) 2.29 (3H, s, CH3), 2.76 (2H, t, J 5.8, CH2CH2O), 
4.07 (2H, t, J 5.8, CH2CH2O), 4.82 (2H, s, ArCH2O), 6.89 (1H, d, J 7.2, ArH), 7.06-7.18 (2H, 
stack, ArH); δC(75 MHz) 18.7 (CH3, CH3), 26.0 (CH2, CH2CH2O), 65.4 (CH2, CH2CH2O or 
ArCH2O), 68.2 (CH2, CH2CH2O or ArCH2O), 121.9 (CH, Ar), 125.5 (CH, Ar), 127.6 (CH, 
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Ar), 131.6 (quat. C, ipso Ar), 134.7 (quat. C, ipso Ar), 136.3 (quat. C, ipso Ar); m/z (EI) 148 
([M] +, 100%), 133 (37, [M – CH3]
+), 118 (67, [M – OCH2]
+), 91 (12). 
 










Elemental Analysis: C, 81.04; H, 8.16; O, 10.80  
 
Isochroman 182c was prepared from MOM ether 181c (2.38 g, 13.2 mmol) and TMSOTf 
(239 µL, 1.32 mmol) in MeCN (67 mL) according to Method A. After 15 h, work-up and 
purification by flash column chromatography (gradient: 99% hexane, 1% Et2O → 95% 
hexane, 5% Et2O) afforded isochroman 182c as a colourless oil (1.57 g, 80%): Rf = 0.30 (90% 
hexane, 10% Et2O); δH(300 MHz) 2.32 (3H, s, CH3), 2.83 (2H, t, J 5.7, CH2CH2O), 3.98 (2H, 
t, J 5.7, CH2CH2O), 4.76 (2H, s, ArCH2O), 6.81 (1H, s, ArH), 6.96-7.15 (2H, stack, ArH); 
δC(100 MHz) 21.0 (CH3, CH3), 28.0 (CH2, CH2CH2O), 65.5 (CH2, CH2CH2O or ArCH2O), 
67.9 (CH2, CH2CH2O or ArCH2O), 124.8 (CH, Ar), 127.1 (CH, Ar), 128.7 (CH, Ar), 130.1 
(quat. C, ipso Ar), 134.7 (quat. C, ipso Ar), 135.4 (quat. C, ipso Ar); m/z (EI) 148 ([M]+, 
71%), 133 (24, [M – CH3]
+), 118 (100, [M – OCH2]
+), 103 (14, [M – CH3 – OCH2]




Data were in agreement with those reported in the literature.[114] 
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C, 81.04; H, 8.16; O, 10.80  
 
Sc(OTf)3 (191 mg, 0.389 mmol) was added to a solution of 3-methylphenethyl alcohol (3.00 
g, 22.0 mmol) in FDMA (85 mL, 1.10 mol) and CHCl3 (85 mL). The resulting mixture was 
heated at 75 °C to generate the corresponding MOM ethers 181b and 181d. After 48 h, the 
solvents were evaporated at 75 °C, which effected cyclisation to isochromans 182b and 182d. 
The dark-brown oil was cooled to R.T. CH2Cl2 (40 mL) and deionised H2O (40 mL) were 
added, and the layers were separated. The aqueous phase was extracted with CH2Cl2 (2 × 20 
mL) and the combined organic fractions were washed with brine (50 mL) and dried (MgSO4). 
The drying agent was removed by filtration and the filtrate concentrated under reduced 
pressure to provide the crude product. Purification by flash column chromatography (gradient: 
99% hexane, 1% Et2O → 95% hexane, 5% Et2O) afforded a mixture of isochromans 182b and 
182d as a colourless oil (2.22 g, 68% from 3-methylphenethyl alcohol, 182b : 182d = 2.6 : 
1.0): Rf = 0.30 (90% hexane, 10% Et2O); δH(300 MHz) [2.19 (3H, s, CH3, minor), 2.36 (3H, s, 
CH3, major)], 2.83-2.94 (2H, stack, CH2CH2O, both isomers), 3.96-4.05 (2H, stack, 
CH2CH2O, both isomers), [4.77 (2H, s, ArCH2O, minor), 4.80 (2H, s, ArCH2O, major)], 6.88-
7.18 (3H, stack, ArH, both isomers); δC(75 MHz) 17.7 (CH3, CH3, minor), 21.0 (CH3, CH3, 
major), 28.2 (CH2, CH2CH2O, major), 28.6 (CH2, CH2CH2O, minor), 64.8 (CH2, CH2CH2O 
or ArCH2O, minor), 65.3 (CH2, CH2CH2O or ArCH2O, major), 66.4 (CH2, CH2CH2O or 
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ArCH2O, minor), 67.8 (CH2, CH2CH2O or ArCH2O, major), 124.2 (CH, Ar, major), 126.0 
(CH, Ar, minor), 126.4 (CH, Ar, minor), 126.7 (CH, Ar, major), 127.4 (CH, Ar, minor), 129.3 
(CH, Ar, major), 131.8 (quat. C, ipso Ar, major), 132.9 (quat. C, ipso Ar, major), 133.0 (quat. 
C, ipso Ar, minor), 133.1 (quat. C, ipso Ar, minor), 133.3 (quat. C, ipso Ar, minor), 135.7 
(quat. C, ipso Ar, major); m/z GC-MS (EI) tR,major = 5.85 min: 148 ([M]
+, 100%), 133 (94, [M 
– CH3]
+), 118 (80, [M – OCH2]
+), 103 (22, [M – CH3 – OCH2]
+), 91 (36), 77 (21, [C6H5]
+); 
tR,minor = 5.97 min: 148 ([M]
+, 100%), 133 (100, [M – CH3]
+), 118 (92, [M – OCH2]
+), 103 
(25, [M – CH3 – OCH2]
+), 91 (61), 77 (22, [C6H5]
+). 
 






Br Chemical Formula: C9H9BrO
Exact Mass: 211.9837
Molecular Weight: 213.0712
Elemental Analysis: C, 50.73; H, 4.26; Br, 37.50; O, 7.51  
 
Isochroman 182e was prepared from MOM ether 181e (5.07 g, 20.7 mmol) and a solution of 
TiCl4 in CH2Cl2 (24.8 mL, 24.8 mmol) in CH2Cl2 (200 mL) according to Method B. After 15 
h, work-up and purification by flash column chromatography (gradient: 99% hexane, 1% 
Et2O → 95% hexane, 5% Et2O) afforded isochroman 182e as a white crystalline solid (3.91 g, 
89%): mp 152-154 °C; Rf = 0.30 (90% hexane, 10% Et2O); δH(300 MHz) 2.81 (2H, t, J 5.8, 
CH2CH2O), 3.99 (2H, t, J 5.8, CH2CH2O), 4.73 (2H, s, ArCH2O), 6.94 (1H, d, J 7.5, ArH), 
7.04 (1H, app. t, J 7.7, ArH), 7.43 (1H, d, J 7.7, ArH); δC(100 MHz, C6D6) 29.5 (CH2, 
CH2CH2O), 65.2 (CH2, CH2CH2O or ArCH2O), 67.8 (CH2, CH2CH2O or ArCH2O), 121.9 
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(CH, Ar), 125.5 (CH, Ar), 127.6 (CH, Ar), 131.6 (quat. C, ipso Ar), 134.7 (quat. C, ipso Ar), 
136.3 (quat. C, ipso Ar); m/z (EI) 214 ([M]+, 53%), 212 (61, [M]+), 184 (83, [M – OCH2]
+), 
182 (84, [M – OCH2]
+), 133 (100, [M – Br]+), 103 (59, [M – Br – OCH2]
+), 77 (17, [C6H5]
+). 
 


















MOM ether 181f was prepared from 2-trifluoromethylphenethyl alcohol (2.00 g, 10.5 mmol), 
FDMA (37 mL, 526 mmol) and Sc(OTf)3 (259 mg, 0.526 mmol) in CHCl3 (37 mL) according 
to the general procedure for the MOM-protection of different phenethyl alcohols. After 48 h, 
work-up afforded the MOM ether as a colourless liquid (2.44 g, 10.4 mmol) which was used 
directly and without purification in the preparation of isochroman 182f from a solution of 
TiCl4 in CH2Cl2 (12.5 mL, 12.5 mmol) in CH2Cl2 (100 mL) according to Method B. After 15 
h, work-up and purification by flash column chromatography (gradient: 99% hexane, 1% 
Et2O → 95% hexane, 5% Et2O) afforded isochroman 182f as a colourless liquid (934 mg, 
44% over two steps): Rf = 0.25 (90% hexane, 10% Et2O); νmax(film)/cm-1 2944w, 2894w, 
1497w (C=C aromatic), 1322s, 1307s, 1263w, 1200w, 1186m, 1157s, 1102s, 1075s, 1063s, 
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1011m, 973m, 957m, 925m, 845w, 794s, 727m, 690m, 653m; δH(300 MHz) 3.01 (2H, t, J 
5.7, CH2CH2O), 3.99 (2H, t, J 5.7, CH2CH2O), 4.82 (2H, s, ArCH2O), 7.15 (1H, d, J 7.7, 
ArH), 7.21-7.30 (1H, m, ArH), 7.51 (1H, d, J 7.5, ArH); δC(100 MHz) 25.3 (CH2, CH2CH2O), 
64.7 (CH2, CH2CH2O or ArCH2O), 68.0 (CH2, CH2CH2O or ArCH2O), 124.13 (CH, q, 
3JC-F 
5.6, Ar), 124.4 (quat. C, q, 1JC-F 272.4, ArCF3), 125.8 (CH, Ar), 128.2 (CH, Ar), 128.8 (quat. 
C, q, 2JC-F 28.4, ipso Ar), 132.1 (quat. C, ipso Ar), 136.4 (quat. C, ipso Ar); δF(282 MHz) –
61.5 (s, ArCF3); m/z (EI) 202 ([M]
+, 26%), 172 (100, [M – OCH2]
+), 151 (18), 133 (32, [M – 
CF3]
+), 103 (14); HRMS: C10H9OF3 calcd 202.0605 ([M]










Elemental Analysis: C, 71.04; H, 5.96; F, 12.49; O, 10.51  
 
Isochroman 182h was prepared from MOM ether 181h (2.51 g, 13.6 mmol) and a solution of 
TiCl4 in CH2Cl2 (16.4 mL, 16.4 mmol) in CH2Cl2 (135 mL) according to Method B. After 15 
h, work-up and purification by flash column chromatography (gradient: 99% hexane, 1% 
Et2O → 95% hexane, 5% Et2O) afforded isochroman 182h as a pale yellow liquid (1.59 g, 
77%): Rf = 0.26 (90% hexane, 10% Et2O); νmax(film)/cm-1 2935w, 2857w, 282w, 1617m, 
1400s (C=C aromatic), 1430m, 1259m, 1248m, 1223s, 1202m, 1114m, 1094s, 1069m, 
1005w, 993m, 949m, 931s, 856s, 809s 747m, 736s; δH(300 MHz) 2.81 (2H, t, J 5.7, 
CH2CH2O), 3.95 (2H, t, J 5.7, CH2CH2O), 4.73 (2H, s, ArCH2O), 6.68 (1H, dd, 
3JH-F 9.1, 
4JH-
H 2.6, ArH), 6.86 (1H, app. td, 
3JH-H and 
3JH-F 8.5, 
4JH-H 2.6, ArH), 7.07 (1H, dd, 
3JH-H 8.5, 
4JH-
F 5.6, ArH); δC(75 MHz) 27.5 (CH2, CH2CH2O), 65.3 (CH2, CH2CH2O or ArCH2O), 67.6 
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(CH2, CH2CH2O or ArCH2O), 110.8 (CH, d, 
2JC-F 21.4, Ar), 113.4 (CH, d, 
2JC-F 21.3, Ar), 
128.62 (quat. C, d, 4JC-F 2.2, ipso Ar), 130.2 (CH, d, 
3JC-F 7.6, Ar), 136.6 (quat. C, d, 
3JC-F 6.5, 
ipso Ar), 161.0 (quat. C, d, 1JC-F 242.9, ipso Ar); δF(282 MHz) –116.6- –116.4 (m, ArF); m/z 
(EI) 152 ([M]+, 17%), 128 (21), 122 (100, [M – OCH2]
+), 96 (11); HRMS: C9H9OF calcd 
152.0637 ([M]+), obsd 152.0636. 
 
 
General procedure for the formation of isochroman-1-ones 183 
 
Substituted isochroman-1-ones 183 were prepared following two previously reported 




A solution of fuming nitric acid (100%) (2.97 mL, 71.6 mmol) in CH2 l2 (5 mL) was added 
dropwise via dropping funnel over 10 min to a cooled (0 °C) solution of the isochroman (23.9 
mmol) in CH2Cl2 (5 mL). A colour change of the colourless solution via green to orange was 
observed. After the addition was complete, the homogeneous reaction mixture was warmed to 
R.T. and stirring was continued for 1 h. The solution was then diluted with CH2Cl2 (50 mL) 
and NaHCO3 solution (30 mL) was added via pipette (caution: rapid gas formation!). The 
layers were separated, and the organic phase was washed with NaHCO3 solution (30 mL) and 
brine (30 mL) and dried (MgSO4). The drying agent was removed by filtration and the filtrate 
concentrated under reduced pressure to provide the crude product, which was purified by a  





KMnO4 (4.74 g, 30.0 mmol) was added to a solution of the isochroman (10.0 mmol) and 
TEBAC (342 mg, 1.50 mmol) in CH2Cl2 (100 mL). The heterogeneous purple solution was 
stirred for 24 h at R.T. The solvent was evaporated, and the residue was loaded on to a 











Elemental Analysis: C, 72.96; H, 5.44; O, 21.60  
 
Isochroman-1-one 172 was prepared from isochroman (3.20 g, 23.9 mmol) in CH2Cl2 (5 mL) 
and fuming nitric acid (100%) (2.97 mL, 71.6 mmol) in CH2 l2 (5 mL) according to Method 
A. Work-up and purification by silica plug (60% hexane, 40% EtOAc) afforded isochroman-
1-one 172 as a pale yellow viscous oil (3.50 g, 99%): Rf = 0.25 (60% hexane, 40% EtOAc); 
δH(300 MHz, C6D6) 2.03-2.24 (2H, stack, CH2CH2O), 3.64-3.83 (2H, stack, CH2CH2O), 6.63 
(1H, d, J 7.0 ArH), 6.86-7.08 (2H, stack, ArH), 8.19 (1H, d, J 7.5, ArH); δC(100 MHz, C6D6) 
27.6 (CH2, CH2CH2O), 66.8 (CH2, CH2CH2O), 126.2 (quat. C, ipso Ar), 127.3 (CH, Ar), 
127.6 (CH, Ar), 130.4 (CH, Ar), 133.2 (CH, Ar), 140.0 (quat. C, ipso Ar), 164.4 (quat. C, 
C=O); m/z (EI) 148 ([M]+, 59%), 118 (100, [M – OCH2]













Elemental Analysis: C, 74.06; H, 6.21; O, 19.73
 
 
Isochroman-1-one 183a was prepared from isochroman 182a (962 mg, 6.49 mmol), KMnO4 
(3.08 g, 19.5 mmol) and TEBAC (222 mg, 0.974 mmol) in CH2 l2 (65 mL) according to 
Method B. Purification by flash column chromatography (gradient: 90% hexane, 10% EtOAc 
→ 80% hexane, 20% EtOAc) afforded isochroman-1-one 183a as a white crystalline solid 
(801 mg, 76%): mp 67-68 °C; Rf = 0.30 (70% hexane, 30% EtOAc); (Found: C, 74.01; H, 
5.92. C10H10O2 requires C, 74.06; H, 6.21%); νmax(film)/cm-1 2994w, 2963w, 2910w, 1700s 
(C=O), 1477m (C=C aromatic), 1396m, 1302m, 1279s, 1258m, 1170m, 1123s, 1084m, 
1071m, 1045s, 1037s, 1011m, 951m, 824m, 768s, 760s, 706m; δH(300 MHz) 2.31 (3H, s, 
CH3), 2.95 (2H, t, J 6.1, CH2CH2O), 4.50 (2H, t, J 6.2, CH2CH2O), 7.26 (1H, dd, J 7.7, 7.2, 
ArH), 7.38 (1H, d, J 7.2, ArH), 7.94 (1H, d, J 7.7, ArH); δC(100 MHz) 18.8 (CH3, CH3), 24.8 
(CH2, CH2CH2O), 66.6 (CH2, CH2CH2O), 125.2 (quat. C, ipso Ar), 127.0 (CH, Ar), 128.1 
(CH, Ar), 134.9 (CH, Ar), 135.0 (quat. C, ipso Ar), 138.1 (quat. C, ipso Ar), 165.4 (quat. C, 
C=O); m/z (EI) 162 ([M]+, 93%), 132 (100, [M – OCH2]



















Elemental Analysis: C, 74.06; H, 6.21; O, 19.73  
 
Isochroman-1-ones 183b and 183d were prepared from the mixture of isochromans 182b and 
182d (1.98 g, 13.4 mmol) in CH2Cl2 (2.8 mL) and fuming nitric acid (100%) (1.66 mL, 40.1 
mmol) in CH2Cl2 (2.8 mL) according to Method A. Work-up and purification by careful
3 
column chromatography (gradient: 95% hexane, 5% EtOAc → 90% hexane, 10% EtOAc) 
afforded, in order of elution, 8-methylisochroman-1-one 183d as a white solid (598 mg, 
28%): mp 64-65 °C; Rf = 0.24 (80% hexane, 20% EtOAc); νmax(film)/cm-1 2963w, 2925m, 
1710s (C=O), 1595m, 1470m (C=C aromatic), 1419m, 1386m, 1379m, 1277s, 1232s, 1187m, 
1115s, 1078m, 1057s, 1046m, 1028s, 978m, 923m, 787m, 768s, 697s, 654m; δH(300 MHz) 
2.60 (3H, s, CH3), 2.95 (2H, t, J 5.9, CH2CH2O), 4.37 (2H, t, J 5.9, CH2CH2O), 7.04 (1H, d, J 
7.6, ArH), 7.13 (1H, d, J 7.6, ArH), 7.31 (1H, app. t, J 7.6, ArH); δC(75 MHz) 21.9 (CH3, 
CH3), 28.7 (CH2, CH2CH2O), 66.5 (CH2, CH2CH2O), 123.5 (quat. C, ipso Ar), 124.8 (CH, 
Ar), 130.8 (CH, Ar), 132.3 (CH, Ar), 140.5 (quat. C, ipso Ar), 142.6 (quat. C, ipso Ar), 164.2 
(quat. C, C=O); m/z (EI) 162 ([M]+, 89%), 147 (20, [M – CH3]
+), 132 (100, [M – OCH2]
+), 
119 (24), 115 (15), 104 (45, [M – CO – OCH2]
+), 91 (10), 78 (14), 77 (15); HRMS: C10H10O2 
calcd 162.0681 ([M]+), obsd 162.0678; and then 6-methylisochroman-1-one 183b as a white 
solid (1.40 g, 65%): mp 52-53 °C; Rf = 0.18 (80% hexane, 20% EtOAc); νmax(film)/cm-1 
2991m, 2904w, 1708s (C=O), 1614s, 1470m (C=C aromatic), 1419m, 1397m, 1288m, 1243s, 
1200w, 1161m, 1127m, 1090s, 1060m, 1030s, 958m, 908m, 894w, 837s, 772s, 730w, 710s, 
678m; δH(300 MHz) 2.34 (3H, s, CH3), 2.95 (2H, t, J 6.0, CH2CH2O), 4.44 (2H, t, J 6.0, 
CH2CH2O), 7.02 (1H, s, ArH), 7.13 (1H, d, J 8.0, ArH), 7.90 (1H, d, J 8.0, ArH); δC(100 
                                                
3 in total three columns were carried out to fully separate the two compounds 
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MHz) 21.5 (CH3, CH3), 27.6 (CH2, CH2CH2O), 67.1 (CH2, CH2CH2O), 122.3 (quat. C, ipso 
Ar), 127.6 (CH, Ar), 128.3 (CH, Ar), 130.1 (CH, Ar), 139.4 (quat. C, ipso Ar), 144.4 (quat. C, 
ipso Ar), 165.0 (quat. C, C=O); m/z (EI) 162 ([M]+, 81%), 132 (100, [M – OCH2]
+), 104 (49, 
[M – CO – OCH2]

















C, 75.84; H, 5.79; O, 18.37  
 
Isochroman 182j was prepared from MOM ether 181j (2.47 g, 12.8 mmol) and TMSOTf (233 
µL, 1.28 mmol) in MeCN (65 mL) according to Method A for the formation of different 
isochromans via cyclisation of MOM-protected phenethyl alcohols. After 15 h, work-up and 
purification by flash column chromatography (gradient: 98% hexane, 2% Et2O → 90% 
hexane, 10% Et2O) afforded crude isochroman 182j as a colourless liquid, which was used 
without further purification for the preparation of isochroman-1-one 183j from KMnO4 (2.14 
g, 13.6 mmol) and TEBAC (154 mg, 0.678 mmol) in CH2 l2 (45 mL) according to Method B. 
Purification by flash column chromatography (gradient: 90% hexane, 10% EtOAc → 85% 
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hexane, 15% EtOAc) afforded isochroman-1-one 183j as a colourless oil (524 mg, 24% over 
two steps): Rf = 0.20 (80% hexane, 20% EtOAc); νmax(film)/cm-1 3004w, 2886w, 1712s 
(C=O), 1605m, 1487m, 1460m, 1427w, 1394m, 1270s, 1220m, 1165w, 1108s, 1074m, 
1037m, 1008m, 941m, 828w, 801w, 755s, 719m, 695s, 656m; δH(300 MHz) 0.97-1.13 (4H, 
stack, cyclopropylCH2), 4.19 (2H, s, CH2O), 6.83 (1H, d, J 7.8, ArH), 7.25 (1H, app. t, J 7.8, 
ArH), 7.45 (1H, app. t, J 7.8, ArH), 8.02 (1H, d, J 7.8, ArH); δC(100 MHz) 13.2 (CH2, CH2), 
18.1 (quat. C, CCH2O), 73.8 (CH2, CH2O), 120.8 (CH, Ar), 125.5 (quat. C, ipso Ar), 126.4 
(CH, Ar), 130.2 (CH, Ar), 133.8 (CH, Ar), 143.3 (quat. C, ipso Ar), 165.1 (quat. C, C=O); 
m/z (EI) 174 ([M]+, 48%), 146 (70, [M – CH2CH2]
+), 145 (100), 131 (11), 118 (66, [M – CO 
– CH2CH2]
















C, 74.98; H, 6.86; O, 18.16  
 
Sc(OTf)3 (191 mg, 0.389 mmol) was added to a solution of 3-methyl-1-phenyl-2-propanol 
(2.21 g, 14.7 mmol) in FDMA (65 mL, 736 mmol) and CHCl3 (65 mL). The resulting mixture 
was heated at 75 °C to generate the corresponding MOM ether 181i. After 48 h, the solvent 
was evaporated at 75 °C, which effected cyclisation to isochroman 182i. The resulting dark-
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brown oil was cooled to R.T. CH2Cl2 (30 mL) and deionised H2O (30 mL) were added, and 
the layers were separated. The aqueous phase was extracted with CH2Cl2 (2 × 20 mL) and the 
combined organic fractions were washed with brine (40 mL) and dried (MgSO4). The drying 
agent was removed by filtration and the filtrate concentrated under reduced pressure to 
provide the crude product. Purification by flash column chromatography (gradient: 99% 
hexane, 1% Et2O → 90% hexane, 10% Et2O) afforded crude isochroman 182i as a colourless 
oil which was used without further purification for the preparation of isochroman-1-one 83i 
from KMnO4 (3.62 g, 22.9 mmol) and TEBAC (261 mg, 1.15 mmol) in CH2 l2 (75 mL) 
according to Method B. Purification by flash column chromatography (gradient: 99% hexane, 
1% EtOAc → 80% hexane, 20% EtOAc) afforded isochroman-1-one 183i as a colourless oil 
(983 mg, 38% from 3-methyl-1-phenyl-2-propanol): Rf = 0.25 (80% hexane, 20% EtOAc); 
νmax(film)/cm-1 2921m, 1708s (C=O), 1607m, 1459m, 1388m, 1373m, 1290s, 1260m, 1211m, 
1199m, 1180m, 1107s, 1079s, 1031m, 943m, 907w, 800m, 740s, 717s, 691m; δH(300 MHz) 
1.38-1.48 (6H, stack, CH3), 2.99 (2H, s, CH2), 7.19 (1H, d, J 7.5, ArH), 7.29-7.39 (1H, m, 
ArH), 7.46-7.55 (1H, m, ArH), 8.05 (1H, dd, J 7.7, 1.2, ArH); δC(100 MHz) 27.4 (CH3, CH3), 
39.3 (CH2, CH2), 80.6 (quat. C, C(CH3)2), 124.6 (quat. C, ipso Ar), 127.4 (CH, Ar), 127.9 
(CH, Ar), 129.8 (CH, Ar), 133.7 (CH, Ar), 138.0 (quat. C, ipso Ar), 165.0 (quat. C, C=O); 
m/z (EI) 176 ([M]+, 32%), 161 (37, [M – CH3]
+), 133 (46, [M – CO – CH3]
+), 118 (100, [M – 
CO – 2 × CH3]
+), 115 (21), 105 (13), 90 (73), 63 (13); HRMS: C11H12O2 calcd 176.0837 










Elemental Analysis: C, 47.61; H, 3.11; Br, 35.19; O, 14.09
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Isochroman-1-one 183e was prepared from isochroman 182e (1.00 g, 4.69 mmol), KMnO4 
(2.23 g, 14.1 mmol) and TEBAC (160 mg, 0.704 mmol) in CH2 l2 (47 mL) according to 
Method B. Purification by flash column chromatography (gradient: 90% hexane, 10% EtOAc 
→ 80% hexane, 20% EtOAc) afforded isochroman-1-one 183e as a white crystalline solid 
(864 mg, 82%): mp 83-84 °C; Rf = 0.23 (80% hexane, 20% EtOAc); (Found: C, 47.88; H, 
3.29. C9H7O2Br requires C, 47.61; H, 3.11%); νmax(film)/cm-1 2969w, 1716s (C=O), 1446m, 
1397m, 1295m, 1274s, 1240s, 1210m, 1179m, 1141m, 1095s, 1059s, 1030s, 954m, 811m, 
775m, 741s, 696m; δH(300 MHz) 3.13 (2H, t, J 6.1, CH2CH2O), 4.54 (2H, t, J 6.1, 
CH2CH2O), 7.28 (1H, app. t, J 7.9, ArH), 7.77 (1H, dd, J 7.9, 1.2, ArH), 8.07 (1H, dd, J 7.9, 
1.2, ArH); δC(75 MHz) 28.0 (CH2, CH2CH2O), 66.5 (CH2, CH2CH2O), 122.8 (quat. C, ipso 
Ar), 127.2 (quat. C, ipso Ar), 128.7 (CH, Ar), 129.6 (CH, Ar), 137.3 (CH, Ar), 139.3 (quat. C, 
ipso Ar), 164.1 (quat. C, C=O); m/z (EI) 228 ([M]+, 54%), 226 ([M]+, 57%), 198 (100, [M – 
OCH2]
+), 196 (100, [M – OCH2]
+), 170 (54, [M – CO – OCH2]
+), 168 (52, [M – CO – 
OCH2]
+), 89 (47), 63 (20); HRMS: C9H7O2











Elemental Analysis: C, 55.56; H, 3.26; F, 26.37; O, 14.80
 
Isochroman-1-one 183f was prepared from isochroman 182f (914 mg, 4.52 mmol), KMnO4 
(2.14 g, 13.6 mmol) and TEBAC (154 mg, 0.678 mmol) in CH2 l2 (47 mL) according to 
Method B. Purification by flash column chromatography (gradient: 90% hexane, 10% EtOAc 
→ 80% hexane, 20% EtOAc) afforded isochroman-1-one 183f as a white crystalline solid 
(864 mg, 82%): mp 54-55 °C; Rf = 0.23 (80% hexane, 20% EtOAc); νmax(film)/cm-1 3016w, 
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2916w, 1726s (C=O), 1475m, 1397m, 1325m, 1307m, 1287m, 1246m, 1224m, 1160s, 1133s, 
1091s, 1074s, 1064s, 1041m, 959m, 831m, 757s, 711m; δH(300 MHz) 3.19 (2H, t, J 6.0, 
CH2CH2O), 4.52 (2H, t, J 6.0, CH2CH2O), 7.48 (1H, app. t, J 7.8, ArH), 7.82 (1H, d, J 7.8, 
ArH), 8.26 (1H, d, J 7.8, ArH); δC(75 MHz) 24.9 (CH2, CH2CH2O), 66.4 (CH2, CH2CH2O), 
123.6 (quat. C, q, 1JC-F 272.2, ArCF3), 125.8 (CH, Ar), 127.5 (quat. C, ipso Ar), 128.4 (quat. 
C, q, 2JC-F 46.4, ipso Ar), 130.6 (CH, q, 
3JC-F 5.1, Ar), 134.0 (CH, Ar), 138.2 (quat. C, ipso 
Ar), 163.8 (quat. C, C=O); δF(282 MHz) –60.9 (s, ArCF3); m/z (EI) 216 ([M]+, 52%), 186 
(100, [M – OCH2]
+), 158 (79, [M – CO – OCH2]
+), 138 (16); HRMS: C10H7O2F3 calcd 











Elemental Analysis: C, 67.41; H, 5.66; O, 26.94  
 
Isochroman-1-one 183g was prepared from isochroman 182g (565 mg, 3.44 mmol), KMnO4 
(1.63 g, 10.3 mmol) and TEBAC (118 mg, 0.516 mmol) in CH2 l2 (35 mL) according to 
Method B. Purification by flash column chromatography (gradient: 90% hexane, 10% EtOAc 
→ 75% hexane, 25% EtOAc) afforded isochroman-1-one 183g as a white solid (260 mg, 
42%): mp 53-54 °C; Rf = 0.20 (70% hexane, 30% EtOAc); νmax(film)/cm-1 2994w, 2913w, 
1706s (C=O), 1500m, 1426m, 1324m, 1283m, 1268m, 1242s, 1220m, 1190m, 1177m, 
1131m, 1084s, 1024s, 875m, 820s, 784s, 747m, 715m; δH(300 MHz) 2.98 (2H, t, J 6.0, 
CH2CH2O), 3.83 (3H, s, OCH3), 4.50 (2H, t, J 6.0, CH2CH2O), 7.05-7.22 (2H, stack, ArH), 
7.57 (1H, s, ArH); δC(100 MHz) 26.9 (CH2, CH2CH2O), 55.6 (CH3, OCH3), 67.6 (CH2, 
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CH2CH2O), 112.9 (CH, Ar), 121.6 (CH, Ar), 126.0 (quat. C, ipso Ar), 128.4 (CH, Ar), 131.8 
(quat. C, ipso Ar), 158.9 (quat. C, ipso Ar), 165.2 (quat. C, C=O); m/z (EI) 178 ([M]+, 100%), 
148 (73, [M – OCH2]
+), 120 (86, [M – CO – OCH2]
+), 105 (11), 91 (21), 77 (16); HRMS: 
C10H10O3 calcd 178.0630 ([M]











Elemental Analysis: C, 65.06; H, 4.25; F, 11.43; O, 19.26  
 
Isochroman-1-one 183h was prepared from isochroman 182h (1.57 g, 10.3 mmol), KMnO4 
(4.89 g, 31.0 mmol) and TEBAC (353 mg, 1.55 mmol) in CH2 l2 (100 mL) according to 
Method B. Purification by flash column chromatography (gradient: 90% hexane, 10% EtOAc 
→ 70% hexane, 30% EtOAc) afforded isochroman-1-one 183h as a white crystalline solid 
(1.28 g, 75%): mp 50-51 °C; Rf = 0.21 (70% hexane, 30% EtOAc); (Found: C, 64.80; H, 4.25. 
C9H7O2F requires C, 65.06; H, 4.25%); νmax(film)/cm-1 3069w, 2926w, 1713s (C=O), 1493s, 
1435s, 1307m, 1273s, 1261s, 1237s, 1124s, 1083s, 1061m, 1028m, 927m, 886s, 852m, 841m, 
779s, 745m, 716m; δH(300 MHz) 3.02 (2H, t, J 6.0, CH2CH2O), 4.52 (2H, t, J 6.0, 
CH2CH2O), 7.18-7.29 (2H, stack, ArH), 7.72 (1H, dd, J 8.3, 1.9, ArH); δC(75 MHz) 27.0 
(CH2, CH2CH2O), 67.4 (CH2, CH2CH2O), 116.5 (CH, d, 
2JC-F 23.0, Ar), 121.0 (CH, d, 
2JC-F 
21.8, Ar), 126.8 (quat. C, d, 3JC-F 7.4, ipso Ar), 129.1 (CH, d, 
3JC-F 7.3, Ar), 135.2 (quat. C, d, 
4JC-F 2.5, ipso Ar), 161.7 (quat. C, d, 
1JC-F 245.5, ipso Ar), 164.0 (quat. C, C=O); δF(282 
MHz) –113.3 - –113.1 (m, ArF); m/z (EI) 166 ([M]+, 62%), 136 (76, [M – OCH2]
+), 108 (100, 
[M – CO – OCH2]
+); HRMS: C9H7O2F calcd 166.0430 ([M]
+), obsd 166.0425. 
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General procedure for the formation of 1-alkoxyisochromans 164 
 
1-Alkoxyisochromans 164 were prepared by a modification of previously reported procedures 
for the preparation of different 1-substituted isochromans: 
 
Method A for 1-ethoxyisochromans[150] 
DIBALH (1.5 M solution in toluene, 20.2 mL, 30.3 mmol) was added over 10 min to a 
solution of the isochroman-1-one (10.1 mmol) in toluene (25 mL) at –78 °C. After stirring at 
–78 °C for 2 h, a saturated solution of Rochelle’s salt (25 mL) was added and the mixture was 
warmed up to R.T. overnight. The mixture was transferred to a separating funnel, and without 
shaking, the two layers were separated.4 The aqueous phase was extracted with Et2O (2 × 15 
mL), and the combined organic fractions were washed with NH4Cl solution (25 mL) and brine 
(25 mL) and then dried (MgSO4). The drying agent was removed by filtration and the filtrate 
concentrated under reduced pressure to provide the crude 1-hydroxyisochroman product, 
which was of sufficient purity to be used directly in the next step. The 1-hydroxyisochroman, 
obtained from the previous step, was dissolved in EtOH (20 mL) and stirred with Amberlite 
(IR 120 beads, teaspoon) at R.T. for 2 h. The beads were filtered off and washed with Et2O 
(15 mL). NaHCO3 solution (20 mL) was added and the Et2O and EtOH were evaporated. The 
residue was extracted with Et2O (2 × 20 mL) and the combined organic fractions were washed 
with brine (30 mL) and dried (MgSO4). The drying agent was removed by filtration and the 
filtrate concentrated under reduced pressure to provide the crude acetal product, which was 




                                                
4 with this method,  no problems with Al salts did arise 
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Method B for 1-alkoxyisochromans[114,149] 
The isochroman (7.95 mmol) and anhydrous alcohol (9.54 mmol) were added to a yellow 
suspension of DDQ (2.17 g, 9.54 mmol) in CH2 l2 (50 mL). While vigorously stirring at R.T. 
for 24 h, the colour of the mixture changed from bright red to pale red-brown. More alcohol 
(9.54 mmol) was added, and the mixture was stirred at R.T. for another 24 h. The reaction 
was quenched by addition of NaHCO3 solution (60 mL) (caution: gas formation!) and then 
CH2Cl2 (50 mL) was added. The two phases were separated and the aqueous phase was 
extracted with CH2Cl2 (2 × 30 mL). The combined organic fractions were washed with 
NaHCO3 solution (50 mL) and with brine (50 mL), and then dried (MgSO4). The drying agent 
was removed by filtration and the filtrate concentrated under reduced pressure to provide the 











Elemental Analysis: C, 76.57; H, 6.43; O, 17.00
 
 
1,1-Oxodiisochroman 171 was prepared according to a modification of Method B: 
Isochroman (0.50 mL, 3.98 mmol) and H2O (1.00 mL, 55.5 mmol) were added to a yellow 
suspension of DDQ (1.13 g, 4.97 mmol) in CH2 l2 (20 mL). After stirring for 24 h at R.T., 
the reaction was quenched by addition of NaHCO3 solution (30 mL) (caution: gas formation!) 
and then CH2Cl2 (25 mL) was added. The two phases were separated and the aqueous phase 
was extracted with CH2Cl2 (2 × 15 mL). The combined organic fractions were washed with 
 165 
NaHCO3 solution (25 mL) and with brine (25 mL), and then dried (MgSO4). The drying agent 
was removed by filtration and the filtrate concentrated under reduced pressure to provide the 
crude acetal product. Purification by flash column chromatography (gradient: 98% hexane, 
2% Et2O → 90% hexane, 10% Et2O) afforded oxodiisochroman 171 as a white crystalline 
solid (436 mg, 78%; single diastereoisomer; stereochemistry not determined): mp 138-141 °C 
(lit. [198] mp 135-137 °C); Rf = 0.18 (90% hexane, 10% Et2O); νmax(neat)/cm-1 2962m, 2925m, 
2881m, 2814w, 1489m, 1469w, 1455m, 1421m, 1381m, 1355m, 1320m, 1273m, 1201m, 
1118m, 1088s, 1068s, 1032m, 997s, 973w, 955s, 911w, 881w, 865m, 792m, 779w, 740s; 
δH(300 MHz) 2.66 (2H, app. dd, J 16.5, 2.5, CHaHbCH2O), 3.13 (2H, ddd, J 17.0, 12.4, 6.1, 
CHaHbCH2O), 4.09 (2H, ddd, J 11.1, 6.1, 1.2, CH2CHaHbO), 4.36 (2H, app. td, J 11.6, 3.2, 
CH2CHaHbO), 6.14 (2H, s, CH(O)O), 7.08-7.29 (8H, stack, ArH); δC(75 MHz) 27.9 (CH2, 
CH2CH2O), 58.1 (CH2, CH2CH2O), 92.7 (CH, CH(O)O), 126.3 (CH, Ar), 127.5 (CH, Ar), 
128.0 (CH, Ar), 128.4 (CH, Ar), 133.8 (quat. C, ipso Ar), 134.1 (quat. C, ipso Ar); m/z (TOF 




The two enantiomers of the single diastereoisomer were separated by chiral HPLC for a 
mechanistic study: Lux 5u Cellulose-2, 3 mL/min, 1% IPA in hexane, λ = 210 nm, tR,first = 










Elemental Analysis: C, 71.98; H, 6.71; O, 21.31  
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1-Hydroxyisochroman 170 was prepared according to a modification of Method A: DIBALH 
(1.5 M solution in toluene, 13.5 mL, 20.3 mmol) was added over 10 min to a solution of 
isochroman-1-one 172 (2.00 g, 13.5 mmol) in toluene (30 mL) at –78 °C. After stirring at –78 
°C for 2 h, a saturated solution of Rochelle’s salt (30 mL) was added and the mixture was 
warmed up to R.T. overnight. The mixture was transferred to a separating funnel, and without 
shaking, the two layers were separated. The aqueous phase was extracted with Et2O (2 × 15 
mL), and the combined organic fractions were washed with NH4Cl solution (25 mL) and brine 
(25 mL) and then dried (MgSO4). The drying agent was removed by filtration and the filtrate 
concentrated under reduced pressure to provide the crude hemiacetal 170 s a white solid 
(2.03, quantitative), which was sufficiently pure for characterisation and further use: mp 72-
75 °C (lit.[199] mp 73-74 °C); Rf = 0.15 (60% hexane, 40% Et2O); νmax(neat)/cm-1 3357s br 
(OH), 3029w, 2988m, 2883w, 1607m, 1494m, 1459m, 1423w, 1384m, 1289w, 1270m, 
1116m, 1092w, 1078m, 1065s, 1007s, 982s, 949s, 936s, 883s, 868s, 825m, 784s, 738s, 718w; 
δH(300 MHz) 2.65 (1H, app. dt, J 16.5, 3.0, CHaHbCH2O), 2.96 (1H, ddd, J 16.5, 11.0, 5.7, 
CHaHbCH2O), 3.91 (1H, ddd, J 11.4, 5.7, 2.7, CH2CHaHbO), 4.02 (1H, d, J 5.5, OH), 4.19 
(1H, app. td, J 11.2, 3.6, CH2CHaHbO), 5.92 (1H, d, J 5.5, CHOH), 7.08-7.34 (4H, stack, 
ArH); δC(75 MHz) 28.0 (CH2, CH2CH2O), 58.3 (CH2, CH2CH2O), 91.4 (CH, CHOH), 126.4 
(CH, Ar), 127.2 (CH, Ar), 128.1 (CH, Ar), 128.4 (CH, Ar), 134.0 (quat. C, ipso Ar), 135.0 
(quat. C, ipso Ar); m/z (EI) 150 ([M]+, 40%), 149 (78, [M – H]+), 132 (93, [M – H2O]
+), 119 
(99), 104 (76), 91 (100), 77 (47), 65 (37), 51 (34).  
 













Elemental Analysis: C, 73.15; H, 7.37; O, 19.49  
 
1-Methoxyisochroman 161 was prepared from isochroman (1.60 g, 11.9 mmol), DDQ (3.25 g, 
14.3 mmol) and anhydrous MeOH (2 × 482 µL, 2 × 11.9 mmol) in CH2Cl2 (75 mL) according 
to Method B. Purification by flash column chromatography (gradient: 100% hexane → 98% 
hexane, 2% Et2O) afforded acetal 161 as a colourless liquid (1.45 g, 74%): Rf = 0.19 (90% 
hexane, 10% Et2O); νmax(film)/cm-1 2935w, 2881m, 2827w, 1492m, 1457m, 1382m, 1343m, 
1275m, 1204m, 1186m, 1118w, 1093m, 1073s, 1047s, 1031s, 993m, 953s, 936w, 897m, 
779m, 745s; δH(300 MHz, C6H6) 2.10 (1H, ddd, J 16.5, 3.3, 1.6, CHaHbCH2O), 2.72 (1H, 
ddd, J 16.5, 12.0, 6.0, CHa bCH2O), 3.35 (3H, s, OCH3), 3.61 (1H, ddd, J 11.1, 6.0, 1.6, 
CH2CHaHbO), 3.98 (1H, app. td with unresolved fine coupling, J 11.1, 3.3, CH2CHaHbO), 
5.39 (1H, d, CHO), 6.78-6.86 (1H, m, ArH), 6.98-7.06 (2H, stack, ArH), 7.12-7.21 (1H, m, 
ArH); δC(75 MHz, C6H6) 28.4 (CH2, CH2CH2O), 55.2 (CH3, OCH3), 57.9 (CH2, CH2CH2O), 
98.3 (CH, CHO), 126.4 (CH, Ar), 128.1 (CH, Ar), 128.2 (CH, Ar), 128.6 (CH, Ar), 134.6 
(quat. C, ipso Ar), 135.2 (quat. C, ipso Ar); m/z (EI) 164 ([M]+, 21%), 163 (39, [M – H]+), 
133 (100, [M – OCH3]
+), 119 (13), 105 (40), 91 (25), 77 (28), 65 (12), 51 (16).  
 















Elemental Analysis: C, 74.13; H, 7.92; O, 17.95  
 
1-Ethoxyisochroman 166 was prepared from isochroman (1.00 mL, 7.95 mmol), DDQ (2.17 
g, 9.54 mmol) and anhydrous EtOH (2 × 556 µL, 2 × 9.54 mmol) in CH2Cl2 (50 mL) 
according to Method B. Purification by flash column chromatography (gradient: 100% hexane 
→ 98% hexane, 2% Et2O) afforded acetal 166 as a colourless liquid (827 mg, 58%): Rf = 0.28 
(90% hexane, 10% Et2O); νmax(film)/cm-1 2973m, 2880m, 1493w, 1457m, 1382m, 1331m, 
1274m, 1204m, 1094m, 1073s, 1049s, 991s, 956m, 919m, 876w, 775m, 744s; δH(300 MHz) 
1.31 (3H, t, J 7.1, OCH2CH3), 2.63 (1H, ddd, J 17.1, 3.4, 1.6, CHaHbCH2O), 3.03 (1H, ddd, J
17.1, 11.9, 6.1, CHaHbCH2O), 3.72 (1H, dq, J 9.7, 7.1, OCHaHbCH3), 3.91 (1H, ddd, J 11.4, 
6.1, 1.6,  CH2CHaHbO), 3.95 (1H, dq, J 9.7, 7.1, OCHaHbCH3), 4.17 (1H, app. td with 
unresolved fine coupling, J 11.4, 3.4, CH2CHaHbO), 5.58 (1H, s, CHO), 7.09-7.16 (1H, m, 
ArH), 7.19-7.28 (3H, stack, ArH); δC(75 MHz) 15.3 (CH3, OCH2CH3), 28.0 (CH2, 
CH2CH2O), 57.8 (CH2, CH2CH2O), 63.4 (CH2, OCH2CH3), 96.5 (CH, CHO), 126.3 (CH, Ar), 
127.4 (CH, Ar), 128.0 (CH, Ar), 128.4 (CH, Ar), 134.0 (quat. C, ipso Ar), 134.3 (quat. C, ipso 
Ar); m/z (EI) 178 ([M]+, 19%), 177 (26, [M – H]+), 149 (93, [M – CH2CH3]
+), 133 (100, [M – 
OCH2CH3]
+), 105 (29), 91 (17), 77 (22). 
 
The two enantiomers were separated by chiral HPLC (5 mg per 0.5 mL run): Lux 5u 
Cellulose-2, 3 mL/min, 1% IPA in hexane, λ = 210 nm, tR,first = 8.6 min, [α]D
20
 = +59.4 (c 
0.99, CH2Cl2, e.r. 100:0); tR,second = 10.5 min, [α]D
20
 = –54.9 (c 0.99, CH2Cl2, e.r. 0:100). 
 









Elemental Analysis: C, 74.97; H, 8.39; O, 16.64  
 
1-n-Propoxyisochroman 167 was prepared from isochroman (0.50 mL, 3.98 mmol), DDQ 
(1.35 g, 5.96 mmol) and anhydrous n-PrOH (2 × 892 µL, 2 ×11.9 mmol) in CH2Cl2 (25 mL) 
according to Method B. Purification by flash column chromatography (gradient: 100% hexane 
→ 98% hexane, 2% Et2O) afforded acetal 167 as a colourless liquid (373 mg, 49%): Rf = 0.31 
(90% hexane, 10% Et2O); νmax(film)/cm-1 2963m, 2877m, 1457m, 1381m, 1334m, 1274m, 
1205m, 1093m, 1073s, 1050m, 1019s, 993s, 954m, 782m, 744s; δH(300 MHz) 0.99 (3H, t, J 
7.4, OCH2CH2CH3), 1.70 (2H, app. sextet, J 7.3, OCH2CHaHbCH3), 2.63 (1H, ddd, J 16.6, 
3.2, 1.6, CHaHbCH2O), 3.03 (1H, ddd, J 16.6, 11.9, 6.0, CHa bCH2O), 3.61 (1H, app. dt, J
9.6, 6.7, OCHaHbCH2CH3), 3.84 (1H, app. dt, J 9.6, 6.7, OCHaHbCH2CH3), 3.90 (1H, ddd, J 
11.4, 6.0, 1.6, CH2CHaHbO), 4.17 (1H, app. td with unresolved fine coupling, J 11.4, 3.2, 
CH2CHaHbO), 5.56 (1H, s, CHO), 7.09-7.16 (1H, m, ArH), 7.19-7.28 (3H, stack, ArH); δC(75 
MHz) 10.8 (CH3, OCH2CH2CH3), 23.0 (CH2, OCH2CH2CH3), 28.0 (CH2, CH2CH2O), 57.8 
(CH2, CH2CH2O), 69.9 (CH2, OCH2CH2CH3), 96.8 (CH, CHO), 126.3 (CH, Ar), 127.4 (CH, 
Ar), 128.0 (CH, Ar), 128.4 (CH, Ar), 134.1 (quat. C, ipso Ar), 134.4 (quat. C, ipso Ar); m/z 
(EI) 192 ([M]+, 11%), 191 (13, [M – H]+), 149 (13, [M – CH2CH2CH3]
+), 133 (100, [M – 
OCH2CH2CH3]
+), 105 (15), 77 (10); HRMS: C12H16O2 calcd 192.1150 ([M]













Elemental Analysis: C, 74.97; H, 8.39; O, 16.64  
 
1-i-Propoxyisochroman 168 was prepared from isochroman (0.50 mL, 3.98 mmol), DDQ 
(1.08 g, 4.77 mmol) and anhydrous i-PrOH (2 × 365 µL, 2 × 4.77 mmol) in CH2Cl2 (25 mL) 
according to Method B. Purification by flash column chromatography (gradient: 100% hexane 
→ 98% hexane, 2% Et2O) afforded acetal 168 as a colourless liquid (400 mg, 52%): Rf = 0.33 
(90% hexane, 10% Et2O); νmax(film)/cm-1 2970m, 2935w, 2885w, 1494w, 1456m, 1378m, 
1322m, 1274m, 1205m, 1178w, 1124m, 1085m, 1070m, 1016s, 990s, 958w, 945m, 928m, 
870w, 821w, 769m, 744s; δH(300 MHz) 1.25 (3H, d, J 6.2, OCH(CH3)a(CH3)b), 1.27 (3H, d, J 
6.2, OCH(CH3)a(CH3)b), 2.62 (1H, ddd, J 16.6, 3.1, 1.5, CHaHbCH2O), 3.02 (1H, ddd, J 16.6, 
12.0, 6.0, CHaHbCH2O), 3.89 (1H, ddd, J 11.3, 6.0, 1.5, CH2CHaHbO), 4.08-4.25 (2H, stack, 
OCH(CH3)2 and CH2CHaHbO), 5.65 (1H, s, CHO), 7.07-7.15 (1H, m, ArH), 7.16-7.25 (3H, 
stack, ArH); δC(75 MHz) 21.9 (CH3, OCH(CH3)a(CH3)b), 23.6 (CH3, OCH(CH3)a(CH3)b), 
28.0 (CH2, CH2CH2O), 57.6 (CH2, CH2CH2O), 69.4 (CH, OCH(CH3)a(CH3)b), 94.9 (CH, 
CHO), 126.2 (CH, Ar), 127.3 (CH, Ar), 127.8 (CH, Ar), 128.4 (CH, Ar), 134.1 (quat. C, ipso 
Ar), 134.5 (quat. C, ipso Ar); m/z (EI) 192 ([M]+, 6%), 191 (7, [M – H]+), 149 (14, [M – 
CH(CH3)2]
+), 133 (100, [M – OCH(CH3)2]
+), 105 (15), 77 (14); HRMS: C12H16O2 calcd 













Elemental Analysis: C, 75.69; H, 8.80; O, 15.51  
 
1-t-Butoxyisochroman 169 was prepared from isochroman (0.50 mL, 3.98 mmol), DDQ (1.35 
g, 5.96 mmol) and anhydrous t-BuOH (2 × 760 µL, 2 × 7.96 mmol) in CH2Cl2 (25 mL) 
according to Method B. Purification by flash column chromatography (gradient: 100% hexane 
→ 98% hexane, 2% Et2O) afforded acetal 169 as a colourless liquid (180 mg, 22%): Rf = 0.35 
(90% hexane, 10% Et2O); (Found: C, 75.29; H, 8.65. C13H18O2 requires C, 75.69; H, 8.80%); 
νmax(film)/cm-1 2973m, 2932w, 1456m, 1367m, 1341m, 1273w, 1255w, 1192m, 1087m, 
1072m, 1040m, 1009s, 989s, 959m, 918m, 864w, 833w, 789m, 742s; δH(300 MHz, C6D6) 
1.30 (9H, s, OC(CH3)3), 2.17 (1H, ddd, J 16.1, 3.3, 1.5, CHaHbCH2O), 2.77 (1H, ddd, J 16.1, 
12.1, 6.1, CHaHbCH2O), 3.65 (1H, ddd, J 11.1, 6.1, 1.5, CH2CHaHbO), 4.16 (1H, app. td with 
unresolved fine coupling, J 11.8, 3.3, CH2CHaHbO) 5.86 (1H, s, CHO), 6.83-6.91 (1H, m, 
ArH), 7.01-7.21 (3H, stack, ArH); δC(75 MHz, C6D6) 28.5 (CH2, CH2CH2O), 29.3 (CH3, 
OC(CH3)3), 57.6 (CH2, CH2CH2O), 74.4 (quat. C, OC(CH3)3), 91.9 (CH, CHO), [126.3, 
127.6, 128.7 (CH, Ar), the fourth CH, Ar was not observed owing to overlap with the solvent 
signals], 134.9 (quat. C, ipso Ar), 136.7 (quat. C, ipso Ar); m/z (EI) 133 ([M – OC(CH3)3]
+, 
98%), 132 (98, [M – H – OC(CH3)3]
+), 118 (16), 115 (17), 104 (100), 90 (12), 77 (52), 63 
(12), 51 (18), 45 (16); HRMS: C9H9O calcd 133.0653 ([M – OC(CH3)3]













Elemental Analysis: C, 56.90; H, 4.77; F, 24.55; O, 13.78  
 
1-(2’,2’,2’-Trifluoroethoxy)isochroman 174 was prepared from isochroman (1.00 mL, 7.95 
mmol), DDQ (2.17 g, 9.54 mmol) and anhydrous 2,2,2-trifluoroethanol (2 × 695 µL, 2 × 9.54 
mmol) in CH2Cl2 (50 mL) according to Method B. Purification by flash column 
chromatography (gradient: 100% hexane → 98% hexane, 2% Et2O) afforded acetal 174 as a 
yellow oil (970 mg, 52%): Rf = 0.33 (90% hexane, 10% Et2O); νmax(film)/cm-1 2956m, 
2904m, 1434m, 1275m, 1214w, 1170s, 1117m, 1103m, 1076s, 1059s, 1031m, 991s, 969s, 
954s, 904m, 870m, 851w, 827w, 784m, 744s, 727w, 670m; δH(300 MHz) 2.03 (1H, app. d, J 
16.5, 2.4, CHaHbCH2O), 2.65 (1H, ddd, J 16.5, 12.3, 6.0, CHa bCH2O), 3.51 (1H, ddd, J 
11.2, 6.0, 1.4, CH2CHaHbO), 3.58 (1H, dq, J 12.4, 8.9, OCHaHbCF3), 3.76 (1H, dq, J 12.4, 
9.0, OCHaHbCF3), 3.82 (1H, app. td, J 11.7, 3.2, CH2CHaHbO), 5.34 (1H, s, CHO), 6.74-6.83 
(1H, m, ArH), 6.95-7.06 (2H, stack, ArH), 7.10-7.15 (1H, m, ArH); δC(100 MHz) 28.0 (CH2, 
CH2CH2O), 58.2 (CH2, CH2CH2O), 64.6 (CH2, q, 
2JC-F 34.1, OCH2CF3), 97.5 (CH, CHO), 
124.9 (quat. C, q, 1JC-F 276.3, CF3), 126.7 (CH, Ar), 128.2 (CH, Ar), 128.6 (CH, Ar), 128.7 
(CH, Ar), 133.2 (quat. C, ipso Ar), 134.4 (quat. C, ipso Ar); δF(282 MHz, C6D6) –73.9 (s, 
CF3); m/z (EI) 232 ([M]
+, 19%), 231 (26, [M – H]+), 204 (16), 133 (100, [M – OCH2CF3]
+), 
105 (31), 91 (16), 77 (13); HRMS: C11H11O2F3 calcd 232.0711 ([M]













Elemental Analysis: C, 74.97; H, 8.39; O, 16.64
 
 
1-Ethoxyisochroman 179a was prepared by DIBALH reduction (3.10 mL, 4.63 mmol) of 
isochroman-1-one 183a (500 mg, 3.09 mmol), followed by acetalisation using Amberlite and 
EtOH (6.2 mL) according to Method A. Purification by flash column chromatography 
(gradient: 98% hexane, 2% Et2O → 90% hexane, 10% Et2O) afforded 1-ethoxyisochroman 
179a as a colourless liquid (529 mg, 89% over two steps): Rf = 0.24 (80% hexane, 20% Et2O); 
νmax(film)/cm-1 2974m, 2881m, 1471w, 1385w, 1332w, 1105m, 1074s, 1046s, 998s, 932m, 
854w, 779s, 742m, 711w; δH(300 MHz, C6D6) 1.19 (3H, t, J 7.1, OCH2CH3), 1.91 (3H, s, 
ArCH3), 2.03 (1H, app. d with unresolved fine coupling, J 16.7, CHaHbCH2O), 2.48 (1H, ddd, 
J 17.3, 11.9, 6.3, CHa bCH2O), 3.54 (1H, dq, J 9.6, 7.1, OCHaHbCH3), 3.72 (1H, ddd, J 11.2, 
6.3, 1.5, CH2CHaHbO), 3.92 (1H, dq, J 9.6, 7.1, OCHaHbCH3), 4.10 (1H, app. td, J 11.7, 3.7, 
CH2CHaHbO), 5.58 (1H, s, CHO), 6.95 (1H, d, J 7.3, ArH), 7.04 (1H, app. t, J 7.6, ArH), 7.13 
(1H, d, J 7.7, ArH); δC(75 MHz, C6D6) 15.6 (CH3, OCH2CH3), 18.8 (CH3, ArCH3), 26.0 
(CH2, CH2CH2O), 57.7 (CH2, CH2CH2O), 63.4 (CH2, OCH2CH3), 97.3 (CH, CHO), 126.0 
(CH, Ar), 128.4 (CH, Ar), 129.3 (CH, Ar), 133.0 (quat. C, ipso Ar), 135.2 (quat. C, ipso Ar), 
135.7 (quat. C, ipso Ar); m/z (EI) 192 ([M]+, 19%), 191 (21, [M – H]+), 163 (12, [M – 
CH2CH3]
+), 147 (100, [M – OCH2CH3]
+), 133 (18, [M – CH3 – OCH2CH3]
+), 117 (36), 115 
(23), 105 (12), 103 (10), 91 (18); HRMS: C12H16O2 calcd 192.1150 ([M]












Elemental Analysis: C, 74.97; H, 8.39; O, 16.64  
 
1-Ethoxyisochroman 179b was prepared by DIBALH reduction (7.35 mL, 11.0 mmol) of 
isochroman-1-one 183b (1.19 g, 7.35 mmol), followed by acetalisation using Amberlite and 
EtOH (15 mL) according to Method A. Purification by flash column chromatography 
(gradient: 98% hexane, 2% Et2O → 95% hexane, 5% Et2O) afforded 1-ethoxyisochroman 
179b as a colourless liquid (1.17 g, 83% over two steps): Rf = 0.23 (90% hexane, 10% Et2O); 
(Found: C, 74.94; H, 8.14. C12H16O2 requires C, 74.97; H, 8.39%); νmax(film)/cm-1 2974m, 
2876m, 1619w, 1425w, 1381m, 1328m, 1275m, 1203w, 1133m, 1090m, 1073s, 1046s, 1005s, 
985m, 960m, 918m, 902w, 863w, 824m, 803m; δH(300 MHz, C6D6) 1.18 (3H, t, J 7.1, 
OCH2CH3), 2.10 (3H, s, ArCH3), 2.17 (1H, d with unresolved fine coupling, J 16.7, 
CHaHbCH2O), 2.78 (1H, ddd, J 16.7, 12.0, 6.0, CHa bCH2O), 3.53 (1H, dq, J 9.7, 7.1, 
OCHaHbCH3), 3.69 (1H, ddd, J 11.0, 6.0, 1.7, CH2CHaHbO), 3.91 (1H, dq, J 9.7, 7.1, 
OCHaHbCH3), 4.09 (1H, app. td, J 11.5, 3.4, CH2CHaHbO), 5.58 (1H, s, CHO), 6.67 (1H, s, 
ArH), 6.89 (1H, d, J 7.7, ArH), 7.16 (1H, d, J 7.7, ArH); δC(75 MHz, C6D6) 15.6 (CH3, 
OCH2CH3), 21.2 (CH3, ArCH3), 28.5 (CH2, CH2CH2O), 57.9 (CH2, CH2CH2O), 63.4 (CH2, 
OCH2CH3), 97.1 (CH, CHO), 127.2 (CH, Ar), 128.1 (CH, Ar), 129.1 (CH, Ar), 132.7 (quat. 
C, ipso Ar), 134.4 (quat. C, ipso Ar), 137.4 (quat. C, ipso Ar); m/z (EI) 192 ([M]+, 14%), 191 
(34, [M – H]+), 147 (100, [M – OCH2CH3]













Elemental Analysis: C, 74.97; H, 8.39; O, 16.64  
 
1-Ethoxyisochroman 179c was prepared from isochroman 182c (1.56 g, 10.5 mmol), DDQ 
(2.87 g, 12.6 mmol) and EtOH (2 × 735 µL, 2 × 12.6 mmol) in CH2Cl2 (65 mL) according to 
Method B. Purification by flash column chromatography (gradient: 98% hexane, 2% Et2O → 
95% hexane, 5% Et2O) afforded 1-ethoxyisochroman 179c as a yellow crystalline solid (833 
mg, 41%): mp 39-40 °C; Rf = 0.36 (80% hexane, 20% Et2O); νmax(film)/cm-1 2973m, 2886m, 
1504m, 1375m, 1332m, 1273w, 1155m, 1118w, 1090m, 1073s, 1075s, 1049s, 1004s, 990s, 
958m, 936m, 902m, 883m, 851m, 811s, 737w; δH(300 MHz, C6D6) 1.19 (3H, t, J 7.1, 
OCH2CH3), 2.10 (3H, s, ArCH3), 2.18 (1H, d with unresolved fine coupling, J 16.5, 
CHaHbCH2O), 2.78 (1H, ddd, J 16.5, 12.1, 6.0, CHa bCH2O), 3.54 (1H, dq, J 9.6, 7.1, 
OCHaHbCH3), 3.68 (1H, ddd, J 11.0, 6.0, 1.6, CH2CHaHbO), 3.91 (1H, dq, J 9.6, 7.1, 
OCHaHbCH3), 4.07 (1H, app. td with unresolved fine coupling, J 11.6, 3.3, CH2CHaHbO), 
5.55 (1H, s, CHO), 6.81 (1H, d, J 7.8, ArH), 6.90 (1H, dd, J 7.8, 1.5, ArH), 7.04 (1H, s, ArH); 
δC(100 MHz, C6D6) 15.6 (CH3, OCH2CH3), 21.1 (CH3, ArCH3), 28.1 (CH2, CH2CH2O), 58.0 
(CH2, CH2CH2O), 63.4 (CH2, OCH2CH3), 97.2 (CH, CHO), 128.5 (CH, Ar), 128.7 (CH, Ar), 
128.9 (CH, Ar), 131.5 (quat. C, ipso Ar), 135.2 (quat. C, ipso Ar), 135.5 (quat. C, ipso Ar); 
m/z (EI) 192 ([M]+, 29%), 191 (33, [M – H]+), 163 (17, [M – CH2CH3]
+), 147 (100, [M – 
OCH2CH3]
+), 133 (12, [M – CH3 – OCH2CH3]
+), 117 (23), 115 (12), 105 (13), 91 (13); 
HRMS: C12H16O2 calcd 192.1150 ([M]











Elemental Analysis: C, 74.97; H, 8.39; O, 16.64  
 
1-Ethoxyisochroman 179d was prepared by DIBALH reduction (3.30 mL, 4.94 mmol) of 
isochroman-1-one 183d (533 mg, 3.29 mmol), followed by acetalisation using Amberlite and 
EtOH (6.6 mL) according to Method A. Purification by flash column chromatography 
(gradient: 98% hexane, 2% Et2O → 95% hexane, 5% Et2O) afforded 1-ethoxyisochroman 
179d as a pale yellow solid (494 mg, 78% over two steps): mp 35-36 °C; Rf = 0.24 (80% 
hexane, 20% Et2O); (Found: C, 75.31; H, 8.26. C12H16O2 requires C, 74.97; H, 8.39%); 
νmax(film)/cm-1 2973m, 2879m, 1479m, 1471m, 1332m, 1206m, 1123m, 1101m, 1078m, 
1052s, 1036m, 993s, 973m, 918m, 901w, 892w, 866w, 775s, 747w, 715m; δH(300 MHz, 
C6D6) 1.14 (3H, t, J 7.1, OCH2CH3), 2.12-2.23 (4H, stack, CHaHbCH2O and ArCH3), 2.86 
(1H, ddd, J 16.6, 12.8, 6.4, CHa bCH2O), 3.44 (1H, dq, J 9.5, 7.1, OCHaHbCH3), 3.67 (1H, 
ddd, J 11.0, 6.4, 1.1, CH2CHaHbO), 3.90 (1H, dq, J 9.5, 7.1, OCHaHbCH3), 4.14 (1H, dddd, J 
12.7, 11.0, 3.4, 0.5, CH2CHaHbO), 5.53 (1H, s, CHO), 6.78 (1H, d, J 7.5, ArH), 6.90 (1H, d, J 
7.4, ArH), 7.04 (1H, app. t, J7.5, ArH); δC(75 MHz, C6D6) 15.5 (CH3, OCH2CH3), 18.4 (CH3, 
ArCH3), 28.6 (CH2, CH2CH2O), 57.3 (CH2, CH2CH2O), 63.1 (CH2, OCH2CH3), 95.7 (CH, 
CHO), 126.5 (CH, Ar), 127.9 (CH, Ar), 128.5 (CH, Ar), 133.5 (quat. C, ipso Ar), 134.3 (quat. 
C, ipso Ar), 136.6 (quat. C, ipso Ar); m/z (EI) 192 ([M]+, 11%), 147 (100, [M – OCH2CH3]
+), 
119 (17), 91 (11); HRMS: C12H16O2 calcd 192.1150 ([M]












Elemental Analysis: C, 76.44; H, 7.90; O, 15.67
 
 
1-Ethoxyisochroman 179j was prepared by DIBALH reduction (2.95 mL, 4.40 mmol) of 
isochroman-1-one 183j (510 mg, 2.93 mmol), followed by acetalisation using Amberlite and 
EtOH (6.5 mL) according to Method A. Purification by flash column chromatography 
(gradient: 98% hexane, 2% Et2O → 95% hexane, 5% Et2O) afforded 1-ethoxyisochroman 
179j as a colourless oil (502 mg, 84% over two steps): Rf = 0.23 (90% hexane, 10% Et2O); 
νmax(film)/cm-1 2974m, 2870m, 1493w, 1465w, 1383w, 1330m, 1244m, 1206m, 1099m, 
1083m, 1049s, 1003s, 963m, 929m, 855w, 827m, 753s, 721m, 674w; δH(300 MHz, C6D6) 
0.36-0.46 (1H, m, cyclopropylCH), 0.59-0.68 (1H, m, cyclopropylCH), 0.77-0.94 (2H, stack, 
cyclopropylCH), 1.18 (3H, t, J 7.1, OCH2CH3), 2.91 (1H, d, J 11.3, CHaHbO), 3.53 (1H, dq, J 
9.5, 7.0, OCHaHbCH3), 3.92 (1H, dq, J 9.5, 7.0, OCHaHbCH3), 4.46 (1H, d, J 11.3, CHaHbO), 
5.66 (1H, s, CHO), 6.40-6.48 (1H, m, ArH), 6.97-7.06 (2H, stack, ArH), 7.14-7.22 (1H, m, 
ArH); δC(75 MHz, C6D6) 10.5 (CH2, cyclopropylCH2), 15.6 (CH3, OCH2CH3), 18.4 (quat. C, 
CCH2O), 20.4 (CH2, cyclopropyl CH2), 63.4 (CH2, CH2O), 66.0 (CH2, CH2O), 98.1 (CH, 
CHO), 121.1 (CH, Ar), 125.4 (CH, Ar), 127.8 (CH, Ar), 128.5 (CH, Ar), 135.4 (quat. C, ipso 
Ar), 139.3 (quat. C, ipso Ar); m/z (EI) 204 ([M]+, 13%), 176 (10, [M – CH2CH2]
+), 159 (48, 
[M – OCH2CH3]
+), 157 (76), 148 (23), 129 (100), 119 (16), 115 (58), 102 (39), 91 (31), 77 
(15), 51 (11); HRMS: C13H16O2 calcd 204.1150 ([M]












Elemental Analysis: C, 75.69; H, 8.80; O, 15.51  
 
1-Ethoxyisochroman 179i was prepared by DIBALH reduction (4.00 mL, 5.96 mmol) of 
isochroman-1-one 183i (700 mg, 3.97 mmol) followed by acetalisation using Amberlite and 
EtOH (8 mL) according to Method A. Purification by flash column chromatography (gradient: 
98% hexane, 2% Et2O → 95% hexane, 5% Et2O) afforded 1-ethoxyisochroman 179i as a 
colourless oil (590 mg, 72% over two steps): Rf = 0.46 (90% hexane, 10% Et2O); (Found: C, 
75.42; H, 8.82. C13H18O2 requires C, 75.69; H, 8.80%); νmax(film)/cm-1 2973m, 2869w, 
1456w, 1384m, 1370m, 1335m, 1257w, 1212m, 1183m, 1086m, 1048s, 1030s, 1006s, 947w, 
927m, 874w, 804w, 759s, 734m, 723m; δH(300 MHz, C6D6) 1.17 (3H, t, J 7.1, OCH2CH3), 
1.23 (3H, s, CH3), 1.30 (3H, s, CH3), 2.44-2.63 (2H, stack, CH2), 3.52 (1H, dq, J 9.5, 7.1, 
OCHaHbCH3), 3.97 (1H, dq, J 9.5, 7.1, OCHaHbCH3), 5.67 (1H, s, CHO), 6.86-6.94 (1H, m, 
ArH), 7.06-7.14 (2H, stack, ArH), 7.30-7.38 (1H, m, ArH); δC(100 MHz, C6D6) 15.6 (CH3, 
OCH2CH3), 27.7 (CH3, C(CH3)a(CH3)b), 29.7 (CH3, C(CH3)a(CH3)b), 40.5 (CH2, CH2CO), 
63.1 (CH2, OCH2CH3), 71.4 (quat. C, C(CH3)2), 97.2 (CH, CHO), 126.5 (CH, Ar), 127.6 (CH, 
Ar), 128.2 (CH, Ar), 128.6 (CH, Ar), 134.0 (quat. C, ipso Ar), 135.0 (quat. C, ipso Ar); m/z 
(EI) 206 ([M]+, 32%), 205 (44, [M – H]+), 161 (79, [M – OCH2CH3]
+), 159 (45), 148 (22), 
145 (100), 142 (79), 133 (35), 128 (39), 119 (50), 115 (74), 104 (30), 91 (83), 77 (17), 65 
(16); HRMS: C13H18O2 calcd 206.1307 ([M]













Elemental Analysis: C, 51.38; H, 5.10; Br, 31.08; O, 12.44
 
 
1-Ethoxyisochroman 179e was prepared by DIBALH reduction (2.20 mL, 3.30 mmol) of 
isochroman-1-one 183e (500 mg, 2.20 mmol), followed by acetalisation using Amberlite and 
EtOH (4.4 mL) according to Method A. Purification by flash column chromatography 
(gradient: 99% hexane, 1% Et2O → 95% hexane, 5% Et2O) afforded 1-ethoxyisochroman 
179e as a white crystalline solid (555 mg, 98% over two steps): mp 27-28 °C; Rf = 0.34 (90% 
hexane, 10% Et2O); νmax(film)/cm-1 2969m, 2891m, 1442m, 1329m, 1381m, 1339m, 1096m, 
1077m, 1071m, 1044s, 1010s, 996s, 969m, 955m, 927m, 896m, 843m, 774s, 720m, 689m; 
δH(300 MHz, C6D6) 1.13 (3H, t, J 7.1, OCH2CH3), 2.41 (1H, ddd, J 17.4, 3.8, 1.5, 
CHaHbCH2O), 2.61 (1H, ddd, J 17.4, 11.7, 6.2, CHa bCH2O), 3.43 (1H, dq, J 9.6, 7.1, 
OCHaHbCH3), 3.57 (1H, ddd, J 11.3, 6.2, 1.5, CH2CHaHbO), 3.80 (1H, dq, J 9.6, 7.1, 
OCHaHbCH3), 3.90 (1H, app. td, J 11.5, 3.8, CH2CHaHbO), 5.37 (1H, s, CHO), 6.69 (1H, app. 
t, J 7.8, ArH), 6.98 (1H, d, J 7.6, ArH), 7.30 (1H, d, J 7.9, ArH); δC(100 MHz, C6D6) 15.1 
(CH3, OCH2CH3), 28.9 (CH2, CH2CH2O), 57.1 (CH2, CH2CH2O), 63.1 (CH2, OCH2CH3), 
96.0 (CH, CHO), 124.5 (quat. C, ipso ArBr), 126.8 (CH, Ar), 127.2 (CH, Ar), 131.5 (CH, Ar), 
134.2 (quat. C, ipso Ar), 137.4 (quat. C, ipso Ar); m/z (EI) 258 ([M]+, 10%), 257 (11, [M – 
H]+), 256 (10, [M]+), 255 (11, [M – H]+), 213 (100, [M – OCH2CH3]
+), 211 (100, [M – 
OCH2CH3]
+), 184 (26), 182 (26), 132 (30), 103 (39), 77 (29); HRMS: C11H13O2
79Br calcd 












Elemental Analysis: C, 58.54; H, 5.32; F, 23.15; O, 13.00
 
 
1-Ethoxyisochroman 179f was prepared by DIBALH reduction (2.30 mL, 3.47 mmol) of 
isochroman-1-one 183f (500 mg, 2.31 mmol), followed by acetalisation using Amberlite and 
EtOH (4.6 mL) according to Method A. Purification by flash column chromatography 
(gradient: 99% hexane, 1% Et2O → 95% hexane, 5% Et2O) afforded 1-ethoxyisochroman 
179f as a colourless liquid (503 mg, 88% over two steps): Rf = 0.31 (90% hexane, 10% Et2O); 
νmax(film)/cm-1 2976w, 2888w, 1315s, 1263w, 1199m, 1187m, 1156m, 1115s, 1103m, 1074s, 
1047s, 1003m, 969m, 936m, 850m, 805m, 794m, 748w, 726m, 692m; δH(300 MHz, C6D6) 
1.13 (3H, t, J 7.1, OCH2CH3), 2.61 (1H, d with unresolved fine coupling, J 17.4, 
CHaHbCH2O), 2.84 (1H, ddd, J 17.4, 11.9, 6.1, CHa bCH2O), 3.43 (1H, dq, J 9.6, 7.1, 
OCHaHbCH3), 3.52 (1H, ddd, J 11.3, 6.0, 1.2, CH2CHaHbO), 3.74-3.93 (2H, stack, 
OCHaHbCH3 and CH2CHaHbO), 5.36 (1H, s, CHO), 6.80 (1H, app. t, J 7.7, ArH), 7.10 (1H, d, 
J 7.7, ArH), 7.33 (1H, d, J 7.7, ArH); δC(100 MHz, C6D6) 15.4 (CH3, OCH2CH3), 25.5 (CH2, 
CH2CH2O), 57.0 (CH2, CH2CH2O), 63.5 (CH2, OCH2CH3), 96.5 (CH, CHO), 125.1 (quat. C, 
q, 1JC-F 272.0, ArCF3), 125.7 (CH, q, 
3JC-F 5.2, Ar), 126.0 (CH, Ar), 128.4 (quat. C, q, 
2JC-F 
28.4, ipso Ar), 132.0 (CH, Ar), 133.6 (quat. C, ipso Ar), 136.8 (quat. C, ipso Ar); δF(282 
MHz) –61.1 (s, ArCF3); m/z (EI) 246 ([M]
+, 4%), 245 (11, [M – H]+), 201 (100, [M – 
OCH2CH3]














Elemental Analysis: C, 69.21; H, 7.74; O, 23.05  
 
1-Ethoxyisochroman 179g was prepared by DIBALH reduction (1.40 mL, 2.10 mmol) of 
isochroman-1-one 183g (250 mg, 1.40 mmol), followed by acetalisation using Amberlite and 
EtOH (3 mL) according to Method A. Purification by flash column chromatography (gradient: 
99% hexane, 1% Et2O → 90% hexane, 10% Et2O) afforded 1-ethoxyisochroman 179g as a 
colourless liquid (217 mg, 74% over two steps): Rf = 0.23 (90% hexane, 10% Et2O); 
νmax(film)/cm-1 2973m, 2879m, 1615w, 1503m, 1330m, 1318m, 1273m, 1263m, 1237m, 
1165w, 1092m, 1074m, 1049s, 1035s, 997s, 958m, 933w, 866w, 848m, 814m, 802m; δH(300 
MHz, C6D6) 1.18 (3H, t, J 7.1, OCH2CH3), 2.17 (1H, ddd, J 16.1, 3.2, 1.6, CHaHbCH2O), 2.76 
(1H, ddd, J 16.1, 12.0, 5.9, CHa bCH2O), 3.31 (3H, s, OCH3), 3.52 (1H, dq, J 9.6, 7.1, 
OCHaHbCH3), 3.69 (1H, ddd, J 11.0, 5.9, 1.6, CH2CHaHbO), 3.91 (1H, dq, J 9.6, 7.1, 
OCHaHbCH3), 4.07 (1H, app. td, J11.5, 3.2, CH2CHaHbO), 5.57 (1H, s, CHO), 6.74-6.84 (2H, 
stack, ArH), 6.89 (1H, s, ArH); δC(100 MHz, C6D6) 15.6 (CH3, OCH2CH3), 27.7 (CH2, 
CH2CH2O), 54.8 (CH3, OCH3), 58.3 (CH2, CH2CH2O), 63.4 (CH2, OCH2CH3), 97.2 (CH, 
CHO), 112.6 (CH, Ar), 115.1 (CH, Ar), 126.6 (quat. C, ipso Ar), 129.6 (CH, Ar), 136.3 (quat. 
C, ipso Ar), 158.6 (quat. C, ipso Ar); m/z (EI) 208 ([M]+, 18%), 207 (8, [M – H]+), 180 (14), 
163 (63, [M – OCH2CH3]
+), 134 (100), 121 (20), 103 (12), 91 (23); HRMS: C12H16O3 calcd 













Elemental Analysis: C, 67.33; H, 6.68; F, 9.68; O, 16.31  
 
1-Ethoxyisochroman 179h was prepared by DIBALH reduction (4.20 mL, 6.32 mmol) of 
isochroman-1-one 183h (700 mg, 4.21 mmol), followed by acetalisation using Amberlite and 
EtOH (7.3 mL) according to Method A. Purification by flash column chromatography 
(gradient: 98% hexane, 2% Et2O → 95% hexane, 5% Et2O) afforded 1-ethoxyisochroman 
179h as a pale yellow oil (639 mg, 77% over two steps): Rf = 0.23 (90% hexane, 10% Et2O); 
νmax(film)/cm-1 2976w, 2882w, 1499m, 1433m, 1326w, 1257m, 1234m, 1112w, 1189m, 
1075s, 1047s, 1001s, 961m, 942m, 904m, 864m, 855m, 815m, 804m, 739m; δH(300 MHz, 
C6D6) 1.11 (3H, t, J 7.1, OCH2CH3), 2.02 (1H, app. d, J 16.2, CHaHbCH2O), 2.59 (1H, ddd, J
16.6, 12.0, 5.9, CHaHbCH2O), 3.42 (1H, dq, J 9.6, 7.1, OCHaHbCH3), 3.59 (1H, ddd, J 11.1, 
5.9, 1.7, CH2CHaHbO), 3.82 (1H, dq, J 9.6, 7.1, OCHaHbCH3), 3.92 (1H, app. td, J 11.7, 3.4, 
CH2CHaHbO), 5.37 (1H, s, CHO), 6.59 (1H, dd, 
3JH-H 8.4, 
4JH-F 5.7, ArH), 6.72 (1H, app. td, 
3JH-H and 
3JH-F 8.4, 
4JH-H 2.5, ArH), 6.92 (1H, dd, 
3JH-F 9.1, 
4JH-H 2.5, ArH); δC(75 MHz, 
C6D6) 15.5 (CH3, OCH2CH3), 27.6 (CH2, CH2CH2O), 57.9 (CH2, CH2CH2O), 63.6 (CH2, 
OCH2CH3), 96.5 (CH, CHO), 114.6 (CH, d, 
2JC-F 21.3, Ar), 115.3 (CH, d, 
2JC-F 21.3, Ar), 
130.1 (CH, d, 3JC-F 7.2, Ar), 137.1 (quat. C, d, 
4JC-F 6.5, ipso Ar), 161.6 (quat. C, d, 
1JC-F 
237.1, ipso Ar), the third quat. C, ipso Ar was not observed; δF(282 MHz) –116.6 - –116.3 (m, 
ArF); m/z (EI) 196 ([M]+, 7%), 195 (8, [M – H]+), 151 (100, [M – OCH2CH3]
+), 122 (21), 109 
(11), 103 (10); HRMS: C11H13O2F calcd 196.0900 ([M]











Elemental Analysis: C, 73.15; H, 7.37; O, 19.49  
 
1-Ethoxyisobenzofuran 179k was prepared from phthalan 185 (0.50 mL, 4.57 mmol), DDQ 
(1.24 g, 5.48 mmol) and EtOH (2 × 320 µL, 2 × 5.48 mmol) in CH2Cl2 (29 mL) according to 
Method B. Purification by flash column chromatography (gradient: 100% hexane → 98% 
hexane, 2% Et2O) afforded 1-ethoxyisobenzofuran 179k as a pale yellow liquid (669 mg, 
89%): Rf = 0.28 (90% hexane, 10% Et2O); δH(300 MHz) 1.29 (3H, t, J 7.1, OCH2CH3), 3.70 
(1H, dq, J 9.4, 7.1, OCHaHbCH3), 3.82 (1H, dq, J 9.4, 7.1, OCHaHbCH3), 5.06 (1H, d, J 12.7, 
CHaHbO), 5.26 (1H, dd, J 12.7, 1.9, CHaHbO), 6.29 (1H, d, J 1.9, CHO), 7.25-7.47 (4H, stack, 
ArH); δC(100 MHz) 15.4 (CH3, OCH2CH3), 62.9 (CH2, CH2O), 72.1 (CH2, CH2O), 106.7 
(CH, CHO), 121.0 (CH, Ar), 122.9 (CH, Ar), 127.6 (CH, Ar), 129.1 (CH, Ar), 137.7 (quat. C, 
ipso Ar), 139.9 (quat. C, ipso Ar); m/z (EI) 163 ([M – H]+, 9%), 135 (15, [M – OCH2CH3]
+), 
119 (100), 91 (34), 77 (16). 
 












NaBH4 (569 mg, 15.1 mmol) was added in small portions to a solution of 1-tetralone 189 
(4.40 g, 30.1 mmol) in EtOH (75 mL). After heating under reflux for 30 min, the solution was 
cooled to 0 °C and H2O (75 mL) was added. The EtOH was removed under reduced pressure 
and the aqueous phase was extracted with toluene (2 × 75 mL). The combined organic 
fractions were washed with brine (75 mL) and then dried (MgSO4). The drying agent was 
removed by filtration and the filtrate was concentrated to a volume of 100 mL. pTSA (29 mg, 
0.15 mmol) was added to the resulting solution of 1,2,3,4-tetrahydronaphthalen-1-ol in 
toluene and the mixture was heated under reflux with azeotropic removal of H2O (Dean-
Stark) for 15 h. After cooling to R.T., NaHCO3 solution (30 mL) was added and the layers 
were separated. The organic phase was washed with NaHCO3 solution (30 mL) and brine (40 
mL) and dried (MgSO4). The drying agent was removed by filtration and the filtrate 
concentrated under reduced pressure to provide the crude product. Purification by a silica plug 
(100% hexane) afforded 1,2-dihydronaphthalene 190 as a colourless liquid (3.40 g, 87%): Rf = 
0.50 (100% hexane); δH(300 MHz) 2.30-2.41 (2H, stack, CH=CHC2), 2.84 (2H, app. t, J 
8.2, ArCH2), 6.02-6.11 (1H, m, CH=CHCH2), 6.47-6.55 (1H, m, CH=CHCH2), 7.02-7.24 
(4H, stack, ArH); δC(100 MHz) 23.2 (CH2, ArCH2CH2 or ArCH2CH2), 27.5 (CH2, ArCH2CH2 
or ArCH2CH2), [125.9, 126.4, 126.8, 127.5, 127.8, 128.6 (CH, 4 × Ar, CH=CH)], 134.1 (quat. 
C, ipso Ar), 135.4 (quat. C, ipso Ar); m/z (EI) 130 ([M]+, 100%), 115 (43), 64 (14), 51 (13). 
 
Data were in agreement with those reported in the literature.[158] 
 







Elemental Analysis: C, 72.26; H, 8.49; O, 19.25  
 185 
A solution of 1,2-dihydronaphthalene (3.27 g, 25.1 mmol) in CH2Cl2/MeOH (1:1, 130 mL) 
was cooled to –78 °C. O3 was bubbled through the solution until a blue colour developed. The 
excess O3 was then removed by bubbling N2 through the solution until the blue colour had 
dissipated. NaBH4 (1.90 g, 50.2 mmol) was added slowly over 5 min and the mixture was 
warmed to R.T. After stirring for 1.5 h at R.T., the reaction was quenched by the addition of 
NH4Cl solution (80 mL) (caution: gas formation!). CH2Cl2 (50 mL) was added and the two 
phases were separated. The aqueous phase was extracted with CH2Cl2 (2 × 25 mL). The 
combined organic fractions were washed with brine (50 mL), and then dried (MgSO4). The 
drying agent was removed by filtration and the filtrate concentrated under reduced pressure to 
provide the crude diol 191 as a colourless viscous oil (3.17 g, 76%), which was sufficiently 
pure for characterisation and further use: Rf = 0.20 (20% hexane, 80% EtOAc); δH(300 MHz) 
1.79-1.91 (2H, stack, CH2CH2OH), 2.77 (2H, t, J 7.4, ArCH2), 3.49 (2H, t, J 5.9, 
CH2CH2OH), 3.75 (1H, br s, OH), 4.04 (1H, br s, OH), 4.61 (2H, s, CH2OH), 7.13-7.31 (4H, 
stack, ArH); δC(75 MHz) 27.3 (CH2, ArCH2CH2), 33.5 (CH2, ArCH2CH2), [60.7, 63.0 (CH2, 
ArCH2OH, CH2CH2OH)], 126.0 (CH, Ar), 128.1 (CH, Ar), 129.3 (CH, 2 × Ar, resonance 
overlap), 138.3 (quat. C, ipso Ar), 140.2 (quat. C, ipso Ar); m/z (EI) 166 ([M]+, 18%), 148 
(40), 130 (100), 117 (99), 105 (53), 91 (74), 77 (28), 65 (12). 
 










Elemental Analysis: C, 73.15; H, 7.37; O, 19.49  
 186 
Activated MnO2 85% (4.31 g, 42.1 mmol) was added to a solution of diol 191 (1.00 g, 6.02 
mmol) in CH2Cl2 (13 mL). After stirring for 12 h at R.T., more MnO2 (1.85 g, 18.1 mmol) 
was added and the stirring was continued for 2 h. Another portion of MnO2 (1.85 g, 18.1 
mmol) was added and the stirring was continued. After 1 h, the MnO2 was removed by 
filtration over Celite, and the Celite was washed with CH2 l2 (150 mL). The filtrate was 
concentrated under reduced pressure to provide the crude aldehyde 188 as a colourless 
viscous oil (851 mg, 86%), which was sufficiently pure for characterisation and further use: Rf
= 0.20 (40% hexane, 60% EtOAc); δH(300 MHz) 1.82-1.94 (2H, stack, CH2CH2OH), 2.25 
(1H, br s, OH), 3.13 (2H, t, J 7.6, ArCH2), 3.66 (2H, t, J 6.1, CH2CH2OH), 7.31 (1H, d, J 7.6, 
ArH), 7.38 (1H, app. td, J 7.5, 1.2, ArH), 7.51 (1H, app. td, J 7.5, 1.2, ArH), 7.81 (1H, dd, J 
7.6, 1.5 ArH), 10.22 (1H, s, CHO); δC(100 MHz) [28.7, 34.6 (CH2, ArCH2CH2)], 61.7 (CH2, 
CH2OH), 126.6 (CH, Ar), 131.2 (CH, Ar), 133.0 (CH, Ar), 133.8 (CH, Ar), 144.6 (quat. C, 
ipso Ar), 193.1 (CH, CHO), the second ipso Ar resonance was not observed; m/z (EI) 164 
([M] +, 14%), 146 (20), 131 (36), 118 (100, [M – CHO – OH]+), 105 (20), 91 (45), 77 (26), 65 
(20), 55 (10), 51 (14). 
 
Data were in agreement with those reported in the literature.[159] 
 
 
1-Ethoxy-3,4,5-trihydro-2-benzoxepin 179l and 2-(3’-hydroxypropyl)benzaldehyde 













OEt Chemical Formula: C14H22O3
Exact Mass: 238.1569
Molecular Weight: 238.3227
Elemental Analysis: C, 70.56; H, 9.30; O, 20.14  
 
A solution of 2-(3’-hydroxypropyl)benzaldehyde 188 (610 mg, 3.72 mmol) in EtOH (8 mL) 
was stirred with Amberlite (IR 120 beads, spatula tip) at R.T. After 6 h, the beads were 
filtered off and washed with Et2O (15 mL). NaHCO3 solution (20 mL) was added and the 
Et2O and EtOH were evaporated. The residue was extracted with Et2O (2 × 20 mL) and the 
combined organic fractions were washed with brine (30 mL) and dried (MgSO4). The drying 
agent was removed by filtration and the filtrate concentrated under reduced pressure. 
Purification of the residue by column chromatography (gradient: 98% hexane, 2% Et2O → 
50% hexane, 50% Et2O) afforded, in order of elution, benzoxepin 179l as a colourless liquid 
(466 mg, 56%): Rf = 0.58 (50% hexane, 50% Et2O); νmax(film)/cm-1 2933m, 1455m, 1373w, 
1346m, 1288w, 1222m, 1196w, 1142m, 1104m, 1085s, 1069s, 1050s, 1019s, 963m, 947m, 
906m, 876m, 851w, 770m, 746s; δH(300 MHz, C6D6) 1.18 (3H, t, J 7.1, OCH2CH3), 1.41-
1.62 (2H, stack, CH2CH2CH2O), 2.62-2.84 (2H, stack, CH2CH2CH2O), 3.38 (1H, dq, J 9.4, 
7.1, OCHaHbCH3), 3.58 (1H, ddd, J 11.8, 7.2, 4.1, CH2CHaHbO), 3.91 (1H, dq, J 9.4, 7.1, 
OCHaHbCH3), 4.06 (1H, ddd, J 11.8, 6.0, 4.4, CH2CHaHbO), 5.42 (1H, s, CHO), 6.92-6.99 
(1H, m, ArH), 7.02-7.13 (2H, stack, ArH), 7.62-7.70 (1H, m, ArH); δC(100 MHz, C6D6) 15.3 
(CH3, OCH2CH3), [29.9, 34.5 (CH2, CH2CH2CH2O], [63.6, 67.7 (CH2, CH2CH2CH2O and 
OCH2CH3)], 103.8 (CH, CHO), 126.3 (CH, Ar), 127.0 (CH, Ar), 128.2 (CH, Ar), 129.6 (CH, 
Ar), 140.1 (quat. C, ipso Ar), 141.0 (quat. C, ipso Ar); m/z (EI) 192 ([M]+, 3%), 191 (9, [M – 
H]+), 161 (10), 147 (100, [M – OCH2CH3]
+), 133 (21), 129 (32), 117 (96), 115 (25), 105 (11), 
91 (47), 77 (16), 65 (11); HRMS: C12H16O2 calcd 192.1150 ([M]
+), obsd 192.1154; and then 
diethyl acetal 192 as a colourless oil (124 mg, 12%): Rf = 0.35 (50% hexane, 50% Et2O); 
νmax(film)/cm-1 3421m br (OH), 2974m, 2877m, 1452w, 1374m, 1353m, 1285w, 1216m, 
 188 
1048s, 953m, 915m, 753s; δH(300 MHz) 1.25 (6H, t, J 7.1, OCH2CH3), 1.85-1.97 (2H, stack, 
CH2CH2CH2OH), 2.61 (1H, br s, OH), 2.86 (2H, t, J 7.3, CH2CH2CH2OH), 3.50-3.70 (6H, 
stack, OCH2CH3, CH2CH2CH2OH), 5.65 (1H, s, CH(OEt)2), 7.17-7.33 (3H, stack, ArH), 
7.53-7.61 (1H, m, ArH); δC(100 MHz) 15.0 (CH3, OCH2CH3), 27.4 (CH2, CH2CH2CH2OH), 
33.9 (CH2, CH2CH2CH2OH), [61.49, 61.52 (CH2, CH2CH2CH2OH and OCH2CH3)], 100.3 
(CH, CH(OEt)2), 125.5 (CH, Ar), 126.8 (CH, Ar), 128.4 (CH, Ar), 129.5 (CH, Ar), 136.2 
(quat. C, ipso Ar), 139.8 (quat. C, ipso Ar); m/z (TOF ES+) 261 ([M + Na]+, 100%); HRMS: 
C14H22O3Na calcd 261.1467 ([M + Na]
+), obsd 261.1463; and then recovered starting material 









Elemental Analysis: C, 84.68; H, 5.92; O, 9.40  
 
NaBH4 (239 mg, 6.31 mmol) was added to a solution of 1,8-naphthalic anhydride 194 (500 
mg, 2.52 mmol) in THF (1 mL) at 0 °C (caution: gas formation!). A solution of BF3·OEt2 
(935 mL, 7.57 mmol) in THF (0.8 mL) was added over 3 min at 0 °C and the reaction mixture 
was stirred at R.T overnight. A mixture of THF/H2O (1:1, 5 mL) was added carefully 
(caution: gas formation) followed by the addition of more H2O (10 mL). The two phases were 
separated and the aqueous phase was extracted with Et2O (3 × 10 mL). The combined organic 
fractions were washed with brine (20 mL), and then dried (MgSO4). The drying agent was 
removed by filtration and the filtrate concentrated under reduced pressure to provide the crude 
product. Purification by flash column chromatography (gradient: 100% hexane → 99% 
 189 
hexane, 1% Et2O) afforded pyran 195 as a white crystalline solid (319 mg, 74%): mp 84-85 
°C (lit.[202] mp 83-83.5 °C); Rf = 0.25 (90% hexane, 10% Et2O); (Found: C, 84.68; H, 5.98. 
C12H10O requires C, 84.68; H, 5.92%); δH(300 MHz) 5.10 (4H, s, CH2O), 7.19 (2H, d, J 6.9, 
ArH), 7.46 (2H, app. t, J 7.4, ArH), 7.76 (2H, d, J 8.3, ArH); δC(100 MHz) 69.3 (CH2, 
CH2O), 119.9 (CH, Ar), 125.6 (CH, Ar), 126.3 (CH, Ar), 126.7 (quat. C, ipso Ar), 132.5 
(quat. C, ipso Ar), 132.8 (quat. C, ipso Ar); m/z (EI) 170 ([M]+, 97%), 152 (21), 141 (100), 
115 (19). 
 
Data were in agreement with those reported in the literature.[202]  
 
 







Elemental Analysis: C, 78.25; H, 4.38; O, 17.37
 
 
OHHO Chemical Formula: C12H12O2
Exact Mass: 188.0837
Molecular Weight: 188.2225
Elemental Analysis: C, 76.57; H, 6.43; O, 17.00
 
 
1,8-Naphthalic anhydride 194 (5.00 g, 25.2 mol) was added in 1 g portions to a suspension of 
LiAlH 4 (1.92 g, 50.5 mol) in THF (125 mL) over 1 h. After stirring overnight at R.T., the 
reaction was quenched by the cautious addition of a saturated solution of Rochelle’s salt (50 
mL) (caution: gas formation!) at 0 °C. The THF was removed under reduced pressure and 
then CH2Cl2 (100 mL) and H2SO4 (1 M, 100 mL) were added. The two layers were separated 
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and the aqueous phase was extracted with CH2Cl2 (2 × 30 mL). The combined organic 
fractions were washed with NaOH solution (1 M, 50 mL) and brine (50 mL) and then dried 
(MgSO4). The drying agent was removed by filtration and the filtrate concentrated under 
reduced pressure. Purification of the residue by flash column chromatography (residue pre-
adsorbed on silica, gradient: 80% hexane, 10% EtOAc, 10% toluene → 70% hexane, 20% 
EtOAc, 10% toluene) afforded, in order of elution, pyran-1-one 193 as a white crystalline 
solid (1.88 g, 41%): mp 158-159 °C (lit.[203] mp 156-157 °C); Rf = 0.28 (70% hexane, 20% 
EtOAc, 10% toluene); (Found: C, 78.28; H, 4.36. C12H8O2 requires C, 78.25; H, 4.38%); 
δH(300 MHz) 5.80 (2H, s, CH2O),  7.31-7.39 (1H, m, ArH), 7.53 (1H, dd, J 8.3, 7.1, ArH), 
7.62 (1H, dd, J 8.3, 7.4, ArH), 7.83 (1H, dd, J 8.3, 0.7, ArH), 8.08 (1H, dd, J 8.3, 1.1, ArH), 
8.36 (1H, dd, J 7.3, 1.1, ArH); δC(75 MHz) 70.0 (CH2, CH2O), 120.1 (quat. C, ipso Ar), 121.4 
(CH, Ar), 126.4 (CH, 2 × Ar, resonance overlap), 126.6 (CH, Ar), 127.1 (quat. C, ipso Ar), 
128.2 (quat. C, ipso Ar), 129.0 (CH, Ar), 131.9 (quat. C, ipso Ar), 133.4 (CH, Ar), 164.1 
(quat. C, C=O); m/z (EI) 184 ([M]+, 85%), 155 (100), 139 (11), 127 (82), 77 (10), 63 (13); 
and then (gradient: 50% hexane, 50% EtOAc → 10% hexane, 90% EtOAc) diol 196 as a 
white crystalline solid (1.14 g, 24%): mp 155-156 °C (lit.[204] mp 157-158 °C); Rf = 0.15 (50% 
hexane, 50% EtOAc); δH(300 MHz, CD3OD) 4.90 (2H, s, OH), 5.23 (4H, s, CH2O), 7.44 (2H, 
dd, J 8.1, 7.1, ArH), 7.61 (2H, dd, J 7.1, 1.3, ArH), 7.86 (2H, dd, J 8.1, 1.3, ArH); δC(75 
MHz, CD3OD) 66.3 (CH2, CH2OH), 126.2 (CH, Ar), 130.8 (CH, Ar), 131.1 (CH, Ar), 131.9 
(quat. C, ipso Ar), 137.3 (quat. C, ipso Ar), 138.3 (quat. C, ipso Ar); m/z (EI) 188 ([M]+, 
30%), 170 (100), 153 (39), 141 (83), 128 (32), 115 (39), 84 (32), 63 (10), 49 (39). 
 











Elemental Analysis: C, 78.48; H, 6.59; O, 14.93
 
 
Naphthopyran 179m was prepared by DIBALH reduction (3.80 mL, 5.70 mmol) of pyran-1-
one 193 (700 mg, 3.80 mmol), followed by acetalisation using Amberlite and EtOH (6.7 mL) 
according to Method A. Purification by flash column chromatography (gradient: 98% hexane, 
2% Et2O → 95% hexane, 5% Et2O) afforded 1-ethoxynaphthopyran 179m as a colourless oil 
(684 mg, 84% over two steps): Rf = 0.25 (90% hexane, 10% Et2O); νmax(film)/cm-1 2976w, 
2894w, 1372m, 1331m, 1316w, 1176m, 1162w, 1128m, 1107w, 1076m, 1041s, 1013s, 985m, 
933m, 902w, 833m, 817s, 797m, 771s, 735m; δH(300 MHz, C6D6) 1.17 (3H, t, J 7.1, 
OCH2CH3), 3.58 (1H, dq, J 9.6, 7.1, OCHaHbCH3), 3.96 (1H, dq, J 9.6, 7.1, OCHaHbCH3), 
4.73 (1H, d, J 14.4, CHaHbO), 5.26 (1H, d, J 14.4, CHaHbO), 5.84 (1H, s, CHO), 6.80-6.86 
(1H, m, ArH), 7.13-7.26 (3H, stack, ArH), 7.49-7.60 (2H, stack, ArH); δC(75 MHz, C6D6) 
15.5 (CH3, OCH2CH3), 61.5 (CH2, CH2O), 63.6 (CH2, CH2O), 98.5 (CH, CHO), 120.6 (CH, 
Ar), 123.3 (CH, Ar), 125.7 (CH, Ar), 125.9 (CH, Ar), 126.5 (CH, Ar), 128.1 (CH, Ar), [132.3 
(quat. C, ipso Ar), 133.1 (quat. C, ipso Ar), resonance overlap]; m/z (EI) 214 ([M]+, 15%), 
169 (79, [M – OCH2CH3]
+), 152 (24), 141 (100), 139 (21), 115 (24); HRMS: C14H14O2 calcd 
214.0994 ([M]+), obsd 214.0993. 
 
2-Phenylethyl trimethylsilyl ether 198[143] 
 
OTMS Chemical Formula: C11H18OSi
Exact Mass: 194.1127
Molecular Weight: 194.3455
Elemental Analysis: C, 67.98; H, 9.34; O, 8.23; Si, 14.45  
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I2 (508 mg, 2.00 mmol) was added to a solution of 2-phenylethyl alcohol (2.40 mL, 20.0 
mmol) in CH2Cl2 (80 mL). A solution of HMDS (3.30 mL, 16.00 mmol) in CH2Cl2 (20 mL) 
was added dropwise over 5 min to the dark purple solution. After stirring for 1 h, the reaction 
was quenched by the addition of Na2S2O3 solution (60 mL), and the mixture was stirred until 
the solution turned colourless. The phases were separated and the organic phase was washed 
with brine (40 mL), and then dried (MgSO4). The drying agent was removed by filtration and 
the filtrate concentrated under reduced pressure to provide the crude silyl ether 198 as a pale 
yellow liquid (3.79 g, 98%), which was sufficiently pure for characterisation and further use: 
δH(300 MHz) 0.10 (9H, s, Si(CH3)3), 2.87 (2H, t, J 7.3, ArCH2), 3.81 (2H, t, J 7.3, 
CH2OTMS), 7.19-7.36 (5H, stack, ArH). 
  









Elemental Analysis: C, 81.04; H, 8.16; O, 10.80  
 
TMSI (1.00 mL, 7.07 mmol) was added to a solution of freshly distilled acetaldehyde (400 
µL, 7.07 mmol) in CHCl3 (1 mL) at R.T. After stirring for 5 min, silyl ether 198 (1.92 g, 9.90 
mmol) was added and the mixture was warmed to 50 °C for 2 h. After cooling to R.T., Et2O 
(20 mL) was added. The organic phase was washed with Na2S2O3 solution (3 × 20 mL), H2O 
(10 mL) and brine (10 mL) and then dried (MgSO4). The drying agent was removed by 
filtration and the filtrate concentrated under reduced pressure to provide the crude product. 
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Purification by flash column chromatography (99% hexane, 1% Et2O) afforded isochroman 
197 as a colourless liquid (340 mg, 32%): Rf = 0.30 (90% hexane, 10% Et2O); δH(300 MHz) 
1.58 (3H, d, J 6.5, CH3), 2.72 (1H, app. dt, J 16.3, 3.3, CHaHbCH2O), 3.07 (1H, ddd, J 15.9, 
10.1, 5.6, CHaHbCH2O), 3.84 (1H, ddd, J 11.3, 10.1, 3.3, CH2CHaHbO), 4.20 (1H, ddd, J 
11.3, 5.6, 3.3, CH2CHaHbO), 4.90 (1H, q, J 6.5, CHCH3), 7.08-7.27 (4H, stack, ArH); δC(75 
MHz) 21.8 (CH3, CH3), 29.0 (CH2, CH2CH2O), 63.6 (CH2, CH2CH2O), 72.3 (CH, CHO), 
124.7 (CH, Ar), 126.1 (CH, Ar), 126.2 (CH, Ar), 128.8 (CH, Ar), 133.4 (quat. C, ipso Ar), 
139.5 (quat. C, ipso Ar); m/z (EI) 148 ([M]+, 15%), 147 (15, [M – H]+), 133 (100, [M – 
CH3]
+), 117 (11), 115 (12), 105 (26), 91 (10), 77 (11). 
 














C, 74.97; H, 8.39; O, 16.64  
 
MeLi (1.6 M solution in Et2O, 5.10 mL, 8.18 mmol) was added over 10 min to a solution of 
isochroman-1-one 172 (1.10 g, 7.43 mmol) in THF (37 mL) at –78 °C. After stirring at –78 
°C for 2 h, AcOH (470 µL, 8.18 mmol) was added and the mixture was stirred for 15 min. 
The mixture was poured into ice-water (100 mL) and transferred to a separating funnel. The 
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phases were separated and the aqueous phase was extracted with CH2Cl2 (3 × 20 mL). The 
combined organic fractions were washed with brine (30 mL) and dried (MgSO4). The drying 
agent was removed by filtration and the filtrate concentrated under reduced pressure to 
provide the crude hemiacetal product, which was of sufficient purity for it to be used directly 
in the next step: 1-Hydroxy-1-methylisochroman was dissolved in EtOH (15 mL) and stirred 
with Amberlite (IR 120 beads, tea spoon) at R.T. for 2 h. The beads were filtered off and 
washed with Et2O (15 mL). NaHCO3 solution (20 mL) was added and the Et2O and EtOH 
were evaporated. The residue was extracted with Et2O (2 × 20 mL) and the combined organic 
fractions were washed with brine (30 mL) and dried (MgSO4). The drying agent was removed 
by filtration and the filtrate concentrated under reduced pressure. Purification of the residue 
by flash column chromatography (gradient: 99% hexane, 1% NEt3 → 95% hexane, 4% Et2O, 
1% NEt3) afforded 1-ethoxy-1-methylisochroman 179n as a colourless oil (857 mg, 60% over 
two steps): Rf = 0.28 (90% hexane, 10% Et2O); νmax(film)/cm-1 2974m, 2933m, 2880m, 
1492w, 1451w, 1427w, 1388w, 1372m, 1304w, 1289m, 1267m, 1252m, 1160m, 1121s, 
1096s, 1084s, 1069s, 1047s, 1029s, 973w, 941m, 907m, 872m, 840w, 789w, 758s, 732m; 
δH(300 MHz, C6D6) 1.15 (3H, app. t, J 7.1, OCH2CH3), 1.64 (3H, s, CCH3), 2.24 (1H, app. dt, 
J 16.1, 3.2, CHaHbCH2O), 2.70 (1H, ddd, J 16.1, 10.6, 5.4, CHa bCH2O), 3.55 (1H, app. q, J
7.1, OCH2CH3), 3.66 (1H, ddd, J 11.0, 5.4, 3.0, CH2CHaHbO), 3.91 (1H, app. td, J 10.9, 3.5, 
CH2CHaHbO), 6.82-6.91 (1H, m, ArH), 7.00-7.12 (2H, stack, ArH), 7.33-7.41 (1H, m, ArH); 
δC(75 MHz, C6D6) 16.0 (CH3, OCH2CH3), 26.1 (CH3, CCH3), 29.2 (CH2, CH2CH2O), 56.8 
(CH2, CH2O), 59.5 (CH2, CH2O), 98.9 (quat. C, CCH3O), 126.6 (CH, Ar), 127.2 (CH, Ar), 
127.5 (CH, Ar), 128.5 (CH, Ar), 134.2 (quat. C, ipso Ar), 139.8 (quat. C, ipso Ar); m/z (TOF 





















OH Chemical Formula: C15H14O2
Exact Mass: 226.0994
Molecular Weight: 226.2705
Elemental Analysis: C, 79.62; H, 6.24; O, 14.14
 
 
PhLi (1.8 M solution in Et2O, 3.50 mL, 6.26 mmol) was added over 10 min to a solution of 
isochroman-1-one 172 (842 mg, 5.69 mmol) in THF (28 mL) at –78 °C. After stirring at –78 
°C for 1 h, the mixture was warmed up to 0 °C over 5 h. AcOH (360 µL, 6.26 mmol) was 
added and the mixture was stirred for 15 min. The mixture was poured into ice-water (100 
mL) and transferred to a separating funnel. The phases were separated and the aqueous phase 
was extracted with CH2Cl2 (3 × 20 mL). The combined organic fractions were washed with 
brine (30 mL) and dried (MgSO4). The drying agent was removed by filtration and the filtrate 
concentrated under reduced pressure. Purification of the residue by flash column 
chromatography (gradient: 95% hexane, 4% EtOAc, 1% NEt3 → 92% hexane, 7% EtOAc, 
1% NEt3) afforded, in order of elution, 2-(2’-(1’’-oxo-1’’-phenyl-
isochroman)ethyl)benzophenone 201 as a pale yellow solid (593 mg, 48%): mp 109-110 °C; 
Rf = 0.55 (70% hexane, 30% EtOAc); νmax(film)/cm-1 2883w, 1660s (C=O), 1447m, 1312m, 
1285m, 1262m, 1196m, 1175m, 1075m, 1068m, 1048s, 1006m, 1000m, 986m, 939m, 925s, 
769s, 752s, 732m, 703s, 660m; δH(300 MHz, C6D6) 2.23 (1H, app. dt, J 16.2, 3.2, 
CHaHbCH2O), 2.76 (1H, ddd, J 16.1, 10.7, 5.5, CHa bCH2O), 3.11-3.31 (2H, stack, 
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OCH2CH2Ar), 3.70 (1H, ddd, J 11.0, 5.5, 3.0, CH2CHaHbO), 3.75-3.96 (3H, stack, 
CH2CHaHbO, OCH2CH2Ar), 6.75-7.31 (14H, stack, ArH), 7.58-7.65 (2H, stack, ArH), 7.71-
7.78 (2H, stack, ArH); δC(100 MHz, C6D6) 28.9 (CH2, CH2CH2O), 34.2 (CH2, CH2CH2O), 
59.8 (CH2, CH2CH2O), 64.0 (CH2, CH2CH2O), 101.1 (quat. C, CPh), [125.7 (CH, Ar), 126.6 
(CH, Ar), 127.4 (CH, Ar), 127.6 (CH, Ar), 128.4 (CH, Ar), 128.5 (CH, Ar), 128.9 (CH, Ar), 
129.0 (CH, Ar), 130.1 (CH, Ar), 130.5 (CH, Ar), 131.5 (CH, Ar), 132.8 (CH, Ar), resonance 
overlap], 134.0 (quat. C, ipso Ar), 138.3 (quat. C, ipso Ar), 138.6 (quat. C, ipso Ar), 139.0 
(quat. C, ipso Ar), 139.8 (quat. C, ipso Ar), 143.4 (quat. C, ipso Ar), 197.6 (quat. C, C=O); 
m/z (TOF ES+) 457 ([M + Na]+, 100%); HRMS: C30H26O3Na calcd 457.1780 ([M + Na]
+), 
obsd 457.1775; and then 2-(2’-hydroxyethyl)benzophenone 200 (gradient: 80% hexane, 19% 
EtOAc, 1% NEt3 → 70% hexane, 29% EtOAc, 1% NEt3) as a pale orange viscous oil (288 
mg, 22%): Rf = 0.23 (70% hexane, 30% EtOAc); δH(300 MHz, C6D6) 2.79 (2H, t, J 6.4, 
CH2CH2OH), 3.71 (2H, t, J 6.4, CH2CH2OH), 6.75-7.22 (7H, stack, ArH), 7.67-7.81 (2H, 
stack, ArH); δC(100 MHz, C6D6) 36.8 (CH2, CH2CH2OH), 63.9 (CH2, CH2CH2OH), 125.6 
(CH, Ar), 128.6 (CH, Ar), 129.2 (CH, Ar), 130.6 (CH, Ar), 130.7 (CH, Ar), 131.4 (CH, Ar), 
133.1 (CH, Ar), 138.3 (quat. C, ipso Ar), 139.3 (quat. C, ipso Ar), 139.5 (quat. C, ipso Ar), 
198.4 (quat. C, C=O); m/z (EI) 226 ([M]+, 10%), 208 (100), 195 (95, [M – CH2OH]
+), 179 
(32), 165 (39), 152 (13), 131 (20), 119 (10), 105 (35), 91 (17), 77 (51), 51 (16). 
 



















Elemental Analysis: C, 80.28; H, 7.13; O, 12.58
 
2-(2’-Hydroxyethyl)benzophenone 200 (288 mg, 1.25 mmol) was dissolved in EtOH (2.5 mL) 
and stirred with Amberlite (IR 120 beads, spatula tip) at R.T. for 2 h. The beads were filtered 
off and washed with Et2O (15 mL). NaHCO3 solution (15 mL) was added and the Et2O and 
EtOH were evaporated. The residue was extracted with Et2O (2 × 15 mL) and the combined 
organic fractions were washed with brine (25 mL) and dried (MgSO4). The drying agent was 
removed by filtration and the filtrate concentrated under reduced pressure. Purification of the 
residue by flash column chromatography (gradient: 99% hexane, 1% NEt3 → 97% hexane, 
2% Et2O, 1% NEt3) afforded 1-ethoxy-1-phenylisochroman 179o as a colourless oil (130 mg, 
40%): Rf = 0.46 (90% hexane, 10% Et2O); νmax(film)/cm-1 2973m, 2935w, 2886w, 1489m, 
1448m, 1259w, 1239m, 1201m, 1121m, 1089m, 1080m, 1068s, 1048s, 1001s, 970m, 958m, 
943m, 920m, 763s, 748s, 730m, 700s, 659m; δH(300 MHz, C6D6) 1.21 (3H, app. t, J 7.1, 
OCH2CH3), 2.32 (1H, app. dt, J 16.2, 3.2, CHaHbCH2O), 2.83 (1H, ddd, J 16.2, 10.8, 5.6, 
CHaHbCH2O), 3.49-3.70 (2H, stack, OCH2CH3), 3.66-3.78 (1H, ddd, J 11.0, 5.5, 2.9, 
CH2CHaHbO), 4.02 (1H, app. td, J 10.9, 3.5, CH2CHaHbO), 6.81-6.99 (3H, stack, ArH), 7.05-
7.25 (3H, stack, ArH), 7.36-7.43 (1H, m, ArH), 7.72-7.79 (2H, stack, ArH); δC(100 MHz, 
C6D6) 15.8 (CH3, OCH2CH3), 29.0 (CH2, CH2CH2O), 58.3 (CH2, CH2O), 59.8 (CH2, CH2O), 
101.2 (quat. C, CPhO), 126.6 (CH, Ar), 127.4 (CH, Ar), 127.7 (CH, Ar), 128.0 (CH, Ar), 
128.3 (CH, Ar), 128.6 (CH, Ar), 129.1 (CH, Ar), 134.0 (quat. C, ipso Ar), 138.7 (quat. C, ipso 
Ar), 143.7 (quat. C, ipso Ar); m/z (EI) 209 ([M – OCH2CH3]
+, 100%), 194 (18), 177 (29, [M 
– C6H5]




General procedure for the formation of 1-allylisochromans 202 
 
Method A: Racemic allylation 
MeSO3H (32 µL, 0.49 mmol) was added to a solution of the 1-ethoxyisochroman (0.490 
mmol) and allyltrimethylsilane (117 µL, 0.734 mmol) in CH2Cl2 (1 mL) at 0 °C. A colour 
change from colourless to a bright colour (depending on the 1-ethoxyisochroman) was 
observed. After stirring at R.T. for 30 min, NaHCO3 solution (15 mL) and Et2O (15 mL) were 
added. The two phases were separated and the aqueous phase was extracted with Et2O (10 
mL). The combined organic fractions were washed with brine (15 mL) and then dried 
(MgSO4). The drying agent was removed by filtration and the filtrate concentrated under 
reduced pressure to provide the crude 1-allylisochroman product, which was purified by flash 
column chromatography. 
 
Method B: Asymmetric allylation 
The phosphoramide catalyst (R)-45g (0.049, 0.074 or 0.098 mmol (see specific experimental 
details)) was added to a solution of the 1-ethoxyisochroman (0.490 mmol) and 
allyltrimethylsilane (117 µL, 0.735 mmol) in o-xylene (327 or 490 µL (see specific 
experimental details)). After stirring at R.T. for the specified time, NaHCO3 solution (15 mL) 
and Et2O (15 mL) were added. The two phases were separated and the aqueous phase was 
extracted with Et2O (10 mL). The combined organic fractions were washed with brine (15 
mL) and then dried (MgSO4). The drying agent was removed by filtration and the filtrate 
concentrated under reduced pressure to provide the crude 1-allylisochroman product, which 











Elemental Analysis: C, 82.72; H, 8.10; O, 9.18
 
 
Racemic 1-allylisochroman 163 was prepared from 1-ethoxyisochroman 166 (87 mg, 0.49 
mmol), allyltrimethylsilane (120 µL, 0.74 mmol) and MeSO3H (32 µL, 0.49 mmol) in CH2Cl2 
(1 mL) according to Method A. Purification by flash column chromatography (99% hexane, 
1% Et2O) afforded 1-allylisochroman 163 as a colourless liquid (80 mg, 94%): Rf = 0.37 (90% 
hexane, 10% Et2O); νmax(film)/cm-1 3077w, 3024w, 2965w, 2926m, 2852m, 1641w, 1492m, 
1453m, 1428m, 1375w, 1340w, 1280m, 1105s, 1038m, 987m, 910s, 852w, 742s; δH(300
MHz) 2.53-2.82 (3H, stack, CH2CH=CH2, CHaHbCH2O), 3.03 (1H, ddd, J 15.7, 9.7, 5.4, 
CHaHbCH2O), 3.80 (1H, ddd, J 11.3, 9.7, 3.7, CH2CHaHbO), 4.19 (1H, ddd, J 11.3, 5.4, 3.6, 
CH2CHaHbO), 4.87 (1H, dd, J 7.4, 2.9, CHO), 5.05-5.23 (2H, stack, CH=CH2), 5.94 (1H, ddt, 
J 17.1, 10.2, 6.8, CH=CH2), 7.03-7.28 (4H, stack, ArH); δC(75 MHz) 29.0 (CH2, CH2CH2O), 
40.3 (CH2, CH2CH=CH2), 63.3 (CH2, CH2CH2O), 75.5 (CH, CHO), 116.9 (CH2, 
CH2CH=CH2), 124.8 (CH, Ar), 126.0 (CH, Ar), 126.2 (CH, Ar), 128.8 (CH, Ar), 134.0 (quat. 
C, ipso Ar), 135.0 (CH, CH2CH=CH2), 137.7 (quat. C, ipso Ar); m/z (EI) 133 ([M – C3H5]
+, 
100%), 115 (24), 105 (49), 91 (14), 77 (31), 55 (11); HRMS: C9H9O calcd 133.0653 ([M – 
C3H5]
+), obsd 133.0651. 
 
Asymmetric allylation:  
Enantiomerically enriched 1-allylisochroman 163 was prepared from 1-ethoxyisochroman 
166 (87 mg, 0.49 mmol), allyltrimethylsilane (120 µL, 0.74 mmol) and the phosphoramide 
catalyst (R)-45g (48.5 mg, 0.049 mmol) in o-xylene (327 µL) according to Method B. After 
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stirring for 24 h and work-up, purification by flash column chromatography (99% hexane, 1% 
Et2O) afforded enantiomerically enriched 1-allylisochroman 163 (70 mg, 82%): [α]D
20
 = +88.1 
(c 0.74, CHCl3, e.r. 10:90); Chiralpak AD, 1.0 mL/min, 100% hexane, λ = 210 nm, tR,minor = 
11.5 min, tR,major = 12.6 min. 
 









Elemental Analysis: C, 82.94; H, 8.57; O, 8.50
 
 
Racemic 1-allylisochroman 202a was prepared from 1-ethoxyisochroman 179a (94 mg, 0.49 
mmol), allyltrimethylsilane (120 µL, 0.73 mmol) and MeSO3H (32 µL, 0.49 mmol) in CH2Cl2 
(1 mL) according to Method A. Purification by flash column chromatography (99% hexane, 
1% Et2O) afforded 1-allylisochroman 202a as a colourless liquid (88 mg, 95%): Rf = 0.39 
(90% hexane, 10% Et2O); (Found: C, 82.90; H, 8.50. C13H16O requires C, 82.94; H, 8.57%); 
νmax(film)/cm-1 3074w, 2918m, 2854m, 1640w, 1469m, 1432w, 1379w, 1330w, 1263w, 
1113s, 1088m, 1057m, 991m, 911s, 804w, 778s, 751m, 738m, 705w; δH(300 MHz) 2.26 (3H, 
s, CH3), 2.54-2.90 (4H, stack, CH2CH=CH2, CH2CH2O), 3.82 (1H, ddd, J 11.4, 9.5, 4.2, 
CH2CHaHbO), 4.23 (1H, ddd, J 11.4, 5.6, 3.6, CH2CHaHbO), 4.86 (1H, dd, J 8.1, 3.6, CHO), 
5.08-5.22 (2H, stack, CH=CH2), 5.94 (1H, ddt, J 17.1, 10.3, 6.8, CH=CH2), 6.99 (1H, d, J 7.6, 
ArH), 7.04-7.17 (2H, stack, ArH); δC(75 MHz) 19.0 (CH3, CH3), 26.6 (CH2, CH2CH2O), 40.3 
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(CH2, CH2CH=CH2), 63.1 (CH2, CH2O), 75.7 (CH, CHO), 116.8 (CH2, CH=CH2), 122.4 
(CH, Ar), 125.6 (CH, Ar), 127.6 (CH, Ar), 132.6 (quat. C, ipso Ar), 135.1 (CH, CH=CH2), 
136.2 (quat. C, ipso Ar), 137.6 (quat. C, ipso Ar); m/z (EI) 188 ([M]+, 3%), 147 (100, [M – 
C3H5]
+), 132 (16, [M – C3H5 – CH3]
+), 129 (48), 119 (66), 117 (50), 115 (53), 105 (65), 91 
(62), 77 (18), 65 (10); HRMS: C13H16O calcd 188.1201 ([M]
+), obsd 188.1205. 
 
Asymmetric allylation:  
Enantiomerically enriched 1-allylisochroman 202a was prepared from 1-ethoxyisochroman 
179a (77 mg, 0.40 mmol), allyltrimethylsilane (95 µL, 0.60 mmol) and the phosphoramide 
catalyst (R)-45g (39.6 mg, 0.040 mmol) in o-xylene (267 µL) according to Method B. After 
stirring for 7 h and work-up, purification by flash column chromatography (99% hexane, 1% 
Et2O) afforded enantiomerically enriched 1-allylisochroman 202a (63 mg, 84%): [α]D
20
 = 
+93.9 (c 1.15, CHCl3, e.r. 8:92); Chiralpak AD, 1.0 mL/min, 100% hexane, λ = 210 nm, 









Elemental Analysis: C, 82.94; H, 8.57; O, 8.50
 
 
Racemic 1-allylisochroman 202b was prepared from 1-ethoxyisochroman 179b (100 mg, 0.52 
mmol), allyltrimethylsilane (125 µL, 0.78 mmol) and MeSO3H (34 µL, 0.52 mmol) in CH2Cl2 
(1 mL) according to Method A. Purification by flash column chromatography (99% hexane, 
1% Et2O) afforded 1-allylisochroman 202b as a colourless oil (93 mg, 95%): Rf = 0.43 (90% 
 202 
hexane, 10% Et2O); (Found: C, 82.61; H, 8.91. C13H16O requires C, 82.94; H, 8.57%); 
νmax(film)/cm-1 3072w, 2920m, 2850m, 1641w, 1617w, 1503m, 1428m, 1376m, 1331m, 
1283m, 1251w, 1105s, 1063m, 987m, 908s, 872w, 847w, 815s, 778m, 713w; δH( 00 MHz) 
2.35 (3H, s, CH3), 2.54-2.81 (3H, stack, CH2CH=CH2, CHaHbCH2O), 3.01 (1H, ddd, J 16.0, 
9.8, 5.4, CHaHbCH2O), 3.80 (1H, ddd, J 11.3, 9.8, 3.8, CH2CHaHbO), 4.19 (1H, ddd, J 11.3, 
5.4, 3.4, CH2CHaHbO), 4.85 (1H, dd, J 7.9, 3.4, CHO), 5.09-5.24 (2H, stack, CH=CH2), 5.96 
(1H, ddt, J 17.1, 10.3, 6.8, CH2CH=CH2), 6.95-7.06 (3H, stack, ArH); δC(100 MHz) 20.9 
(CH3, CH3), 29.0 (CH2, CH2CH2O), 40.3 (CH2, CH2CH=CH2), 63.4 (CH2, CH2O), 75.4 (CH, 
CHO), 116.8 (CH2, CH=CH2), 124.6 (CH, Ar), 126.8 (CH, Ar), 129.4 (CH, Ar), 133.8 (quat. 
C, ipso Ar), 134.7 (quat. C, ipso Ar), 135.1 (CH, CH=CH2), 135.7 (quat. C, ipso Ar); m/z (EI) 
188 ([M]+, 2%), 147 (100, [M – C3H5]
+), 129 (11), 119 (19), 117 (17), 115 (13), 91 (21); 
HRMS: C13H16O calcd 188.1201 ([M]
+), obsd 188.1204. 
 
Asymmetric allylation:  
Enantiomerically enriched 1-allylisochroman 202b was prepared from 1-ethoxyisochroman 
179b (77 mg, 0.40 mmol), allyltrimethylsilane (95 µL, 0.60 mmol) and the phosphoramide 
catalyst (R)-45g (59.4 mg, 0.060 mmol) in o-xylene (400 µL) according to Method B. After 
stirring for 6 h and work-up, purification by flash column chromatography (99% hexane, 1% 
Et2O) afforded enantiomerically enriched 1-allylisochroman 202b (60 mg, 79%): [α]D
20
 = 
+98.1 (c 1.04, CHCl3, e.r. 13:87); Chiralcel OD, 1.0 mL/min, 100% hexane, λ = 210 nm, 













Elemental Analysis: C, 82.94; H, 8.57; O, 8.50
 
 
Racemic 1-allylisochroman 202c was prepared from 1-ethoxyisochroman 179c (100 mg, 0.52 
mmol), allyltrimethylsilane (125 µL, 0.78 mmol) and MeSO3H (34 µL, 0.52 mmol) in CH2Cl2 
(1 mL) according to Method A. Purification by flash column chromatography (99% hexane, 
1% Et2O) afforded 1-allylisochroman 202c as a yellow oil (89 mg, 91%): Rf = 0.35 (90% 
hexane, 10% Et2O); νmax(film)/cm-1 3076w, 2922m, 2855m, 1728w, 1641w, 1504m, 1429m, 
1373w, 1327w, 1277w, 1250w, 1155w, 1105s, 1041m, 988m, 911s, 877m, 810s, 713w, 
666w; δH(300 MHz) 2.35 (3H, s, CH3), 2.54-2.81 (3H, stack, CH2CH=CH2, CHaHbCH2O), 
2.98 (1H, ddd, J 15.7, 9.6, 5.3, CHaHbCH2O), 3.78 (1H, ddd, J 11.2, 9.7, 3.8, CH2CHaHbO), 
4.18 (1H, ddd, J 11.2, 5.3, 3.5, CH2CHaHbO), 4.83 (1H, dd, J 8.2, 3.5, CHO), 5.09-5.24 (2H, 
stack, CH=CH2), 5.96 (1H, ddt, J 17.1, 10.3, 6.8, CH=CH2), 6.92-7.07 (3H, stack, ArH); 
δC(100 MHz) 21.3 (CH3, CH3), 28.7 (CH2, CH2CH2O), 40.4 (CH2, CH2CH=CH2), 63.5 (CH2, 
CH2O), 75.6 (CH, CHO), 116.9 (CH2, CH=CH2), 125.3 (CH, Ar), 127.2 (CH, Ar), 128.8 (CH, 
Ar), 131.0 (quat. C, ipso Ar), 135.2 (CH, CH=CH2), 135.6 (quat. C, ipso Ar), 137.6 (quat. C, 
ipso Ar); m/z (EI) 188 ([M]+, 1%), 147 (100, [M – C3H5]
+), 119 (13), 117 (10), 91 (12); 
HRMS: C13H16O calcd 188.1201 ([M]
+), obsd 188.1191. 
 
Asymmetric allylation:  
Enantiomerically enriched 1-allylisochroman 202c was prepared from 1-ethoxyisochroman 
179c (77 mg, 0.40 mmol), allyltrimethylsilane (95 µL, 0.60 mmol) and the phosphoramide 
catalyst (R)-45g (59.4 mg, 0.060 mmol) in o-xylene (267 µL) according to Method B. After 
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stirring for 8 h and work-up, purification by flash column chromatography (99% hexane, 1% 
Et2O) afforded enantiomerically enriched 1-allylisochroman 202c (53 mg, 71%): [α]D
20
 = 
+120.0 (c 0.98, CHCl3, e.r. 13:87); Chiralpak AD, 1.0 mL/min, 100% hexane, λ = 210 nm, 









Elemental Analysis: C, 82.94; H, 8.57; O, 8.50
 
 
Racemic 1-allylisochroman 202d was prepared from 1-ethoxyisochroman 179d (100 mg, 0.52 
mmol), allyltrimethylsilane (125 µL, 0.78 mmol) and MeSO3H (34 µL, 0.52 mmol) in CH2Cl2 
(1 mL) according to Method A. Purification by flash column chromatography (99% hexane, 
1% Et2O) afforded 1-allylisochroman 202d as a colourless oil (56 mg, 57%): Rf = 0.40 (90% 
hexane, 10% Et2O); (Found: C, 82.68; H, 8.40. C13H16O requires C, 82.94; H, 8.57%); 
νmax(film)/cm-1 3071w, 2920m, 2849m, 1639m, 1590w, 1464m, 1430m, 1374w, 1338w, 
1267m, 1222w, 1194w, 1103s, 1080m, 1062m, 1029m, 999m, 910s, 850w, 768s, 736w, 
711w; δH(300 MHz) 2.27 (3H, s, CH3), 2.42-2.99 (4H, stack, CH2CH=CH2, CH2CH2O), 3.82 
(1H, app. dt, J 11.3, 5.1, CH2CHaHbO), 4.11 (1H, ddd, J 11.3, 8.1, 4.6, CH2CHaHbO), 4.97 
(1H, dd, J 9.3, 2.3, CHO), 5.09-5.22 (2H, stack, CH=CH2), 5.99 (1H, ddt, J 17.1, 10.2, 6.9, 
CH=CH2), 6.94-7.16 (3H, stack, ArH); δC(100 MHz) 19.0 (CH3, CH3), 29.0 (CH2, 
CH2CH2O), 38.0 (CH2, CH2CH=CH2), 59.5 (CH2, CH2O), 73.3 (CH, CHO), 116.5 (CH2, 
CH=CH2), 126.2 (CH, Ar), 126.6 (CH, Ar), 128.5 (CH, Ar), 133.5 (quat. C, ipso Ar), 133.7 
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(quat. C, ipso Ar), 135.3 (CH, CH=CH2), 136.2 (quat. C, ipso Ar); m/z (EI) 188 ([M]
+, 1%), 
147 (100, [M – C3H5]
+); HRMS: C13H16O calcd 188.1201 ([M]
+), obsd 188.1195. 
 
Asymmetric allylation:  
Enantiomerically enriched 1-allylisochroman 202d was prepared from 1-ethoxyisochroman 
179d (67 mg, 0.35 mmol), allyltrimethylsilane (85 µL, 0.53 mmol) and the phosphoramide 
catalyst (R)-45g (69.3 mg, 0.070 mmol) in o-xylene (233 µL) according to Method B. After 
stirring for 48 h and work-up, purification by careful5 column chromatography (99% hexane, 
1% Et2O) afforded enantiomerically enriched 1-allylisochroman 202d (34 mg, 52%): [α]D
20
 = 
+53.0 (c 0.37, CHCl3, e.r. 21:79); Chiralcel OD, 1.0 mL/min, 100% hexane, λ = 210 nm, 









Elemental Analysis: C, 83.96; H, 8.05; O, 7.99
 
 
Racemic 1-allylisochroman 202j was prepared from 1-ethoxyisochroman 179j (100 mg, 0.49 
mmol), allyltrimethylsilane (120 µL, 0.73 mmol) and MeSO3H (32 µL, 0.49 mmol) in CH2Cl2 
(0.95 mL) according to Method A. Purification by flash column chromatography (99% 
hexane, 1% Et2O) afforded 1-allylisochroman 202j as a colourless oil (92 mg, 94%): Rf = 0.34 
(90% hexane, 10% Et2O); νmax(film)/cm-1 3075w, 2948w, 2843m, 1641w, 1605w, 1492m, 
                                                
5 in total, two long columns were carried out to obtain a pure product 
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1454w, 1430m, 1379m, 1336w, 1254m, 1146w, 1093s, 1033m, 997m, 910s, 856w, 830m, 
751s, 712m; δH(300 MHz) 0.84 (1H, ddd, J 9.4, 6.0, 4.4, cyclopropylCHaHb), 0.94-1.14 (3H, 
stack, cyclopropylCHaHbCH2), 2.64-2.84 (2H, stack, CH2CH=CH2), 3.62 (1H, d, J 11.5, 
CHaHbO), 3.85 (1H, dd, J 11.5, 1.1, CHaHbO), 4.98 (1H, dd, J 8.2, 3.9, CHO), 5.09-5.24 (2H, 
stack, CH=CH2), 5.98 (1H, ddt, J 17.1, 10.3, 6.8, CH=CH2), 6.71-6.78 (1H, m, ArH), 7.08-
7.22 (3H, stack, ArH); δC(100 MHz) [13.4, 17.8 (CH2, cyclopropylCH2)], 18.9 (quat. C, 
CCH2O), 40.0 (CH2, CH2CH=CH2), 71.4 (CH2, CH2O), 76.6 (CH, CHO), 116.9 (CH2, 
CH=CH2), 121.3 (CH, Ar), 124.4 (CH, Ar), 125.1 (CH, Ar), 126.8 (CH, Ar), 135.1 (CH, 
CH=CH2), 137.7 (quat. C, ipso Ar), 138.7 (quat. C, ipso Ar); m/z (EI) 159 ([M – C3H5]
+, 
100%), 131 (25), 129 (25), 115 (19), 103 (17), 91 (16), 77 (11); HRMS: C11H11O calcd 
159.0810 ([M – C3H5]
+), obsd 159.0801. 
 
Asymmetric allylation:  
Enantiomerically enriched 1-allylisochroman 202j was prepared from 1-ethoxyisochroman 
179j (82 mg, 0.40 mmol), allyltrimethylsilane (95 µL, 0.60 mmol) and the phosphoramide 
catalyst (R)-45g (79.2 mg, 0.080 mmol) in o-xylene (267 µL) according to Method B. After 
stirring for 8 h and work-up, purification by careful6 column chromatography (99% hexane, 
1% Et2O) afforded enantiomerically enriched 1-allylisochroman 202j (35 mg, 44%): [α]D
20
 = 
+5.1 (c 0.35, CHCl3, e.r. 43:57); Chiralpak AD, 1.0 mL/min, 1% IPA in hexane, λ = 210 nm, 






                                                




O Chemical Formula: C14H18O
Exact Mass: 202.1358
Molecular Weight: 202.2921
Elemental Analysis: C, 83.12; H, 8.97; O, 7.91
 
 
Racemic 1-allylisochroman 202i was prepared from 1-ethoxyisochroman 179i (100 mg, 0.485 
mmol), allyltrimethylsilane (120 µL, 0.73 mmol) and methanesulfonic acid (31 µL, 0.485 
mmol) in CH2Cl2 (0.95 mL) according to Method A. Purification by flash column 
chromatography (gradient: 100% hexane → 99% hexane, 1% Et2O) afforded 1-
allylisochroman 202i as a colourless oil (86 mg, 88%): Rf = 0.40 (95% hexane, 5% Et2O); 
νmax(film)/cm-1 3073w, 2973m, 2900w, 1493w, 1453w, 1431w, 1380m, 1367m, 1337m, 
1255w, 1234w, 1206w, 1180m, 1110m, 1069s, 1040m, 992m, 910s, 801w, 739s, 712w; 
δH(300 MHz) 1.17 (3H, s, CH3), 1.38 (3H, s, CH3), 2.53 (1H, d, J 15.7, CHaHb), 2.53-2.65 
(1H, m, CHaHbCH=CH2), 2.68-2.79 (1H, m, CHaHbCH=CH2), 2.88 (1H, d, J 15.7, CHaHb), 
4.83-4.90 (1H, m, CHO), 5.00-5.15 (2H, stack, CH=CH2), 5.88 (1H, ddt, J 17.2, 10.3, 6.8, 
CH=CH2), 7.04-7.24 (4H, stack, ArH); δC(100 MHz) [23.3, 30.1 (CH3, C(CH3)a(CH3)b], 
[40.5, 40.7 (CH2, CH2CO, CH2CH=CH2)], 70.8 (quat. C, CH2CO), 71.2 (CH, CHO), 116.6 
(CH2, CH=CH2), 124.3 (CH, Ar), 125.9 (CH, Ar), 126.2 (CH, Ar), 128.9 (CH, Ar), 133.8 
(quat. C, ipso Ar), 135.0 (CH, CH=CH2), 137.0 (quat. C, ipso Ar); m/z (EI) 161 ([M – C3H5]
+, 
100%), 143 (85), 128 (10); HRMS: C11H13O calcd 161.0966 ([M – C3H5]
+), obsd 161.0969. 
 
Asymmetric allylation:  
Enantiomerically enriched 1-allylisochroman 202i was prepared from 1-ethoxyisochroman 
179i (82.5 mg, 0.400 mmol), allyltrimethylsilane (95 µL, 0.60 mmol) and the phosphoramide 
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catalyst (R)-45g (79.2 mg, 0.080 mmol) in o-xylene (267 µL) according to Method B. After 
stirring for 24 h and work-up, purification by flash column chromatography (99% hexane, 1% 
Et2O) afforded enantiomerically enriched 1-allylisochroman 202i (54 mg, 67%): [α]D
21
 = –
10.0 (c 0.96, CHCl3, e.r. 43:57); Chiralcel OD, 1.0 mL/min, 100% hexane, λ = 210 nm, tR,minor 










Elemental Analysis: C, 56.94; H, 5.18; Br, 31.57; O, 6.32
 
 
Racemic 1-allylisochroman 202e was prepared from 1-ethoxyisochroman 179e (100 mg, 0.39 
mmol), allyltrimethylsilane (95 µL, 0.58 mmol) and MeSO3H (25 µL, 0.39 mmol) in CH2Cl2 
(0.75 mL) according to Method A. Purification by flash column chromatography (gradient: 
100% hexane → 99% hexane, 1% Et2O) afforded 1-allylisochroman 202e as a colourless oil 
(61 mg, 62%): Rf = 0.45 (90% hexane, 10% Et2O); νmax(film)/cm-1 2933m, 2858m, 1640w, 
1563m, 1461m, 1439s, 1377w, 1329m, 1255w, 1177w, 1113s, 1076m, 988s, 913s, 861w, 
813w, 771s, 744m, 717m, 675m; δH(300 MHz) 2.51-2.95 (4H, stack, CH2CH=CH2, 
CH2CH2O), 3.77 (1H, ddd, J 11.5, 9.2, 4.4, CHaHbO), 4.19 (1H, ddd, J 11.5, 5.6, 3.8, 
CHaHbO), 4.80 (1H, dd, J 7.9, 3.8, CHO), 5.06-5.19 (2H, stack, CH=CH2), 5.88 (1H, ddt, J 
17.1, 10.3, 6.8, CH=CH2), 7.02-7.11 (2H, stack, ArH), 7.40-7.48 (1H, m, ArH); δC(100 MHz) 
29.8 (CH2, CH2CH2O), 40.1 (CH2, CH2CH=CH2), 63.1 (CH2, CH2O), 75.3 (CH, CHO), 117.2 
(CH2, CH=CH2), 123.9 (CH, Ar), 125.3 (quat. C, ipso Ar), 127.2 (CH, Ar), 130.3 (CH, Ar), 
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133.9 (quat. C, ipso Ar), 134.5 (CH, CH=CH2), 140.4 (quat. C, ipso Ar); m/z (EI) 213 ([M – 
C3H5]
+, 100%), 211 (10, [M – C3H5]
+), 132 (41), 104 (17), 103 (17), 77 (11); HRMS: 
C9H8O
79Br calcd 210.9759 ([M – C3H5]
+), obsd 210.9764. 
 
Asymmetric allylation:  
Enantiomerically enriched 1-allylisochroman 202e was prepared from 1-ethoxyisochroman 
179e (77 mg, 0.30 mmol), allyltrimethylsilane (70 µL, 0.45 mmol) and the phosphoramide 
catalyst (R)-45g (59.4 mg, 0.060 mmol) in o-xylene (200 µL) according to Method B. After 
stirring for 48 h and work-up, purification by careful7 column chromatography (99% hexane, 
1% Et2O) afforded enantiomerically enriched 1-allylisochroman 202e (34 mg, 45%): [α]D
20
 = 
+53.8 (c 0.74, CHCl3, e.r. 17:83); Chiralcel OD, 1.0 mL/min, 1% IPA in hexane, λ = 210 nm, 









Elemental Analysis: C, 86.32; H, 7.63; O, 6.05
 
 
Racemic 1-allyl-5-bromoisochroman 202e (150 mg, 0.593 mmol), 4-tolylboronic acid (161 
mg, 1.19 mmol) and Na2CO3 (530 mg, 5.00 mmol) were dissolved in a mixture of degassed 
toluene/EtOH/H2O (2:1:1, 10 mL). Pd(PPh3)4 (68 mg, 0.059 mmol) was added, and the 
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mixture was heated under reflux for 3 h. The black suspension was cooled t R.T., the 
solvents were removed under reduced pressure and the resulting solid was dissolved in 
CH2Cl2 (20 mL). H2O (20 mL) was added and the layers were separated. The aqueous phase 
was extracted with CH2Cl2 (10 mL). The combined organic fractions were washed with brine 
(20 mL), and then dried (MgSO4). The drying agent was removed by filtration and the filtrate 
concentrated under reduced pressure to provide the crude product. Purification by flash 
column chromatography (99.5% hexane, 0.5% Et2O) afforded 1-allyl-5-tolylisochroman 211 
as a colourless oil (152 mg, 97%): Rf = 0.31 (90% hexane, 10% Et2O); νmax(film)/cm-1 2927m, 
2855m, 1643w, 1515m, 1463m, 1377w, 1338w, 1110s, 990m, 911s, 822s, 790s, 736s; δH(300 
MHz) 2.32 (3H, s, CH3), 2.43 (1H, app. dt, J 16.6, 3.4, CHaHbCH2O), 2.49-2.74 (2H, stack, 
CH2CH=CH2), 2.82 (1H, ddd, J 16.6, 9.6, 5.3, CHaHbCH2O), 3.58 (1H, ddd, J 11.2, 9.6, 3.5, 
CHaHbO), 3.98 (1H, ddd, J 11.2, 5.3, 3.6, CHaHbO), 4.83 (1H, dd, J 7.9, 3.3, CHO), 5.00-5.17 
(2H, stack, CH=CH2), 5.88 (1H, ddt, J 17.1, 10.2, 6.8, CH=CH2), 7.00-7.09 (2H, stack, ArH), 
7.10-7.22 (5H, stack, ArH); δC(100 MHz) 21.1 (CH3, ArCH3), 28.3 (CH2, CH2CH2O), 40.9 
(CH2, CH2CH=CH2), 63.4 (CH2, CH2O), 75.8 (CH, CHO), 117.0 (CH2, CH=CH2), 123.9 
(CH, Ar), 125.8 (CH, Ar), 127.7 (CH, Ar), 128.8 (CH, Ar), 129.1 (CH, Ar), 132.0 (quat. C, 
ipso Ar), 135.1 (CH, CH=CH2), 136.7 (quat. C, 2 × ipso Ar), 138.0 (quat. C, ipso Ar), 141.8 
(quat. C, ipso Ar); m/z (EI) 223 ([M – C3H5]
+, 100%), 195 (40), 180 (29), 179 (25), 178 (27), 
167 (24), 165 (34); HRMS: C19H20O calcd 264.1514 ([M]
+), obsd 264.1526. 
 
The same protocol was followed for the preparation of enantiomerically enriched 1-allyl-5-
tolylisochroman 211 from enantiomerically enriched 1-allyl-5-bromoisochroman 202e (17.0 
mg, 0.067 mmol, e.r. 17:83), 4-tolylboronic acid (18 mg, 0.134 mmol), Na2CO3 (60 mg, 0.565 
mmol) and Pd(PPh3)4 (7.7 mg, 0.007 mmol) in degassed toluene/EtOH/H2O (2:1:1, 1.13 mL). 
Purification by flash column chromatography (99.5% hexane, 0.5% Et2O) afforded 
enantiomerically enriched 1-allylisochroman 211 (16.0 mg, 90%): [α]D
20
 = +22.6 (c 0.46, 
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CHCl3, e.r. 17:83); Lux 5u Cellulose-2, 3 mL/min, 0.5% IPA in hexane, λ = 254 nm, tR,major = 










Elemental Analysis: C, 64.46; H, 5.41; F, 23.53; O, 6.60
 
 
Racemic 1-allylisochroman 202f was prepared from 1-ethoxyisochroman 179f (100 mg, 0.41 
mmol), allyltrimethylsilane (100 µL, 0.61 mmol) and MeSO3H (25 µL, 0.41 mmol) in CH2Cl2 
(0.80 mL) according to Method A. Purification by flash column chromatography (gradient: 
100% hexane → 99.5% hexane, 0.5% Et2O) afforded 1-allylisochroman 202f as a colourless 
oil (77 mg, 78%): Rf = 0.46 (90% hexane, 10% Et2O); νmax(film)/cm-1 3070w, 2969w, 2860w, 
1469w, 1458w, 1429w, 1316s, 1261w, 1183w, 1156s, 1112s, 1078s, 1046m, 995m, 969w, 
914m, 801m, 755m, 742m, 727m, 675m; δH(300 MHz) 2.54-2.78 (2H, stack, CH2CH=CH2), 
2.85-2.98 (1H, m, CHaHbCH2O), 3.00-3.14 (1H, m, CHa bCH2O), 3.77 (1H, ddd, J 11.5, 9.4, 
3.9, CHaHbO), 4.17 (1H, ddd, J 11.5, 5.3, 3.9, CHaHbO), 4.89 (1H, dd, J 7.7, 3.9, CHO), 5.06-
5.19 (2H, stack, CH=CH2), 5.88 (1H, ddt, J 17.1, 10.3, 6.8, CH=CH2), 7.22-7.33 (2H, stack, 
ArH), 7.48-7.56 (1H, m, ArH); δC(100 MHz) 25.9 (CH2, CH2CH2O), 40.5 (CH2, 
CH2CH=CH2), 62.5 (CH2, CH2O), 75.4 (CH, CHO), 117.3 (CH2, CH=CH2), 124.0 (CH, q, 
3JC-F 5.5, Ar), 124.4 (quat. C, q, 
1JC-F 272.6, ArCF3), 125.7 (CH, Ar), 128.5 (quat. C, ipso Ar), 
128.7 (CH, Ar), 133.1 (quat. C, ipso Ar), 134.4 (CH, CH=CH2), 139.3 (quat. C, ipso Ar); 
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δF(282 MHz) –61.2 (s, ArCF3); m/z (EI) 201 ([M – C3H5]+, 100%), 181 (16), 153 (10), 151 
(10), 133 (15); HRMS: C10H8OF3 calcd 201.0527 ([M – C3H5]
+), obsd 201.0523. 
 
Asymmetric allylation:  
Enantiomerically enriched 1-allylisochroman 202f was prepared from 1-ethoxyisochroman 
179f (98.5 mg, 0.40 mmol), allyltrimethylsilane (95 µL, 0.60 mmol) and the phosphoramide 
catalyst (R)-45g (59.4 mg, 0.060 mmol) in o-xylene (267 µL) according to Method B. After 
stirring for 48 h and work-up, purification by careful8 column chromatography (99% hexane, 
1% Et2O) afforded enantiomerically enriched 1-allylisochroman 202f (23 mg, 24%): [α]D
20
 = 
+43.8 (c 0.78, CHCl3, e.r. 88:12); Lux 5u Cellulose-2, 3 mL/min, 0.5% IPA in hexane, λ = 










Elemental Analysis: C, 76.44; H, 7.90; O, 15.67
 
 
Racemic 1-allylisochroman 202g was prepared from 1-ethoxyisochroman 179g (70 mg, 0.34 
mmol), allyltrimethylsilane (80 µL, 0.50 mmol) and MeSO3H (22 µL, 0.34 mmol) in CH2Cl2 
(0.65 mL) according to Method A. Purification by flash column chromatography (gradient: 
99% hexane, 1% Et2O → 90% hexane, 10% Et2O) afforded 1-allylisochroman 202g as a 
colourless oil (50 mg, 72%): Rf = 0.23 (90% hexane, 10% Et2O); νmax(film)/cm-1 3075w, 
2919w, 2835w, 1612m, 1502s, 1464m, 1428m, 1314m, 1281s, 1255s, 1207m, 1161w, 1107s, 
                                                
8 in total, two long columns were carried out to obtain a pure product 
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1037s, 989m, 912m, 866w, 848w, 804m, 733w, 709w; δH(300 MHz) 2.53-2.77 (3H, stack, 
CH2CH=CH2, CHaHbCH2O), 2.93 (1H, ddd, J 15.7, 9.7, 5.4, CHaHbCH2O), 3.70-3.82 (4H, 
stack, CH2CHaHbO, OCH3), 4.16 (1H, ddd, J 11.3, 5.4, 3.7, CHaHbO), 4.81 (1H, dd, J 7.8, 
3.7, CHO), 5.07-5.22 (2H, stack, CH=CH2), 5.93 (1H, ddt, J 17.1, 10.1, 6.8, CH=CH2), 6.65 
(1H, d, J 2.5, ArH), 6.75 (1H, dd, J 8.4, 2.5, ArH), 7.04 (1H, d, J 8.4, ArH); δC(75 MHz) 28.2 
(CH2, CH2CH2O), 40.3 (CH2, CH2CH=CH2), 55.2 (CH3, OCH3), 63.6 (CH2, CH2O), 75.5 
(CH, CHO), 110.0 (CH, Ar), 112.2 (CH, Ar), 116.9 (CH2, CH=CH2), 126.1 (quat. C, ipso Ar), 
129.7 (CH, Ar), 135.0 (CH, CH=CH2), 138.7 (quat. C, ipso Ar), 157.8 (quat. C, ipso Ar); m/z 
(EI) 204 ([M]+, 3%), 163 (100, ([M – C3H5]
+), 121 (24), 105 (12); HRMS: C13H16O2 calcd 
204.1150 ([M]+), obsd 204.1153. 
 
Asymmetric allylation:  
Enantiomerically enriched 1-allylisochroman 202g was prepared from 1-ethoxyisochroman 
179g (90 mg, 0.432 mmol), allyltrimethylsilane (105 µL, 0.648 mmol) and the phosphoramide 
catalyst (R)-45g (64.3 mg, 0.065 mmol) in o-xylene (290 µL) according to Method B. After 
stirring for 24 h and work-up, purification by column chromatography (99% hexane, 1% 
Et2O) afforded enantiomerically enriched 1-allylisochroman 202g (57 mg, 65%): [α]D
20
 = 
+64.6 (c 1.27, CHCl3, e.r. 21:79); Chiralpak AD, 1.0 mL/min, 10% IPA in hexane, λ = 230 














Racemic 1-allylisochroman 202h was prepared from 1-ethoxyisochroman 179h (100 mg, 0.51 
mmol), allyltrimethylsilane (120 µL, 0.76 mmol) and MeSO3H (33 µL, 0.51 mmol) in CH2Cl2 
(1 mL) according to Method A. Purification by flash column chromatography (gradient: 100% 
hexane → 99.5% hexane, 0.5% Et2O) afforded 1-allylisochroman 202h as a colourless oil (81 
mg, 83%): Rf = 0.33 (90% hexane, 10% Et2O); νmax(film)/cm-1 2930w, 2855w, 1616w, 
1592w, 1497s, 1427m, 1249m, 1201m, 1108s, 992m, 938m, 914m, 866m, 811s, 736m; 
δH(300 MHz) 2.50-2.75 (3H, stack, CH2CH=CH2, CHaHbCH2O), 2.88-3.01 (1H, m, 
CHaHbCH2O), 3.74 (1H, ddd, J 11.3, 9.8, 3.8, CHaHbO), 4.16 (1H, ddd, J 11.3, 5.4, 3.4, 
CHaHbO), 4.79 (1H, dd, J 7.6, 3.6, CHO), 5.06-5.21 (2H, stack, CH=CH2), 5.89 (1H, ddt, J 
17.1, 10.3, 6.8, CH=CH2), 6.77-6.92 (2H, stack, ArH), 7.07 (1H, dd, J 8.3, 5.8, ArH); δC(75 
MHz) 28.3 (CH2, CH2CH2O), 40.1 (CH2, CH2CH=CH2), 63.5 (CH2, CH2O), 75.3 (CH, CHO), 
111.4 (CH, d, 2JC-F 21.8, Ar), 113.4 (CH, d, 
2JC-F 21.2, Ar), 117.3 (CH2, CH=CH2), 129.5 
(quat. C, ipso Ar), 130.2 (CH, d, 3JC-F 7.5, Ar), 134.5 (CH, CH=CH2), 139.5 (quat. C, d, 
4JC-F 
6.1, ipso Ar), 161.1 (quat. C, d, 1JC-F 242.2, ipso Ar); δF(282 MHz) –116.2 - –116.0 (F, m, 
ArF); m/z (EI) 151 ([M – C3H5]
+, 100%), 133 (20), 109 (13), 103 (18); HRMS: C9H8OF calcd 
151.0559 ([M – C3H5]
+), obsd 151.0552. 
 
Asymmetric allylation:  
Enantiomerically enriched 1-allylisochroman 202h was prepared from 1-ethoxyisochroman 
179h (98.1 mg, 0.500 mmol), allyltrimethylsilane (120 µL, 0.750 mmol) and the 
phosphoramide catalyst (R)-45g (74.2 mg, 0.075 mmol) in o-xylene (333 µL) according to 
Method B. After stirring for 48 h and work-up, purification by column chromatography (99% 
hexane, 1% Et2O) afforded enantiomerically enriched 1-allylisochroman 202h (39 mg, 41%): 
[α]D
21
 = +76.7 (c 0.67, CHCl3, e.r. 20:80); Lux 5u Cellulose-2, 3 mL/min, 0.5% IPA in 
hexane, λ = 210 nm, tR,major = 8.5 min, tR,minor = 9.1 min. 
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1-Allylphthalan 202k and 1-(2’-hydroxyethyl)phthalan 203[151] 
 
 
O Chemical Formula: C11H12O
Exact Mass: 160.0888
Molecular Weight: 160.2124








Elemental Analysis: C, 73.15; H, 7.37; O, 19.49
 
 
Racemic 1-allylphthalan 202k was prepared from 1-ethoxyphthalan 179k (100 mg, 0.61 
mmol), allyltrimethylsilane (145 µL, 0.91 mmol) and MeSO3H (40 µL, 0.61 mmol) in CH2Cl2 
(1.2 mL) according to Method A. Purification by flash column chromatography (99% 
pentane, 1% Et2O) afforded 1-allylphthalan 202k as a colourless liquid (70 mg, 72%, reduced 
yield owing to product volatility): Rf = 0.28 (90% pentane, 10% Et2O); νmax(film)/cm-1 
3076w, 2899w, 2851m, 1641m, 1479m, 1461m, 1415w, 1365m, 1350w, 1317w, 1259w, 
1107w, 1043s, 1021m, 996m, 964m, 913s, 881w, 865w, 841m, 821w, 746s, 729s, 717s, 
693m; δH(300 MHz) 2.50-2.75 (2H, stack, CH2CH=CH2), 5.06-5.26 (4H, stack, CH2O, 
CH=CH2), 5.31-5.39 (1H, m, CHO), 5.92 (1H, ddt, J 17.1, 10.2, 6.9, CH=CH2), 7.20-7.36 
(4H, stack, ArH); δC(100 MHz) 40.6 (CH2, CH2CH=CH2), 72.6 (CH2, CH2O), 83.1 (CH, 
CHO), 117.5 (CH2, CH=CH2), 120.9 (CH, Ar), 121.2 (CH, Ar), 127.1 (CH, Ar), 127.4 (CH, 
Ar), 134.0 (CH, CH=CH2), 139.4 (quat. C, ipso Ar) 141.5 (quat. C, ipso Ar); m/z (EI) 160 
([M] +, 1%), 119 (100, [M – C3H5]




Racemic 1-(2’-hydroxyethyl)phthalan 203 was prepared from 1-allylphthalan 202k by a one-
pot oxidative cleavage–reduction sequence. NaIO4 (915 mg, 4.28 mmol), 2,6-lutidine (250 
µL, 2.14 mmol) and OsO4 (a small crystal) were added to a mixture of the starting material 
(171 mg, 1.07 mmol) in dioxane/H2O (3:1, 10.7 mL) at 0 °C. After stirring at R.T. for 2 h, 
NaBH4 (202 mg, 5.35 mmol) was added in small portions over a period of 5 min. The mixture 
was stirred for additional 10 min, and then quenched with NH4Cl solution (15 mL) at 0 °C. 
The two phases were separated and the aqueous phase was extracted with CH2Cl2 (3 × 10 
mL). The combined organic fractions were washed with brine (20 mL) and then dried 
(MgSO4). The drying agent was removed by filtration and the filtrate concentrated under 
reduced pressure to provide the crude product as a dark-red liquid. Purification by flash 
column chromatography (gradient: 90% hexane, 10% EtOAc → 50% hexane, 50% EtOAc) 
afforded alcohol 203 as a colourless9 viscous oil (129 mg, 73%): Rf = 0.18 (50% hexane, 50% 
EtOAc); δH(300 MHz) 1.88-2.02 (1H, m, CHaHbCH2OH), 2.11-2.24 (1H, m, CHa bCH2OH), 
3.13 (1H, br s, OH), 3.80-3.95 (2H, stack, CH2CH2OH), 5.03-5.20 (2H, stack, ArCH2O), 
5.40-5.49 (1H, m, CHO), 7.13-7.35 (4H, stack, ArH); δC(100 MHz) 37.9 (CH2, CH2CH2OH), 
60.4 (CH2, CH2CH2OH), 72.4 (CH2, ArCH2O), 83.2 (CH, CHO), 120.8 (CH, Ar), 120.9 (CH, 
Ar), 127.3 (CH, Ar), 127.5 (CH, Ar), 138.8 (quat. C, ipso Ar), 141.4 (quat. C, ipso Ar); m/z 
(EI) 164 ([M]+, 17%), 119 (100, [M – CH2CH2OH]
+), 91 (33); HRMS: C10H12O2 calcd 
164.0837 ([M]+), obsd 164.0839. 
 
Asymmetric allylation:  
Enantiomerically enriched 1-allylphthalan 202k was prepared from 1-ethoxyphthalan 179k 
(98.5 mg, 0.600 mmol), allyltrimethylsilane (145 µL, 0.900 mmol) and the phosphoramide 
catalyst (R)-45g (89.1 mg, 0.090 mmol) in o-xylene (400 µL) according to Method B. After 
stirring for 24 h, a few drops of NEt3 were added and from the resulting wet solid the o-xylene 
                                                
9 in total, two columns were carried out to obtain a pure colourless product 
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was removed under reduced pressure. Purification by column chromatography (99% hexane, 
1% Et2O) afforded enantiomerically enriched 1-allylisochroman 202k (59 mg, 61%, reduced 
yield owing to product volatility): [α]D
20
 = +25.0 (c 1.31, CHCl3); no baseline separation of 
the two enantiomers by chiral HPLC. 
Enantiomerically enriched 1-(2’-hydroxyethyl)phthalan 203 was prepared from 
enantiomerically enriched 1-allylphthalan 202k (59 mg, 0.368 mmol), NaIO4 (315 mg, 1.47 
mmol), 2,6-lutidine (80 µL, 0.737 mmol), OsO4 (a small crystal) and then NaBH4 (70 mg, 
1.84 mmol) in dioxane/H2O (3:1, 370 µL). Work-up and purification by column 
chromatography (gradient: 90% hexane, 10% EtOAc → 50% hexane, 50% EtOAc) afforded 
enantiomerically enriched alcohol 203 (42 mg, 70%): [α]D
20
 = +??? (c ???, CHCl3, e.r. 
26:74); Chiralpak AD, 1.0 mL/min, 0.5% IPA in hexane, λ = 210 nm, tR,major = 13.8 min, 
tR,minor = 15.3 min. 
 
 
















Elemental Analysis: C, 78.91; H, 8.48; O, 12.61
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Racemic 1-allylbenzoxepin 202l was prepared from 1-ethoxybenzoxepin 179l (100 mg, 0.52 
mmol), allyltrimethylsilane (125 µL, 0.78 mmol) and MeSO3H (35 µL, 0.52 mmol) in CH2Cl2 
(1 mL) according to Method A. Purification by flash column chromatography (gradient: 99% 
hexane, 1% Et2O → 90% hexane, 10% Et2O) afforded, in order of elution, benzoxepin 202l as 
a colourless liquid (25 mg, 26%): Rf = 0.33 (90% hexane, 10% Et2O); νmax(film)/cm-1 3075w, 
2934m, 2846m, 1641w, 1490w, 1454m, 1335w, 1281w, 1096s, 1021m, 998m, 980m, 911s, 
876w, 851w, 807w, 763s, 744s; δH(300 MHz) 1.70-1.97 (2H, stack, CH2CH2CH2O), 2.61-
2.81 (2H, stack, CH2CH=CH2), 3.02 (2H, app. t, J 6.0, CHaHbCH2CH2O), 3.82 (1H, ddd, J 
12.1, 11.2, 3.6, CHaHbO), 4.22 (1H, ddd, J 12.1, 4.8, 2.7, CHaHbO), 4.65 (1H, dd, J 8.4, 5.2, 
CHO), 5.08-5.23 (2H, stack, CH=CH2), 5.99 (1H, ddt, J 17.1, 10.3, 6.7, CH=CH2), 7.12-7.25 
(4H, stack, ArH); δC(75 MHz) 29.5 (CH2, CH2CH2CH2O), 33.9 (CH2, CH2CH2CH2O), 38.5 
(CH2, CH2CH=CH2), 72.2 (CH2, CH2O), 81.0 (CH, CHO), 116.7 (CH2, CH=CH2), 125.4 
(CH, Ar), 126.0 (CH, Ar), 127.4 (CH, Ar), 129.5 (CH, Ar), 135.6 (CH, CH=CH2), 141.5 
(quat. C, ipso Ar), 141.6 (quat. C, ipso Ar); m/z (EI) 147 ([M – C3H5]
+, 100%), 129 (59), 115 
(15), 91 (24); HRMS: C10H11O calcd 147.0810 ([M – C3H5]
+), obsd 147.0809; and then 
benzoxepin 205 (15 mg, 15%): Rf = 0.23 (90% hexane, 10% Et2O); νmax(film)/cm-1 3071w, 
2930m, 1640w, 1454m, 1349m, 1281w, 1224w, 1140m, 1085s, 1020s, 964m, 946m, 913m, 
876w, 852w, 747s; δH(300 MHz) 1.13-1.19 (3H, m, OCH2CH3), 1.74-2.08 (4H, stack, 2 × 
CH2CH2CH2O), 2.26-2.42 (1H, m, CHaHbCH=CH2), 2.46-2.60 (1H, m, CHaHbCH=CH2), 
2.69-3.06 (4H, stack, 2 × CH2CH2CH2O), 3.23-3.43 (2H, stack, OCH2CH3), 3.59 (1H, app. dt, 
J 9.5, 6.0, CH2CH2CHaHbO), 3.89 (1H, ddd, J 11.9, 7.4, 4.7, CH2CH2CHaHbO), 3.97-4.07 
(1H, m, CH2CH2CHaHbO), 4.21-4.32 (1H, m, CH2CH2CHaHbO), 4.62 (1H, app. dt, J 8.1, 4.7, 
CHO), 4.97-5.12 (2H, stack, CH=CH2), 5.53 (1H, s, acetal CH), 5.75-5.92 (1H, m, CH=CH2), 
7.10-7.29 (6H, stack, ArH), 7.42-7.56 (2H, stack, ArH); δC(100 MHz) 15.3 (CH3, OCH2CH3), 
29.0 (CH2), 29.5 (CH2), 31.4 (CH2), 34.2 (CH2), 42.5 (CH2), 64.0 (CH2, CH2O), 67.7 (CH2, 
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CH2O), 68.4 (CH2, CH2O), 77.5 (CH, CHOEt), 103.5 (CH, acetal CH), 116.5 (CH2, 
CH=CH2), 126.1 (CH, 2 × Ar), 126.1 (CH, Ar), 126.4 (CH, Ar), 127.1 (CH, Ar), 128.1 (CH, 
Ar), 129.3 (CH, Ar), 129.4 (CH, Ar), 135.3 (CH, CH=CH2), 139.2 (quat. C, ipso Ar), 139.7 
(quat. C, ipso Ar), 139.9 (quat. C, ipso Ar), 140.3 (quat. C, ipso Ar); m/z (TOF ES+) 403 ([M 
+ Na]+, 100%); HRMS: C25H32O3Na calcd 403.2249 ([M + Na]
+), obsd 403.2240.  
 
Asymmetric allylation:  
Enantiomerically enriched 1-allylbenzoxepin 202l was prepared from 1-ethoxybenzoxepin 
179l (76.9 mg, 0.400 mmol), allyltrimethylsilane (95 µL, 0.600 mmol) and the 
phosphoramide catalyst (R)-45g (79.2 mg, 0.080 mmol) in o-xylene (267 µL) according to 
Method B. After stirring for 48 h and work-up, purification by column chromatography (99% 
hexane, 1% Et2O) afforded traces of enantiomerically enriched 1-allylbenzoxepin 202l.
 
 






Elemental Analysis: C, 85.68; H, 6.71; O, 7.61
 
 
Racemic 1-allylpyran 202m was prepared from 1-ethoxypyran 179m (100 mg, 0.47 mmol), 
allyltrimethylsilane (110 µL, 0.70 mmol) and MeSO3H (45 µL, 0.47 mmol) in CH2Cl2 (0.9 
mL) according to Method A. Purification by flash column chromatography (gradient: 100% 
hexane → 99% hexane, 1% Et2O) afforded 1-allylpyran 202m as a colourless oil (94 mg, 
96%): Rf = 0.34 (90% hexane, 10% Et2O); δH(300 MHz) 2.76-2.97 (2H, stack, CH2CH=CH2), 
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5.02-5.33 (5H, stack, CH2O, CHO, CH=CH2), 6.08 (1H, ddt, J 17.1, 10.3, 6.8, CH=CH2), 
7.17-7.24 (1H, m, ArH), 7.25-7.32 (1H, m, ArH), 7.41-7.53 (2H, stack, ArH), 7.73-7.82 (2H, 
stack, ArH); δC(75 MHz) 38.3 (CH2, CH2CH=CH2), 66.7 (CH2, CH2O), 76.2 (CH, CHO), 
117.3 (CH2, CH=CH2), 120.0 (CH, Ar), 120.1 (CH, Ar), 125.5 (CH, 2 × Ar), 126.4 (CH, Ar), 
126.5 (CH, Ar), 126.7 (quat. C, ipso Ar), 132.4 (quat. C, ipso Ar), 132.9 (quat. C, ipso Ar), 
134.6 (CH, CH=CH2), 135.1 (quat. C, ipso Ar); m/z (EI) 210 ([M]
+, 4%), 169 (100, [M – 
C3H5]
+), 141 (43), 115 (18); HRMS: C15H14O calcd 210.1025 ([M]
+), obsd 210.1046. 
 
Asymmetric allylation:  
Enantiomerically enriched 1-allylpyran 202m was prepared from 1-ethoxypyran 179m (85.7 
mg, 0.400 mmol), allyltrimethylsilane (95 µL, 0.600 mmol) and the phosphoramide catalyst 
(R)-45g (59.4 mg, 0.060 mmol) in o-xylene (348 µL) according to Method B. After stirring 
for 24 h and work-up, purification by column chromatography (99% hexane, 1% Et2O)
afforded enantiomerically enriched 1-allylpyran 202m (35 mg, 42%): [α]D
20
 = +56.3 (c 0.67, 
CHCl3, e.r. 31:69); Chiralcel OD, 1.0 mL/min, 100% hexane, 10% IPA in hexane, λ = 210 
nm, tR,minor = 5.4 min, tR,major = 5.9 min. 
 
 






Elemental Analysis: C, 82.94; H, 8.57; O, 8.50
 
 
Racemic 1-allylisochroman 202n was prepared from 1-ethoxyisochroman 179n (120 mg, 0.61 
mmol), allyltrimethylsilane (145 µL, 0.92 mmol) and MeSO3H (40 µL, 0.61 mmol) in CH2Cl2 
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(1.2 mL) according to Method A. Purification by flash column chromatography (gradient: 
99% hexane, 1% Et2O → 90% hexane, 10% Et2O) afforded, in order of elution, 1-
allylisochroman 202n as a colourless oil (47 mg, 41%): Rf = 0.36 (90% hexane, 10% Et2O); 
νmax(film)/cm-1 3076w, 2975m, 2930m, 1639w, 1490m, 1447m, 1428m, 1372m, 1285m, 
1159w, 1094s, 1058m, 1036m, 997m, 973w, 910s, 827w, 790w, 758s, 734s, 659m; δH(300 
MHz) 1.51 (3H, s, CH3), 2.51 (1H,  dd, J 14.4, 7.7, CHaHbCH2O), 2.64-2.94 (3H, stack, 
CHaHbCH2O, CH2CH=CH2), 3.87-4.05 (2H, stack, CH2O), 5.00-5.12 (2H, stack, CH=CH2), 
5.72-5.88 (1H, m, CH=CH2), 7.06-7.25 (4H, stack, ArH); δC(75 MHz) 27.4 (CH3, CH3), 29.5 
(CH2, CH2CH2O), 46.6 (CH2, CH2CH=CH2), 59.5 (CH2, CH2CH2O), 76.2 (quat. C, CO), 
117.4 (CH2, CH=CH2), 125.4 (CH, Ar), 125.9 (CH, Ar), 126.1 (CH, Ar), 128.7 (CH, Ar), 
133.6 (quat. C, ipso Ar), 134.1 (CH, CH=CH2), 141.9 (quat. C, ipso Ar); m/z (EI) 147 ([M – 
C3H5]
+, 100%), 129 (30); HRMS: C10H11O calcd 147.0810 ([M – C3H5]
+), obsd 147.0811; 
and then a second product 204 whose structure was not determined as a colourless wax (39 
mg, 38%, mixture of diastereoisomers): selected data: Rf = 0.15 (90% hexane, 10% Et2O); 
νmax(film)/cm-1 3073w, 3019w, 2928m, 2858w, 1489m, 1448m, 1427m, 1370m, 1341w, 
1285m, 1188w, 1157w, 1094s, 1057m, 1037m, 986w, 910m, 811w, 755s, 735s, 674w; m/z 




Asymmetric allylation:  
Enantiomerically enriched 1-allylisochroman 202n was prepared from 1-ethoxyisochroman 
179n (76.9 mg, 0.400 mmol), allyltrimethylsilane (95 µL, 0.600 mmol) and the 
phosphoramide catalyst (R)-45g (59.4 mg, 0.060 mmol) in o-xylene (270 µL) according to 
Method B. After stirring for 24 h and work-up, purification by column chromatography (99% 




 = +43.4 (c 0.73, CHCl3, e.r. 37:63); Chiralcel OD, 1.0 mL/min, 100% hexane, λ = 210 





O Chemical Formula: C18H18O
Exact Mass: 250.1358
Molecular Weight: 250.3349
Elemental Analysis: C, 86.36; H, 7.25; O, 6.39
 
 
Racemic 1-allylisochroman 202o was prepared from 1-ethoxyisochroman 179o (60 mg, 0.24 
mmol), allyltrimethylsilane (55 µL, 0.35 mmol) and MeSO3H (15 µL, 0.24 mmol) in CH2Cl2 
(0.5 mL) according to Method A. Purification by flash column chromatography (gradient: 
100% hexane → 98% hexane, 2% Et2O) afforded 1-allylisochroman 202o as a white 
crystalline solid (26 mg, 44%): mp 65-66 °C; Rf = 0.43 (90% hexane, 10% Et2O); 
νmax(film)/cm-1 3064w, 2935w, 2914m, 2883w, 1488m, 1442m, 1429m, 1161w, 1097s, 
1080m, 1069m, 1036m, 1013m, 994m, 973m, 942m, 920s, 886w, 849w, 759s, 733m, 701s, 
671m; δH(300 MHz) 2.62 (1H, app. dt, J 16.4, 3.6, CHaHbCH2O), 2.94 (1H, ddt, J 15.7, 6.5, 
2.0, CHaHbCH2O), 3.01-3.15 (2H, stack, CH2CH=CH2), 3.66 (1H, ddd, J 11.4, 10.8, 3.6, 
CH2CHaHbO), 3.92 (1H, ddd, J 11.4, 6.5, 2.0, CH2CHaHbO), 4.94-5.11 (2H, stack, CH=CH2), 
5.71 (1H, ddt, J 17.2, 10.3, 6.7, CH=CH2), 7.14-7.42 (9H, stack, ArH); δC(100 MHz) 29.0 
(CH2, CH2CH2O), 47.0 (CH2, CH2CH=CH2), 60.0 (CH2, CH2O), 80.7 (quat. C, CO), 117.3 
(CH2, CH=CH2), 125.4 (CH, Ar), 126.5 (CH, Ar), 127.2 (CH, Ar), 127.3 (CH, Ar), 127.8 
(CH, Ar), 128.0 (CH, Ar), 129.2 (CH, Ar), 134.4 (CH, CH=CH2), 134.7 (quat. C, ipso Ar), 
137.8 (quat. C, ipso Ar), 145.6 (quat. C, ipso Ar); m/z (EI) 209 ([M – C3H5]
+, 100%), 194 
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Asymmetric allylation:  
Enantiomerically enriched 1-allylisochroman 202o was prepared from 1-ethoxyisochroman 
179o (102 mg, 0.400 mmol), allyltrimethylsilane (95 µL, 0.600 mmol) and the phosphoramide 
catalyst (R)-45g (59.4 mg, 0.060 mmol) in o-xylene (270 µL) according to Method B. After 
stirring for 24 h and work-up, purification by column chromatography (99% hexane, 1% 
Et2O) afforded enantiomerically enriched 1-allylisochroman 202o (16 mg, 16%): [α]D
 not 
recorded; e.r. 49:51; Chiralcel OD, 1.0 mL/min, 100% hexane, λ = 210 nm, tR,minor = 14.3 min, 










Elemental Analysis: C, 74.13; H, 7.92; O, 17.95
 
 
Racemic 1-(2’-hydroxyethyl)isochroman 177 was prepared by bubbling O3 through a cooled 
(–78 °C) solution of  1-allylisochroman 163 (100 mg, 0.58 mmol) in CH2Cl2/MeOH (1:1, 6 
mL) until a blue colour persisted. The excess O3 was then removed by bubbling N2 through 
the solution until the blue colour had dissipated. NaBH4 (141 mg, 3.73 mmol) was added 
slowly over 2 min and the mixture was warmed to R.T. After stirring for 30 min, the reaction 
was quenched by the addition of NH4Cl solution (10 mL) (caution: gas formation!). Et2O (10 
mL) was added and the two phases were separated. The aqueous phase was extracted with 
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Et2O (2 × 5 mL). The combined organic fractions were washed with brine (10 mL), and then 
dried (MgSO4). The drying agent was removed by filtration and the filtrate concentrated 
under reduced pressure to provide the crude product. Purification by flash column 
chromatography (gradient: 95% hexane, 5% EtOAc → 60% hexane, 40% EtOAc) afforded 
alcohol 177 as a colourless viscous oil (70 mg, 68%): Rf = 0.15 (60% hexane, 40% EtOAc); 
δH(300 MHz) 1.98-2.30 (2H, stack, CH2CH2OH), 2.69 (1H, app. dt, J 16.2, 3.1, 
CHaHbCH2O), 2.95 (1H, br s, OH), 3.03 (1H, ddd, J 15.9, 10.0, 5.5, CHaHbCH2O), 3.78 (1H, 
ddd, J 11.2, 10.0, 3.7, CH2CHaHbO), 3.85 (2H, t, J 5.1, CH2CH2OH), 4.17 (1H, ddd, J 11.2, 
5.5, 3.1, CH2CHaHbO), 4.99 (1H, dd, J 8.5, 1.7, CHO), 6.98-7.24 (4H, stack, ArH); δC(100 
MHz) 28.9 (CH2, CH2CH2O), 37.6 (CH2, CH2CH2OH) [60.8, 63.6 (CH2, CH2O)], 76.0 (CH, 
CHO), 124.4 (CH, Ar), 126.2 (CH, Ar), 126.4 (CH, Ar), 128.9 (CH, Ar), 133.6 (quat. C, ipso 
Ar), 137.4 (quat. C, ipso Ar); m/z (EI) 178 ([M]+, 6%), 133 (100, [M – CH2CH2OH]
+), 115 
(13), 105 (18), 77 (13). 
 
Enantiomerically enriched 1-(2’-hydroxyethyl)isochroman 177 was prepared from 
enantiomerically enriched 1-allylisochroman 163 by a one-pot oxidative cleavage – reduction 
sequence. NaIO4 (354 mg, 1.66 mmol), 2,6-lutidine (95 µL, 0.828 mmol) and OsO4 (a small 
crystal) were added to a mixture of the starting material (72 mg, 0.414 mmol, e.r. 82:18) in 
dioxane/H2O (3:1, 4 mL) at 0 °C. After stirring at R.T. for 2 h, NaBH4 (78 mg, 2.07 mmol) 
was added in small portions over a period of 2 min. The mixture was stirred for additional 10 
min, and then quenched with NH4Cl solution (8 mL) at 0 °C. The two phases were separated 
and the aqueous phase was extracted with CH2Cl2 (3 × 10 mL). The combined organic 
fractions were washed with brine (20 mL) and then dried (MgSO4). The drying agent was 
removed by filtration and the filtrate concentrated under reduced pressure to provide the crude 
product as a dark-red liquid. Purification by flash column chromatography (gradient: 95% 
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hexane, 5% EtOAc → 60% hexane, 40% EtOAc) afforded alcohol 177 as a colourless10 
viscous oil (57 mg, 77%): [α]D
20
 = +102.2 (c 1.08, CH2Cl2, e.r. 82:18); Chiralcel OD, 1.0 




= +43.5 (c 0.20, CH2Cl2, e.r. 80:20)).
11 
 









Elemental Analysis: C, 49.77; H, 6.27; 
N, 17.41; O, 13.26; S, 13.29  
 
A mixture of 4-fluorobenzenesulfonamide (1.00 g, 5.71 mmol) and piperazine (2.46 g, 28.5 
mmol) in H2O (12 mL) was heated at 100 °C for 24 h. The resulting precipitate was collected 
by filtration and washed with H2O (50 mL) and toluene (50 mL). The white solid was dried 
under reduced pressure to provide sulfonamide 213 (1.38 g, 95%): mp 217-219 °C (lit.[153] mp 
219-221 °C); νmax(neat)/cm-1 3307m, 3097m, 3069m, 2949m, 2929m, 2863w, 2824m, 1592m, 
1496m, 1458m, 1446m, 1438m, 1413w, 1379m, 1330s, 1308m, 1294m, 1261w, 1229m, 
1187w, 1152s, 1135s, 1122s, 1097s, 1041w, 1023m, 976w, 936w, 882s, 815s, 754s, 725m, 
679s; δH(300 MHz, DMSO-d6) 2.31 (1H, br s, NH), 2.76-2.86 (4H, stack, CH2N), 3.12-3.21 
(4H, stack, CH2N), 6.99 (2H, d, J 9.0, ArH), 7.05 (2H, br s, SO2NH2), 7.60 (2H, d, J 9.0, 
                                                
10 in total, two columns were carried out to obtain a pure colourless product 
11 the (R)-(+)-correlation has been established in[153] 
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ArH); δC(100 MHz) [45.4, 48.2 (CH2, CH2N)], 113.5 (CH, Ar), 127.1 (CH, Ar), 132.5 (quat. 
C, ipso Ar), 153.4 (quat. C, ipso Ar); m/z (TOF ES+) 242.1 ([M + H]+, 100%). 
 
Data were in agreement with those reported in the literature.[209] 
 
 





SO2NH2 Chemical Formula: C21H27N3O3S
Exact Mass: 401.1773
Molecular Weight: 401.5224
Elemental Analysis: C, 62.82; H, 6.78; 
N, 10.47; O, 11.95; S, 7.99  
 
DMAP (1.3 mg, 0.010 mmol), DIPEA (90 µL, 0.520 mmol) and MsCl (20 µL, 0.230 mmol) 
were added to a solution of (R)-(+)-1-(2’-hydroxyethyl)isochroman 177 (37 mg, 0.208 mmol, 
e.r. 82:18) in THF (235 µL) at 0 °C. After stirring for 30 min, 4-piperazin-1-yl-
benzenesulfonamide 213 (58 mg, 0.239 mmol) and ethylene glycol (235 µL) were added and 
the mixture was heated at 100 °C for 15 h. After cooling to R.T., H2O (3 mL) and CH2Cl2 (3 
mL) were added. The phases were separated and the aqueous phase was extracted again with 
CH2Cl2 (5 mL). The combined organic fractions were washed with brine (10 mL), and then 
dried (MgSO4). The drying agent was removed by filtration and the filtrate concentrated 
under reduced pressure to provide the crude product. Purification by flash column 
chromatography (gradient: 100% CH2Cl2 → 95% CH2Cl2, 5% MeOH) afforded (R)-(+)-U-
101387 212 as a white solid (57 mg, 69%): mp 192-194 °C (lit.[153] mp 189-190 °C); Rf = 0.15 
(95% CH2Cl2, 5% MeOH); [α]D
21
 = +41.1 (c 0.36, DMF) (lit.
[153] [α]D = +48 (c 0.88, DMF); 
νmax(neat)/cm-1 2921m, 2835m, 1594m, 1496m, 1453m, 1390w, 1330s, 1306m, 1297m, 
1245m, 1152s, 1112s, 1098s, 1083m, 1062w, 1016w, 1004m, 925m, 907m, 850w, 829s, 
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809m, 758s, 739s, 688w, 652w; δH(300 MHz) 1.80-1.97 (1H, m, CHaHb), 2.02-2.18 (1H, m, 
CHaHb), 2.31-2.73 (7H, stack, 3 × CH2N and ArCHaHb), 2.78-2.93 (1H, m, ArCHaHb), 3.19-
3.31 (4H, stack, 2 × CH2NAr), 3.60-3.73 (1H, m, CHaHbO), 3.98-4.09 (1H, m, CHa bO), 4.76 
(1H, app. d, J 7.2, CHO), 6.96-7.28 (8H, stack, 6 × ArH and SO2NH2), 7.61 (2H, d, J 8.7, 
ArH); δC(100 MHz) 28.5 (CH2, CH2), 32.6, (CH2, ArCH2), [47.1, 52.6 (CH2, 2 × CH2N)], 
54.2 (CH2, CH2NAr), 62.2 (CH2, CH2O), 73.6 (CH, CHO), 113.6 (CH, Ar), 124.7 (CH, Ar), 
126.0 (CH, Ar), 126.1 (CH, Ar), 127.1 (CH, Ar), 128.7 (CH, Ar), 132.7 (quat. C, ipso Ar), 
133.6 (quat. C, ipso Ar), 138.1 (quat. C, ipso Ar), 152.8 (quat. C, ipso Ar); m/z (TOF ES+) 
402.2 ([M + H]+, 100%); HRMS: C21H28 N3O3S calcd 402.1851 ([M + H]
+), obsd 402.1841. 
 
Data were in agreement with those reported in the literature.[153] 
 
 







Elemental Analysis: C, 83.90; H, 4.93; O, 11.18
 
 
(±)-2,2’-Dihydroxy-1,1’-binaphthyl rac-109 was prepared using a variation of a previously 
reported method:[125,126]  
A solution of FeCl3 (10.2 g, 62.9 mmol) in H2O (90 mL) was added dropwise over 5 min to a 
solution of 2-naphthol (9.0 g, 62.4 mmol) in H2O (1.2 L) at 100 °C. A further portion of 2-
naphthol (9.0 g, 62.4 mmol) was added and the reaction mixture was stirred for 10 min at 100 
°C before another solution of FeCl3 (10.2 g, 62.9 mmol) in H2O (90 mL) was added dropwise 
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over 5 min. These additions and time delays were repeated with further portions of 2-naphthol 
(3 × 9.0 g) and solutions of FeCl3 (3 × 10.2 g in 90 mL H2O). The reaction was stirred for a 
further 30 min at 100 °C before the brown precipitate was filtered off and washed with boiling 
H2O (6 × 500 mL). The solid residue was dissolved in Et2O (750 mL) and activated charcoal 
(30 g) was added. The suspension was heated at reflux for 3 h. Removal of the charcoal by 
filtration and concentration of the filtrate under reduced pressure provided the crude product 
as a pale brown solid. Recrystallisation from toluene afforded BINOL rac-109 as a fluffy 
white solid (34.4 g, 77%): mp 219-222 °C (lit.[126] mp 216-218 °C); (Found: C, 83.77; H, 4.87. 
C20H14O2 requires C, 83.90; H, 4.93%); νmax(film)/cm-1 3532s (OH), 3484s (OH), 3398s 
(OH), 1957w, 1618s (C=C aromatic), 1597s (C=C aromatic), 1517s (C=C aromatic), 1470m, 
1436w, 1382s, 1345m, 1314m, 1272m, 1182w, 1144s, 1125m, 978w, 960w, 930m, 863m, 
625s; δH(300 MHz, CD3CN) 6.62 (2H, br s, OH), 7.00 (2H, d, J 8.5, ArH), 7.20-7.36 (6H, 
stack, ArH), 7.90 (2H, d, J 8.1, ArH), 7.96 (2H, d, J 9.2, ArH); δC(75 MHz, CD3CN) 114.5 
(quat. C, ipso Ar), 119.3 (CH, Ar), 124.2 (CH, Ar), 125.1 (CH, Ar), 127.6 (CH, Ar), 129.1 
(CH, Ar), 130.2 (quat. C, ipso Ar), 131.1 (CH, Ar), 135.3 (quat. C, ipso Ar), 154.2 (quat. C, 
ipso Ar); m/z (EI) 286 ([M]+, 100%), 257 (14), 239 (14), 120 (13). 
 
Data were in agreement with those reported in the literature.[126]  
 
 







                                              (R)-109                           (S)-109 
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N-Benzylcinchonidinium chloride 111 (18.6 g, 44.2 mmol) was added to a solution of (±)-
2,2’-dihydroxy-1,1’-binaphthyl rac-109 (23.0 g, 80.3 mmol) in CH3CN (300 mL) and the 
resulting suspension was heated at reflux for 4 h. After cooling to R.T. and stirring for 12 h, 
the mixture was cooled to 0 °C, kept at this temperature for 2 h, and then filtered. The filtrate 
was concentrated to dryness, redissolved in EtOAc (300 mL), and washed with 1 M 
hydrochloric acid (2 × 100 mL) and then brine (100 mL). The organic layer was dried 
(Na2SO4), filtered, and concentrated under reduced pressure to afford (S)-BINOL (S)-109 as a 
light brown solid (10.90 g, 95%): [α]D
20
 = –33.3 (c 1.0, THF, e.r. 0.4:99.6); Chiralpak AD 
column, 1.0 mL/min, 10% IPA in hexane, λ = 280 nm, tR,minor = 28.2 min, tR,major = 32.8 min; 
(lit. [127] [α]D
21
 = –34.0 (c 1.0, THF, e.r. 0.5:99.5)). The solid was washed with CH3CN (50 
mL) and heated at reflux in MeOH (100 mL) for 24 h. After cooling to R. T., the mixture was 
filtered, and the solid was washed with MeOH (20 mL). The resulting solid was suspended in 
a mixture of EtOAc (300 mL) and 1 M hydrochloric acid (150 mL) and stirred until it was 
completely dissolved. The organic layer was washed with 1 M hydrochloric acid (150 mL) 
and then brine (150 mL), dried (Na2SO4), filtered, and concentrated under reduced pressure to 
afford (R)-BINOL (R)-109 as a white solid (10.92 g, 95%): [α]D
20
 = +33.0 (c 1.0, THF, e.r. 
99.5:0.5); Chiralpak AD column, 1.0 mL/min, 10% IPA in hexane, λ = 280 nm, tR,minor = 29.0 
min, tR,major = 32.2 min; (lit.
[127] [α]D
21
 = +34.3 (c 1.0, THF, e.r. > 99.9:0.1). 
 
 










C, 84.05; H, 5.77; O, 10.18
 
                  (R)-112                            (S)-112                   
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A suspension of (S)-BINOL (S)-109 (5.10 g, 17.8 mmol) in acetone (150 mL) was heated 
until all of the starting material had dissolved. K2CO3 (8.29, 60.0 mmol) and MeI (4.36 mL, 
70.0 mmol) were added, and the mixture was heated under reflux for 24 h. After adding more 
MeI (1.87 mL, 30.0 mmol), the heating was continued for another 12 h. The mixture was 
cooled to R.T. and concentrated under reduced pressure to 1/5 of its volume. H2O (160 mL) 
was added and the suspension was stirred for 8 h. The resulting solid was filtered, washed 
with H2O (2 × 50 mL) and dried to afford (S)-dimethyl ether (S)-112 as a white powder (5.43 
g, 97%). The crude product is usually used directly in the next step; however it can be further 
purified by recrystallisation from hexane/toluene (1:1) to afford the pure product as a cream-
coloured powder (4.76 g, 85%): mp 227-230 °C (lit.[210] mp 222.9-227.0 °C); [α]D
21
 = –54.0 (c 
0.43, CHCl3);
12 (Found: C, 84.02; H, 5.86. C22H18O2 requires C, 84.05; H, 5.77%); 
νmax(film)/cm-1 2838w, 1616m (C=C aromatic), 1589s (C=C aromatic), 1506s (C=C 
aromatic), 1459m, 1353w, 1264s, 1147m, 1131w, 1090s, 1062s, 1018m, 894w; δH(300 MHz) 
3.76 (6H, s, OCH3), 7.10 (2H, d, J 8.5, ArH), 7.16-7.34 (4H, stack, ArH), 7.46 (2H, d, J 9.2, 
ArH), 7.86 (2H, d, J 8.1, ArH), 7.97 (2H, d, J 9.2, ArH); δC(75 MHz) 56.9 (CH3, OCH3), 
114.2 (CH, Ar), 119.6 (quat. C, ipso Ar), 123.5 (CH, Ar), 125.2 (CH, Ar), 126.3 (CH, Ar), 
127.9 (CH, Ar), 129.2 (quat. C, ipso Ar), 129.4 (CH, Ar), 134.0 (quat. C, ipso Ar), 154.9 
(quat. C, ipso Ar); m/z (EI) 314 ([M]+, 100%), 268 (51), 239 (14), 237 (14), 199 (16), 181 
(11), 163 (13), 119 (9), 69 (9). 
 
The same protocol was followed for the preparation of the (R)-enantiomer (R)-112: [α]D
21
 = 
+55.8 (c 0.43, CHCl3) (lit.
[210]  [α]D
21
 = +54.9 (c 1.0, CHCl3).
12 
 
Data were in agreement with those reported in the literature.[210]   
 
                                                
12 the ee-value could not be determined by chiral HPLC owing to poor resolution of the racemic mixture 
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           (R)-113                           (S)-113 
 
nBuLi (19.1 mL of a 2.50 M solution in hexane, 47.7 mmol) was added to a solution of 
TMEDA (7.15 mL, 47.7 mmol) in Et2O (250 mL) at R.T. The solution was stirred for 30 min, 
and then (S)-2,2’-dimethoxy-1,1’-binaphthyl (S)-112 (5.00 g, 15.9 mmol) was added in one 
portion, and the mixture was stirred for 3.5 h. The resulting light brown suspension was 
cooled to –78 °C, and B(OEt)3 (18.9 mL, 111 mmol) was added over 15 min. After warming 
to R.T., the suspension was stirred overnight at R.T. The mixture was cooled to 0 °C, 1 M 
hydrochloric acid (125 mL) was added, and the resulting solution was stirred vigoriously for 
3.5 h at R.T. The organic layer was washed with 1 M hydrochloric acid (125 mL) and brine 
(125 mL), and then dried (Na2SO4). The drying agent was removed by filtration and the 
filtrate concentrated under reduced pressure to provide the crude product. The pale yellow 
solid was recrystallised from cyclohexane/toluene (2:1) to afford (S)-boronic acid (S)-113 as a 
white powder (3.53 g, 55%): δH(300 MHz, CD3CN) 3.37 (6H, s, OCH3), 6.56 (4H, s, 
B(OH)2), 7.07 (2H, d, J 8.5, ArH), 7.26-7.36 (2H, m, ArH), 7.44 (2H, app. t, J 7.0, ArH), 8.02 
(2H, d, J 8.1, ArH), 8.51 (2H, s, ArH); δC(75 MHz, (CD3)2CO) 61.8 (CH3, OCH3), 124.2 
(quat. C, ipso Ar), 125.7 (CH, Ar), 126.3 (CH, Ar), 128.2 (CH, Ar), 129.6 (CH, Ar), 131.4 
(quat. C, ipso Ar), 136.6 (quat. C, ipso Ar), 139.0 (CH, Ar), 161.1 (quat. C, ipso Ar), (quat. C, 
ipso CB(OH)2) not observed because peak is too broad due to adjacent quadrupole boron 
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nucleus (11B: I = 3/2) resulting in the resonance being lost in the noise; m/z (TOF ES+) 481 
([M – 4 × OH + 4 × OMe + Na]+, 100%). 
 
The same protocol was followed for the preparation of the (R)-enantiomer (R)-113. 
 












Elemental Analysis: C, 46.67; H, 2.85; I, 44.83; O, 5.65
 
 
nBuLi (28.6 mL of a 2.5 M solution in hexane, 71.6 mmol) was added to a solution of 
TMEDA (5.40 g, 35.8 mmol) in Et2O (250 mL), and the mixture was stirred for 30 min before 
adding the solid dimethoxy binaphthalenyl (R)-112 (7.50 g, 23.9 mmol). After stirring 
overnight at R.T., the mixture was cooled to –78 °C and a solution of I2 (15.1 g, 59.6 mmol) 
in THF (30 mL) was added dropwise over 15 min v a syringe. The reaction mixture was 
stirred for 1 h at –78 °C, and then warmed up to R.T. overnight. Na2S2O3 solution (150 mL) 
was added and stirring was continued for 2 h. The layers were separated, and the aqueous 
phase was extracted with Et2O/THF (1:1, 3 × 80 mL). The combined organic fractions were 
washed with Na2S2O3 solution (100 mL), H2O (100 mL) and brine (100 mL), and then dried 
(MgSO4). The drying agent was removed by filtration and the filtrate concentrated under 
reduced pressure to provide the crude product. Et2O (30 mL) was added, and the suspension 
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was stirred vigorously for 1 h. Filtration provided a yellow powder. Recrystallisation from 
Et2O/CH2Cl2 (3:2) afforded diiodo binaphthalenyl (R)-114  as a cream-coloured solid (9.07 g, 
67%): δH(300 MHz) 3.41 (6H, s, OCH3), 7.07 (2H, d, J 8.5, ArH), 7.22-7.31 (2H, stack, ArH), 
7.37-7.45 (2H, stack, ArH), 7.80 (2H, d, J 8.1, ArH), 8.54 (2H, s, ArH); δC(75 MHz) 61.1 
(CH3, OCH3), 92.3 (quat. C, ipso Ar), 125.3 (quat. C, ipso Ar), 125.6 (CH, Ar), 125.7 (CH, 
Ar), 126.9 (CH, Ar), 127.0 (CH, Ar), 132.1 (quat. C, ipso Ar), 133.8 (quat. C, ipso Ar), 139.9 
(CH, Ar), 154.4 (quat. C, ipso Ar); m/z (TOF ES+) 589.0 ([M + Na]+, 100%). 
 











Elemental Analysis: C, 81.60; H, 7.53; O, 10.87
 
 
PtO2 (286 mg, 1.26 mmol) was added to a solution of (R)-BINOL (R)-109 (3.00 g, 10.5 
mmol) in AcOH (84 mL). The atmosphere of the flask was purged under vacuum and flushed 
with H2 three times. The reaction mixture was stirred under a balloon pressure of H2 for 48 h 
and then filtered through a bed of Celite, washing with CHCl3 (150 mL) and H2O (200 mL). 
The layers were separated and the organic phase was washed with H2O (150 mL), NaHCO3 
solution (300 mL) and brine (300 mL), and then dried (MgSO4). The drying agent was 
removed by filtration and the filtrate concentrated under reduced pressure to provide the crude 
diol (R)-H8-115 as a white solid (3.19 g, quantitative), which was sufficiently pure for 
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characterisation and further use: mp 164-166 °C (lit.[213] mp 165-166 °C); [α]D
19




 = +47.1 (c 1.04, CHCl3); δH(300 MHz) 1.56-1.81 (8H, stack, 
CH2CH2CH2CH2), 2.08-2.36 (4H, stack, ArCH2), 2.67-2.80 (4H, stack, ArCH2), 4.66 (2H, s, 
OH), 6.81 (2H, d, J 8.5, ArH), 7.04 (2H, d, J 8.5, ArH); δC(75 MHz) 22.92 (CH2, 
CH2CH2CH2CH2), 22.98 (CH2, CH2CH2CH2CH2), 27.1 (CH2, ArCH2), 29.2 (CH2, ArCH2), 
112.9 (CH, Ar), 118.9 (quat. C, ipso Ar), 130.0 (quat. C, ipso Ar), 130.1 (CH, Ar), 137.1 
(quat. C, ipso Ar), 151.3 (quat. C, ipso Ar); m/z (TOF ES–) 293 ([M – H]–, 100%). 
 













Elemental Analysis: C, 53.12; H, 4.46; Br, 35.34; O, 7.08
 
 
Br2 (150 µL, 2.89 mmol) was added to a solution of (R)-H8-BINOL (R)-H8-115 (370 mg, 1.26 
mmol) in CH2Cl2 (12.5 mL) at –30 °C. After stirring for 30 min at –30 °C, the brown solution 
was warmed to –10 °C and Na2S2O3 solution (15 mL) was added. The mixture was warmed to 
R.T. and diluted with CH2Cl2 (15 mL) and H2O (15 mL). The layers were separated and the 
organic phase was washed with NaHCO3 solution (20 mL) and brine (20 mL), and then dried 
(MgSO4). The drying agent was removed by filtration and the filtrate concentrated under 
reduced pressure to provide the crude product. Purification by flash column chromatography 
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(90% hexane, 10% Et2O) afforded diol (R)-H8-116 as a white crystalline solid (0.467 g, 82%): 
mp 125-127 °C (lit.[213] mp 142-143 °C); [α]D
20
 = +24.4 (c 1.0, CHCl3) (lit.
[213] [α]D
25
 = +29.2 
(c 1.05, CHCl3); δH(300 MHz) 1.56-1.78 (8H, stack, CH2CH2CH2CH2), 2.00-2.15 (2H, m, 
ArCHaHb), 2.21-2.36 (2H, m, ArCHaHb), 2.65-2.80 (4H, stack, ArCH2), 5.01 (2H, s, OH), 
7.27 (2H, s, ArH); δC(75 MHz) 22.7 (CH2, CH2CH2CH2CH2), 22.8 (CH2, CH2CH2CH2CH2), 
26.9 (CH2, ArCH2), 29.0 (CH2, ArCH2), 107.1 (quat. C, ipso Ar), 122.1 (quat. C, ipso Ar), 
131.5 (quat. C, ipso Ar), 132.5 (CH, Ar), 136.7 (quat. C, ipso Ar), 147.1 (quat. C, ipso Ar); 
m/z (TOF ES+) 475 ([M + Na]+, 100%). 
 











Elemental Analysis: C, 81.95; H, 8.13; O, 9.92
 
 
(R)-2,2’-Dimethoxy-5,6,7,8,5’,6’,7’,8’-octahydro-[1,1’]-binaphthalenyl (R)-H8-117 was 
prepared employing the procedure used for the methylation of BINOL:[128,129] 
A suspension of (R)-H8-BINOL (R)-H8-115 (3.08 g, 10.5 mmol) in acetone (100 mL) was 
heated until all of the starting material had dissolved. K2CO3 (7.24 g, 52.4 mmol) and MeI 
(2.45 mL, 39.4 mmol) were added, and the mixture was heated under reflux for 24 h. After 
adding more MeI (2.45 mL, 39.4 mmol), heating was continued for another 12 h. The mixture 
was cooled to R.T. and concentrated under reduced pressure to 1/5 of its volume. H2O (120 
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mL) was added and the suspension was stirred for 8 h. The resulting solid was filtered, 
washed with H2O (2 × 50 mL) and dissolved in CH2Cl2 (150 mL). Brine (50 mL) was added 
and the layers were separated. The organic phase was dried (MgSO4). The drying agent was 
removed by filtration and the filtrate concentrated under reduced pressure to provide the crude 
product in quantitative yield. Recrystallisation from toluene/hexane (1:1) afforded (R)-H8-117 
as a white crystalline solid (2.91 g, 85%): δH(300 MHz) 1.56-1.80 (8H, stack, 
CH2CH2CH2CH2), 2.01-2.15 (2H, m, ArCHaHb), 2.20-2.34 (2H, m, ArCHaHb), 2.68-2.87 (4H, 
stack, ArCH2), 3.38 (6H, s, OCH3), 6.79 (2H, d, J 8.1, ArH), 7.07 (2H, d, J 8.1, ArH); δC(75 
MHz) 23.1 (CH2, CH2CH2CH2CH2), 23.2 (CH2, CH2CH2CH2CH2), 27.1 (CH2, ArCH2), 29.4 
(CH2, ArCH2), 55.9 (CH3, OCH3), 108.7 (CH, Ar), 125.8 (quat. C, ipso Ar), 128.7 (CH, Ar), 
129.4 (quat. C, ipso Ar), 136.7 (quat. C, ipso Ar), 154.6 (quat. C, ipso Ar); m/z (TOF ES+) 
345 ([M + Na]+, 100%). 
 














Elemental Analysis: C, 55.02; H, 5.04; Br, 33.28; O, 6.66
 
 
Br2 (990 µL, 19.3 mmol) was added to a solution of (R)-H8-BINOL derivative (R)-H8-117 
(2.70 g, 8.37 mmol) in CH2Cl2 (85 mL) at –30 °C. After stirring for 30 min at –30 °C, 
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Na2S2O3 solution (70 mL) was added and the mixture was warmed to R.T. over 1 h. CH2Cl2 
(30 mL) and H2O (30 mL) were added and the layers were separated. The organic phase was 
washed with NaHCO3 solution (40 mL), H2O (40 mL) and brine (20 mL), and then dried 
(MgSO4). The drying agent was removed by filtration and the filtrate concentrated under 
reduced pressure to provide the crude product (R)-H8-118 as a cream-white solid (4.01 g, 
quantitative), which was sufficiently pure for characterisation and further use: mp 138-140 
°C; [α]D
20
 = –20.8 (c 1.0, CHCl3); δH(300 MHz) 1.53-1.79 (8H, stack, CH2CH2CH2CH2), 
1.98-2.13 (2H, m, ArCHaHb), 2.18-2.36 (2H, m, ArCHaHb), 2.65-2.83 (4H, stack, ArCH2), 
3.57 (6H, s, OCH3), 7.32 (2H, s, ArH); δC(75 MHz) 22.68 (CH2, CH2CH2CH2CH2), 22.71 
(CH2, CH2CH2CH2CH2), 27.4 (CH2, ArCH2), 29.2 (CH2, ArCH2), 60.5 (CH3, OCH3), 113.9 
(quat. C, ipso Ar), 132.1 (quat. C, ipso Ar), 133.0 (CH, Ar), 134.9 (quat. C, ipso Ar), 136.1 
(quat. C, ipso Ar), 151.7 (quat. C, ipso Ar); m/z (TOF ES+) 503 ([M + Na]+, 100%). 
 














Elemental Analysis: C, 46.02; H, 4.21; I, 44.20; O, 5.57
 
 
tBuLi (10.4 mL of a 1.7 M solution in pentane, 17.7 mmol) was added to a solution of 
binaphthalenyl (R)-H8-117 (2.00 g, 4.16 mmol) in Et2O (100 mL) at –78 °C. The orange 
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mixture was warmed to 0 °C over 30 min, after which time, a solution of I2 (2.43 g, 9.58 
mmol) in Et2O (20 mL) was added. After warming up to R.T. overnight, the mixture was 
poured into Na2S2O3 solution (100 mL) and stirred for 2 h. The layers were separated and the 
aqueous phase was extracted with Et2O (2 × 100 mL). The combined organic fractions were 
washed with H2O (150 mL) and brine (150 mL), and then dried (MgSO4). The drying agent 
was removed by filtration and the filtrate concentrated under reduced pressure to provide the 
crude product. Purification by flash column chromatography (70% hexane, 30% toluene) 
afforded binaphthalenyl (R)-H8-119 as a white solid (1.69 g, 71%): mp 123-125 °C; Rf = 0.23 
(70% hexane, 30% toluene); [α]D
20
 = –50.4 (c 1.0, CHCl3); δH(300 MHz) 1.57-1.78 (8H, 
stack, CH2CH2CH2CH2), 2.01-2.14 (2H, m, ArCHaHb), 2.20-2.34 (2H, m, ArCHaHb), 2.68-
2.79 (4H, stack, ArCH2), 3.49 (6H, s, OCH3), 7.56 (2H, s, ArH); δC(75 MHz) 22.6 (CH2, 
CH2CH2CH2CH2), 22.7 (CH2, CH2CH2CH2CH2), 27.4 (CH2, ArCH2), 29.0 (CH2, ArCH2), 
60.4 (CH3, OCH3), 88.3 (quat. C, ipso Ar), 131.4 (quat. C, ipso Ar), 135.5 (quat. C, ipso Ar), 
137.2 (quat. C, ipso Ar), 139.1 (CH, Ar), 154.3 (quat. C, ipso Ar); m/z (TOF ES+) 597.0 ([M 
+ Na]+, 100%). 
 











(R)- and (S)-3,3’-Bis(4-methylphenyl)-2,2’-dimethoxy-1,1’-binaphthyl (R)- and (S)-123 






















C, 86.11; H, 5.98; O, 7.91
 
         (R)-124                                     (S)-124 
 
(R)- and (S)-3,3’-Bis(4-methylphenyl)-2,2’-dimethoxy-1,1’-binaphthyl (R)- and (S)-123 And 
the by-products (R)- and (S)-3-(4-methylphenyl)-2,2’-dimethoxy-1,1’-binaphthyl (R)- and (S)-
124 were prepared using a previously reported general procedure for the formation of 
different 3,3’-bis-aryl-2,2’-dimethoxy-1,1’-binaphthyl compounds:[128]  
4-Bromotoluene (0.370 mL, 3.00 mmol), Ba(OH)2 (946 mg, 3.00 mmol) and Pd(PPh3)4 (46 
mg, 0.04 mmol) were added to a solution of bis-boronic acid (S)-113 (402 mg, 1.00 mmol) in 
a mixture of degassed dioxane/H2O (3:1, 8 mL). The mixture was heated under reflux for 3 h 
and then cooled to room temperature. The solvents were removed under reduced pressure, and 
the resulting grey residue was redissolved in CH2 l2 (25 mL) and 1 M hydrochloric acid (25 
mL). The organic layer was washed with 1 M hydrochloric acid (25 mL) and brine (25 mL), 
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and then dried (MgSO4). The drying agent was removed by filtration and the filtrate 
concentrated under reduced pressure to provide the crude product. Purification by flash 
column chromatography (60% hexane, 40% toluene) afforded, in order of elution, bis-coupled 
product (S)-123 as a white foamy solid (300 mg, 61%): mp 204-207 °C; Rf = 0.40 (60% 
hexane, 40% toluene); [α]D
20
 = +19.2 (c 1.0, CHCl3); (Found: C, 87.59; H, 6.27. C36H30O2 
requires C, 87.42; H, 6.11%); νmax(film)/cm-1 3054m, 3012m, 2934m, 2863w, 1907w, 1806w, 
1620w (C=C aromatic), 1591w (C=C aromatic), 1514s (C=C aromatic), 1492m, 1456s, 
1398s, 1352m, 1330w, 1308w, 1249s, 1186w, 1172w, 1148m, 1139w, 1131w, 1112w, 
1079w, 1039s, 1016s, 979m, 954w, 936w, 916m, 893m, 856w, 822s, 691w, 638w, 615m, 
573w; δH(300 MHz) 2.44 (6H, s, ArCH3), 3.22 (6H, s, OCH3), 7.23-7.32 (8H, stack, ArH), 
7.38-7.45 (2H, stack, ArH), 7.70 (4H, d, J 8.1, ArH), 7.92 (2H, d, J 8.1, ArH), 7.98 (2H, s, 
ArH); δC(75 MHz) 21.2 (CH3, ArCH3), 60.4 (CH3, OCH3), 124.9 (CH, Ar), 125.7 (CH, Ar), 
125.9 (quat. C, ipso Ar), 126.1 (CH, Ar), 127.9 (CH, Ar), 129.0 (CH, Ar), 129.1 (CH, Ar), 
130.3 (CH, Ar), 130.8 (quat. C, ipso Ar), 133.5 (quat. C, ipso Ar), 134.9 (quat. C, ipso Ar), 
136.0 (quat. C, ipso Ar), 136.9 (quat. C, ipso Ar), 154.1 (quat. C, ipso Ar); m/z (TOF ES+) 
517.3 ([M + Na]+, 100%), 495.3 (55, [M]+); HRMS: C36H30O2Na calcd 517.2144 ([M + Na]
+), 
obsd 517.2161; and after increasing the polarity of the eluent (40% hexane, 60% toluene), 
mono-coupled product (S)-124 as a white foamy solid (73 mg, 18%): mp 90-92 °C; Rf = 0.20 
(40% hexane, 60% toluene); [α]D
22
 = –103.4 (c 1.0, CHCl3); νmax(film)/cm-1 3055m, 3009m, 
2935m, 2838w, 1622m (C=C aromatic), 1594m (C=C aromatic), 1511s (C=C aromatic), 
1456s, 1432w, 1398m, 1356m, 1334m, 1267s, 1249s, 1181w, 1147m, 1131w, 1112w, 1089s, 
1057m, 1037m, 1018s, 973w, 954w, 924w, 901m, 894m, 865w, 822s, 808m, 706w, 689w, 
609m; δH(300 MHz) 2.46 (3H, s, ArCH3), 3.17 (3H, s, OCH3), 3.85 (3H, s, OCH3), 7.16-7.46 
(8H, stack, ArH), 7.51 (1H, d, J 8.1, ArH), 7.72 (2H, d, J 8.8, ArH), 7.93 (2H, t, J 7.9, ArH), 
7.98-8.07 (2H, stack, ArH); δC(75 MHz) 21.2 (CH3, ArCH3), 56.5 (CH3, OCH3),  60.3 (CH3, 
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OCH3), 113.6 (CH, Ar), 119.6 (quat. C, ipso Ar), 123.5 (CH, Ar), 124.8 (CH, Ar), 125.3 (CH, 
Ar), 125.5 (CH, Ar), 125.6 (quat. C, ipso Ar), 126.0 (CH, Ar), 126.5 (CH, Ar), 127.87 (CH, 
Ar), 127.94 (CH, Ar), 128.9 (CH, tolyl Ar), 129.0 (quat. C, ipso Ar), 129.2 (CH, tolyl Ar), 
129.5 (CH, Ar), 130.1 (CH, Ar), 130.8 (quat. C, ipso Ar), 133.3 (quat. C, ipso Ar), 134.1 
(quat. C, ipso Ar), 134.9 (quat. C, ipso Ar), 135.9 (quat. C, ipso Ar), 136.8 (quat. C, ipso Ar), 
154.1 (quat. C, ipso Ar), 154.8 (quat. C, ipso Ar); m/z (TOF ES+) 427 ([M + Na]+, 100%); 
HRMS: C29H24O2Na calcd 427.1674 ([M + Na]
+), obsd 427.1681. 
 
The same protocol was followed for the preparation of the (R)-enantiomers (R)-123: [α]D
20
 = –
19.0 (c 1.0, CHCl3); and (R)-124: [α]D
21
 = +100.8 (c 1.0, CHCl3). 
 
 










C, 87.52; H, 5.62; O, 6.86
 
         (R)-125                                     (S)-125 
 
(R)- and (S)-3,3’-Bis(4-methylphenyl)-2,2’-dihydroxy-1,1’-binaphthyl (R)- and (S)-125 were 
prepared using a previously reported general procedure for the deprotection of different 3,3’-
bis-aryl-2,2’-dimethoxy-1,1’-binaphthyl compounds:[128]  
A solution of BBr3 in CH2Cl2 (1.0 M, 5.90 mL, 5.90 mmol) was added to a solution of bis-
ether (S)-123 (587 mg, 1.19 mmol) in CH2Cl2 (100 mL) at 0 °C and the mixture was warmed 
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to R.T. overnight. H2O (4 mL) was added at 0 °C and the mixture was poured into 
CH2Cl2/H2O (1:1, 200 mL). After stirring for 30 min, the layers were separated and the 
organic fraction was washed with brine (150 mL), and then dried (MgSO4). The drying agent 
was removed by filtration and the filtrate concentrated under reduced pressure to provide the 
crude product. Purification by flash column chromatography (80% hexane, 20% Et2O) 
afforded diol (S)-125 as a white foamy solid (537 mg, 97%): mp 115-125 °C; Rf = 0.33 (80% 
hexane, 20% Et2O); [α]D
23
 = –58.4 (c 1.0, CHCl3, e.r. 100:0); Chiralpak AD column, 1.0 
mL/min, 10% IPA in hexane, λ = 254 nm, tR = 22.0 min; (Found: C, 87.24; H, 5.64. C34H26O2 
requires C, 87.52; H, 5.62%); νmax(film)/cm-1 3519s (OH), 3056m, 3016m, 2921w (CH3), 
2866w (OCH3), 1907w, 1802w, 1621m (C=C aromatic), 1597m (C=C aromatic), 1514m 
(C=C aromatic), 1498m, 1436s, 1403s, 1384m, 1360m, 1335w, 1318m, 1292w, 1238s, 
1197w, 1170m, 1147m, 1128s, 1066m, 1022m, 996m, 973w, 951w, 933w, 899m, 879w, 
820s, 691m, 638w, 614m; δH(300 MHz) 2.45 (6H, s, ArCH3), 5.38 (2H, s, OH), 7.21-7.45 
(10H, stack, ArH), 7.65 (4H, d, J 7.7, ArH), 7.93 (2H, d, J 7.7, ArH), 8.03 (2H, s, ArH); δC(75 
MHz) 21.2 (CH3, ArCH3), 112.4 (quat. C, ipso Ar), 124.2 (CH, Ar), 124.3 (CH, Ar), 127.1 
(CH, Ar), 128.3 (CH, Ar), 129.2 (CH, Ar), 129.4 (CH, Ar), 130.6 (quat. C, ipso Ar), 131.1 
(CH, Ar), 132.8 (quat. C, ipso Ar), 134.5 (quat. C, ipso Ar), 137.5 (quat. C, 2 × ipso Ar), 
150.2 (quat. C, ipso Ar); m/z (TOF ES+) 489.2 ([M + Na]+, 100%); HRMS: C34H26O2Na 
calcd 489.1831 ([M + Na]+), obsd 489.1825. 
 
The same protocol was followed for the preparation of the (R)-enantiomer: [α]D
20
 = +55.8 (c 
1.0, CHCl3, e.r. 2:98); Chiralpak AD column, 1.0 mL/min, 10% IPA in hexane, λ = 254 nm, 

























Elemental Analysis: C, 68.44; H, 3.83; F, 21.65; O, 6.08
 
 
3,5-Bis(trifluoromethyl) iodobenzene (490 µL, 2.75 mmol) and Pd(PPh3)4 (63 mg, 0.055 
mmol) were added sequentially to a solution of bis-boronic acid (S)-113 (368 mg, 0.915 
mmol) and Na2CO3 (291 mg, 2.75 mmol) in degassed DME/EtOH/H2O (5.5:1.0:1.4, 7.9 mL). 
The mixture was heated under reflux for 24 h. After cooling to R.T., the solvents were 
removed under reduced pressure and the resulting solid was dissolved in CH2Cl2 (25 mL). 
Hydrochloric acid (1 M, 25 mL) was added and the layers were separated. The aqueous phase 
was extracted with CH2Cl2 (3 × 10 mL). The combined organic fractions were washed with 
H2O (30 mL) and brine (30 mL), and then dried (MgSO4). The drying agent was removed by 
filtration and the filtrate concentrated under reduced pressure to provide the crude product as 
a pale yellow oil. Purification by flash column chromatography (gradient: 100% hexane → 
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80% hexane, 20% toluene) afforded, in order of elution, bis-ether (S)-127 as a white fluffy 
solid (330 mg, 49%, 7:1 impurity of Ph3P=O): Rf = 0.35 (80% hexane, 20% toluene); [α]D was 
not determined; νmax(film)/cm-1 3061m, 3012m, 2941m, 2836w, 1955w, 1806w, 1621m (C=C 
aromatic), 1594m (C=C aromatic), 1496m, 1464m, 1444m, 1406m, 1378s, 1353w, 1327m, 
1279s, 1248m, 1174s br, 1134s br, 1108w, 1085m, 1048s, 1034w, 1018m, 998m, 960m, 
924m, 893s, 870w, 845s, 707s, 682s, 669m, 620m; δH(300 MHz) 3.21 (6H, s, OCH3), 7.27 
(2H, d, J 8.5, ArH), 7.31-7.55 (4H, stack, ArH and ArH from 12.5 mol% Ph3P=O), 7.94 (2H, 
s, ArH), 8.00 (2H, d, J 8.1, ArH), 8.07 (2H, s, ArH), 8.28 (4H, s, ArH); δC(75 MHz) 60.9 
(CH3, OCH3), 121.1 (CH, septet, 
3JC-F 4.0, Ar), 123.4 (quat. C, q, 
1JC-F 271.0, ArCF3), 125.7 
(CH, Ar), 125.8 (CH, Ar), 125.9 (quat. C, ipso Ar), 127.4 (CH, Ar), 128.4 (CH, Ar), 129.5-
129.8 (CH, m, Ar), 130.7 (quat. C, 2 × ipso Ar), 131.1 (CH, Ar), 131.8 (quat. C, q, 2JC-F 33.1, 
ipso Ar), 134.2 (quat. C, ipso Ar), 140.7 (quat. C, ipso Ar), 153.4 (quat. C, ipso Ar); δF(282 
MHz) –63.09 (s, ArCF3); m/z (TOF ES+) 760.9 ([M + Na]
+, 100%); HRMS: C38H22O2F12Na 
calcd 761.1326 ([M + Na]+), obsd 761.1335; and then mono-ether (S)-128 as a white foamy 
solid (50 mg, 10%): mp 145-148 °C; Rf = 0.15 (80% hexane, 20% toluene); [α]D was not 
determined; νmax(film)/cm-1 2937w, 2840w, 1622m (C=C aromatic), 1594m (C=C aromatic), 
1510m, 1463m, 1444w, 1432w, 1377s, 1355m, 1326m, 1279s, 1249m, 1181s br, 1139s br, 
1107w, 1090m, 1061m, 1038m, 1021m, 990w, 929w, 902m, 892m, 845m, 809m, 708m, 
682m; δH(300 MHz) 3.71 (3H, s, OCH3), 3.86 (3H, s, OCH3), 7.17-7.55 (7H, stack, ArH), 
7.88-8.10 (5H, stack, ArH), 8.30 (2H, s, ArH); δC(75 MHz) 56.5 (CH3, OCH3), 60.6 (CH3, 
OCH3), 113.4 (CH, Ar), 118.7 (quat. C, ipso Ar), 120.9 (CH, septet, 
3JC-F 4.0, Ar), 123.5 
(quat. C, q, 1JC-F 271.0, ArCF3), 123.7 (CH, Ar), 125.0 (CH, Ar), 125.5 (CH, Ar), 125.6 (CH, 
Ar), 126.3 (quat. C, ipso Ar), 126.8 (CH, Ar), 127.0 (CH, Ar), 128.1 (CH, Ar), 128.2 (CH, 
Ar), 129.1 (quat. C, ipso Ar), 129.3-129.7 (CH, m, Ar), 130.0 (CH, Ar), 130.4 (CH, Ar), 
130.7 (quat. C, ipso Ar), 131.5 (quat. C, q, 2JC-F 33.1, ipso Ar), 132.0 (quat. C, ipso Ar), 133.9 
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(quat. C, ipso Ar), 134.3 (quat. C, ipso Ar), 141.0 (quat. C, ipso Ar), 153.4 (quat. C, ipso Ar), 
154.8 (quat. C, ipso Ar); δF(282 MHz) –62.99 (s, ArCF3); m/z (TOF ES+) 549.0 ([M + Na]+, 
100%); HRMS: C30H20O2F6Na calcd 549.1265 ([M + Na]















Elemental Analysis: C, 60.86; H, 2.55; F, 32.09; O, 4.50
 
 
A solution of BBr3 in CH2Cl2 (1.0 M, 1.60 mL, 1.60 mmol) was added to a solution of bis-
ether (S)-127 (295 mg, 0.399 mmol) in CH2Cl2 (13 mL) at 0 °C and the mixture was warmed 
to R.T. overnight. H2O (5 mL) was slowly added over a period of 2 min at 0 °C and the 
mixture was poured into CH2Cl2/H2O (1:1, 30 mL). After stirring for 30 min, the layers were 
separated and the organic fraction was washed with brine (10 mL), and then dried (MgSO4). 
The drying agent was removed by filtration and the filtrate concentrated under reduced 
pressure to provide the crude product. Purification by flash column chromatography (gradient: 
100% hexane → 80% hexane, 20% toluene) afforded diol (S)-126 as a white fluffy solid (275 
mg, 97%): mp 212-215 °C; Rf = 0.20 (80% hexane, 20% toluene); [α]D
19




 = +45.3 (c 1.06, CHCl3); νmax(film)/cm-1 3534s (OH), 
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3064m, 1809w, 1621m (C=C aromatic), 1598m (C=C aromatic), 1503m (C=C aromatic), 
1473m, 1463m, 1427m, 1378s, 1359m, 1336m, 1279s, 1236m, 1174s br, 1135s br, 1036m, 
1022m, 990m, 954w, 936m, 896s, 872m, 845m, 705s, 682m; δH(300 MHz) 5.41 (2H, s, OH), 
7.26 (2H, d, J 7.4, ArH), 7.40-7.54 (4H, stack, ArH), 7.94 (2H, br s, ArH), 8.02 (2H, d, J 8.1, 
ArH), 8.14 (2H, br s, ArH), 8.27 (4H, br s, ArH); δC(75 MHz) 111.8 (quat. C, ipso Ar), 121.3 
(CH, septet, 3JC-F 4.0, Ar), 123.4 (quat. C, q, 
1JC-F 271.0, ArCF3), 124.0 (CH, Ar), 125.2 (CH, 
Ar), 127.7 (quat. C, ipso Ar), 128.7 (CH, Ar), 128.9 (CH, Ar), 129.5 (quat. C, ipso Ar), 129.7-
130.1 (CH, m, Ar), 131.6 (quat. C, q, 2JC-F 32.8, ipso Ar), 132.3 (CH, Ar), 133.2 (quat. C, ipso 
Ar), 139.5 (quat. C, ipso Ar), 149.9 (quat. C, ipso Ar); δF(282 MHz) –63.13 (s, ArCF3); m/z 























nBuLi (500 µL of a 2.5 M solution in hexane, 1.24 mmol) was added to a solution of 1-bromo-
2,4,6-triisopropylbenzene (310 µL, 1.22 mmol) in THF (0.8 mL) at –78 °C. After stirring for 
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20 min, a solution of ZnBr2 (320 mg, 1.42 mmol) in THF (1.4 mL) was added at –78 °C via 
cannula. The mixture was warmed to R.T. over 5 h, and then the solvent was removed under 
reduced pressure (~ 10 mmHg) and the colourless oil was dried under reduced pressure (~ 10 
mmHg) for 2 h. THF (4.2 mL), diiodo binaphthalenyl (R)-114 (300 mg, 0.530 mmol) and 
Pd(PtBu3)2 (2.7 mg, 5.3 µmol) were added, and the resulting mixture was heated at 60 °C 
overnight. After cooling to R.T., Et2O (15 mL) and hydrochloric acid (1 M, 10 mL) were 
added, and the layers were separated. The aqueous phase was extracted with Et2O (2 × 10 
mL). The combined organic fractions were washed with H2O (15 mL) and brine (15 mL), and 
then dried (MgSO4). The drying agent was removed by filtration and the filtrate concentrated 
under reduced pressure to provide the crude product which was redissolved in CH2Cl2 (15 
mL). A solution of BBr3 in CH2Cl2 (1.0 M, 2.65 mL, 2.65 mmol) was added at 0 °C and the 
mixture was warmed to R.T. overnight. H2O (5 mL) was added at 0 °C and the mixture was 
poured into CH2Cl2/H2O (1:1, 30 mL). After stirring for 30 min, the layers were separated and 
the organic fraction was washed with brine (10 mL), and then dried (MgSO4). The drying 
agent was removed by filtration and the filtrate concentrated under reduced pressure to 
provide the crude product. Purification by flash column chromatography (gradient: 90% 
hexane, 10% toluene → 70% hexane, 30% toluene) afforded diol (R)-129 as a white fluffy 
solid (194 mg, 53% over two steps): mp 128-131 °C; Rf = 0.23 (70% hexane, 30% toluene); 
[α]D
20
 = +71.8 (c 1.0, CHCl3) (lit.
[136] [α]D
27
 = +88.8 (c 3.03, THF); νmax(film)/cm-1 3522s 
(OH), 2961s, 2927w, 2869m, 1604m (C=C aromatic), 1497m (C=C aromatic), 1460s, 1423s, 
1383m, 1362m, 1318m, 1257m, 1171m, 1148m, 1016m, 1067m, 994w, 936m, 896m, 879m, 
855m, 692m; δH(300 MHz) 1.10 (6H, d, J 7.0, 2 × CH3 of iPr), 1.16 (6H, d, J 6.6, 2 × CH3 of 
iPr), 1.18 (6H, d, J 7.0, 2 × CH3 of 
iPr), 1.27 (6H, d, J 6.6, 2 × CH3 of 
iPr), 1.38 (12H, d, J7.0, 
4 × CH3 of 
iPr), 2.77 (2H, septet, J 6.7, CH(CH3)2), 2.92 (2H, septet, J 6.7, CH(CH3)2), 3.03 
(2H, septet, J 6.7, CH(CH3)2), 5.00 (2H, s, OH), 7.16-7.24 (4H, stack, ArH), 7.33-7.48 (6H, 
stack, ArH), 7.84 (2H, s, ArH), 7.93 (2H, d, J 7.7, ArH); δC(75 MHz) [23.7, 23.9, 24.0, 24.1, 
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24.29, 24.32 (CH3, 3 × CH(CH3)(CH3))], [30.8, 30.9, 34.3 (CH, CH(CH3)2)], 113.1 (quat. C, 
ipso Ar), 121.15 (CH, Ar), 121.21 (CH, Ar), 123.8 (CH, Ar), 124.5 (CH, Ar), 126.6 (CH, Ar), 
128.2 (CH, Ar), 129.0 (quat. C, ipso Ar), 129.1 (quat. C, ipso Ar), 130.4 (quat. C, ipso Ar), 
130.6 (CH, Ar), 133.4 (quat. C, ipso Ar), 147.7 (quat. C, ipso Ar), 147.8 (quat. C, ipso Ar), 
149.1 (quat. C, ipso Ar), 150.6 (quat. C, ipso Ar); m/z (TOF ES+) 713.5 ([M + Na]+, 100%); 
HRMS: C50H58O2Na calcd 713.4335 ([M + Na]
+), obsd 713.4343. 
 
Data were in agreement with those reported in the literature.[136] 
 
 






Elemental Analysis: C, 75.73; H, 4.99; B, 4.87; O, 14.41
 
 
nBuLi (2.50 mL of a 2.36 M solution in hexane, 5.83 mmol) was added to a solution of 9-
bromoanthracene (1.00 g, 3.89 mmol) in THF (32 mL) at –78 °C. The reaction mixture was 
stirred for 1 h, over which time, the pale brown solution turned orange. B(OMe)3 (650 µL, 
5.83 mmol) was added dropwise over 2 min, and the mixture was warmed to R.T. overnight. 
Hydrochloric acid (2 M, 30 mL) was added at 0 °C and the mixture was stirred at R.T. for 3 h. 
The layers were separated, and the THF was removed under reduced pressure. The resulting 
solid was dissolved in EtOAc (50 mL) and washed with NaHCO3 solution (30 mL) and brine 
(30mL), and then dried (MgSO4). The drying agent was removed by filtration and the filtrate 
concentrated under reduced pressure to provide the crude product 121 as a red-orange powder 
(900 mg, quantitative), which was used without further purification and characterisation. 
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General procedure for the formation of binaphthalenyl diols (R)-H8-122, (R)-130 and 
(R)-133-136[134] 
 
The diiodo binaphthalenyl starting material (3.53 mmol), the boronic acid (14.1 mmol) and 
Na2CO3 (3.03 g, 28.2 mmol) were dissolved in a mixture of degassed toluene/EtOH/H2  
(2:1:1, 58 mL). Pd(PPh3)4 (404 mg, 0.35 mmol) was added, and the mixture was heated under 
reflux for 24 h. After cooling to R.T., the solvents were removed under reduced pressure and 
the resulting solid was dissolved in CH2Cl2 (100 mL). Hydrochloric acid (1 M, 100 mL) was 
added and the layers were separated. The aqueous phase was extracted with CH2Cl2 (2 × 30 
mL). The combined organic fractions were washed with H2O (50 mL) and brine (50 mL), and 
then dried (MgSO4). The drying agent was removed by filtration and the filtrate concentrated 
under reduced pressure to provide the crude product, which was redissolved in CH2Cl2 (125 
mL). A solution of BBr3 in CH2Cl2 (1.0 M, 17.7 mL, 17.7 mmol) was added at 0 °C and the 
mixture was warmed to R.T. overnight. H2O (20 mL) was added at 0 °C and the mixture was 
poured into CH2Cl2/H2O (1:1, 200 mL). After stirring for 30 min, the layers were separated 
and the organic fraction was washed with brine (100 mL), and then dried (MgSO4). The 
drying agent was removed by filtration and the filtrate concentrated under reduced pressure to 

















Elemental Analysis: C, 90.26; H, 4.73; O, 5.01
 
 
Diol (R)-130 was prepared by Suzuki coupling of (R)-3,3’-diiodo-2,2’-dimethoxy-[1,1’]-
binaphthalenyl (R)-114 (400 mg, 0.707 mmol) with crude 9-anthracene boronic acid (628 mg, 
2.82 mmol), followed by demethylation with BBr3 in CH2Cl2 (1.0 M, 2.80 mL, 2.80 mmol) 
according to the general procedure. Purification by flash column chromatography (30% 
hexane, 70% toluene) afforded diol (R)-130 as a pale brown solid (420 mg, 93% over two 
steps): mp >330 °C; Rf = 0.20 (30% hexane, 70% toluene); [α]D
20
 = +193.2 (c 1.0, CHCl3); 
νmax(neat)/cm-1 3529s (OH), 3053w, 3009w, 2926w, 1624m (C=C aromatic), 1498m, 1441s, 
1401w, 1380w, 1355m, 1333w, 1247s, 1193s, 1148s, 1094m, 1014m, 947m, 931w, 890s, 
850s, 796m, 787m, 777w, 736s; δH(300 MHz) 5.09 (2H, s, OH), 7.22-7.31 (2H, m, ArH), 
7.37-7.72 (14H, stack, ArH), 7.83-7.97 (4H, stack, ArH), 8.00-8.14 (6H, stack, ArH), 8.58 
(2H, s, ArH); δC(75 MHz) 113.5 (quat. C, ipso Ar), 124.3 (CH, Ar), 124.8 (CH, Ar), 125.3 
(CH, 2 × Ar), 126.1 (CH, Ar), 126.15 (CH, 2 × Ar), 126.20 (CH, Ar), 127.1 (quat. C, ipso 
Ar), 127.4 (CH, Ar), 127.8 (CH, Ar), 128.47 (CH, Ar), 128.54 (CH, Ar), 128.7 (CH, Ar), 
129.3 (quat. C, ipso Ar), 130.7 (quat. C, ipso Ar), 130.76 (quat. C, ipso Ar), 130.83 (quat. C, 
ipso Ar), 131.4 (quat. C, ipso Ar), 131.5 (quat. C, ipso Ar), 133.0 (CH, Ar), 133.9 (quat. C, 
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ipso Ar), 151.0 (quat. C, ipso Ar); m/z (TOF ES–) 637.1 ([M – H]–, 100%); HRMS: C48H29O2 
calcd 636.2168 ([M – H]–), obsd 637.2160.  
 



























Diol (R)-134 was prepared by Suzuki coupling of (R)-3,3’-diiodo-2,2’-dimethoxy-[1,1’]-
binaphthalenyl (R)-114 (2.00 g, 3.53 mmol) with 10-bromoanthracene-9-boronic acid 120 
(4.25 g, 14.1 mmol) followed by deprotection with BBr3 in CH2Cl2 (1.0 M, 17.7 mL, 17.7 
mmol) according to the general procedure. Purification by flash column chromatography 
(gradient: 90% hexane, 10% toluene → 70% hexane, 30% toluene) afforded, in order of 
elution, diol (R)-134 as a yellow crystalline solid (2.65 g, 75% over two steps): mp 245-248 
°C; Rf = 0.25 (60% hexane, 40% toluene); [α]D
20
 = +116.0 (c 1.0, CHCl3); νmax(neat)/cm-1 
3526m (OH), 1622m (C=C aromatic), 1498m, 1438m, 1363w, 1345m, 1329m, 1256m, 1207s, 
1149m, 1093m, 1026m, 936m, 890s, 784m, 751s, 735s; δH(300 MHz) 5.08 (2H, s, OH), 7.24-
7.33 (2H, m, ArH), 7.43-7.72 (14H, stack, ArH), 7.83-7.98 (4H, stack, ArH), 8.02 (2H, s, 
ArH), 8.62 (2H, d, J 8.8, ArH), 8.67 (2H, d, J 8.8, ArH); δC(75 MHz) 113.2 (quat. C, ipso Ar), 
124.1 (quat. C, ipso Ar), 124.5 (CH, Ar), 124.7 (CH, Ar), 126.3 (CH, Ar), 126.4 (CH, Ar), 
126.57 (CH, Ar), 126.62 (CH, Ar), 126.8 (quat. C, ipso Ar), 127.12 (CH, Ar), 127.14 (CH, 
Ar), 127.7 (CH, Ar), 128.1 (CH, Ar), 128.2 (CH, Ar), 128.6 (CH, Ar), 129.2 (quat. C, ipso
Ar), 130.37 (quat. C, ipso Ar), 130.42 (quat. C, ipso Ar), 131.4 (quat. C, ipso Ar), 131.5 (quat. 
C, ipso Ar), 131.7 (quat. C, ipso Ar), 133.2 (CH, Ar), 133.9 (quat. C, ipso Ar), 150.9 (quat. C, 
ipso Ar); m/z (TOF ES–) 795.3 ([M – H]–, 100%); HRMS: C48H27O2
79Br81Br calcd 795.0357 
([M – H]–), obsd 795.0341; and then after increasing the polarity of the eluents (gradient: 70% 
hexane, 30% toluene → 40% hexane, 60% toluene) diol (R)-135 as a pale orange crystalline 
solid (481 mg, 19%): mp 245-247 °C; Rf = 0.15 (60% hexane, 40% toluene); [α]D
21
 = +159.6 
(c 1.05, CHCl3); νmax(neat)/cm-1 3521m (OH), 3050w, 1622w, 1496w, 1438m, 1381w, 
1347m, 1258m, 1207m, 1145m, 1093w, 1024w, 935w, 892s, 859m, 843m, 784m, 749s, 730s, 
681m; δH(300 MHz) 5.07 (1H, s, OH), 5.12 (1H, s, OH), 7.27-7.33 (2H, stack, ArH), 7.40-
7.75 (14H, stack, ArH), 7.84-8.15 (8H, stack, ArH), 8.58-8.72 (3H, stack, ArH); δC(75 MHz) 
112.9 (quat. C, ipso Ar), 113.8 (quat. C, ipso Ar), 123.9 (quat. C, ipso Ar), [124.4 (CH, Ar), 
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124.7 (CH, Ar), 124.9 (CH, Ar), 125.4 (CH, Ar), 125.9 (CH, Ar), 126.0 (CH, Ar), 126.2 (CH, 
Ar), 126.28 (CH, Ar), 126.33 (CH, Ar), 126.8 (CH, Ar), 127.1 (CH, Ar), 127.5 (CH, Ar), 
127.97 (CH, Ar), 128.04 (CH, Ar), 128.2 (CH, Ar), 128.49 (CH, Ar), 128.53 (CH, Ar), 128.6 
(CH, Ar), 128.7 (CH, Ar), resonance overlap], 129.2 (quat. C, ipso Ar), 129.3 (quat. C, ipso 
Ar), 130.2 (quat. C, ipso Ar), 130.37 (quat. C, ipso Ar), 130.42 (quat. C, ipso Ar), 130.8 (quat. 
C, ipso Ar), 130.9 (quat. C, ipso Ar), 131.4 (quat. C, ipso Ar), 131.5 (CH, Ar), 132.2 (quat. C, 
ipso Ar), 133.0 (CH, Ar), 133.3 (CH, Ar), 133.9 (quat. C, ipso Ar), 150.8 (quat. C, ipso Ar), 
151.1 (quat. C, ipso Ar), resonance overlap of 5 × (quat. C, ipso Ar); m/z (TOF ES–) 715.2 
([M – H]–, 100%); HRMS: C48H28O2













Elemental Analysis: C, 71.65; H, 4.51; Br, 19.86; O, 3.98
 
 
Diol (R)-H8-122 was prepared by Suzuki coupling of (R)-3,3’-diiodo-2,2’-dimethoxy-
5,6,7,8,5’,6’,7’,8’-octahydro-[1,1’]-binaphthalenyl (R)-H8-119 (500 mg, 0.871 mmol) with 
10-bromoanthracene-9-boronic acid 120 (1.05 g, 3.48 mmol) followed by deprotection with 
BBr3 in CH2Cl2 (1.0 M, 3.50 mL, 3.50 mmol). Purification by flash column chromatography 
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(60% hexane, 40% toluene) afforded diol (R)-H8-122 as a yellow solid (118 mg, 17% over 
two steps): mp 190-192 °C; Rf = 0.16 (60% hexane, 40% toluene); [α]D
20
 = –26.0 (c 1.0, 
CHCl3); νmax(neat)/cm-1 3525m (OH), 2926s (CH2), 2855w, 1720w br, 1608w (C=C 
aromatic), 1438s, 1346m, 1256s, 1217s, 1157s, 1088w, 1027m, 968w, 929m, 893s, 860w, 
788m, 756s; δH(300 MHz) 1.80-1.98 (8H, stack, CH2CH2CH2CH2), 2.54-2.88 (8H, stack, 
ArCH2), 4.59 (2H, s, OH), 7.07 (2H, s, ArH), 7.23-7.35 (2H, m, ArH), 7.45-7-73 (8H, stack, 
ArH), 7.83 (2H, d, J 8.8, ArH), 8.59 (2H, d, J 8.8, ArH), 8.64 (2H, d, J 8.8, ArH); δC(75 
MHz) 23.0 (CH2, CH2CH2CH2CH2), 23.2 (CH2, CH2CH2CH2CH2), 27.4 (CH2, ArCH2), 29.2 
(CH2, ArCH2), 120.6 (quat. C, ipso Ar), 122.0 (quat. C, ipso Ar), 123.4 (quat. C, ipso Ar), 
125.9 (CH, Ar), 126.1 (CH, Ar), 126.95 (CH, Ar), 126.97 (CH, 2 × Ar), 127.1 (CH, Ar), 
127.9 (CH, Ar), 128.1 (CH, Ar), 130.2 (quat. C, ipso Ar), 130.4 (quat. C, ipso Ar), 130.5 
(quat. C, ipso Ar), 131.3 (quat. C, ipso Ar), 131.4 (quat. C, ipso Ar), 132.8 (quat. C, ipso Ar), 
133.2 (CH, Ar), 137.5 (quat. C, ipso Ar), 149.2 (quat. C, ipso Ar); m/z (TOF ES+) 827 ([M + 
Na]+, 100%); HRMS: C48H36
79Br81BrO2Na calcd 827.0959 ([M + Na]
















Binaphthalenyl (R)-131 was prepared by Suzuki coupling of (R)-3,3’-diiodo-2,2’-dimethoxy-
[1,1’]-binaphthalenyl (R)-114 (720 mg, 1.27 mmol) with 10-bromoanthracene-9-boronic acid 
120 (1.53 g, 5.09 mmol) according to the general procedure. After work-up and removal of 
solvent, the residue was redissolved in toluene (50 mL) and passed through a silica plug 
(100% toluene). The solvent was removed under reduced pressure to afford a shiny yellow 
solid which was stirred in CH2Cl2 (10 mL) for 1 h. Filtration afforded binaphthalenyl (R)-131 
as a cream white solid (839 mg, 80%): mp 338-341 °C; [α]D
19
 = +182.4 (c 0.25, CHCl3); 
νmax(neat)/cm-1 3068w, 2933m, 2840w, 1907w, 1622w (C=C aromatic), 1493m, 1439m, 
1398m, 1347m, 1319m, 1256m, 1233s, 1146m, 1099s, 1028m, 1014s, 937m, 894s, 783m, 
757s, 729s; δH(300 MHz, C6D5CD3) 2.73 (6H, s, OCH3), 6.81-7.34 (12H, stack, ArH), 7.59-
7.68 (6H, stack, ArH), 7.77 (2H, d, J 8.8, ArH), 8.02 (2H, d, J 8.8 ArH), 8.62 (2H, d, J 8.8, 
ArH), 8.70 (2H, d, J 8.8, ArH); δC(75 MHz, CD2Cl2) 61.4 (CH3, OCH3), 123.7 (quat. C, ipso 
Ar), 126.0 (CH, Ar), 126.1 (quat. C, ipso Ar), 126.37 (CH, Ar), 126.43 (CH, Ar), 126.6 (CH, 
Ar), 127.5 (CH, Ar), 127.68 (CH, Ar), 127.72 (CH, Ar), 127.90 (CH, Ar), 127.93 (CH, Ar), 
128.4 (CH, Ar), 128.5 (CH, Ar), 128.9 (CH, Ar), 130.90 (quat. C, ipso Ar), 130.92 (quat. C, 
ipso Ar), 131.3 (quat. C, ipso Ar), 131.9 (quat. C, ipso Ar), 132.0 (quat. C, ipso Ar), 132.4 
(quat. C, ipso Ar), 133.5 (CH, Ar), 134.97 (quat. C, ipso Ar), 135.0 (quat.C, ipso Ar), 156.0 
(quat. C, ipso Ar); m/z (TOF ES+) 795.3 ([M + Na]+, 100%); HRMS: C50H32O2
79Br81BrNa 









4-Tolylboronic acid 132[139] 
 
B(OH)2 Chemical Formula: C7H9BO2
Exact Mass: 136.0696
Molecular Weight: 135.9562
Elemental Analysis: C, 61.84; H, 6.67; B, 7.95; O, 23.54  
 
nBuLi (7.0 mL of a 2.50 M solution in hexane, 17.5 mmol) was slowly added over a period of 
7 min to a solution of 4-bromotoluene (2.50 g, 14.6 mmol) in THF (25 mL) at –78 °C. After 
stirring for 20 min, a solution of B(OMe)3 (2.40 mL, 21.9 mmol) in THF (10 mL) was added. 
While warming up to R.T. overnight, the clear solution became a white suspension. The 
mixture was cooled to 0 °C, hydrochloric acid (2 M, 25 mL) was added, and the resulting 
solution was stirred vigorously at R.T for 3 h. The layers were separated and the solvent was 
removed under reduced pressure from the organic phase. The resulting white residue was 
redissolved in EtOAc (50 mL) and washed with NaHCO3 solution (30 mL) and brine (30 mL) 
and then dried (MgSO4). The drying agent was removed by filtration and the filtrate 
concentrated under reduced pressure to provide the crude product. The white solid was 
recrystallised from H2O to afford boronic acid 132 as a white powder (1.44 g, 72%): mp 248-
250 °C (lit.[214] mp 245-247 °C); δH(300 MHz) 2.45 (3H, s, ArCH3), 7.32 (2H, d, J 8.0, ArH), 
8.13 (2H, d, J 8.0, ArH); δC(75 MHz) 21.9 (CH3, ArCH3), 128.8 (CH, Ar), 135.7 (CH, Ar), 
142.9 (quat. C, ipso CCH3), (quat. C, ipso CB(OH)2) not observed because peak is very broad 
due to adjacent quadrupole boron nucleus (11B: I = 3/2) resulting in the resonance being lost 
in the noise. 
 












Elemental Analysis: C, 90.92; H, 5.17; O, 3.91
 
 
Diol (R)-133 was prepared using a modification of the previously reported Suzuki coupling 
used for similar coupling partners:[138] 
Dibromo binaphthalenyl (R)-131 (300 mg, 0.364 mmol), 4-tolylboronic acid 132 (198 mg, 
1.46 mmol), tri(3-tolyl)phosphine (17 mg, 0.055 mmol) and K2CO3 (96 mg, 0.691 mmol) 
were dissolved in a mixture of degassed toluene/DME/H2O (2:2:1, 7.5 mL). Pd(OAc)2 (4 mg, 
0.018 mmol) was added, and the mixture was heated under reflux for 24 h. After cooling to 
R.T., the solvents were removed under reduced pressure and the resulting solid was dissolved 
in CH2Cl2 (30 mL). Hydrochloric acid (1 M, 30 mL) was added and the layers were separated. 
The aqueous phase was extracted with CH2Cl2 (2 × 10 mL). The combined organic fractions 
were washed with H2O (25 mL) and brine (25 mL), and then dried (MgSO4). The drying 
agent was removed by filtration and the filtrate concentrated under reduced pressure to 
provide the crude product which was redissolved in CH2Cl2 (13 mL). A solution of BBr3 in 
CH2Cl2 (1.0 M, 1.5 mL, 1.5 mmol) was added at 0 °C and the mixture was warmed to R.T. 
overnight. H2O (5 mL) was added at 0 °C and the mixture was poured into CH2Cl2/ 2O (1:1, 
30 mL). After stirring for 30 min, the layers were separated and the organic fraction was 
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washed with brine (20 mL), and then dried (MgSO4). The drying agent was removed by 
filtration and the filtrate concentrated under reduced pressure to provide the crude diol 
product. Purification by flash column chromatography (60% hexane, 40% toluene) afforded 
diol (R)-133 as a yellow solid (286 mg, 96% over two steps): mp 270-272 °C; Rf = 0.31 (60% 
hexane, 40% toluene); [α]D
20
 = +45.6 (c 1.0, CHCl3); νmax(neat)/cm-1 3526m (OH), 3060w, 
3033w, 1623w (C=C aromatic), 1497m, 1439s, 1379s, 1209s, 1144m, 1023m, 944m, 908m, 
814s, 768s, 747s; δH(300 MHz) 2.55 (6H, s, ArCH3), 5.20 (2H, s, OH), 7.16-7.56 (20H, stack, 
ArH), 7.60-7.66 (2H, m, ArH), 7.69-7.82 (6H, stack, ArH), 7.88-7.99 (4H, stack, ArH), 8.08 
(2H, s, ArH); δC(75 MHz) 19.8 (CH3, ArCH3), 111.9 (quat. C, ipso Ar), 122.7 (CH, Ar), 123.3 
(CH, Ar), 123.5 (CH, 2 × Ar), 124.2 (CH, Ar), 124.3 (CH, Ar), 124.55 (CH, Ar), 124.62 (CH, 
Ar), 125.75 (CH, Ar), 125.79 (CH, Ar), 125.86 (CH, Ar), 125.91 (quat. C, ipso Ar), 126.9 
(CH, Ar), 127.49 (CH, Ar), 127.51 (CH, Ar), 127.8 (quat. C, ipso Ar), 128.57 (quat. C, ipso 
Ar), 128.63 (quat. C, ipso Ar), 128.88 (quat. C, ipso Ar), 128.94 (quat. C, ipso Ar), 128.98 
(quat. C, ipso Ar), 129.49 (CH, Ar), 129.53 (CH, Ar), 131.6 (CH, Ar), 132.3 (quat. C, ipso 
Ar), 134.1 (quat. C, ipso Ar), 135.6 (quat. C, ipso Ar), 136.9 (quat. C, ipso Ar), 149.5 (quat. 
C, ipso Ar); m/z (TOF ES+) 841.3 ([M + Na]+, 100%); HRMS: C62H42O2Na calcd 841.3083 
([M + Na]+), obsd 841.3087. 
 
 
General procedure for the formation of chiral N-triflyl phosphoramides 45[87] 
 
NEt3 (1.85 mL, 13.3 mmol), POCl3 (210 µL, 2.27 mmol) and DMAP (463 mg, 3.79 mmol) 
were added to a solution of the diol (1.90 mmol) in CH2 l2 (9.5 mL) at 0 °C. After stirring for 
2 h at R.T., EtCN (9.5 mL) and TfNH2 (565 mg, 3.79 mmol) were added and the mixture was 
heated under reflux for 15 h. After cooling to R.T., the reaction was quenched with H2O (5 
mL). Et2O (40 mL) and hydrochloric acid (4 M, 30 mL) were added, and the layers were 
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separated. The aqueous phase was extracted with Et2O (2 × 20 mL), and the combined 
organic fractions were dried (MgSO4). The drying agent was removed by filtration and the 
filtrate concentrated under reduced pressure. Purifiation of the crude product by flash column 
chromatography afforded the phosphoramide which may be a salt. The product was extracted 
with Et2O (40 mL) and hydrochloric acid (4 M, 2 × 25 mL), and then dried (MgSO4). The 
drying agent was removed by filtration and the filtrate concentrated under reduced pressure to 
provide the desired phosphoramide.   
 
 












Elemental Analysis: C, 51.11; H, 5.51; F, 11.55; N, 2.84; O, 16.21; 
P, 6.28; S, 6.50
 
 
Phosphoramide 162 was prepared from 4-sec-butylphenol (360 mg, 2.40 mmol) according to 
the general procedure. Purification by flash column chromatography (gradient: 60% CH2Cl2, 
40% EtOAc → 40% CH2Cl2, 60% EtOAc) afforded phosphoramide 162 as a yellow wax 
which changes its colour to purple after the HCl-wash (285 mg, 48%): Rf = 0.18 (50% 
CH2Cl2, 50% EtOAc); νmax(film)/cm-1 2962m, 2925m, 2876w, 1504m (C=C aromatic), 
1434m, 1378m, 1272m, 1187s, 1162s, 1139s, 1095m, 935s, 835m; δH(300 MHz) 0.79 (6H, t, 
J 7.4, CH2CH3), 1.19 (6H, d, J 6.9, CHCH3), 1.46-1.63 (4H, stack, CH2), 2.57 (2H, app. 
sextet, J 7.1, CH), 7.04-7.20 (8H, stack, ArH); δC(75 MHz) 12.1 (CH3, CH3), 21.7 (CH3, 
CH3), 31.1 (CH2, CH2), 41.0 (CH, ArCH), 119.1 (quat. C, q, 
1JC-F 319.3, S(O)2CF3), 119.8 
(CH, Ar), 128.4 (CH, Ar), 145.7 (quat. C, ipso Ar), 147.6 (quat. C, d, JC-P 7.5, ipso Ar); 
 260 
δP(121 MHz) –14.95 (s, P(O)NH); δF(282 MHz) –77.34 (s, CF3); m/z (TOF ES–) 492.0 ([M – 
H]–, 100%); HRMS: C21H26NO5F3PS calcd 492.1221 ([M – H]
–), obsd 492.1223. 
 
 
(R)- and (S)-[3,3’-Bis(4-methylphenyl)-1,1’-binaphthalen-2,2’-yl]-N-triflyl phosphor-





















Elemental Analysis: C, 63.73; H, 3.82; F, 8.64; N, 2.12; O, 12.13; P, 4.70; S, 4.86  
 
Phosphoramide (S)-45d was prepared from diol (S)-125 (280 mg, 0.600 mmol) according to 
the general procedure. Purification by flash column chromatography (10% EtOAc, 10% 
toluene, 80% CH2Cl2) afforded phosphoramide (S)-45d  as a white solid (351 mg, 89%): mp 
257-260 °C; Rf = 0.28 (20% EtOAc, 80% CH2Cl2); [α]D
20
 = +366 (c 1.0, CHCl3); 
νmax(film)/cm-1 2924w (CH3), 1614w (C=C aromatic), 1516m (C=C aromatic), 1497w, 
1423m, 1290s, 1191s, 1150s, 1097m, 1078w, 1023w, 996m, 974s, 898s, 845m, 820s, 610m; 
δH(300 MHz) 2.29 (6H, s, ArCH3), 6.43 (1H, br s, NH), 7.00-7.14 (3H, stack, ArH), 7.20-7.48 
(8H, stack, ArH), 7.51-7.62 (3H, stack, ArH), 7.87-8.01 (3H, stack, ArH), 8.09 (1H, s, ArH); 
δC(75 MHz) 20.96 (CH3, ArCH3), 21.01 (CH3, ArCH3), 118.7 (quat. C, q, 1JC-F 317.9, 
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S(O)2CF3), 122.06 (quat. C, d, JC-P 2.9, ipso Ar), 122.17 (quat. C, d, JC-P 2.9, ipso Ar), 126.1 
(CH, Ar), 126.4 (CH, Ar), 126.5 (CH, Ar), 126.65 (CH, Ar), 126.68 (CH, Ar), 127.1 (CH, 
Ar), 128.3 (CH, Ar), 128.4 (CH, Ar), 128.8 (CH, 2 × Ar), 129.3 (CH, 2 × Ar), 129.6 (CH, 2 × 
Ar), 129.9 (CH, 2 × Ar), 131.4 (CH, Ar), 131.65 (CH, Ar), 131.66 (quat. C, d, JC-P 5.1, ipso 
Ar), 131.9 (quat. C, d, JC-P 4.4, ipso Ar), 133.01 (quat. C, ipso Ar), 133.03 (quat. C, ipso Ar), 
133.5 (quat. C, d, JC-P 3.1, ipso Ar), 133.8 (quat. C, d, JC-P 2.6, ipso Ar), 137.7 (quat. C, 2 × 
ipso Ar), 137.9 (quat. C, 2 × ipso Ar), 142.9 (quat. C, d, JC-P 9.4, ipso Ar), 143.6 (quat. C, d, 
JC-P 11.4, ipso Ar); δP(121 MHz) –1.74 (s, P(O)NH); δF(282 MHz) –78.97 (s, S(O)2CF3); m/z 
(TOF ES+) 682.0 ([M + Na]+, 100%); HRMS: C35H25NO5F3PSNa calcd 682.1041 ([M + 
Na]+), obsd 682.1058. 
 
The same protocol was followed for the preparation of the (R)-enantiomer: [α]D
20





















Elemental Analysis: C, 49.18; H, 1.90; F, 31.54; N, 1.55; O, 8.85;




Phosphoramide (S)-45e was prepared from diol (S)-26 (460 mg, 0.647 mmol) according to the 
general procedure. Purification by flash column chromatography (gradient: 100% CH2Cl2 → 
90% CH2Cl2, 10% EtOAc) afforded phosphoramide (S)-45e as a pale purple solid (532 mg, 
91%): mp 174-177 °C; Rf = 0.10 (2% EtOAc, 98% CH2Cl2); [α]D
19
 = +225 (c 0.5, CHCl3); 
νmax(film)/cm-1 3385m br (NH), 1693w (C=C aromatic), 1621w, 1503m (C=C aromatic), 
1475w, 1380m, 1280s, 1141s, 1082m, 991m, 965m, 925m, 889m, 874w, 845m, 705w, 696w, 
681m, 669s; δH(300 MHz) 6.01 (1H, br s, NH), 7.33-7.72 (7H, stack, ArH), 7.88 (1H, br s, 
ArH), 8.00-8.16 (8H, stack, ArH); δC(75 MHz) 118.4 (quat. C, dq, 1JC-F 317.9, 3JC-P 2.0, 
S(O)2CF3), 121.6-121.8 (CH, m, Ar), 121.9-122.2 (CH, m, Ar), 122.5 (quat. C, d, JC-P 2.6, 
ipso Ar), 122.7 (quat. C, d, JC-P 2.3, ipso Ar), 123.08 (quat. C, q, 
1JC-F 271.3, 2 × ArCF3), 
123.10 (quat. C, q, 1JC-F 271.3, 2 × ArCF3), 126.9 (CH, Ar), 127.1 (CH, 2 × Ar), 127.4 (CH, 
Ar), 127.97 (CH, Ar), 128.03 (CH, Ar), 128.8 (CH, Ar), 128.9 (CH, Ar), 129.7 (CH, stack, 2 
×Ar), 130.1 (CH, stack, 2 × Ar), 130.5 (quat. C, d, JC-P 3.4, ipso Ar), 130.9 (quat. C, d, JC-P 
2.6, ipso Ar), 131.7-131.9 (quat. C, m, ipso Ar), 131.80 (quat. C, q, 2JC-F 33.4, 2 × ipso Ar), 
131.9 (quat. C, q, 2JC-F 33.4, 2 × ipso Ar), 132.2-132.4 (quat. C, m, ipso Ar), 132.5 (CH, Ar), 
132.7 (CH, Ar), 137.75 (quat. C, 2 × ipso Ar), 137.83 (quat. C, 2 × ipso Ar), 141.6 (quat. C, 
ipso Ar), 141.7 (quat. C, ipso Ar), 142.7 (quat. C, ipso Ar), 142.9 (quat. C, ipso Ar); δP(121 
MHz) –4.13 (s, P(O)NH); δF(282 MHz) –63.26 (s, 2 × ArCF3), –63.566 (s, ArCF3), –63.570 
(s, ArCF3), –78.74 (s, S(O)2CF3); m/z (TOF ES–) 902.2 ([M – H]
–, 100%); HRMS: 
C37H16NO5F15PS calcd 902.0247 ([M – H]

























Elemental Analysis: C, 69.29; H, 6.50; F, 6.45; N, 1.58; O, 9.05; 
P, 3.50; S, 3.63
 
 
Phosphoramide (R)-45a  was prepared from diol (R)-129 (334 mg, 0.483 mmol) according to 
the general procedure. Purification by flash column chromatography (gradient: 100% CH2Cl2
→ 90% CH2Cl2, 10% EtOAc) afforded phosphoramide (R)-45a as a pale brown solid (355 
mg, 83%): mp 158-161 °C; Rf = 0.20 (5% EtOAc, 95% CH2Cl2); [α]D
21




 = +29.9 (c 0.42, CH2Cl2); νmax(film)/cm-1 3424m br (NH), 2962s 
(CH3), 2870w, 1606m (C=C aromatic), 1567w (C=C aromatic), 1496w, 1462m, 1412w, 
1384w, 1363m, 1315m, 1195s, 1149m, 1116m, 998m, 976m, 940w, 901m, 878w, 856w, 
805w, 666m, 598w; δH(300 MHz) 0.95 (3H, d, J 7.0, 1 × CH3 of iPr), 1.01 (3H, d, J 7.0, 1 × 
CH3 of 
iPr), 1.06-1.33 (30H, stack, 10 × CH3 of 
iPr), 2.47-2.67 (2H, stack, CH(CH3)2), 2.68-
2.84 (2H, stack, CH(CH3)2), 2.85-3.02 (2H, stack, CH(CH3)2), 4.85 (1H, br s, NH), 7.05 (1H, 
br s, ArH), 7.10-7.19 (3H, stack, ArH), 7.26-7.42 (4H, stack, ArH), 7.52-7.62 (2H, stack 
ArH), 7.92-7.83 (4H, stack, ArH); δC(75 MHz) 22.76 (CH3, CH3 of iPr), 22.85 (CH3, CH3 of 
iPr), 22.91 (CH3, CH3 of 
iPr), 23.0 (CH3, CH3 of 
iPr), 23.87 (CH3, CH3 of 
iPr), 23.94 (CH3, 
CH3 of 
iPr), 24.0 (CH3, CH3 of 
iPr), 24.1 (CH3, CH3 of 
iPr), 25.1 (CH3, CH3 of 
iPr), 25.5 
(CH3, CH3 of 
iPr), 26.8 (CH3, CH3 of 
iPr), 26.9 (CH3, CH3 of 
iPr), 30.4 (CH, CH(CH3)2), 31.1 
(CH, 2 × CH(CH3)2), 31.5 (CH, CH(CH3)2), 34.4 (CH, CH(CH3)2), 34.5 (CH, CH(CH3)2), 
118.7 (quat. C, q, 1JC-F 320.4, S(O)2CF3), 120.3 (CH, Ar), 121.0 (quat. C, d, JC-P 1.7, ipso Ar), 
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121.3 (CH, Ar), 121.4 (CH, Ar), 121.7 (quat. C, d, JC-P 2.6, ipso Ar), 121.8 (CH, Ar), 126.4 
(CH, Ar), 126.5 (CH, Ar), 126.7 (CH, Ar), 126.8 (CH, Ar), 127.3 (CH, 2 × Ar), 128.4 (CH, 2 
× Ar), 129.7 (quat. C, ipso Ar), 130.0 (quat.C, ipso Ar), 130.3 (quat. C, d, JC-P 4.3, ipso Ar), 
131.2 (quat. C, d, JC-P 0.9, ipso Ar), 131.6 (quat. C, d, JC-P 1.1, ipso Ar), 132.08 (quat. C, d, 
JC-P 0.8, ipso Ar), 132.1 (quat. C, d, JC-P 1.7, ipso Ar), 132.5 (quat. C, d, JC-P 2.9, ipso Ar), 
132.9 (CH, Ar), 133.2 (CH, Ar), 144.6 (quat. C, JC-P 8.9, ipso Ar), 145.4 (quat. C, JC-P 11.1, 
ipso Ar), 146.2 (quat. C, ipso Ar), 146.9 (quat. C, ipso Ar), 147.7 (quat. C, ipso Ar), 148.0 
(quat. C, ipso Ar), 149.0 (quat. C, ipso Ar), 149.8 (quat. C, ipso Ar); δP(121 MHz) –3.79 (s, 
P(O)NH); δF(282 MHz) –77.40 (s, CF3); m/z (TOF ES–) 882.1 ([M – H]–, 100%); HRMS: 
C51H56NO5F3PS calcd 882.3569 ([M – H]
–), obsd 882.3564. 
 
Data were in agreement with those reported in the literature.[87] 
 
 
(R)-[3,3’-Bis(anthracen-9’’-yl)-[1,1’]-binaphthalen-2,2’-yl]- N-triflyl phosphoramide (R)-












Elemental Analysis: C, 70.75; H, 3.51; F, 6.85; N, 1.68; O, 9.62; 




Phosphoramide (R)-45f was prepared from diol (R)-130 (330 mg, 0.517 mmol) according to 
the general procedure. Purification by flash column chromatography (gradient: 100% CH2Cl2
→ 90% CH2Cl2, 10% EtOAc) afforded phosphoramide (R)-45f as its ether solvate 45f·0.55 
Et2O as a brown solid (340 mg, 75%): mp 250-253 °C °C; Rf = 0.11 (100% Et2O); [α]D
20
 = 
+9.6 (c 0.83, CHCl3); νmax(neat)/cm-1 3308w, 3053w, 2933w, 2832w, 1594w, 1497w, 1445w, 
1402w, 1380w, 1329m, 1308m, 1296m, 1262w, 1226m, 1194m, 1151s, 1135m, 1123m, 
1098s, 1024w, 953w, 883s, 839m, 818m, 788m, 775w, 751m, 727s, 706w, 677m, 655w; 
δH(300 MHz, C6D6) 0.64 (0.55 × 6H, t, J 6.8, O(CH2CH3)2), 2.88 (0.55 × 4H, q, J 6.8, 
O(CH2CH3)2), 6.80-8.06 (26H, stack, ArH), 8.17 (1H, s, ArH), 8.23 (1H, s, ArH), NH was not 
observed; δC(100 MHz, C6D6) 14.5 (CH3, O(CH2CH3)2), 66.1 (CH2, O(CH2CH3)2), 122.3 
(quat. C, ipso Ar), 122.8 (quat. C, ipso Ar), 125.1-129.1 (stack, CH, Ar, resonance overlap), 
130.6-133.1 (stack, quat. C, S(O)2CF3 and ipso Ar, resonance overlap), 134.8 (CH, Ar), 135.2 
(CH, Ar), 146.3 (quat. C, ipso Ar), 146.9 (quat. C, ipso Ar); δP(121 MHz) –3.36 (s, P(O)NH); 
δF(282 MHz) –78.58 (s, CF3); m/z (TOF ES–) 830 ([M – H]–, 100%); HRMS: 
C49H28NO5F3PS calcd 830.1378 ([M – H]

















Elemental Analysis: C, 59.47; H, 2.75; Br, 16.15; F, 5.76; N, 1.42; 
O, 8.08; P, 3.13; S, 3.24
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Phosphoramide (R)-45g was prepared from diol (R)-134 (1.52 g, 1.91 mmol) according to the 
general procedure. Purification by flash column chromatography (gradient: 100% CH2Cl2 → 
85% CH2Cl2, 15% EtOAc) afforded phosphoramide (R)-45g as its ether solvate 45g·1.79 Et2O 
as a pale brown solid (1.49 g, 70%): mp 245-250 °C (dec.); Rf = 0.25 (100% Et2O); [α]D
21
 = 
+16.2 (c 1.06, CHCl3); νmax(neat)/cm-1 3074w, 2926w, 1622w, 1497w, 1441m, 1347w, 
1259w, 1195s, 1148w, 1086s, 1029m, 952s, 906s, 881m, 802w, 751s, 713w; δH( 00 MHz) 
0.87 (1.79 × 6H, t, J 7.1, O(CH2CH3)2), 3.25 (1.79 × 4H, t, J 7.1, O(CH2CH3)2), 7.08-7.76 
(18H, stack, NH and ArH), 7.89 (1H, d, J 8.7, ArH), 8.01-8.09 (2H, stack, ArH), 8.11-8.17 
(2H, stack, ArH), 8.43 (1H, d, J 8.7, ArH), 8.53-8.63 (3H, stack, ArH), NH not observed; 
δC(100 MHz) 14.4 (CH3, O(CH2CH3)2), 66.0 (CH2, O(CH2CH3)2), 118.4 (quat. C, q, 1JC-F 
319.7, S(O)2CF3), 121.9 (quat. C, ipso Ar), 122.3 (quat. C, ipso Ar), 124.0 (quat. C, ipso Ar), 
124.2 (quat. C, ipso Ar), 125.2 (CH, Ar), 126.3 (CH, Ar), 126.36 (CH, Ar), 126.38 (CH, Ar), 
126.5 (CH, Ar), [126.6, 126.7 (CH, Ar), resonance overlap], 126.9 (CH, Ar), 127.0 (CH, Ar), 
[127.5, 127.57, 127.62, 127.7 (CH, Ar), resonance overlap], 127.9 (CH, Ar), 128.1 (CH, Ar), 
128.7 (CH, Ar), 128.8 (CH, Ar), 129.8 (quat. C, 2 × ipso Ar), 130.0 (quat. C, ipso Ar), 130.2 
(quat. C, 3 × ipso Ar), 130.5 (quat. C, ipso Ar), 130.9 (quat. C, ipso Ar), 131.08 (quat. C, ipso 
Ar), 131.14 (quat. C, ipso Ar), 131.5 (quat. C, ipso Ar), 131.6 (quat. C, ipso Ar), 131.66 (quat. 
C, ipso Ar), 131.74 (quat. C, ipso Ar), 132.7 (quat. C, 2 × ipso Ar), 134.4 (CH, Ar), 134.6 
(CH, Ar), 145.3 (quat. C, d JC-P 9.8, ipso Ar), 145.8 (quat. C, d, JC-P 10.5, ipso Ar); δP(121 
MHz) –2.21 (s, P(O)NH); δF(282 MHz) –79.24 (s, CF3); m/z (TOF ES–) 988.3 ([M – H]–, 
100%); HRMS: C49H26NO5F3PS



















Elemental Analysis: C, 74.77; H, 4.08; F, 5.63; N, 1.38; O, 7.90;
P, 3.06; S, 3.17
 
 
Phosphoramide (R)-45h was prepared from diol (R)-133 (265 mg, 0.324 mmol) according to 
the general procedure. Purification by flash column chromatography (gradient: 100% CH2Cl2
→ 80% CH2Cl2, 20% EtOAc) afforded phosphoramide (R)-45h as a brown glittery solid (207 
mg, 63%): mp 273-278 °C (dec.); Rf = 0.18 (20% hexane, 80% Et2O); [α]D
21
 = –5.6 (c 1.00, 
CHCl3); νmax(neat)/cm-1 3065w, 2922w, 2867w, 1515w, 1441m, 1382m, 1321m br, 1196s, 
1150w, 1135w, 1100m, 1030m, 956m, 902s, 815s, 767s, 751w, 727s; δH(300 MHz) 2.55 (6H, 
s, CH3), 7.13-7.88 (30H, stack, ArH), 8.09 (1H, d, J 9.5 ArH), 8.12 (1H, d, J 9.2, ArH), 8.26 
(1H, s, ArH), 8.31 (1H, s, ArH); δC(75 MHz) 21.4 (CH3, 2 × ArCH3), 118.3 (quat. C, q, 1JC-F 
320.1, 3JC-P 1.4, S(O)2CF3), 121.9 (quat. C, d, JC-P 1.7, ipso Ar), 122.3 (quat. C, d, JC-P 2.6, 
ipso Ar), 124.6 (CH, Ar), 124.76 (CH, Ar), 124.78 (CH, Ar), 125.0 (CH, Ar), 125.1 (CH, Ar), 
125.2 (CH, Ar), 125.6 (CH, Ar), 125.7 (CH, Ar), 125.97 (CH, Ar), 126.03 (CH, Ar), 126.7 
(CH, 2 × Ar), 127.1-127.5 (CH, stack, 8 × Ar), 127.6 (CH, Ar), 127.8 (CH, Ar), 128.6 (CH, 
Ar), 128.76 (CH, Ar), 128.84 (CH, Ar), 128.9 (CH, Ar), 129.13 (CH, Ar), 129.15 (CH, Ar), 
129.57 (quat. C, ipso Ar), 129.59 (quat. C, ipso Ar), 129.7 (quat. C, ipso Ar), 129.8 (quat. C, 
ipso Ar), 128.98 (quat. C, ipso Ar), 130.04 (quat. C, ipso Ar), 130.06 (quat. C, ipso Ar), 
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130.09 (quat. C, ipso Ar), 130.1 (quat. C, ipso Ar), 130.17 (quat. C, ipso Ar), 130.22 (quat. C, 
ipso Ar), 130.5 (quat. C, ipso Ar), 130.8 (CH, Ar), 130.9 (CH, Ar), 131.2 (CH, 2 × Ar), 131.7 
(quat. C, d, JC-P 0.9, ipso Ar), 132.0 (quat. C, d, JC-P 1.1, ipso Ar), 132.5 (quat. C, d, JC-P 1.4, 
ipso Ar), 132.7 (quat. C, d, JC-P 0.6, ipso Ar), 134.5 (CH, 2 × Ar), 135.5 (quat. C, ipso Ar), 
136.0 (quat. C, ipso Ar), 136.9 (quat. C, ipso Ar), 137.1 (quat. C, ipso Ar), 138.5 (quat. C, 
ipso Ar), 138.9 (quat. C, ipso Ar), 145.3 (quat. C, d JC-P 9.1, ipso Ar), 146.1 (quat. C, d, JC-P 
11.4, ipso Ar); δP(121 MHz) –3.68 (s, P(O)NH); δF(282 MHz) –78.72 (s, CF3); m/z (TOF 




















Elemental Analysis: C, 58.99; H, 3.54; Br, 16.02; F, 5.71; N, 1.40; 
O, 8.02; P, 3.10; S, 3.21
 
 
Phosphoramide (R)-H8-45j was prepared from diol (R)-H8-122 (118 mg, 0.147 mmol) 
according to the general procedure. Purification by flash column chromatography (gradient: 
90% CH2Cl2, 10% EtOAc → 70% CH2Cl2, 30% EtOAc) afforded phosphoramide (R)-H8-45j 
as its ether solvate 45j·0.49 Et2O as brown solid (106 mg, 70%): mp 195-198 °C; Rf = 0.09 
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(95% CH2Cl2, 5% EtOAc); [α]D
21
 = –128.9 (c 0.76, CHCl3); νmax(neat)/cm-1 2925m, 2852m, 
1699m, 1605w, 1523w, 1440m, 1407w, 1296m, 1259m, 1193s, 1134m, 1089m, 1029m, 941s, 
906s, 885s, 860m, 785m, 755s, 726m, 682m, 662w; δH(300 MHz) 1.25 (0.49 × 6H, t, J 7.1, 
O(CH2CH3)2), 1.95-2.07 (8H, stack, CH2CH2CH2CH2), 2.59-3.12 (8H, stack, ArCH2), 4.09 
(0.49 × 4H, q, J 7.1, O(CH2CH3)2), 7.26-7.65 (10H, stack, ArH), 7.77 (1H, d, J 8.9, ArH), 
7.86 (1H, d, J 8.5, ArH), 8.21 (2H, br s, ArH), 8.49 (1H, d, J 8.9, ArH), 8.58 (3H, app. d, J
8.7, ArH), NH not observed; δC(100 MHz) not recorded; δP(121 MHz, C6D6) –3.88 (s, 
P(O)NH); δF(282 MHz, C6D6) –78.97 (s, CF3); m/z (TOF ES–) 996.0 ([M – H]–, 100%); 
HRMS: C49H34NO5F3PS


















Elemental Analysis: C, 59.63; H, 2.50; Br, 14.69; F, 8.73; N, 1.29; 
O, 7.36; P, 2.85; S, 2.95
 
Phosphoramide (R)-107 was prepared from diol (R)-134 (150 mg, 0.188 mmol) using a 
modification of the general procedure: C6F5SO2NH2 (93 mg, 0.377 mmol) was added instead 
of TfNH2. Purification by flash column chromatography (gradient: 100% CH2Cl2 → 90% 
CH2Cl2, 10% EtOAc) afforded phosphoramide (R)-107 as a yellow-brown crystalline solid 
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(160 mg, 78%): mp 255-260 °C (dec.); Rf = 0.23 (90% CH2Cl2, 10% EtOAc); [α]D
20
 = +14.4 
(c 1.00, CHCl3); νmax(neat)/cm-1 3068w, 1644w, 1520m, 1498s, 1441m, 1402m, 1346m, 
1302m, 1259w, 1227m, 1206w, 1179m, 1147m, 1099m, 1029m, 991m, 976m, 954m, 936m, 
906s, 889s, 807w, 785w, 775w, 752s, 713m, 681m; δH(300 MHz) 4.57 (1H, br s, NH), 7.12-
7.80 (17H, stack, ArH), 7.87 (1H, d, J 8.7, ArH), 7.97-8.13 (3H, stack, ArH), 8.20 (1H, s, 
ArH), 8.51 (1H, d, J 8.7, ArH), 8.58-8.73 (3H, stack, ArH); δC(100 MHz) 121.8 (quat. C, ipso 
Ar), 122.4 (quat. C, ipso Ar), 124.0 (quat. C, ipso Ar), 124.8 (quat. C, ipso Ar), [125.3 (CH, 
Ar), 125.6 (CH, Ar), 125.8 (CH, Ar), 125.9 (CH, Ar), 126.4 (CH, Ar), 126.5 (CH, Ar), 126.7 
(CH, Ar), 126.75-127.15 (CH, stack, Ar), 127.3 (CH, Ar), 127.6 (CH, Ar), 128.1 (CH, Ar), 
128.2 (CH, Ar), 128.7 (CH, Ar), resonance overlap], 129.4 (quat. C, ipso Ar), 129.5 (quat.C, 
ipso Ar), 130.2 (quat. C, 2 × ipso Ar), 130.3 (quat. C, 2 × ipso Ar), 130.5 (quat. C, ipso Ar), 
130.6 (quat. C, ipso Ar), 130.8 (quat. C, ipso Ar), 131.0 (quat. C, ipso Ar), 131.3 (quat. C, 
ipso Ar), 131.6 (quat. C, 2 × ipso Ar), 131.9 (quat. C, ipso Ar), 132.5 (quat. C, ipso Ar), 132.7 
(quat. C, ipso Ar), 134.3 (CH, Ar), 134.4 (CH, Ar), 135.4 (quat. C, app. br s, ipso ArCF), 
137.9 (quat. C, app. br s, ipso ArCF), 142.3 (quat. C, app. br s, ipso ArCF), 144.3 (quat. C, d 
JC-P 8.3, ipso Ar), 144.9 (quat. C, app. br s, ipso ArCF), 145.7 (quat. C, d, JC-P 11.8, ipso Ar); 
δP(121 MHz) –6.46 (s, P(O)NH); δF(282 MHz) –159.1- –158.4 (m, 2 × ArF), –143.2- –142.8 
(m, ArF), –136.9- –136.4 (m, 2 × ArF); m/z (TOF ES–) 1086.1 ([M – H]–, 100%); HRMS: 
C54H26NO5F5PS
























Elemental Analysis: C, 58.52; H, 2.71; Br, 15.89; F, 5.67; N, 1.39; 
O, 6.36; P, 3.08; S, 6.38
 
Thiophosphoramide (R)-108 was prepared from diol (R)-134 (188 mg, 0.236 mmol) using a 
modification of the general procedure: PSCl3 (30 µL, 0.283 mmol) was added instead of 
POCl3. Purification by flash column chromatography (gradient: 100% CH2Cl2 → 90% 
CH2Cl2, 10% EtOAc) afforded thiophosphoramide (R)-108 as its ether solvate 108·0.70 Et2O 
as a brown-orange solid (116 mg, 46%): mp 247-252 °C; Rf = 0.20 (100% Et2O); [α]D
20
 = 
+25.1 (c 0.91, CHCl3); νmax(neat)/cm-1 3076w, 1440w, 1424w, 1311w, 1200s, 1133m, 1100w, 
1081w, 955m, 931w, 907s, 882s, 866s, 805w, 752s, 720w, 710w, 675w, 652w; δH(300 MHz) 
0.98 (0.70 × 6H, t, J 7.0, O(CH2CH3)2), 3.27 (0.70 × 4H, q, J 7.0, O(CH2CH3)2), 5.72 (1H, br 
s, P(S)NH), 7.27-7.78 (16H, stack, ArH), 7.94-8.27 (6H, stack, ArH), 8.54-8.73 (4H, stack, 
ArH); δC(100 MHz) 14.7 (CH3, O(CH2CH3)2), 65.5 (CH2, O(CH2CH3)2), 118.0 (quat. C, q, 
1JC-F 321.3, S(O)2CF3), 122.4 (quat. C, ipso Ar), 123.0 (quat. C, ipso Ar), 124.2 (quat. C, ipso 
Ar), 124.8 (quat. C, ipso Ar), 125.2 (CH, Ar), 126.0 (CH, Ar), 126.2 (CH, Ar), 126.3 (CH, 
Ar), 126.5 (CH, Ar), 126.7 (CH, Ar), 126.8 (CH, Ar), 126.9 (CH, 3 × Ar), 127.2 (CH, 2 × 
Ar), 127.3 (CH, Ar), 127.5 (CH, 2 × Ar), 127.6 (CH, 2 × Ar), 127.8 (CH, Ar), 128.0 (CH, 
Ar), 128.1 (CH, Ar), 128.5 (CH, Ar), 128.6 (CH, Ar), 128.7 (CH, 2 × Ar), 129.8 (quat. C, ipso 
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Ar), 130.1 (quat.C, ipso Ar), 130.4 (quat. C, br s, 4 × ipso Ar), 130.6 (quat. C, ipso Ar), 130.8 
(quat. C, ipso Ar), 131.0 (quat. C, 2 × ipso Ar), 131.2 (quat. C, ipso Ar), 131.5 (quat. C, ipso 
Ar), 131.8 (quat. C, ipso Ar), 131.9 (quat. C, ipso Ar), 132.8 (quat. C, ipso Ar), 132.9 (quat. 
C, ipso Ar), 134.75 (CH, Ar), 134.82 (CH, Ar), 144.8 (quat. C, d JC-P 8.6, ipso Ar), 146.6 
(quat. C, d, JC-P 15.7, ipso Ar); δP(121 MHz) 54.03 (s, P(S)NH); δF(282 MHz) –76.13 (s, 
CF3); m/z (TOF ES–) 1004.3 ([M – H]
–, 100%); HRMS: C49H26NO4F3PS2
79Br81Br calcd 
1003.9339 ([M – H]–), obsd 1003.9344. 
 
 






O Chemical Formula: C34H25O4P
Exact Mass: 528.1490
Molecular Weight: 528.5337
Elemental Analysis: C, 77.26; H, 4.77; O, 12.11; P, 5.86
 
 
Phosphoric acid (S)-32g was prepared using a previously reported general procedure for the 
formation of different BINOL-derived phosphoric acids:[90]  
POCl3 (80 µL, 0.857 mmol) was added to a solution of diol (S)-125 (200 mg, 0.439 mmol) in 
pyridine (1 mL) at R.T. After stirring for 3 h at R.T., the reaction was quenched with H2O (1 
mL) and the resulting suspension was stirred overnight. CH2Cl2 (15 mL) was added and the 
pyridine was removed by reverse extraction with hydrochloric acid (1 M, 2 × 15 mL). The 
organic layer was dried (Na2SO4), the drying agent was removed by filtration and the filtrate 
concentrated under reduced pressure to provide the crude product. Purification by flash 
column chromatography (90% CH2Cl2, 10% EtOH) afforded the phosphoric acid as a white 
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solid. The product was extracted with hydrochloric acid (4 M, 20 mL) again, dried (Na2SO4), 
filtered, and concentrated under reduced pressure to afford the desired phosphoric acid (S)-
32g (201 mg, 87%): mp 230-265 °C (dec.); Rf = 0.38 (90% CH2Cl2, 10% EtOH); [α]D
21
 = 
+167.5 (c 0.53, CHCl3); νmax(film)/cm-1 2922m, 1615w, 1516s (C=C aromatic), 1497m, 
1447w, 1419s, 1362w, 1332m, 1265s, 1244s, 1191s, 1151s, 1024s, 998w, 970s, 900m, 888w, 
879w, 845m, 820s, 611m, 603w; δH(300 MHz) 2.18 (6H, s, ArCH3), 7.08 (4H, d, J 7.7, ArH), 
7.24-7.39 (4H, stack, ArH), 7.44-7.54 (6H, stack, ArH), 7.94 (2H, d, J 8.5, ArH), 7.99 (2H, s, 
ArH), 9.47 (1H, br s, P(O)OH); δC(75 MHz) 20.7 (CH3, ArCH3), 123.2 (quat. C, ipso Ar), 
124.9 (CH, Ar), 125.8 (CH, Ar), 126.9 (CH, Ar), 128.1 (CH, Ar), 128.8 (CH, Ar), 129.7 (CH, 
Ar), 130.2 (CH, Ar), 130.9 (quat. C, ipso Ar), 132.2 (quat. C, ipso Ar), 134.6 (quat. C, ipso 
Ar), 134.9 (quat. C, ipso Ar), 136.6 (quat. C, ipso Ar), 146.8 (quat. C, d, 2JP-C 9.5, ipso Ar); 
δP(121 MHz) 4.00 (s, P(O)OH); m/z (TOF ES–) 527.1 ([M – H] –, 100%); HRMS: C34H24O4P 




















Phosphoric acid (S)-32h was prepared using a previously reported general procedure for the 
formation of different BINOL-derived phosphoric acids:[90]  
POCl3 (50 µL, 0.502 mmol) was added to a solution of diol (R)-134 (200 mg, 0.251 mmol) in 
pyridine (0.6 mL) at R.T. After stirring for 3 h at R.T., the reaction was quenched with H2O (1 
mL) and the resulting suspension was stirred overnight. CH2Cl2 (25 mL) was added and the 
pyridine was removed by reverse extraction with hydrochloric acid (1 M, 2 × 15 mL). The 
organic layer was dried (MgSO4), the drying agent was removed by filtration and the filtrate 
concentrated under reduced pressure to provide the crude product. Purification by flash 
column chromatography (gradient: 100% CH2 l2 → 95% CH2Cl2, 5% EtOH) afforded the 
phosphoric acid as a pale yellow crystalline solid. The product was extracted with 
hydrochloric acid (4 M, 20 mL) again, dried (MgSO4), filtered, and concentrated under 
reduced pressure to afford the desired phosphoric acid (S)-32h as a brown crystalline solid 
(200 mg, 93%): mp 252-257 °C (dec.); Rf = 0.19 (95% CH2Cl2, 5% EtOH); [α]D
20
 = +70.5 (c 
0.76, CHCl3); νmax(film)/cm-1 3045w, 2924w, 1622w (C=C aromatic), 1599w, 1523w, 1497w, 
1440m, 1419s, 1398w, 1346m, 1311m, 1259m, 1229m, 1183w, 1147m, 1102m, 1087m, 
1017s, 972s, 948m, 937m, 903s, 884s, 840m, 783w, 775w, 749s, 714m, 682m, 669w; δH(300 
MHz) 6.95 (1H, br s, OH), 7.10-7.19 (4H, stack, ArH), 7.20-7.29 (2H, stack, ArH), 7.39-7.75 
(12H, stack, ArH), 7.95 (2H, s, ArH), 7.99 (2H, d, J 7.9, ArH), 8.11-8.20 (2H, stack, ArH), 
8.43 (2H, d, J 8.9, ArH); δC(100 MHz) 122.2 (quat. C, ipso Ar), 123.8 (quat. C, ipso Ar), 
125.2 (CH, Ar), 126.0 (CH, Ar), 126.3 (CH, Ar), 126.4 (CH, Ar), 126.5 (CH, Ar), 126.6 (CH, 
Ar), 127.2 (CH, 2 × Ar), 127.4 (CH, Ar), 127.8 (CH, Ar), 127.9 (CH, Ar), 128.5 (CH, Ar), 
129.8 (quat. C, ipso Ar), 130.1 (quat. C, ipso Ar), 130.4 (quat. C, ipso Ar), 131.0 (quat. C, 
ipso Ar), 131.2 (quat. C, ipso Ar), 131.3 (quat. C, ipso Ar), 131.4 (quat. C, ipso Ar), 132.7 
(quat. C, ipso Ar), 134.0 (CH, Ar), 146.1 (quat. C, d, JC-P 8.9, ipso Ar); δP(121 MHz) 0.57 (s, 
P(O)OH); m/z (TOF ES–) 857.0 ([M – H]–, 100%); HRMS: C48H26O4P
79Br81Br calcd 













Elemental Analysis: C, 68.93; H, 4.71; Br, 16.98; O, 3.40; Si, 5.97
 
 
TMS-protected diol (R)-140 was prepared using a general procedure for the TMS-protection 
of alcohols:[143] 
I2 (13 mg, 0.051 mmol) was added to a suspension of diol (R)-134 (410 mg, 0.515 mmol) in 
CH2Cl2 (5.7 mL). HMDS (170 µL, 0.826 mmol) in CH2Cl2 (2.4 mL) was added dropwise 
over 2 min to the dark purple suspension, which turned to a solution during the addition. After 
stirring for 10 min, the reaction was quenched by the addition of Na2S2O3 solution (10 mL), 
and the mixture was stirred until the solution turned yellow-orange. More CH2Cl2 (10 mL) 
was added and the layers were separated. The organic phase was washed with brine (15 mL), 
and then dried (MgSO4). The drying agent was removed by filtration and the filtrate 
concentrated under reduced pressure to provide the crude product. Purification by a silica plug 
(100% Et2O) afforded the TMS-protected diol (R)-140 as a yellow-orange solid (465 mg, 
96%): mp 345-350 °C; Rf = 0.58 (60% hexane, 40% toluene); [α]D
20
 = +147.3 (c 0.88, 
CHCl3); νmax(film)/cm-1 3059w, 2961m, 2163w, 1947w, 1799w, 1703w, 1620w, 1589w, 
1522w, 1489w, 1424m, 1403m, 1345m, 1325m, 1280m, 1260m, 1246s, 1203m, 1173w, 
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1150m, 1104m, 1041w, 1026m, 974s, 936m, 894s, 860s, 837s, 778m, 745s, 695m, 658m; 
δH(300 MHz, C6D6) –1.01 (18H, s, SiCH3), 7.07-7.14 (2H, m, ArH), 7.19-7.40 (10H, stack, 
ArH), 7.62-7.80 (6H, stack, ArH), 8.20 (2H, d, J 8.7, ArH), 8.26 (2H, d, J 8.7, ArH), 8.82 
(4H, app. t, J 8.0, ArH); δC(75 MHz, C6D6) –0.14 (CH3, SiCH3), 123.8 (quat. C, ipso Ar), 
124.8 (CH, Ar), 125.9 (CH, Ar), 126.1 (CH, Ar), 126.3 (CH, Ar), 127.0 (CH, Ar), 127.3 (CH, 
Ar), 127.5 (CH, Ar), 128.1 (CH, Ar), 128.6 (CH, Ar), 128.7 (CH, Ar), 129.3 (CH, Ar), 130.2 
(quat. C, ipso Ar), 131.1 (quat. C, ipso Ar), 131.2 (quat. C, ipso Ar), 131.4 (quat. C, ipso Ar), 
132.1 (quat. C, ipso Ar), 132.2 (quat. C, ipso Ar), 133.2 (CH, Ar), 135.0 (quat. C, ipso Ar), 
135.3 (quat.C, ipso Ar), 151.4 (quat. C, ipso Ar), one (CH, Ar) and one (quat. C, ipso Ar) 
were not observed; m/z (TOF ES+) 963.1 ([M + Na]+, 100%); HRMS: 
C54H44O2Si2
79Br81BrNa calcd 963.1124 ([M + Na]+), obsd 963.1120. 
 
 


















C, 85.44; H, 4.18; F, 5.63; O, 4.74
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tBuLi (940 µL of a 1.7 M solution in pentane, 1.59 mmol) was added dropwise over 2 min to 
a solution of TMEDA (95 µL, 0.638 mmol) and TMS-protected diol (R)-140 (300 mg, 0.319 
mmol) in THF (7.2 mL) at –78 °C. After stirring for 2 h at –78 °C, a solution of N-
fluorodibenzenesulfonimide (402 mg, 1.28 mmol) in THF (2.4 mL) was added dropwise over 
5 min over which time the solution changed its colour from black-green to orange. The 
syringe was washed with THF (2.4 mL) and the mixture was warmed to R.T. overnight. H2O 
(10 mL), Et2O (10 mL) and hydrochloric acid (1 M, 5 mL, for a better phase separation) were 
added and the layers were separated. The aqueous phase was extracted with Et2O (10 mL) and 
the combined organic fractions were washed with brine (15 mL), and then dried (MgSO4). 
The drying agent was removed by filtration and the filtrate concentrated under reduced 
pressure to provide the crude product. Purification by flash column chromatography13 
(gradient: 100% hexane → 95% hexane, 5% toluene) afforded the TMS-protected diol (R)-
141 as a yellow solid (200 mg, 0.244 mmol, 77%) which was dissolved in THF (1.25 mL) and 
cooled to 0 °C. TBAF (535 µL of a 1 M solution in THF, 0.537 mmol) was added dropwise 
over 2 min and the mixture was stirred at R.T. for 30 min. H2O (10 mL) and Et2O (10 mL) 
were added and the layers were separated. The aqueous phase was extracted with Et2O (10 
mL) and the combined organic fractions were washed with brine (15 mL), and then dried 
(MgSO4). The drying agent was removed by filtration and the filtrate concentrated under 
reduced pressure to provide the crude product. Purification by flash column chromatography 
(60% hexane, 20% toluene, 20% CH2Cl2) afforded diol (R)-139 as a yellow solid (90 mg, 
55%): mp 228-231 °C; Rf = 0.16 (60% hexane, 20% toluene, 20% CH2 l2); [α]D
20
 = +121.0 (c 
1.0, CHCl3); νmax(neat)/cm-1 3530m (OH), 1620m (C=C aromatic), 1498m, 1436m, 1364w, 
1345m, 1327m, 1255m, 1223s (ArC–F), 1148m, 1093m, 1025m, 936m, 918s, 836s, 784m, 
734s; δH(300 MHz) 5.08 (2H, s, OH), 7.26-7.34 (2H, m, ArH), 7.42-7.72 (14H, stack, ArH), 
                                                
13 the crude product was loaded onto the column with a few drops of CH2Cl2; in total, three long columns were   
carried out with the mixed fractions to be able to fully separate the product from the F-H- and H-H-diols 
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7.82-8.05 (6H, stack, ArH), 8.35 (2H, d, J 8.6, ArH), 8.40 (2H, d, J 8.6, ArH); δC(75 MHz) 
113.5 (quat. C, ipso Ar), 118.9 (quat. C, d, 3J 4.8, ipso Ar), 119.0 (quat. C, d, 3J 4.8, ipso Ar), 
120.7 (CH, d, 3J 4.4, Ar), 120.8 (CH, d, 3J 4.4, Ar), 124.4 (CH, Ar), 124.7 (CH, Ar), 125.5 
(CH, 2 × Ar), 125.9 (CH, 2 × Ar), 126.1 (quat. C, d, 2J 6.5, ipso Ar), 126.6 (quat. C, d, 2J 6.5, 
ipso Ar), 126.7 (CH, 2 × Ar), 127.5 (CH, Ar), 128.5 (CH, Ar), 129.3 (quat. C, ipso Ar), 
131.17 (quat. C, ipso Ar), 131.20 (quat. C, ipso Ar), 133.4 (CH, Ar), 133.9 (quat. C, ipso Ar), 
151.1 (quat.C, ipso Ar), 154.6 (quat. C, 1J 257.3, ipso Ar); δF(282 MHz) –129.2 (s, ArF); m/z 


















Elemental Analysis: C, 78.26; H, 3.69; F, 5.16; O, 8.69; P, 4.20
 
 
Phosphoric acid (R)-32i was prepared using a previously reported general procedure for the 
formation of different BINOL-derived phosphoric acids:[90]  
POCl3 (20 µL, 0.238 mmol) was added to a solution of diol (R)-139 (80 mg, 0.119 mmol) in 
pyridine (0.3 mL) at R.T. After stirring for 3 h at R.T., the reaction was quenched with H2O (1 
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mL) and the resulting suspension was stirred overnight. CH2Cl2 (15 mL) was added and the 
pyridine was removed by reverse extraction with hydrochloric acid (1 M, 2 × 10 mL). The 
organic layer was dried (MgSO4), the drying agent was removed by filtration and the filtrate 
concentrated under reduced pressure to provide the crude product. Purification by flash 
column chromatography (gradient: 100% CH2 l2 → 95% CH2Cl2, 5% EtOH) afforded the 
phosphoric acid as a brown solid. The product was extracted with hydrochloric acid (4 M, 10 
mL) again, dried (MgSO4), filtered, and concentrated under reduced pressure to afford the 
desired phosphoric acid (R)-32i as a brown solid (80 mg, 91%): mp 248-253 °C (dec.); Rf =
0.23 (95% CH2Cl2, 5% EtOH); [α]D
21
 = +11.9 (c 0.47, CHCl3); νmax(film)/cm-1 3058w, 
2924w, 2852w, 1625w, 1562w, 1487w, 1441w, 1414w, 1379s, 1325m, 1277w, 1229m, 
1184m, 1148m, 1096m, 1069m, 1021s, 971m, 947m, 888m, 849m, 822m, 786w, 763s, 749s, 
701s, 675m; δH(300 MHz) 5.49 (1H, br s, OH), 7.06-7.76 (19H, stack, ArH), 7.92-8.06 (5H, 
stack, ArH), 8.18 (2H, d, J 8.5, ArH); δC(100 MHz) 118.4 (d, 2JC-F 19.9, ipso Ar), 118.6 (d, 
2JC-F 19.9, ipso Ar), 119.7 (d, JC-F 3.0), 120.5 (d, JC-F 4.0), 122.4, 125.0, 125.4, 125.8, 126.1, 
126.3, 127.0, 127.3, 128.5, 130.3, 130.7, 131.1, 131.4, 132.7, 134.1, 146.5 (d, JC-P 9.2, ipso 
Ar), 154.2 (d, 1JC-F 256.3, ipso Ar), resonance overlap; δP(121 MHz) 0.82 (s, P(O)OH); 
δF(282 MHz) –130.1 (s, ArF); m/z (TOF ES–) 735.1 ([M – H]–, 100%); HRMS: C48H26O4PF2 
calcd 735.1537 ([M – H]–), obsd 735.1542. 
 
 












                  (R)-221                           (S)-221 
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(R)- and (S)-2-Hydroxy-2’-methoxy-1,1’-binaphthyl (R)- and (S)-221 were prepared using a 
variation of a previously reported procedure:[166] 
DEAD (785 µL, 5.00 mmol) was added dropwise over 2 min to a solution of (S)-BINOL (S)-
109 (1.43 g, 5.00 mmol), Ph3P (1.31 g, 5.00 mmol) and anhydrous MeOH (1.0 mL, 24.7 
mmol) in THF (50 mL) at R.T. After stirring for 24 h, the mixture was concentrated under 
reduced pressure. The resulting pale pink solid was dissolved in CH2Cl2 (30 mL) and hexane 
was added under vigorous stirring leading to precipitation of the by-product N,N-
bis(ethoxycarbonyl)hydrazine. Removal of the white fluffy solid by filtration and 
concentration of the filtrate under reduced pressure provided the crude product as a pale pink 
foam. Purification by flash column chromatography (100% toluene) afforded (S)-monomethyl 
ether (S)-221 as a white foamy solid (1.25 g, 83%): mp 69-71 °C (lit.[166] mp 89-91 °C); Rf = 
0.15 (100% toluene); [α]D
21
 = +53.6 (c 0.41, CHCl3) (lit.
[166] [α]D
28
 = +44.8 (c 1.4, CHCl3), 
99.3% ee);14 (Found: C, 84.06; H, 5.39. C21H16O2 requires C, 83.98; H, 5.37%); 
νmax(film)/cm-1 3498m br (OH), 3422m br (OH), 3958m, 2937w, 2839m (OCH3), 1954w, 
1620s (C=C aromatic), 1592s (C=C aromatic), 1507s (C=C aromatic), 1462m, 1431w, 
1380m, 1362w, 1346w, 1332m, 1300w, 1264s, 1248s, 1173m, 1147s, 1129m, 1083s, 1055m, 
1020m, 972w, 940w, 905w, 863w, 813s, 708w, 573w; δH(300 MHz) 3.80 (3H, s, OCH3), 4.94 
(1H, br s, OH), 7.06 (1H, d, J 8.1, ArH), 7.15-7.41 (6H, stack, ArH), 7.48 (1H, d, J 9.2, ArH), 
7.84-7.94 (3H, stack, ArH), 8.05 (1H, d, J 9.2, ArH); δC(75 MHz) 56.6 (CH3, OCH3), 113.8 
(CH, Ar), 115.0 (quat. C, ipso Ar), 115.3 (quat. C, ipso Ar), 117.4 (CH, Ar), 123.2 (CH, Ar), 
124.1 (CH, Ar), 124.8 (CH, Ar), 124.9 (CH, Ar), 126.4 (CH, Ar), 127.3 (CH, Ar), 128.09 
(CH, Ar), 128.10 (CH, Ar), 129.1 (quat. C, ipso Ar), 129.4 (quat. C, ipso Ar), 129.7 (CH, Ar), 
131.0 (CH, Ar), 133.7 (quat. C, ipso Ar), 134.0 (quat. C, ipso Ar), 151.2 (quat. C, ipso Ar), 
155.9 (quat. C, ipso Ar); m/z (EI) 300 ([M]+, 100%), 285 (10, [M – CH3]
+), 268 (19), 239 
(18), 228 (10), 119 (12), 84 (20), 49 (25). 
                                                
14 the ee-value could not be determined by chiral HPLC owing to poor resolution of the racemic mixture 
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The same protocol was followed for the preparation of the (R)-enantiomer: [α]D
21




Data were in agreement with those reported in the literature.[166] 
 
 
















Elemental Analysis: C, 74.39; H, 5.46; N, 3.61; O, 8.26; S, 8.28  
 
(R)- and (S)-2-(N,N-Dimethylthiocarbamoyloxy)-2’-methoxy-1,1’-binaphthyl (R)- and (S)-
222 were prepared using a previously reported procedure for the formation of (R)- and (S)-2-
(N,N-dimethylthiocarbamoyloxy)-2’-hydroxy-1,1’-binaphthyl:[170]  
N,N-Dimethylcarbamoyl chloride (1.17 g, 9.47 mmol) was added to a solution of (S)-2-
hydroxy-2’-methoxy-1,1’-binaphthyl (S)-221 (2.47 g, 8.22 mmol), NEt3 (1.38 mL, 9.90 
mmol) and DMAP (251 mg, 2.05 mmol) in CH2Cl2 (80 mL) at R.T. After heating at reflux for 
60 h, more N,N-dimethylcarbamoyl chloride (1.60 g, 12.9 mmol), NEt3 (1.00 mL, 7.17 mmol) 
and DMAP (251 mg, 2.05 mmol) were added to the yellow mixture. After heating at reflux 
for another 24 h, CH2Cl2 (100mL) and hydrochloric acid (0.1M, 200 mL) were added to the 
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orange solution. The layers were separated and the aqueous layer was extracted with CH2Cl2 
(2 × 50 mL). The combined organic layers were washed with brine (100 mL) and dried 
(MgSO4). The drying agent was removed by filtration and the filtrate concentrated under 
reduced pressure to provide the crude product. Recrystallisation from EtOH afforded (S)-
thiocarbamate (S)-222 as colourless crystals (2.81 g, 88%): mp 161-164 °C; [α]D
21
 = –102.8 (c 
1.0, CHCl3, e.r. 0:100); Chiralpak AD column, 1.0 mL/min, 1% IPA in hexane, λ = 254 nm, tR 
= 36.5 min; (Found: C, 74.35; H, 5.67; N, 3.33. C24H21NO2S requires C, 74.39; H, 5.46; N, 
3.61%); νmax(film)/cm-1 3012m, 2838w (OCH3), 1719w, 1622m (C=C aromatic), 1592m 
(C=C aromatic), 1533s (C=C aromatic), 1509s (C=C aromatic), 1475m, 1462m, 1430w, 
1396s, 1359w, 1330w, 1289s, 1272s, 1261s, 1250s, 1194w, 1147s, 1128w, 1085m, 1056m, 
1020m, 986w, 906w, 863w, 811s; δH(300 MHz) 2.50 (3H, s, NCH3), 3.08 (3H, s, NCH3), 3.75 
(3H, s, OCH3), 7.19-7.34 (5H, stack, ArH), 7.37-7.48 (2H, stack, ArH), 7.58 (1H, d, J 8.8, 
ArH), 7.83 (1H, d, J 8.1, ArH), 7.91-8.01 (3H, stack, ArH); δC(75 MHz) 37.5 (CH3, NCH3), 
42.6 (CH3, NCH3), 56.6 (CH3, OCH3), 113.5 (CH, Ar), 117.7 (quat. C, ipso Ar), 123.4 (CH, 
Ar), 123.6 (CH, Ar), 125.37 (CH, Ar), 125.45 (quat. C, ipso Ar), 125.9 (CH, Ar), 126.17 (CH, 
Ar), 126.21 (CH, Ar), 126.3 (CH, Ar), 127.5 (CH, Ar), 128.1 (CH, Ar), 128.2 (CH, Ar), 128.7 
(quat. C, ipso Ar), 129.8 (CH, Ar), 131.7 (quat. C, ipso Ar), 133.6 (quat. C, ipso Ar), 133.8 
(quat. C, ipso Ar), 149.5 (quat. C, ipso Ar), 155.0 (quat. C, ipso Ar), 186.5 (quat. C, C=S); 
m/z (EI) 387 ([M]+, 100%), 284 (12, [M – (CH3 + C(S)N(CH3)2)]
+), 268 (37), 239 (25), 226 
(15); HRMS: C24H21NO2S calcd 387.1293 ([M]
+), obsd 387.1281. 
 
The same protocol was followed for the preparation of the (R)-enantiomer: [α]D
21
 = +100.8 (c 
1.0, CHCl3, e.r. 100:0); Chiralpak AD column, 1.0 mL/min, 1% IPA in hexane, λ = 254 nm, tR 
= 29.2 min. 
 
Data were in agreement with those reported in the literature.[215]  
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Elemental Analysis: C, 74.39; H, 5.46; N, 3.61; O, 8.26; S, 8.28  
 
(R)- and (S)-2-(N,N-Dimethylcarbamoylthio)-2’-methoxy-1,1’-binaphthyl (R)- and (S)-223 
were prepared using a previously reported procedure for the formation of (R)- and (S)-2-(N,N-
dimethylcarbamoyloxy)-2’-(N,N-dimethylcarbamoylthio)-1,1’-binaphthyl:[170]   
(S)-2-(N,N-Dimethylthiocarbamoyloxy)-2’-methoxy-1,1’-binaphthyl (S)-222 (2.70 g, 6.97 
mmol) was heated (3.5 h at 250 °C) under argon. After cooling to R.T., the dark-brown mass 
was dissolved in CH2Cl2 (50 mL) and activated charcoal (5 g) was added. The suspension was 
stirred for 6 h at R.T. Removal of the charcoal by filtration and concentration of the filtrate 
under reduced pressure provided the crude product as a yellow-brown foamy solid. 
Purification by flash column chromatography (100% CH2 l2) afforded (S)-carbamate (S)-223 
as a white foamy solid (2.23 g, 83%): mp 80-83 °C; Rf = 0.16 (100% CH2Cl2); [α]D
21
 = +19.2 
(c 1.0, CHCl3, e.r. 98.7:1.3); Chiralpak AD column, 1.0 mL/min, 10% IPA in hexane, λ = 254 
nm, tR = 13.2 min; νmax(film)/cm-1 3010m, 2935m, 2839w (OCH3), 1661s (C=O), 1623w 
(C=C aromatic), 1594m (C=C aromatic), 1510m (C=C aromatic), 1462m, 1406w, 1364m, 
1333w, 1270s, 1260s, 1251s, 1216s, 1179w, 1148m, 1096s, 1052m, 1020m, 952w, 908m, 
869w, 811s, 691w; δH(300 MHz) 2.77 (6H, br s, N(CH3)2), 3.73 (3H, s, OCH3), 7.05 (1H, d, J 
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8.5, ArH), 7.11-7.34 (4H, stack, ArH), 7.39-7.48 (2H, stack, ArH), 7.79-8.01 (5H, stack, 
ArH); δC(75 MHz) 36.7 (CH3, N(CH3)2), 56.6 (CH3, OCH3), 113.6 (CH, Ar), 121.7 (quat. C, 
ipso Ar), 123.6 (CH, Ar), 125.5 (CH, Ar), 126.1 (CH, Ar), 126.4 (CH, Ar), 126.5 (CH, Ar), 
126.6 (CH, Ar), 127.6 (CH, Ar), 127.9 (CH, Ar), 128.0 (CH, Ar), 128.3 (quat. C, ipso Ar), 
128.8 (quat. C, ipso Ar), 129.7 (CH, Ar), 133.18 (CH, Ar), 133.20 (quat. C, ipso Ar), 133.4 
(quat. C, ipso Ar), 133.7 (quat. C, ipso Ar), 138.7 (quat. C, ipso Ar), 154.8 (quat. C, ipso Ar), 
166.5 (quat. C, C=O); m/z (TOF ES+) 410.0 ([M + Na]+, 100%); HRMS: C24H21NO2SNa 
calcd 410.1191 ([M + Na]+), obsd 410.1188. 
 
The same protocol was followed for the preparation of the (R)-enantiomer: [α]D
20
 = –18.1 (c 
1.0, CHCl3, e.r. 2.7:97.3); Chiralpak AD column, 1.0 mL/min, 10% IPA in hexane, λ = 254 
nm, tR = 28.5 min. 
 
Data were in agreement with those reported in the literature.[215] 
 
 








Elemental Analysis: C, 79.71; H, 5.10; O, 5.06; S, 10.13
 









Elemental Analysis: C, 79.97; H, 4.79; O, 5.07; S, 10.17
 
                       (R)-225  
 
(R)-2-Mercapto-2’-methoxy-1,1’-binaphthyl (R)-224 and (R,R)-bis(2’-methoxy-1,1’-
binaphthyl-2-yl)disulfide (R,R)-225 as a by-product were prepared using a variation of a 
previously reported procedure for the formation of 2-hydroxy-2’-mercapto-1,1’-
binaphthyl:[170]   
(R)-2-(N,N-Dimethylcarbamoylthio)-2’-methoxy-1,1’-binaphthyl (R)-223 (814 mg, 2.10 
mmol) was added to a solution of KOH (1.41 g, 25.2 mmol) in a mixture of degassed 
MeOH/H2O (4:1, 40 mL) and the resulting suspension was heated at reflux for 5 h. After 
cooling to R.T., the mixture was evaporated to dryness under reduced pressure providing a 
pale yellow solid which was dissolved in deoxygenated H2O (45 mL). After acidification with 
concentrated hydrochloric acid (3.5 mL), the product was extracted with CH2Cl2 (2 × 20 mL) 
and the combined organic layers were dried (Na2SO4). The drying agent was removed by 
filtration and the filtrate concentrated under reduced pressure to provide the crude product. 
Purification by flash column chromatography (40% hexane, 60% toluene) afforded, in order 
of elution, thiol (R)-224 as a white foamy solid (485 mg, 73%): mp 105-107 °C; Rf = 0.38 
(40% hexane, 60% toluene); [α]D
23
 = +6.3 (c 0.51, CHCl3); (Found: C, 79.87; H, 4.91. 
C21H16OS requires C, 79.71; H, 5.10%); νmax(film)/cm-1 3054m, 3006m, 2934m, 2838m 
(OCH3), 2566w (SH), 1954w, 1814w, 1755w, 1621m (C=C aromatic), 1592s (C=C aromatic), 
1562w, 1504s (C=C aromatic), 1472m, 1461m, 1431m, 1402w, 1352m, 1332m, 1271s, 
1261s, 1250s, 1179m, 1148m, 1136w, 1126m, 1082s, 1052m, 1020m, 952w, 907m, 860m, 
845w, 809s, 710w, 631w, 617w; δH(300 MHz) 3.26 (1H, s, SH), 3.81 (3H, s, OCH3), 7.04 
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(1H, d, J 8.1, ArH), 7.07 (1H, d, J 8.5, ArH), 7.19-7.30 (2H, stack, ArH), 7.32-7.41 (2H, 
stack, ArH), 7.48 (1H, d, J 8.8, ArH), 7.55 (1H, d, J 8.8, ArH), 7.80-7.92 (3H, stack, ArH), 
8.04 (1H, d, J 9.2, ArH); δC(75 MHz) 56.7 (CH3, OCH3), 113.9 (CH, Ar), 120.7 (quat. C, ipso 
Ar), 123.9 (CH, Ar), 124.6 (CH, Ar), 124.9 (CH, Ar), 125.3 (CH, Ar), 126.6 (CH, Ar), 127.01 
(CH, Ar), 127.04 (CH, Ar), 128.0 (CH, Ar), 128.1 (CH, Ar), 128.2 (CH, Ar), 129.3 (quat. C, 
ipso Ar), 130.3 (CH, Ar), 130.8 (quat. C, ipso Ar), 130.9 (quat. C, ipso Ar), 131.6 (quat. C, 
ipso Ar), 133.0 (quat. C, ipso Ar), 133.6 (quat. C, ipso Ar), 154.7 (quat. C, ipso Ar); m/z 
(TOF ES+) 339 ([M + Na]+, 100%); HRMS: C21H16OSNa calcd 339.0820 ([M + Na]
+), obsd 
339.0811; and then disulfide (R,R)-225 as a pale yellow solid (73 mg, 11%): mp 269-273 °C; 
Rf = 0.23 (40% hexane, 60% toluene); [α]D
23
 = –103.4 (c 1.0, CHCl3); (Found: C, 79.93; H, 
4.92. C42H30O2S2 requires C, 79.97; H, 4.79%); νmax(film)/cm-1 3056m, 3010m, 2935w, 
2838w (OCH3), 1951w, 1757w, 1622m (C=C aromatic), 1592s (C=C aromatic), 1562w, 
1504s (C=C aromatic), 1461m, 1431m, 1402w, 1351m, 1331m, 1269s, 1247s, 1178w, 
1149m, 1134w, 1121m, 1079s, 1050m, 1020m, 956w, 904m, 859m, 809s, 686w, 627w; 
δH(300 MHz) 3.80 (6H, s, OCH3), 6.98 (2H, d, J 8.5, ArH), 7.10 (2H, d, J 8.5, ArH), 7.18-
7.26 (4H, stack, ArH), 7.32-7.41 (4H, stack, ArH), 7.46 (2H, d, J 9.2, ArH), 7.85-7.75 (4H, 
stack, ArH), 7.81 (2H, d, J 8.1, ArH), 7.90 (2H, d, J 8.1, ArH), 8.04 (2H, d, J 9.2, ArH); δC(75 
MHz) 56.7 (CH3, OCH3), 113.9 (CH, Ar), 120.7 (quat. C, ipso Ar), 123.9 (CH, Ar), 124.6 
(CH, Ar), 124.9 (CH, Ar), 125.3 (CH, Ar), 126.6 (CH, Ar), 127.01 (CH, Ar), 127.04 (CH, 
Ar), 128.0 (CH, Ar), 128.1 (CH, Ar), 128.2 (CH, Ar), 129.3 (quat. C, ipso Ar), 130.3 (CH, 
Ar), 130.8 (quat. C, ipso Ar), 130.9 (quat. C, ipso Ar), 131.6 (quat. C, ipso Ar), 133.0 (quat. 
C, ipso Ar), 133.6 (quat. C, ipso Ar), 154.7 (quat. C, ipso Ar); m/z (TOF ES+) 653 ([M + 
Na]+, 100%); HRMS: C42H30O2S2Na calcd 653.1585 ([M + Na]












Elemental Analysis: C, 69.21; H, 4.43; O, 17.56; S, 8.80
 
 
(R)-2-Methoxy-2’-sulfonic-acid-1,1’-binaphthyl (R)-226 was prepared using a previously 
reported procedure for a common formation of sulfonic acids:[164,175]  
A suspension of (R)-2-mercapto-2’-methoxy-1,1’-binaphthyl (R)-224 (100 mg, 0.316 mmol) 
in acetic acid (1 mL) was stirred at 60 °C for 15 min before it was treated with H2O2 (35% in 
water, 140 µL, 1.58 mmol) dropwise over 5 min. Over 20 min the white suspension darkened 
and the resulting clear dark brown solution was stirred for 3 h at 60 °C. After cooling to R.T., 
the acetic acid was removed azeotropically with toluene. An attempt to purify the product by 
recrystallisation from toluene afforded impure sulfonic acid (R)-226 as a pale brown solid (14 
mg, 12%): δH(300 MHz) 3.76 (3H, s, OCH3), 6.82 (1H, d, J 8.1, ArH), 6.95 (1H, br s, SO3H), 
7.09-7.41 (4H, stack, ArH), 7.53-7.68 (2H, stack, ArH), 7.91 (1H, d, J 8.1, ArH), 8.03-8.28 
(4H, stack, ArH); m/z (TOF ES–) 363 ([M – H]–, 100%); HRMS: C21H15O4S calcd 363.0691 
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